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This textbook is designed as an adjunct to the lecture program presented in the Orientation 
Course for the RACDS Primary Examinations, and for undergraduate and postgraduate 
students to support their studies in microbiology and infection control. Both microbiology 
and the closely related discipline of immunology have a strong clinical focus, and key 
concepts of the host response to infection can be appreciated using examples drawn from 
clinical dental practice. In this context, it should be remembered that the two most common 
bacterial diseases in humans are dental caries and adult periodontitis, and that microbial 
diseases remain a major cause of morbidity and mortality across the globe. 
 
This text provides the fundamentals of microbiology for dentistry, and should not be 
regarded as a a primer on the major points in each topic. Companion texts in both dental 
microbiology and general immunology (at a basic level for the health sciences) and material 
from the literature would be useful for advanced study. Several such titles are listed in 
Section 18. There is limited information provided in this textbook on aspects of applied 
therapeutics, and the reader will need to consult other sources for detailed information on 
anti-microbial agents (e.g. mode of action, spectrum of activity, indications and contra-
indications, interactions with other agents). No specific prescribing information has been 
given in this text; readers should consult specific prescribing guides for dentistry, such as 
“Therapeutic Guidelines: Oral and Dental” published in 2007.  
 
In this sixth edition, the text has been revised to incorporate and new developments 
regarding biofilms, cariology, endodontic microbiology, chairaide diagnostic tests, and 
recent changes in infection control standards and sterilization quality assurance products. 
 
 
Laurence J Walsh 
March 18, 2009 
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1. THE MICROBIAL WORLD 
 
1.1 Agents of infection 
 
The oral cavity contains one of the most concentrated accumulations of microorganisms in 
the human body, with more than 700 different species having been detected so far by 
molecular methods - however, only some 50% of the oral species are cultivable or have yet 
been cultivated. Thus our understanding of oral microbiology will need to be continually 
redefined over time as more species in the “other half” of the microflora are identified. 
 
Agents of infection 
____________________________________ 
· prions (proteinase resistant proteins)  
· viruses (0.1 mm) 
· bacteria (10 mm) 
· fungi (100 mm) 
· protozoa (100 mm) 
· metazoa (1 cm to 1 m). 
____________________________________ 
 




DISEASE                    CAUSATIVE AGENT  
_________________________________________________  
The Common Cold  Rhinovirus, Adenovirus 
Influenza   Influenza virus  
Respiratory infections  Parainfluenza virus  
                            Respiratory syncytial virus  
                            Coronavirus (SARS)  
    Cytomegalovirus 
    Pseudomonas aeruginosa 
Legionnaire’s disease  Legionella pneumophila 
Tonsillitis   Streptococcus pyogenes  
Tuberculosis   Mycobacterium tuberculosis  
Chickenpox   Varicella Zoster virus  
Herpangina   Coxsackie virus  
Rubella (German measles) Togavirus  
Mumps    Paramyxovirus  
Salivary gland infection  Cytomegalovirus  
Herpetic Infections  Human Herpesvirus 1 and 2  
Gonococcal Infections  Neisseria gonorrhoea  
Condyloma Acuminatum  Human papilloma virus  
Syphilis    Treponema pallidum  
Infectious mononucleosis  Epstein Barr virus  
Hepatitis B   Hepatitis B virus  
AIDS    Human immunodeficiency virus (HIV)  
Candidoses    Candida albicans  
___________________________________________ 
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Portals of entry for agents of infection 
___________________________________________ 
· Skin and mucosa 
· Staphylococcus aureus (wound infections) 
· Pseudomonas aeruginosa (wound infections) 
· Clostridium tetani (tetanus) 
· Respiratory tract 
· Mycobacterium tuberculosis (tuberculosis) 
· Legionella pneumophila (Legionnaire’s disease) 
· Rhinovirus (Common cold) 
· Gastro-intestinal tract 
· Poliovirus (Polio) 
· Hepatitis A and E 
· Genito-urinary tract 
· Neisseria gonorrhoea (gonorrhoea) 
· Treponema pallidum (syphilis) 
· Blood 
· Hepatitis B, C, D 
· HIV (AIDS) 
· HHV 8 (Kaposi’s sarcoma) 
· Plasmodium falciparum (malaria) 
______________________________________________ 
 
1.2 Bacteria and their properties 
 
Bacteria are single organisms with a relatively simple overall structure. They are 
PROKARYOTES – they  
· lack a nucleus,  
· have only chromosome, and  
· replicate by binary fission. 
 
Fungi and protozoa, like higher life forms, are EUKARYOTES – they 
· have a nucleus, which contains many chromosomes,  
· replicate by mitosis 
· have membrane-bound organelles (e.g. mitochondria).   
 
1.2 Properties of bacteria 
 
Bacteria can have a number of morphological forms, including: 
· Coccus 
· Single (e.g. Staphylococcus aureus) 
· Paired (e.g. Neisseria gonorrhoea ) 
· Chains (e.g. Streptococcus sanguis) 
· Rod 
· Straight (e.g. Bacillus stearothermophilus) 
· Curved (e.g. Vibrio cholerae) 
· Spiral (e.g. Treponema pallidum) 
· Filament (e.g. Actinomyces viscosus). 
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Bacteria inhabit a diverse range of ecological niches (“habitats”), and usually exist in a 
synergistic relationship with other species in a mixed microbial environment, which 
provides metabolic advantages to each species.  
 
The requirements for bacterial growth include: 
 
· Water – which is a source of hydrogen and oxygen 
· Carbon -  from either carbon dioxide or carbohydrates  
· Organic nutrients - Carbohydrates, proteins, amino acids 
· Inorganic nutrients - e.g. Mg, N, S, K, PO4, trace elements  
· Environmental factors – Temperature, pH, Redox potential (Eh). 
 
Chemical factors in the environment can influence growth both favourably (e.g. nutrients 
and trace elements) and negatively (toxic and acidic metabolites). A nutrient for one 
species may be toxic for another, and by-products of bacterial growth can alter dramatically 
the environment (e.g. acids produced by mutans streptococci suppress growth of bacterial 
species which are not aciduric). Bacteria can also produce bacteriocins which suppress the 
growth of other species, e.g. Streptococcus sanguis can suppress the periodontopathic 
organism A. actinomycetemcomitans. 
 
Oxygen needs are a major determinant of bacterial growth.  
 
· Obligate anaerobes: can only grow in the total absence of oxygen. These bacteria 
typically lack catalase or superoxide dismutase, or both enzymes (e.g. Porphyromonas 
gingivalis).   
 
· Facultative anaerobes: can grow in the presence or absence of oxygen. If oxygen is 
present, this can be used for energy production, but if there is no oxygen present, ATP 
can be generated by fermentation (e.g. mutans streptococci). Many facultative 
anaerobes prefer an atmosphere enriched in carbon dioxide. Major cariogens and 
periodontopathogens are in this grouping.  
 
· Microaerophiles: grow well in low oxygen levels (e.g. 5%) 
 
· Obligate aerobes: oxygen is an absolute requirement for growth, e.g. Mycobacteria. 
 
When bacteria replicate, the growth pattern follows several distinct phases:  
 
· Lag phase. There is no increase in bacterial numbers. During this phase, the bacteria are 
adapting to their environment. 
· Log phase. Numbers of bacteria increase exponentially (base 2) as the bacteria replicate 
by binary fission. Most bacteria can replicate within 30-120 minutes.  
·  Stationary phase. The number of bacteria becomes constant as cell death balances cell 
proliferation. Depletion of nutrients, build-up of toxic metabolites and waster products, 
and a reduction in pH all serve to suppress growth.  
It is in stationary phase that the maximum total number of viable bacteria is reached. 
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Biofilms form in wet environments, both natural (such as the mouth) and artificial (such as 
dental unit water lines, water filtration systems, irrigators). The biofilm itself adheres to 
surfaces which are submerged in, or subjected to, an aquatic environment. 
 
Biofilms are a cooperative ecosystem of bacteria (as well as fungi and protozoa), where 
there are numerous nutritional advantages to the organisms. Biofilms do not contain 
viruses, as these cannot replicate outside the host. Nutrients are bound by the biofilm 
matrix, and the matrix also provides protection from antimicrobial agents (physical agents, 
chemical agents such as germicides and antibiotics, and the host immune response). This 
poses a major problem for the use of antibiotics and biocides (germicides), since bacteria in 
planktonic form (free floating) may be susceptible to the agent but the same organism in a 
biofilm may need 1000 times greater concentration to achieve killing.  
 
Reasons for this increased resistance may include: 
· Physical protection by other microorganisms 
· Reduced penetration 
· Slower growth rate of bacteria 
· Altered gene expression. 
 
Biofilms are composed of micro-colonies of bacterial cells that are non-randomly 
distributed in a matrix - this matrix consists of polysaccharides, proteins, salts and cell 
material in an aqueous solution. In nature, microorganisms often do not exist as isolated 
single cells suspended in an aqueous environment (i.e the planktonic model) but rather 
grow as adherent biofilms. Planktonic bacteria that are either leaving or joining the biofilm 
surround it. 
 
Bacteria in biofilms can:  
· communicate with one another (via quorum sensing) which can influence the 
structure and behaviour of the biofilm.  
· transfer genetic information to other bacteria within the biofilm, which provides an 
effective defense against host protective mechanisms and antimicrobial agents. 
· respond differently to antimicrobial agents, depending on their growth phase, as 
well as the dose and frequency of exposure to the antimicrobial agent. 
· protect themselves by being located within the inner parts of the biofilm, since 
topical agents will only act on microorganisms in the exposed peripheral portion of 
the biofilm. 
 
Resistance of bacterial biofilms to antibiotics can occur due to several factors:  
· The polysaccharide matrix retards diffusion of the antibiotic. 
· Chemical changes to the environment in the biofilm, for example a lack of oxygen 
inhibits some antibiotics from working, or accumulated acidic waste products create 
a lowered pH which antagonizes the antibiotic. The depletion of substrate or 
accumulation of waste products could result in bacteria entering a non-growing 
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quiescent state which would protect them from antibiotics acting upon biochemical 
pathways used only during cell division. 
· Subpopulationsof bacteria in a biofilm are in a phenotypic state (altered gene 
expression) were they are highly protected from external influences – in some ways, 
their unresponsive state is similar to that seen with spore formation.  
 
It is estimated that bacteria grown in a biofilm have a 1000-1500 times greater resistance to 
antibiotics than bacteria in planktonic form. With regard to host defences, bacteria in 
biofilms are less easily phagocytosed, and are less susceptible to complement than their 
planktonic counterparts. 
 
Biofilms are a major problem in  
· Water treatment systems (commercial and domestic) 
· Water-based equipment such as irrigators and renal dialysis equipment 
· Industrial manufacturing systems (e.g. manufacture of food products and 
pharmaceuticals, sugar processing) 
· Medical devices such as catheters (particularly intra-vascular catheters) 
· Dental unit water lines. 
 
2.1 Dental plaque  
 
Dental plaque can be defined as a structured film of bacteria which forms on both hard 
and soft structures in the mouth, which consists of bacteria embedded in an inter-
microbial matrix of bacterial origin. 
 
Dental plaque is the archetype of biofilms, and the stages of formation of dental plaque 
correspond with those of biofilms in other sites: 
 
1. Conditioning film (e.g. pellicle from adsorbed salivary glycoproteins). These large 
molecules are hydrophobic and are dispersed onto the surface, where they alter the 
surface characteristics and enhance bacterial adhesion. 
2. Seeding of bacteria (e.g. Gram positive cocci and rods as initial colonisers) via 
reversible and then irreversible adhesion. This adhesion is mediated by extracellular 
polymers, fimbriae, and adhesins. 
3. Multiplication of bacteria as well as sequential colonisation by other organisms 
(recruitment) (e.g. Gram negative cocci and rods, followed by filamentous organisms, 
fusobacteria and spirochaetes) 
4. Deposition of extracellular matrix material by bacteria accompanies this.  
5. Increasing biomass, complexity and thickness over time 
6. An equilibrium state is reached where there is balance between biofilm growth and loss 
of bacteria into the environment.  
 
The inter-microbial matrix in dental plaque consists of polymers which are assembled 
extracellularly by enzymes such as gluocsyl- and fructosyl-transferase. In the extracellular 
polysaccharides, both glucose and fructose moieties can be arranged in two forms: glucose 
forms glucans (1,6-alpha-linkages) and mutans (1,3-alpha-linkages), while fructose forms 
inulin (2,1-beta linkages) and fructans (2,6-beta linkages).  
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These nutrients are then made available to the organisms by the action of lytic enzymes 
such as dextranases and mutanases. Several types of these lytic enzymes are produced – 
some cleave from the terminal end of polymers (“exo” enzymes) while others cleave within 
the internal structure (“endo” enzymes).  
 
The bacterial nature of dental plaque was first recognised by Anton van Leeuwenhoek 
(1632-1723), who described to the Royal Society of London on September 17, 1683, a 
variety of “animicules” (microorganisms-  particularly motile rods and spirochaetes) in a 
sample of plaque taken from the mouth of an elderly gentleman who had never cleaned his 
teeth in his lifetime: 
 
“… a little white matter, which is as thick as if ‘twere batter…. I then most always 
saw, with great wonder, that in the said matter there were very little living animicules, 
very prettily a-moving. The biggest sort....... had a very strong and swift motion, and 
shot through the water (or spittle) like a pike does through the water. The second 
sort........ oft-times spun round like a top...... and these were far more in number. ...an 
unbelievably great company of living animicules, a-swimming more nimbly than any I 
had ever seen up to this time. The biggest sort.... bent their body into curves in going 
forwards.... Moreover, the other animicules were in such enormous numbers, that all 
the water seemed to be alive.” 
     
 
2.2 Biofilm aging 
 
Within the dental plaque biofilm, bacteria inhabit a diverse range of ecological niches 
(“habitats”), and exist not as isolated species but in complex physical and metabolical 
synergistic relationships with other species, which provides metabolic advantages to each.  
 
Dental plaque forms continually, and we strive (with greater or lesser success) to keep 
visible plaque levels low. Based on the modern concept of dental plaque as a biofilm, a 
number of important questions arise for clinical practice:  
· Is plaque equally pathogenic in all our patients?  
· If not, how can we assess this?  
· Is it necessary to remove (to the microscopic level) all deposits of plaque?  
· If not, how can we encourage “healthy” plaque?  
 
Our mouths have a complex ecology, and the conditions for microbial growth vary from 
site to site within the mouth. Ecological differences between sites (in terms of factors such 
as pH, oxygen levels, and salivary host defense systems) explain why plaque differs from 
site to site (for example, between buccal and proximal sites on the same tooth) and why 
certain habitats (such as proximal sites) are more likely over time to develop “thick/old 
plaque” which has higher levels of the facultative anaerobic bacterial species that are 
associated with caries and periodontitis. 
 
“Thin/young” plaque does not have high levels of disease-related facultative species and its 
microbial constituents can be regarded as “normal” in the sense that they are present 
continuously on many tooth surfaces, even though this thin biofilm may not be clinically 
visible without the use of disclosing dyes. The use of combination products with two dyes 
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to show “thick/old” versus “thin/young” plaque offers a significant advantage when 
assessing risk for dental caries or periodontitis, and when providing oral hygiene 
instruction. Such products use a mixture of the food dyes erythrosin and fast green to stain 
“young” plaque red, and “old” plaque blue, respectively. 
 
The adjunctive use of biocides such as Triclosan and essential oil preparations in 
toothpastes and mouthrinses can provide a worthwhile clinical benefit to patients in 
maintaining adequate control of dental plaque and gingivitis, particularly in terms of 
reducing interproximal plaque and gingivitis. This is important since for the interproximal 
region the lack of salivary defences and poor access for mechanical cleaning means that 
“thick/old” plaque is very likely to develop here. Triclosan and essential oils have been 
shown to reduce plaque levels in interproximal sites, however these agents do not interfere 
with the balance of organisms in supragingival dental plaque, and microbial resistance does 
not occur even with daily usage for personal oral hygiene. 
  
Two important factors which disrupt the normal endogenous dental plaque flora and can 
increase the risk of disease development are reductions in oral pH (from regular 
consumption of acidic drinks) and reduced oxygen tension (e.g. from smoking), which 
provide a growth advantage to acid tolerant and facultative anaerobes respectively.  
 
This leads naturally to the question, how often to brush? Regular (twice daily) brushing 
reduces the thickness of plaque. Plaque that is kept thin (with the biofilm brushed away 
regularly) does not have low oxygen micro-environments within it. Conversely, the oxygen 
tension in plaque falls if there is no brushing. As plaque thickens, the deeper layers with 
lower oxygen tensions favour the growth of facultative anaerobes, including mutans 
streptococci (which are associated with caries), and Gram negative rods (associated with 
periodontitis). 
 
As the microflora of “thick/old” dental plaque becomes dominated by pathogens linked to 
dental caries and periodontal diseases, its reduction and removal becomes more of a 
challenge. Well established biofilms resist environmental, physical and chemical 
stresses, and because of diffusion barriers and metabolic changes (such as dormancy) the 
bacteria within them are less prone to the actions of biocides than planktonic (free floating) 
forms of bacteria.  
 
Recently developed tests for plaque acid production, such as the 3M-Espe ClinPro Cario 
Diagnosis ™ test for lactate, and the GC Plaque-Check+pH ™ fermentation test have an 
important place in risk assessment and in patient education. The GC test is based on the 
causal association between caries activity and the production of strong acids from plaque in 
response to sucrose, which was first identified by the work of Stephan more than 65 years 
ago.  
 
But, which acid to measure? Many dental plaque bacteria can ferment carbohydrate 
substrates, and this leads to the production of numerous organic acids (of varying potency 
for demineralization). Thus, it is logical to look at the intact plaque biomass and the net 
result of fermentation, rather than to focus narrowly on just one species or just one organic 
acid (such as lactate). The GC kit assesses plaque pH, using a colourimetric test to show 
the pH-drop which occurs in intact plaque samples when exposed to an excess supply of 
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sucrose. As fermentation occurs, the greatest reduction in pH occurs after 5 minutes, and 
this can be seen as a colour change in a pH indicator. 
 
In relation to dental caries, “good plaque” (formed in a low cariogenic environment) has 
limited fermentation capabilities, and produces primarily acetate, (with lesser quantities of 
propionate and butyrate). These weaker acids can effectively buffer plaque pH changes. In 
contrast, “bad plaque” (formed in a highly cariogenic environment) produces large 
quantities of lactate, formate and pyruvate, stronger organic acids that can readily 
demineralize enamel.   
 
The use of simple chairside tools such 2-tone plaque disclosing and plaque fermentation 
tests are a low cost method for (1) assessing caries risk; (2) engaging patients in a 
discussion of whether their plaque is “young/good” or “old/bad”, and (3) assessing their 
compliance with oral hygiene and lifestyle changes designed to reduce the cariogenic 
potential of their plaque. 
 
2.3 Biofilms on teeth: gingivitis 
 
The classic work of Harald Loe and others in the 1960’s regarding the association of 
plaque accumulation and the subsequent development of gingivitis is well known, however 
it is timely to remember that the obvious visual presenting signs of gingival inflammation 
(redness and bleeding) may be suppressed by smoking, because of the vasoconstrictive 
effects of nicotine on the microvasculature. Assuming that, periodontally, all is well, merely 
because the gingival tissues are NOT red is a simple by common pitfall. 
 
Conversely, one should also suspect a modifying factor is operating when there are low 
levels of plaque but extensive and profuse visible signs of inflammation. A clinical 
technique that may be of assistance is to use a 2-tone disclosing product which identifies 
mature versus newly formed thin deposits of plaque. One would expect to see a spatial 
relationship between the mature plaque deposits and gingival inflammation, but little or no 
visible erythema associated with clean tooth surfaces. If either is not the case, factors which 
alter the vascular response should be looked for – smoking which suppresses it, and 
hormonal changes (pregnancy, oral contraceptives) which enhance it.  
 
Clinical studies indicate that the inflammatory response to plaque accumulation varies 
somewhat between individuals, in the absence of any such modifying factors. There still 
remains much to learn about how susceptibility to gingivitis differs from or mimics 
susceptibility to periodontitis. Both are the host response to plaque, but direct parallels 
between the two cannot be drawn. 
 
2.4 Biofilms on teeth: dental caries 
 
Dental caries can be defined as a diet- and saliva-modified bacterial disease caused by 
alterations in the normal dental plaque biofilm. The key microbial feature of dental caries 
is a dietary carbohydrate-induced enrichment of the normal oral flora with bacteria that 
are both acidogenic (acid producing) and aciduric (acid tolerant) located within a dense 
biofilm, rich in extracellular polysaccharides, which maintains a favourable environment for 
microbial community and protects it from physical and chemical assaults. 
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The biofilm which causes dental caries arises from the normally thin dental plaque biofilm 
which is present continuously on hard surfaces in the oral cavity, when this is subject to 
particular ecological pressures related to intake of fermentable carbohydrates and 
subsequent production of organic acids by bacterial fermentation.  
 
Within a cariogenic biofilm, factors affecting bacterial growth and metabolism include: 
• Water – which is a source of hydrogen and oxygen. This is delivered throughout the 
biofilm by water channels which develop as part of the biofilm structure. 
• Carbon - from carbon dioxide and from carbohydrates.  
• Organic nutrients - Carbohydrates, proteins (peptides), and amino acids. Bacteria 
require amino acids for the protein synthesis which is essential for their replication 
by binary fission. The breakdown and metabolism of certain amino acids such as 
arginine can alter the local pH, as will be discussed further below. Various peptides 
(termed bacteriocins) produced by bacteria can suppress the growth of other non-
compatible species, e.g. bacteriocins from Streptococcus salivarius and 
Streptococcus sanguis can suppress Streptococcus mutans and the periodontopathic 
organism Actinobacillus actinomycetemcomitans, respectively. 
• Inorganic nutrients - e.g. magnesium, nitrogen, sulphur, potassium, phosphate, as 
well as selenium and other trace elements  
• Environmental factors – Temperature, pH, and Redox potential (eH). The falling 
levels of pH (with acid production) and eH (with thickening of the plaque) help 
provide ecological niches deep within the plaque for highly fermentative facultative 
species such as the mutans streptococci (MS). Acids produced deep within the 
plaque not only demineralize enamel, but suppress the growth of bacterial species 
which are not aciduric. The shift toward aciduric organisms also promotes an 
increase in the proportion of lactobacilli, which are highly acidogenic in their own 
right, producing lactic acid from glucose fermentation. Although lactobacilli are not 
regarded as important in the initiation of caries, their presence in large numbers 
indicates that the necessary environmental conditions for producing dental caries 
exist. 
• Salivary factors - resting and stimulated flow, pH, fluoride, calcium and bicarbonate 
levels; salivary anti-bacterial properties (antibodies, lysozyme, lactoferrin, 
peroxidase).  
• Tooth factors - anatomical features such as hypoplasia and other surface defects 
(which are influenced by maternal and peri-natal health and nutrition), and fixed 
orthodontic appliances, which provide increased surface area for retention of the 
biofilm. 
 
MS are normal (commensal) members of the oral microflora, rather than external 
pathogens. While transmission of MS from mother to child via a spoon was demonstrated 
conclusively in the landmark studies of Kohler and Bratthall in the late 1970’s, the concept 
of a “window of infectivity” at 26 months of age has now been disproven in a series of 
studies from UQ which demonstrated that inoculation with mutans streptococci and other 
oral bacteria occurs within the first three months of life, with repeated exposure from carers 
(particularly the mother) and siblings through saliva microdroplets. Moreover, the 
traditional concept that MS lack a suitable ecological niche in the pre-dentate oral cavity, 
and cannot establish until the primary teeth erupt, has also been formally disproven by 
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studies which demonstrate pre-dentate acquisition, i.e. before hard tissue surfaces are 
present. 
 
Once acquired, the oral flora with respect to dental caries appears to be relatively stable, 
adding further weight to the premise that so-called cariogens are normal parts of the oral 
flora. Genotypes (strains) of mutans streptococci are relatively stable within the one 
individual, and tend to persist for several years. 
 
This leads, inevitably, to the biofilm catastrophe concept of dental caries, as originally 
proposed by Marsh in 1995. The “ecological concept” of dental caries is based on the view 
that a catastrophic change in the normal plaque biofilm is responsible for disease. The main 
advantages of this approach are that it: 
• Deals with problems in and limitations of the specific plaque hypothesis. 
• Recognizes the possibility that bacteria yet to be cultured can participate in the 
caries process. 
• Aligns with a comprehensive approach to caries as a disease which results from the 
interplay of host, microbial, lifestyle and behavioural factors. 
• Supports a concept of “caries risk management throughout life”, rather than 
focusing only on “windows of infection” or assumed high risk period. In so doing, it 
recognizes the clinical reality that caries can develop at any time after tooth 
eruption. 
• Leads to novel and improved strategies for risk assessment, risk reduction and 
clinical management.  
 
Applying this “ecological catastrophe” concept to the issue of pH within the biofilm, it is 
clear that the low pH environment generated from carbohydrate metabolism is the major 
factor responsible for the shifts observed in the oral microflora with high carbohydrate 
diets.  
 
Laboratory studies using chemostat systems in which pH conditions can be manipulated 
provide useful insights into how the microbially generated pH changes can cause such 
shifts. When the pH falls, the numbers and proportions of Streptococcus mutans and 
Lactobacillus rhamnosus increases. This is accompanied by a fall in the proportions of 
acid-sensitive species (such as Fusobacterium nucleatum, Streptococcus gordonii and 
Streptococcus oralis). A fall in pH to between 5.5 and 4.5 will allow the enrichment of 
potentially cariogenic species whilst permitting species associated with health to remain 
relatively unaffected. However, a further reduction in pH (<pH 4.5) will not only enhance 
the competitiveness of cariogenic organisms, but will inhibit the growth and metabolism of 
non-caries-associated species.  
 
In patients with low salivary flow rates (regardless of the cause of this), the concurrent 
reduction in salivary flow and pH can be expected to provide a more favourable growth 
environment in which aciduric organisms can flourish. While this effect is well recognized 
for salivary dysfunction induced by medications, irradiation of salivary glands, and salivary 
gland diseases such as Sjogren's syndrome, it should also be remembered that the same 
acidic conditions can be created both by a diet with high intakes of acidic drinks and foods 
(exogenous acids), and by eating disorders or gastrointestinal conditions (such as chronic 
gastric reflux) in which the source of the acid is endogenous (hydrochloric acid from the 
stomach). The latter patients will typically present with dental erosion and occasionally 
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with frank caries. The more dramatic and unusual nature of dental erosion may well distract 
the clinician from realizing the likelihood of greatly increased counts of aciduric bacteria 
because of their preferential growth under acidic conditions. Several studies have reported 
that patients with eating disorders are more susceptible to both dental caries and erosion, 
and that such patients with low resting salivary flow rates have very high counts of MS and 
lactobacilli. Clearly, the preventive program for such patients must be targeted to address 
the global risk factor of low pH which underpins both dental caries and dental erosion. 
 
Novel strategies for manipulating cariogenic biofilms 
 
Manipulating the physical, ionic, and metabolic factors which modulate the properties of 
the biofilm provides a powerful approach to caries prevention and control. Likewise, a 
range of approaches have been developed to overcome the greater defensive capabilities of 
biofilms, including disruption using sonic energy, and photosensitization (with red or blue 
light). Methods which alter the structure and composition of biofilms as they develop 
include repellants, probiotics, and replacement therapy. 
 
Caries prevention agents which influence biofilm behaviour 




Mechanical oral hygiene (biofilm disruption) 
Surfactants (in dentifrices and mouthrinses) 
High concentration and low pH topical fluorides 
Metallic ions (Cu, Fe, Zn, Sn, Ag) 
Oxygen radicals (ozone, hydrogen peroxide) 
Bisguanides - chlorhexidine 
Naturally occuring phenolics (including essential oils) 






Other natural plant-derived products (ingestible antimicrobials) 
Inhibitory bacterial species (probiotics) 
Alkalinizing approaches (arginine, urea) 
Synthetic peptides with antibacterial properties 
Agents which modulate biofilm behaviour (quorum sensing) 
Photosensitization 
______________________________________________________________    
 
Novel means for interfering with biofilms may reduce their cariogenicity, to support 
appropriate lifestyle changes. The underlying concept is that, from the caries perspective, 
dental plaque biofilms range from benign (thin, immature) through to more harmful (thick, 
fermenting). One important implication of the belief that caries is a multi-pathogen biofilm 
disease is that “single pathogen” approaches such as vaccines to S. mutans or its 
components (such as glucosyl transferase), and the use of genetically modified S. mutans 
(with deletions of glucosyltransferase enzymes (B/C/D), the phosphoenolpyruvate-
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dependent phosphotransferase system (PTS), or of lactate dehydrogenase) would no 
longer be appropriate. 
 
A. Xylitol  
 
Xylitol is a naturally occurring polyol which is taken up by MS but is not fermentable. 
Numerous studies have documented the non-cariogenicity of xylitol, however more 
recently attention has been directed to the effects of prolonged consumption of xylitol on 
MS. Chewing a xylitol gum three times daily for a minimum of five minutes each time for 
three months may give a 10 fold reduction in salivary levels of MS, a strategy which would 
be useful in high caries risk patients, orthodontic patients and mothers of infants, as an 
adjunct to other suppressive approaches such as chlorhexidine therapy.  
 
Habitual consumption of xylitol in the diet appears to select for MS with impaired adhesion 
properties, i.e., they bind poorly to teeth and shed easily from plaque to saliva. One 
important advantage of this approach is that it is suitable for maintaining long-term 
suppression of pathogens without concerns of safety with prolonged use. Use of high 
xylitol containing gums such as Xylimax ™ (0.6 grams per pellet of gum) is a simple 
measure to incorporate into a daily routine, and brings the important advantages of 
increased salivary clearance, buffering and remineralization. This needs to be balanced 
against the issue of adaptation to xylitol in the diet. 
 
B. Natural peptides 
 
Casein phosphopeptides (CPP) are naturally occurring molecules from bovine milk which 
are able to bind calcium and phosphate ions and stabilize amorphous calcium phosphate 
(ACP). Under acidic conditions, CPP are able to release calcium and phosphate ions and 
thereby maintain a state of supersaturation with respect to tooth enamel, reducing 
demineralization and enhancing remineralization.  
 
The delivery of CPP or complexes of CPP and ACP (Recaldent ™) to the plaque fluid can 
be achieved by a range of vehicles, including chewing gums, dentifrices and topical gels, 
such as GC Tooth Mousse and Tooth Mousse Plus (designated MI Paste and MI Paste 
Plus in some countries). CPP bind strongly to dental plaque, and are able to slow or 
prevent the diffusion of calcium ions from enamel during episodes of acid challenge, and 
serve as a source of calcium for subsequent remineralization. CPP may also affect 
adhesion of MS and modulate fermentation by dental plaque bacteria.  
 
An important aspect of CPP is their long half-life in saliva, which is due to their unique 
amino acid composition and to the release of phosphate ions which may inhibit proteolytic 
breakdown of these peptides. Their metabolism in plaque (with a half life of 2.8 hours) also 
results in a pH elevating effect because of their substantial arginine content. 
 
C. Synthetic peptides 
 
Peptides with antimicrobial properties can also be synthesized, with inherent antimicrobial 
properties or as delivery systems for established biocides or toxins. Issues with these 
synthetic agents include: low binding affinity to plaque, poor penetration, limited stability in 
the biofilm because of proteolysis, low specific activity, and high cost. For these reasons, 
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antibacterial peptides (bacteriocins) from oral bacteria would seem a more fruitful avenue 
to explore.  
 
D. Natural plant products 
 
A number of plant-derived extracts which has been shown to possess significant anti-
cariogenic properties. Propolis, essential oils and flavonoids have been of interest for many 
years, with recent attention being directed towards cranberry extracts and the combination 
of the agents apigenin and farnesol, which block expression and secretion of the glucosyl 
transferase enzyme from MS, preventing their synthesis of insoluble glucans. Combinations 
of these agents with fluoride may allow a change in biofilm behaviour without necessarily 
reducing the levels of MS or other bacteria. 
 
Cacao bean husk extract (CBH) is one such material which under laboratory conditions can 
reduce the growth rate of MS and other oral streptococci, reduce acid production by MS, 
inhibit the synthesis of insoluble glucans by the glucosyltransferases from S. mutans and S. 
sobrinus, and thereby impair sucrose-dependent cell adherence. In the rat animal model of 
dental caries, administration of CBH in drinking water at concentrations exceeding 1.0 
mg/mL has been shown to cause significant reductions in both plaque accumulation and in 
dental caries. 
 
Chewing sticks from the tree Juglandaceae regia have been used in the Indian subcontinent 
to maintain oral hygiene. Laboratory and clinical studies of the aqueous extracts from these 
sticks show a variety of anti-cariogenic properties, including reduced growth and adherence 
of S. mutans for up to 3 hours; reduced acid production by S. mutans for 90 minutes; 
reduced glucan-induced aggregation of S. mutans, and direct bactericidal effects on S. 
mutans. An assessment of the aqueous extract from Terminalia chebula by the same 
authors yielded similar properties. The extract strongly inhibited the growth, acid 
production, sucrose induced adherence and glucan induced aggregation of S. mutans.  
 
E. Alkalinization strategies 
 
Increasing alkali production in dental plaque is a simple means of applying ecological 
pressure to the biofilm. S. sanguis and S. gordonii use arginine deiminase to elevate pH 
through metabolism of amino acids, while urease breaks down urea releasing ammonia 
which again elevates pH. Supplying substrate for these two enzyme pathways is the basis 
for poly-arginine (arginine bicarbonate/calcium carbonate, CaviStat ™) and V-6 ™ 
chewing gum, respectively. While the urease gene from S. salivarius has been inserted into 
a genetically modified strain of S. mutans to make it ureolytic, acceptance of genetically 
modified bacteria by the community as a dental intervention would likely pose major 
problems. 
 
F. Inhibitory organisms and probiotic approaches 
 
A number of novel strategies exploit competition between bacterial species. This can be 
direct (through secretion of bacteriocins, toxins, enzymes or waste products) or indirect 
(through environmental changes in pH). Organisms of interest have included clinical 
isolates of S. sanguis, S. salivarius (strain K12) and S. oligofermentans. The probiotic 
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approach makes sound biological sense, provided the organisms can be delivered often 
enough to establish their presence over their commensal counterparts. 
 
In fact, there is increasing evidence of an important interaction between oral bacteria within 
the sanguinis (sanguis) group and MS. These bacteria have the advantage of being 
naturally derived, normal commensals, and thus come under the “generally recognized as 
safe” (GRAS) regulatory classification. A recent study demonstrated that there may be 
competition and antagonism between S. sanguinis and MS. Children who did not harbour 
detectable levels of MS had higher levels of S. sanguinis in their saliva than children 
colonized with MS. If S. sanguinis (or other bacterial species) were to be used as a 
probiotic therapy in a topical product, issues of shelf life (for a product containing live 
bacteria) would provide an important technical challenge to overcome.  
 
Screening libraries and culture collections of food-derived bacteria for inhibitory effects on 
dental caries has also become a major area of investigation in recent years, aiming to find 
agents which are GRAS and thus free of safety concerns for repeated ingestion. Several 
species have been identified which can cause lectin-glycoprotein adhesion to S. mutans, 
raising the possibility of reducing levels of these in saliva and the superficial layers of dental 
plaque after using rinses or dentifrices to aggregate S. mutans and the probiotic bacteria 
into clumps which are then ingested or expectorated. These adhesive interactions should be 
effective even if the probiotic bacteria have been inactivated (for long term storage) by 
pasteurization, as the lectins would be heat resistant. The same approach could also be 
taken with delivery using sugar-free confectioneries. Current species of interest include 
certain isolates of Lactobacillus paracasei and Lactobacillus rhamnosus. 
 
G. Altering biofilm communication pathways  
 
Biofilm properties may also be manipulated by affecting the pathways of biofilm 
manipulation, or of cell to cell signaling within the biofilm. Blocking this “quorum sensing” 
would reduce the ability of the biofilm to tolerate stresses such as reductions in nutrients or 
assault by external chemical agents (such as biocides). Slowing the biofilm accumulation 
rate may be possible using agents such as furanone which affect quorum sensing. 
 
H. Targeted therapies 
 
“Magic bullet” and “smart bomb” therapies are of ongoing interest. Antibodies to particular 
bacterial species in the biofilm could be conjugated to a toxin or biocide, however the 
challenges remain of gaining penetration and resisting degradation by proteases within the 
plaque biofilm, which may prove to be insurmountable. Using endogenous 
photosensitization of protoporphyrins in biofilm bacteria with light as the vector may 
overcome the penetration problem, and remains an important area for further investigation. 
 
2.5 Biofilms inside teeth: endodontic biofilms 
 
Bacteria play a central role in the development and progression of pulp and periapical 
diseases as shown by the classical studies of Kakehashi, Moller, Dahlen, Fabricius and 
others. These authors have also shown that root canal infections cause periapical 
inflammatory responses (which appear as periapical radiolucencies on radiographs). The 
microflora in teeth with root canal fillings that have become infected again and have apical 
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periodontitis (i.e. a periapical radiolucency) differs from that seen in initial pulp necrosis. 
Molecular methods have demonstrated that bacteria can be detected in virtually all cases of 
root-filled teeth with persisting periapical radiolucencies.  
 
Bacteria can exist within the root canal itself, or within other aspects of the root canal 
system such as the dentinal tubules, accessory canals, canal ramifications, apical deltas, fins 
and transverse anastomoses. Bacteria may also colonise in cemental defects or on extruded 
root canal filling materials. Apart from the canal itself, all of these other areas are 
inaccesible to the mechanical instrumentation procedures used and the irrigating solutions. 
 
Biofilms can form in the root canal system, depending on the cause of pulpal breakdown. 
Root canals may not always be fluid-filled, and the canals of teeth with necrotic pulps often 
appear macroscopically dry on entry, at least in the coronal portion. The question remains 
as to whether bacterial biofilms can develop in sites of the root canal system other than the 
apical third, where host derived proteins and bacterially produced adhesive substances 
provide the proper prerequisites. 
 
Because of the presence of biofilms in the area most difficult to access, disinfection of the 
root canal system is difficult to achieve reliably. Where bacterial biofilms are well 
established in the root canal, the joint issues of contact time with antimicrobial agents, and 
penetration into biofilms, come to the fore. Even when using potent antimicrobial agents 
and techniques, achieving reliable and complete disinfection remains a challenge. The 
published literature indicates that current treatment protocols with rotary NiTi 
instrumentation and copious antibacterial irrigation will render some 50%-70% of infected 
canals free of microorganisms by culture-based methods. This does not, however, mean an 
absence of viable microorganisms. 
 
Resistance of bacterial biofilms to antibiotics can occur due to several factors. Firstly, the 
polysaccharide matrix of the biofilm retards diffusion of the antibiotic. Secondly, the 
chemical milieu in the biofilm (low oxygen tension, low pH, waste products, enzymes) can 
antagonize the effects on the antibiotic. Thirdly, in response to depletion of substrate 
and/or the accumulation of waste products, bacteria in the biofilm enter a quiescent non-
growing state, rendering them safe from agents which target the metabolic activity of 
bacterial replication. Finally, subpopulations of bacteria in a biofilm may enter a phenotypic 
state with altered gene expression which is akin to spore formation. Because of these 
changes, bacteria in biofilms may display a 1000-1500 times greater resistance to 
antibiotics than when in the freely dispersed planktonic form. Because biofilms provide a 
powerful barrier to the diffusion of medicaments, it is essential that materials and 
techniques are tested not in in plate or broth cultures, but rather using biofilm models – 
since in the latter the microorganisms will be in a metabolically less active state, making 
them less prone to inactivation by antimicrobial agents.  
 
The outcome of endodontic treatment is largely dependent on the effectiveness of the 
control or elimination of microorganisms from the root canal system. Antimicrobial agents 
are typically used during two different stages of endodontic treatment - firstly, as a 
chemically active irrigating solution during the mechanical instrumentation phase of root 
canal treatment and, secondly, as an antiseptic medication within the root canal system 
between appointments. 
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Medicaments are used in endodontic therapy to:  
• eliminate or destroy any remaining viable bacteria in the tooth and the root canal 
system that have not been destroyed by the chemo-mechanical preparation process 
(i.e. instrumentation and irrigation)  
• reduce peri-radicular inflammation and hence reduce pain 
• help eliminate apical exudate, if present 
• prevent or arrest inflammatory root resorption, if present, and 
• prevent re-infection of the root canal system by acting as both a chemical and a 
physical barrier if the temporary restoration breaks down-(13).   
 
Intracanal medication between appointments has been unequivocally shown to contribute to 
a favourable outcome in treating endodontic infections in infected cases. The need for 
intracanal medication increases especially in those cases where an infection is resistant to 
regular treatment, and the therapy cannot be successfully completed due to presence of 
pain or continuing exudation. 
 
2.6 Biofilms on teeth, appliances and implants 
 
With the increasing use of dental implants for tooth replacement and for stabilization and 
support of dentures, the need for a comprehensive hygiene approach to dental implants in 
general practice settings is greater than ever before. Both patients and dental staff need to 
recognize that long-term success of implant therapy is dependant on home care and 
professional hygiene, as well as on proper surgical and restorative techniques and careful 
case selection. For patients whose dentitions have been compromised by dental caries or 
periodontitis, the above lessons relating to dental plaque biofilms are particularly relevant. 
While dental implant components do not undergo demineralization in the same manner as 
natural tooth structure, the microbiota and soft tissue responses seen in peri-implant 
inflammation bears a striking similarity to periodontitis – a condition underpinned by the 
response of the host to the same bacteria (anaerobic Gram-negative rods, motile organisms 
and spirochaetes) present in dental plaque biofilms surrounding teeth.  
 
Inflammation in the implant-mucosal unit (mucositis) can, when plaque is allowed to 
accumulate for prolonged periods of time, progress to periimplantitis with loss of 
circumferential coronal bone, in a susceptible patient. Thus the two questions arise, how to 
best provide professional hygiene care, and what methods to use as part of regular at-
home care?  A well trained dental hygienist and/or auxilliary can be instrumental in 
maximising the compliance, motivation and education of the patient as it relates to 
maintenance of dental implants. Different protocols for professional care have been 
suggested, but it is unclear at present which is the most effective.  
 
In relation to at-home care, a Cochrane review conducted in 2004 yielded 14 RCTs [4], 
with follow-up periods from 6 weeks to 5 months. Two trials evaluated the efficacy of 
powered and sonic toothbrushes, respectively, when compared to manual toothbrushing 
and showed no statistically significant differences. There was no evidence that the use of 
powered or sonic toothbrushes was superior to manual toothbrushing.  
 
One trial compared self administered subgingival chlorhexidine irrigation versus a 
chlorhexidine mouthrinse. The group using chlorhexidine irrigation resulted in statistically 
significantly lower mean plaque scores and a marginal bleeding index than the group using 
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chlorhexidine mouthwash, however the mouthwash was given at a suboptimal dosage. One 
study compared Listerine versus placebo mouthwashes, and showed a reduction of 54% in 
plaque and 34% in marginal bleeding compared with the placebo. This indicates that 
Listerine mouthrinse, used twice a day for 30 seconds, as adjunct to routine oral hygiene is 
effective in reducing plaque formation and marginal bleeding around implants. The positive 
benefits of chemical plaque control agents reinforce the value of these as adjuncts to 
meticulous physical removal of dental plaque for patients with implants.  
 
More recent work has also stressed the convenience and comfort of powered toothbrushes 
for mechanical oral hygiene, which are effective, as well as safe and comfortable for 
patients with implant-supported prostheses. Use of powered, counter-rotational and sonic 
toothbrushes can reduce plaque, gingival inflammation and bleeding, and probing pocket 
depths around implants. 
 
To keep plaque biofilms thin and non-pathogenic (i.e. with few Gram negative anaerobes), 
several factors should be considered: the maintenance of a relatively smooth abutment and 
implant surface; attention to the level of periodontal health in the remaining dentition (to 
prevent translocation of bacteria from one site to another), and reduction of modifying 
factors such as smoking.  
 
Of note, the link between susceptibility to periodontitis and susceptibility for peri-
implantitis may vary according to the implant type and surface topography, so each patient 
will need careful individual assessment and review. 
 
In terms of orofessional (in-office) hygiene care, there is an extensive literature which 
explores the effects of exposing implant components to various oral prophylaxis devices 
and procedures. From both laboratory and clinical studies, a number of key points emerge:  
 
· Ultrasonic scalers, sonic scalers, and stainless steel scalers: These will roughen and 
damage titanium surfaces. 
· Reinforced resin curettes, graphite-reinforced scalers, titanium-alloy tipped curettes, 
gold platinum curettes, and air-powder abrasive devices: These will, in general, 
increase surface roughness, but with less damage than ultrasonic and steel scalers.  
· Plastic scalers, Eva plastic tips, rubber prophylaxis cups, used dry or with zirconium 
silicate, tin oxide, or flour of pumice, give little or no surface changes compared 
with untreated controls on most common implant surfaces. 
 
New devices and methods for professional implant care are constantly being developed, and 
further work is needed to develop methods which are suitable for cleaning all types of 
implant surfaces. In the interim, clinicians should focus on the “first do no harm” principle 
and use instruments with care to prevent roughening implant surfaces during patient care 
and thereby making at-home plaque control more difficult. 
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2.7 Biofilms in dental equipment 
 
Biofilms form in dental equipment immediately the equipment is connected to a water 
supply which is not sterile. Dental unit waterlines (DUWL) provide an ideal environment 
for microbial colonisation and proliferation because the high surface area to fluid volume 
ratio results in stagnation and low flow. Because of the laminar flow characteristics of 
narrow bore tubing (a  central high flow rate, but a low flow rate on the periphery), water-
borne organisms are dispersed onto the surfaces of the tubing, where they can then attach. 
 
For DUWL biofilms, the sources of contamination are 
· the municipal reticulated public water supply 
· supplies of distilled or purified water (which are not sterile) 
· environmental contamination of “clean water” system bottles 
· retrograde contamination from patients – via aspiration through handpieces etc into 
DUWL, or venturi suction systems. 
 
In untreated waterlines, levels of contamination in the output water may exceed 1,000,000 
colony-forming units per milliliter of water (CFU/ml). This water is not only delivered into 
the patient’s mouth (where it can come in contact with wounds, or can be swallowed) but it 
is also aerosolised by handpieces, air-water syringes and ultrasonic scalers, causing 
respiratory exposure to bacteria in both patients and dental staff.  
 
There are ongoing health concerns regarding the presence of biofilms in DUWL. Microbial 
biofilms are not unique to dental equipment and can be found in nature on any solid surface 
which is immersed in or subjected to an aquatic environment. Biofilms form in dental 
equipment immediately the equipment is connected to a water supply which is not sterile. 
DUWL provide an ideal environment for microbial colonisation and proliferation because 
the high surface area to fluid volume ratio results in stagnation and low flow. 
 
DUWL may contain in excess of one million microorganisms per mL of water. This water 
is not only delivered into the patient’s mouth (where it can come in contact with wounds, 
or be swallowed), but it is also aerosolised by handpieces, air-water syringes and ultrasonic 
scalers. This gives respiratory exposure to DUWL bacteria. 
 
The extent of DUWL biofilm can be assessed by culturing exit water using commercially 
available (Millipore ®) Heterotrophic Plate Counter dip-sticks. These estimate the number 
of free floating aerobic mesophilic heterotrophic bacteria in the water. Once a sample is 
taken, 2-3 days incubation at room temperature is required before the plates can be read. 
 
The bacteria in DUWL biofilms include both overt and opportunistic pathogens, such as:  
· Pseudomonas aeruginosa (causes wound infections) 
· Escherichia coli 
· Legionella (pathogenic and non-pathogenic species) 
· Cryptosporidium 
· Mycobacteria (several species).  
 
There have been several reports of pathogenic Legionella in DUWL, and there is good 
evidence of occupational exposure of dental staff through aerosolisation. For example, 
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older dental staff show a higher sero-prevalence rate than the normal population. Published 
data also incriminate dental units in human legionellosis. 
 
The patients most at risk of infections from DUWL organisms are those with: 
· depressed immunity 
· chronic illness 
· poor general health 
· alcoholism 
· chronic lung disease (including long term smokers) 
· advanced age and infirmity. 
 
Current recommendations are that for medically compromised patients, the exit water from 
dental waterlines should contain less than 200 CFU/mL of bacteria. In addition, sterile 
irrigants must be used for surgical procedures. 
 
The microorganisms in DUWL biofilms include both overt and opportunistic pathogens, 
such as Legionella (pathogenic and non-pathogenic species), Cryptosporidium, Klebsiella, 
Nocardia, Moraxella, Serratia, and several species of non-tuberculous Mycobacteria 
(several species). Psuedomonas aeruginosa is a ubiquitous organism in water systems and 
is found in high levels in many DUWL biofilms. It may cause a severe life-threatening 
pneumonia in patients with existing lung disease. Commercial or hospital-based 
microbiology laboratories can undertake specific culture-based tests of water samples for 
pathogenic Legionellae or Pseudomonas aeruginosa, although it needs to be borne in mind 
that the former tests have a long reporting time (typically 10 days). 
 
Studies conducted by the author of water from dental unit water provide evidence that 
biofilm control remains a concern. A total of 60 dental units in 40 dental practices in South-
East Queensland were sampled at two time intervals, with tap water samples from the same 
locations analyzed in parallel. Over 86 per cent of dental unit water samples contained 
more than 500 colony forming units (CFU)/mL, which is the accepted standard for drinking 
water quality, while only 12% of water samples were under target level of 200 CFU/mL 
recommended in the 2004 CDNA Infection Control Guidelines for the treatment of immune 
compromised patients. As would be expected, factors which influenced water quality were 
the age and brand of the dental unit, quality of input water, and the flushing and purging 
protocols used. In some cases, high concentrations of bacteria were found in tap water in 
some shopping centres, with an adverse influence on biofilm levels in the dental practices in 
those locations. 
 
2.8 Dental Unit waterline biofilm respiratory diseases: Legionellosis 
 
There are two forms of Legionella-related disease: 
· pneumonic disease - Legionnaires' Disease (a severe pneumonia which may be fatal) 
· non-pneumonic disease - Pontiac Fever ( which has mild flu-like symptoms). 
 
For both conditions, spread is by the inhalation of aerosols.  
 
There are some 39 species of Legionella. These Gram negative bacilli reside in surface and 
drinking water, and are typically transmitted via aerosols, including from showers, 
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fountains, nebulizers, humidifiers, hot tubs, cooling towers and airconditioning systems as 
well as aerosols from dental unit waterlines.  
 
Person-to-person transmission has never been demonstrated, and (fortunately) Legionella 
species are not members of the normal bacterial flora of humans.  
 
Potentially, any of the 39 species of Legionella may cause the disease, however the most 
commonly implicated species are L. pneumophila and L. micdadei. Some other species 
cause Pontiac fever, but most are non-pathogenic. 
 
L. pneumophila is found in soil, and Legionella species are ubiquitous in wet environments, 
including  
· reticulated water systems 
· cooling towers (particularly when not maintained according to the requirements of 
national standards such as AS/NZS 3666 “Control of microbial growth in air-handling 
and water systems”) 
· spas, showers, and hot tubs 
· faucet aerators 
· air conditioning plants 
· dental unit water lines.  
 
Spa pools are particularly problematic as sources of infection because 
· the higher water temperatures favour the growth of pathogens 
· water filters are often not used 
· the spa system which creates turbulence dissipates chlorine 
· chemical treatment may be performed irregularly or not at all. 
 
Water stagnation in DUWL creates biofilms and promotes the proliferation of these 
microorganisms. Pathogenic Legionella seeded by reticulated water into DUWL are a 
potential source of infection for both dental personnel and patients during dental treatment. 
Legionella species are widespread in nature, and pathogenic Legionella species are not 
uncommonly isolated from DUWL both locally and overseas. They grow luxuriantly in tap 
water (but fortunately not in sterile tap water), and are normal inhabitants of reticulated 
water systems, being relatively resistant to the effects of both chlorine, and heat (as in 
domestic hot water systems).  
 
The importance of Legionella species as respiratory pathogens was first recognized in July 
1976, when a mysterious epidemic of pneumonia struck members of the American Legion 
attending a convention in Philadelphia, Pennsylvania. Some 29 of 182 cases of this atypical 
pneumonia were fatal. The condition was termed Legionnaire's disease by the press at the 
time, however the term legionellosis is more precise. The most common clinical 
presentation of infection is acute multi-lobar pneumonia with an incubation period of 
several days after inhalation of the pathogen, associated with a high unremitting fever and 
unproductive cough together with prominent neurological and/or gastrointestinal symptoms 
such as headache, confusion, muscle aches, nausea, and vomiting. The condition can be 
fatal unless treated with erythromycin (it is unresponsive to beta lactam antibiotics such as 
penicillins). Most patients respond promptly to appropriate antimicrobial therapy, but 
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convalescence is often prolonged (lasting many weeks or even months). Mortality is much 
higher in patients who are immune compromised than in healthy staff and patients. 
 
Less often, disease presents as a non-pneumonic, influenza-like illness called Pontiac fever 
(named after the city in Michigan, USA where the first epidemic of this was identified), 
which has a short incubation period of several hours and can involve other species such as 
L. ansia and L. feelei.  
 
Exposure to Legionella bacteria seems to be an inevitable consequence of involvement in 
dentistry, as shown by studies of DUWL in large dental teaching facilities, and of the 
development of serum antibodies to Legionella in dental students during their dental 
education and subsequent clinical practice after graduation. The development of Pontiac 
fever in both dental staff members and patients would normally go undetected because this 
mimics acute influenza, with symptoms such as fever, headache, and muscle aches, of short 
duration with an uneventful convalescence. Staff or patients would not normally attribute 
such symptoms to an exposure in the dental workplace, or indeed report for care to their 
medical practitioner (although they would still probably have the day off work because of 
the “flu”). As a result, the epidemiology of transmission of Legionella in the dental 
workplace has not been studied in exquisite detail. 
 
Legionellae occur in environmental water sources (such as rivers, lakes and dams), and 
from the municipal water supply can colonize dental unit biofilms in dental units connected 
directed to mains water, or if tap water is used to refill the bottles in self-contained water 
systems. Legionellae require nutrients and thus cannot grow in sterile water. The reported 
prevalence of legionellae in dental unit waterlines varies widely, however the main 
pathogenic species L. pneumophila has been isolated from dental units in both public and 
private practice settings. In public clinics, a major risk factor is where cold water is stored 
in large tanks. A particular risk situation in general practice is where legionellae are present 
in the hot water system because the operating temperature is set too low, and can be 
released from taps used for handwashing or instrument cleaning. Legionellae grow in 
temperatures from 20-45 degrees Celsius, but cannot survive for more than a few seconds 
above 60 degrees Celsius. 
 
Serum antibodies to L. pneumophila have been reported in dental staff in the UK, USA, 
and Europe, indicating that the dental workplace is associated with some level of exposure, 
however it appears that exposure to low levels via aerosols may “immunize” the staff but is 
insufficient to cause frank infection. There has been to date only one case report of a dental 
staff member contracting fatal Legionnaire’s disease by the occupational route, with the 
causal organisms recovered from the dental unit waterlines in high levels. 
 
Because Legionella bacteria reside in and proliferate inside pulmonary macrophages in the 
lower respiratory tract, both dental staff and patients with compromised host defenses are 
at increased risk of infection. Nonspecific inflammatory and physical pulmonary defenses 
such as pulmonary macrophages and the mucociliary escalator of the tracheo-bronchial 
tree, respectively, are important since these physically clear inhaled materials from the 
lungs. Effective cell-mediated immunity is critical in restricting intracellular growth of the 
bacteria. Antibodies are produced in the serum but are not protective against infection, and 
there is no vaccine. At risk patients for legionellosis from dental and other sources include 
smokers, the elderly, patients with chronic lung infections (such as bronchiectasis and cystic 
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fibrosis patients), and immune compromised patients (e.g. patients receiving steroids, anti-
rejection treatments, and patients with leukaemias or HIV).  
 
The major symptoms of Legionnaire’s disease include fever, chills, and cough, while 
additional signs and symptoms may include myalgia, fatigue, abdominal pain, headache, 
diarrhea and loss of appetite. In healthy patients, relatively few cases are fatal 
(approximately 12%).  
 
Risk factors for contracting Legionnaire’s disease 
________________________________________ 
• Male sex 




• Chronic respiratory disease 
• Renal disease 
• Cancer.  
________________________________________ 
 
Because the interactions between Legionella organisms, their aqueous environment, and the 
human host are complex, the problem of control is significant. Legionella are so common in 
water systems that both physical and chemical methods to reduce their numbers are 
employed routinely, such as flushing and purging, and the intermittent or continuous use of 
chemical agents such as oxygen compounds (peroxides, ozone), silver compounds, and 
high dose biocides used for sanitizing waterlines to control biofilm levels. A variety of 
products are available which combine several chemical agents to maximize suppression of 
bacterial growth. The incorporation of silver ions is particularly important because of the 
persisting antimicrobial action this achieves.  
 
With regard to reticulated (tap) water, it must be remembered that if normal (non-sterile) 
chlorinated drinking water is allowed to sit in bottles in self contained water systems, the 
levels of chlorine will decrease readily with time, and the bacteria contained in the bottle 
will flourish.  
 
The 2004 NH&MRC/CDNA Infection Control Guidelines, the 2008 ADA Inc Infection 
Control Guidelines, and other documents stress the need for keeping levels of DUWL 
bacteria below the limits for potability and particularly below 200 CFU/mL for patients in 
the risk groups listed above. Measuring DUWL bacteria levels can be undertaken by 
chairside waterline monitoring with simple bacterial “dipstick” testers. This is an important 
quality control measure which should be undertaken either on a periodic basis or as part of 
normal servicing of dental units. The results for bacterial counts will either be low (which 
reinforces the effectiveness of the protocols being used to minimize DUWL, or high, which 
flags the need for more intense measures such as sanitizing or replacing DUWL. With the 
availability today of effective chemical treatments for DUWL, as well as better DUWL 
designs, the problem of dental units with high DUWL levels of Legionella and other 
microorganisms (and the associated risks to staff and patients) could be considered 
completely preventable. 
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In addition to Legionella, other water-borne pathogens of concern are Giardia and 
Cryptosporidium. These protozoal diarrhoeal diseases can be transmitted by ingestion of 
contaminated water, either from the reticulated water system or from other sources such as 
public swimming pools. Giardiasis is caused by Giardia lamblia, a flagellate protozoan. 
The condition is characterised by abdominal discomfort, flatulence and diarrhoea. Chronic 
infection can leads to malabsorption. Treatment employs metronidazole. Faecal 
contamination of swimming pools is an important means by which Giardia and 
Cryptosporidium are transmitted. 
 
2.9 Other aerosol-related disease risks 
 
In addition to health risks, biofilms in dental equipment cause 
· equipment breakdowns 
· blockage of water lines 
· reduced efficiency of flow control systems 
· unpleasant odours 
· corrosion of metals. 
 
Many dental procedures can generate large quantities of aerosols of 3 microns or less. 
Aerosols can be generated in the dental environment by: 
• Air-water syringes 
• Air turbine and electric micro-motor handpieces 
• Ultrasonic scalers 
• Electrosurgery equipment and lasers (plume) 
• Air abrasion devices 
• Ultrasonic scalers (if operated with the lid removed). 
 
These aerosols can contain material from the patient’s oral fluids (saliva and blood) as well 
as microorganisms from dental unit waterline biofilms. These various sources can 
contribute to pneumonic infections in both patients and dental staff, particularly in patients 
who have reduced host resistance because of impaired general health. The patients most at 
risk of infections from aerosolized microorganisms are those with: 
· depressed immunity 
· chronic illness 
· poor general health 
· alcoholism 
· chronic lung disease (including long term smokers) 
· advanced age and infirmity. 
 
Factors which influence the physical extent of the aerosols created and the level of 
microbial contamination from patient-derived microflora include: 
• The patient’s level of dental hygiene, specifically whether the patient brushed or 
flossed before the appointment 
• Whether the patient has used a pre-procedural disinfectant mouthrinse  
• The type of procedure being undertaken 
• Whether rubber dam is used 
• How often the air turbine or ultrasonic scaler is used 
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Of greater importance, a wide number of diseases are transmitted by the airborne route or 
through droplet nuclei formed from respiratory secretions, and for this reason there are a 
number of conditions in which “standard precautions” used for infection control are NOT 
adequate in terms of the level of protection required: 
 
Patient-derived aerosols can be reduced by: 
 
• Having patients brush and floss before appointments 
• Pre-procedural mouthrinsing (e.g. with Chlorhexidine or essential oil mouthrinses) 
• Use of rubber dam, which gives an up to 70% reduction in airborne particles within 
a 1 metre range of the patient’s mouth. 
 
Conditions for which additional precautions are required 
__________________________________________________ 
Airborne transmission: 
• Pulmonary tuberculosis 
• Measles 




• Pertussis (Whooping cough) 




• Streptococcus pyogenes (Scarlet fever) 
• Meningococcal infection 
___________________________________________________ 
Patients with these conditions CANNOT be treated safely  
in the normal general dental practice setting. 
 
In addition to tuberculosis, a variety of other infections can be transmitted by droplet 
nuclei, including CMV, influenza virus (flu), rhinovirus (cold), adenovirus (cold), measles, 
mumps, varicella (chickenpox), and rubella (German measles). For this reason, patients 




Tuberculosis (TB) has emerged as a major problem in the 1990’s. The incidence of TB 
declined from 1963-85, and since then has increased in prevalence, particularly in immune 
compromised patients, where multi-drug resistance is common.  
 
When exposed to pathogenic mycobacteria, only a small proportion of these individuals 
become infected and develop active disease. After primary infection, the disease may 
develop in 1-3 months. Later in life, previous foci can reactivate. After treatment, patients 
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Major risk populations for TB are: 
· HIV positive patients 
· Refugees 
· Recent migrants from countries with a high prevalence of TB 
· Indigenous populations  
· The elderly 
· Diabetics 
· Individuals with immune suppression or cancer. 
 
Patients with HIV infection have a high risk of infection with Mycobacterium tuberculosis 
as well as environmental mycobacteria which are not pathogenic to normal individuals, 
such as 




Patients with active tuberculosis expel tubercule bacilli by coughing and talking. The 
droplet aerosols are dispersed readily into the environment, where the organisms can 
survive for weeks on surfaces (such as books, anaesthetic masks, bronchoscopes). A single 
cough can disperse as many as 3500 droplets, while a sneeze can generate more than one 
million droplet nuclei. Droplet nuclei are small (less than 100 microns in diameter), and 
evaporate instantly. They remain suspended in the air for many hours and are inhaled into 
the lungs. 
 
Patients with active tuberculosis require special precautions for dental management since 
standard precautions do not provide adequate protection. High speed instrumentation 
should not be used since this creates droplet nuclei as well as larger particles (splatter) of 
more than 100 microns in diameter, which are dispersed at up to 50-60 km/hour. These 
larger particles remain airborne for several minutes, then settle gradually (because of 
gravity) and contaminate environmental surfaces.  
 
The infectiousness of an individual with tuberculosis depends on the: 
· extent of disease (number & size of cavitations) 
· amount of sputum and bacterial load in sputum 
· presence of cough (rare in children) 
· use of anti-mycobacterial drugs. 
 
Typically the source patient in an outbreak of tuberculosis is undiagnosed. Because 
unrecognised cases are the major risk, it is essential that health care workers have adequate 
immunity to TB. Surveillance is via a skin test (the Mantoux test), where the individual 
receives an  intra-dermal injection of purified protein derivative (PPD) and then mounts a 
Type IV delayed hypersensitivity response over the next 24-48 hours. Individuals who fail 
to mount a response in the Mantoux test undergo vaccination with BCG (unless they are 
immune compromised, in which case vaccination is contra-indicated).  
 
Oral lesions (tuberculous ulcers) may occur secondary to primary lesions in the lung. 
Patients with active require 6-9 months therapy with a combination of agents, such as 
isoniazid, rifampicin and ethambutol. 
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Immunity to TB relies on cross-reactivity of antigens of the pathogen with related 
microorganisms which are not pathogenic. The vaccine for tuberculosis, known as BCG 
(Bacille Calmette Guerin), is an attenuated strain of live microorganisms (M. bovis), and 
induces a good cell mediated immune response which is effective against M. tuberculosis. 
 
Mycobacteria are obligate aerobes. They multiply at body temperature and do not grow at 
room temperature. They are relatively resistant to heat, but are killed by sunlight and 
ultraviolet light. Several chemical germicides show good anti-tuberculocidal activity, 
including 






Some agents such as chlorhexidine and quaternary ammonium compounds are not active 
against mycobacteria and thus are unsuitable as surface disinfectants in health care facilities.  
 
2.11 BIOFILM MANAGEMENT STRATEGIES 
 
Methods for minimizing biofilm levels in dental equipment  
 
· preventing aspiration into DUWL during patient treatment by using anti-retraction 
valves 
· avoiding triple syringe heaters, which encourage biofilm formation 
· avoid Venturi units 
 
· flushing DUWL (e.g. triple syringe and handpieces) after each patient (30 seconds) 
· flushing waterlines for 2-3 minutes at the start of the day to reduce overnight or 
weekend biofilm accumulation 
· purging DUWL at the end of each day with air 
 
· chemical treatment of water  
· Hydrogen peroxide 
· Sodium hypochlorite 
· Oxygen-releasing compounds such as hydrogen peroxide and peroxyborates, 
· Silver compounds,  
· Combination products such as ICX ™ 
• Electro-chemical activation. 
 
· using sterile water for self-contained water systems 
· using point-of-use 0.22 micron filters. 
____________________________________________________________  
 
As noted already, sterile irrigants should be used for surgical procedures, rather than exit 
water from dental unit waterlines. 
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Actions which physically disrupt the biofilm include: 
• Flushing at the start of the day, 
• Flushing between patients, and 
• Purging the system at the end of the day. 
 
Other actions which improve water quality include: 
• Using anti-retraction valves on handpiece and triplex waterlines 
• Installing water filters where mains water enters the dental practice 
• Monitoring water quality by microbiological testing. 
 
Backflow prevention serves to prevent water flow back into the mains reticulated water 
system due to negative pressure or back-siphonage in some part of the system. Various 
backflow prevention devices are available on the market, according to the hazard level, and 
these are discussed in AS 2845.1 (Water supply- Backflow prevention devices) and AS/NZ 
3500. Water supplying dental equipment is classed as high hazard, since contamination by 
patient fluids into the potable water supply may have the potential to cause death. These 
lines must have permanent labels indicating non-potable water (not for drinking) and must 
comply with AS 1345 and AS 1319 for the distribution of pipes and outlets. 
 
High hazard device options which protect from back-siphonage include: 
• Registered break tank (RBT) 
• Registered air gap (RAG) 
• Reduced pressure zone (RPZ) 
• Reduced pressure detector assembly (RPDA). 
 
The most common back flow prevention device fitted in modern dental practices is the RPZ 
valve. This must be installed by a registered plumber, and as with all backflow prevention 
devices, these require registration with the local government authority and must be tested 
for proper operation at least every 12 months. 
 
Water ozonation is becoming a more popular approach for eliminating bacteria from the 
supply side of dental unit waterlines. Ozone is used extensively in reticulated water 
treatment in large cities as well as in water recycling and in industry. Exposure of DUWL 
samples to ozone causes a reduction in the total viable count and can eliminate serious 
pathogens such as Legionella pneumophila present in water in planktonic form. Ozonate 
water may not however be able to remove established biofilms within DUWL, despite 
improving the quality of exit water. There is some evidence that regular use of ozonated 
water can give a dramatic (10,000 fold) reduction in bacterial counts, and a thinning of the 
biofilm layer.  For dental units with self-contained water systems, external water ozonation 
devices are now available in which the bottle is placed in the unit and the water ozonated 
immediately before attaching the bottle back on to the dental unit. The dosing is regulated 
electronically to give a consistent ozone concentration. This provides a simple and rapid 
means to ozonate water in removable bottles. 
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3. DIAGNOSTIC MICROBIOLOGY 
 
Diagnostic microbiology of specimens taken the site of a presumptive infection (a swab, 
scraping, or sample of exudate) can be useful for assisting in diagnosis and for reaching a 
decision on anti-microbial therapy. The caveats for successful diagnostic microbiology are 
that the specimen must be: 
· Fresh, so there are minimal delays in processing 
· Collected in an appropriate transport medium (this is a particular problem with 
anaerobes, where pre-reduced transport media are necessary) 
· Free of environmental contaminants 
· From a representative area. 
 
Problems with contamination of specimens taken from sites in the oral cavity are 
significant. Saliva and supragingival plaque are common contaminants. 
 
Because of the delay in achieving bacterial growth in the laboratory, several days may be 
required for routine culture and microscopy, and an interim report may be issued as well as 
a final report. Microscopy, culture and sensitivity (MCS) is the most commonly requested 
form of diagnostic microbiology.  
 
Some modern techniques, such as the antibody-based ELISA (enzyme-linked immun-
sorbent assay) or the polymerase chain reaction (PCR) do not require viable bacteria, and 
thus are well suited to analysis of specimens for obligate anaerobes, which are extremely 
difficult to isolate from clinical samples.  
 
Isolation and culture of anaerobes from clinical sites is a problem that has plagued 
microbiological research in periodontology and endodontology for many years. 
 
Bacteria from a clinical sample can be characterised in the laboratory using a combination 
of: 
 
· Microscopic techniques  
· Microscopic morphology (oil immersion) 
· Differential dark field microscopy 
· Gram staining  
· Special staining (e.g. Ziehl-Neelsen stain for mycobacteria) 
· Fluorescence (dyes or immuno-conjugates) 
· Transmission electron microscopy 
 
· Cultural methods 
· Colony morphology 
· Oxygen needs or tolerance (e.g. strict anaerobes) 
· Specific growth requirements (selective media) 
· Susceptibility to antibiotics 
· Bio-typing (susceptibility to bacteriophages or bacteriocins) 
 
· Biochemical tests (e.g. fermentation, production of enzymes such as proteases) 
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· Immunological tests 
· Serological typing (e.g. by agglutination reactions) 
· Immuno-fluorescence with specific antibodies 
· The patient’s serum can be examined for the presence of antibodies to the 
microorganism. 
· Genetic (e.g. DNA sequencing, “fingerprinting”). 
· Histopathology of tissue samples. 
 
Growth on solid media (such as agar plates) is particularly useful because:  
 
· a single colony can be picked for expansion and subsequent examination 
· colonial characteristics (shape, colour, gloss) can be informative 
· relative proportions of various organisms can be assessed qualitatively 
· counts can be undertaken (CFU/mL) is an appropriate dilution series is used.  
 
Liquid media such as broths can be used  
· to expand small samples 
· to enrich for specific types of organisms 
· to generate source material for biochemical tests. 
 
The Gram and other bacteriological staining techniques rely on differences in the 
composition of bacterial cell walls. The structure of bacterial cell walls varies considerably. 
While some bacteria have outer protective capsules (such as mycobacteria), the majority do 
not.  
 
Gram staining, which uses crystal violet, Burke’s iodine and safranin, is the most commonly 
employed staining method. Gram positive organisms stain blue, while Gram negative 
organisms stain red. The cell walls of Gram positive bacteria are thicker and the 
components are more cross-linked than in Gram negative bacteria. Of note, the intensity of 
Gram staining for Gram negative bacteria can vary according to the growth state of the 
cells (e.g. Bacilli). 
 
In Gram positive bacteria, the cell walls are homogeneous in nature. The major component 
(40-80%) is LTA (lipoteichoic acids) – a 3D mesh of peptidoglycans, teichoic acids and 
other polymers. The wall thickness is 20-80 nm. 
 
In Gram negative bacteria, the cell wall is a complex, multi-layered structure with a 
phospholipid bi-layer configuration. Compared with Gram positive bacteria, the cell wall is 
thin, flexible and relatively porous. The rigid peptidoglycan component is one molecule 
thick and forms a 2 D mesh. The outer layer comprises lipopolysaccharides (LPS). These 
are easily shed into the environment. Some Gram negative bacteria have outer membrane 
components which can mimic inflammatory cytokines such as interleukin-1 (IL-1).  
 
In the diagnostic laboratory, specific growth media can be used to select for particular 
species. These may use a combination of  
· nutrients, growth factors, and trace elements (e.g. nitrogen sources, vitamin K, 
selenium)  
· antibiotics and other inhibitors, to curtail the growth of other species 
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· indicator systems which allow the desired organism to be differentiated from others 
(selective/differential media). 
 
Biochemical tests are used frequently to confirm identity. These can be based upon:  
· detection of the action of an enzyme (e.g. catalase) 
· detection of specific biochemical end-products (e.g. indole, hydrogen sulphide, pyruvic 
acid) 
· utilisation or digestion of specific substrates (e.g. gelatin, citrate) 
· fermentation. Glucose and other simple sugars can be broken down biochemically to 
carbon dioxide and water (in 20-30 sequential reactions as part of the glycolytic 
pathway), with the release of pyruvic and other acids as by-products. (In contrast, in 
respiration, carbon dioxide is generated but acids are not produced). 
 
For fungi, the diagnosis may require 
· direct microscopy of samples (such as alkali-treated smears) 
· use of specific media, such as Sabouraud’s medium, for growth and analysis of colonial 
morphology 
· staining of histopathology specimens (e.g. with Periodic Acid-Schiff, to show fungal 
hyphae or blastospores) 
· immunological techniques to assess the presence of specific antibodies (in the serum) or 
fungal antigens (in the tissues) 
· specific growth tests (e.g. Candida albicans but not other candidal species produces 
germ tubes when grown in the presence of serum). 
 
For viruses, diagnosis may employ 
· analysis of antibody in the patient’s serum (e.g. by ELISA or immunoblotting) 
· examination of tissue specimens (using histopathology as well as more complex 
techniques such as immunohistochemistry or in-situ hybridisation) 
· cell cultures to test for infectious virus 
· genetic amplification (such as the reverse transcriptase - polymerase chain reaction RT-
PCR) to look for very low levels of virus in samples. 
 
3.1 Koch’s postulates 
 
Koch's postulates refer to the causal relationship between a microorganism and a clinical 
disease. It is important to distinguish between primary pathogens and other organisms 
which may colonise a site because they find the environment favourable to their growth.   
 
Koch’s postulates are that the putative pathogen: 
· can be isolated from the site of the disease (i.e. the distribution of the organism matches 
both the patient and the lesion) 
· can then be grown in pure culture 
· will cause the disease when a healthy subject is inoculated with the pure culture 
· can then be recovered from the induced disease site in the experimental subject 
· elicits an immune response, which can be detected in the serum.   
 
A recent example of causality for which Koch’s postulates were applied is the association 
between Helicobacter pylori and gastritis/ulceration.  
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3.2 Selection of antimicrobials 
 
The major indications for antibiotic use in dentistry are: 
· Prophylaxis  
· to prevent bacterial endocarditis in high risk cases 
· to prevent infections of prosthetic joints and shunts 
· to reduce risks of haematogenous spread in immuno-deficient patients 
· in haematology/oncology patients with vascular access devices (Port-a-Cath or 
Hickman catheter)  
· with complex surgery – particularly implant placement 
 
· Acute dento-alveolar (periapical) abscess where there are systemic symptoms  
 
· Periodontal pathology 
· Acute periodontal infections 
· ANUG (metronidazole) 
· HIV-related periodontitis (HIV-P, necrotising ulcerative periodontitis) 
(metronidazole and amoxycillin in combination) 
 
· Periodontal abscess in the compromised host with systemic symptoms (amoxycillin 
or metronidazole)  
 
· Severe and refractory periodontal diseases 
· Single agents such as tetracyclines in LJP 
· Combination therapy with metronidazole plus amoxycillin with clavulanic acid 
[Augmentin]. Analysis of subgingival plaque provides information on the likely 
susceptibility of microorganisms. 
 
In all cases, the agents are used in combination with other PHYSICAL measures (as 
appropriate to the condition), such as  
· drainage of pus 
· mechanical debridement 
· oral hygiene measures 
· antiseptic pre-procedural mouthrinses.  
 
When used to manage a newly diagnosed infection, antimicrobials may be of limited 
effectiveness because of  
· Resistance (see below) 
· Incorrect agent (resistance) 
· Inadequate exposure (dose and time) 
· Poor blood supply to the affected area 
· Reservoirs of re-infection such as foreign bodies 
· Incorrect diagnosis 
· Failure to debride or drain 
· Agent is not active (e.g. low pH environment of pus) 
· Poor patient compliance – particularly when the drug needs to be taken several times 
per day  
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· Interactions with food 
· Drug interactions. 
 
3.3 Resistance to antimicrobial agents 
 
Resistance may be 
· Primary (naturally resistant) 
· Acquired - via mutation within the species or by gene transfer between species 
· Cross resistance between two chemically related drugs. 
 
Mechanisms of resistance include: 
· Inactivation of the drug by enzymes, e.g. beta lactamase for penicillin 
· Prevention of the drug entering via bacterial cell wall 
· Permeability barrier (outer lipid membrane of Gram negative bacteria can interfere 
with the action of Quaternary Ammonium Compounds 
· Spore coat can provide some resistance to ethylene oxide and hypochlorites 
· Chemical modification of the active site of the drug 
· Decreased affinity of the target enzyme 
· Alterations in the binding site 
 
Transfer of drug resistance may occur by:  
· Transduction: a transducing phage picks up a stretch of DNA which confers resistance 
· Transformation: DNA extracted from cells of one strain may be absorbed by a second 
strain “Competent cells” 
· Conjugation: cell/cell contact via a “pilus”.  
· Plasmid transfer: a plasmid is a segment of extra-chromosomal double stranded DNA 
that replicates independently within host cells. 
 
Examples of resistance include: 
· Methicillin-resistant Staphylococcus aureus (MRSA) 
· Extended spectrum beta-lactamase organisms (ESBL) 
· Vancomycin resistant enterococci (VRE), and Enterococcus faecalis – resistant to 
tetracyclines, clindamycin and most commonly used antibiotics. 
 
Antibiotic Resistance in Enterococci  
Antibiotic family Type of resistance 
ß-Lactams (penicillins, cephalosporins) Intrinsic resistance. Can also acquire Beta 
lactamase production. 
Tetracyclines Acquired 
Lincosamides (clindamycin) Low level intrinsic resistance. Can acquire 
high level resistance. 
Macrolides (erythromycin, etc) Acquired 
Aminoglycosides (gentamycin, etc) Low level intrinsic resistance. Can acquire 
high level resistance. 
Glycopeptides (vancomycin, etc) Acquired 
 
LJ Walsh : Microbiology 39 
4. THE IMMUNE RESPONSE TO BACTERIAL INFECTION 
 
All "exterior" surfaces of the human body (including the skin, oral cavity, and gastro-
intestinal tract) are colonised by a range of bacteria known as the commensal flora, which 
under certain conditions (such as reduced host immune resistance) can become pathogenic. 
Exposure to exogenous pathogens occurs through everyday contact with contaminated air, 
food, water, or inanimate objects (fomites). Because of this high level of background 
exposure to opportunistic and overt pathogens, maintenance of the self (homeostasis) is a 
major activity of the immune system. Despite frequent exposure to pathogens, clinically 
evident infections are relatively uncommon in individuals who have an intact immune 
system. 
 
The normal commensal flora plays an important role in preventing colonisation by 
pathogens. The commensal flora occupy a broad range of environmental niches, and thus 
any pathogen must be able to attach, survive and grow at a selective advantage over the 
commensal microorganisms if it is to occupy an ecological niche on the surface. The 
gastrointestinal tract, oral cavity, and vagina are endowed with a diverse and abundant 
commensal flora which provide an important defence against exogenous pathogens. This 
protection can be impaired markedly by the injudicious use of broad spectrum antibiotics. 
These disrupt the normal commensal flora, leaving many of the ecological niches 
unoccupied. Bacterial and fungal overgrowths can occur, resulting in infections by these 
opportunistic pathogens. 
 
Following exposure to a pathogen, the interplay between three factors determine whether 
an infectious disease is acquired:  
· the dose of the pathogen,  
· the virulence of the pathogen, and  
· the resistance of the host.  
 
Low virulence, low dose, and high resistance favour health for the host, while high 




· damage host cells and tissues 
· evade or interfere with host defences. 
 
The immune system can interfere with each of these steps in the process of infection. 
 
Attachment of bacteria can be impaired by:  
· Desquamation of epithelial cells 
· Mucus and flushing (saliva, tears) 
· Low pH 
· hydrochloric acid in stomach,  
· low pH in vagina 
· Fatty and lactic acids on skin 
· specific antibodies (adaptive immune system) 
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Bacterial growth can be suppressed by: 
· Biochemical factors 
· Competition from the commensal flora 
· Lysozyme in secretions (including gingival crevicular fluid) 
· Salivary thiocyanate 
· Salivary amylase 
 
· Humoral factors 
· Complement (Alternative pathway) 
· Transferrin and lactoferrin (which bind iron) 
· Acute phase proteins (these can opsonise and can also activate complement) 
 
Damage to host cells and tissues can be reduced or prevented by the adaptive immune 
response, which can produce sensitised lymphocytes as well as specific antibodies, which 
can neutralise bacterial toxins. 
 
Most pathogens are held in check or neutralised by the natural (or innate) immune system. 
The most important element of the natural immune system is intact epithelium. The loss of 
an intact surface barrier (e.g. from extensive burns or chemotherapy-induced ulceration) 
can leads to severe infection and loss of life, from microorganisms that would not normally 




Once the epithelial barrier is breached, the second major component of natural immunity, 
phagocytosis, comes into prominence. Phagocytes are present within the circulation and 
within tissues, and are positioned strategically so as to encounter potential pathogens.  
Phagocytes include: 
· Neutrophils (polymorphonuclear leukocytes, PMN) 
· Monocytes 
· Fixed macrophages in the tissues 
· Kuppfer cells in the liver 
· Serosal macrophages in the pleural cavity 
· Alveolar macrophages in the lung 
· Microglial cells in the brain 
· The reticulo-endothelial system.  
 
Both neutrophils and monocytes are highly migratory, these cells can be mobilised with 
relative speed from the circulation to sites of injury or infection. This process is facilitated 
by the expression of endothelial-leukocyte adhesion molecules on venular endothelium in 
sites of infection and inflammation. Lipopolysaccharides from Gram-negative bacteria 
stimulate the expression of these adhesion molecules both directly and by eliciting the 
production of pro-inflammatory cytokines. Lipopolysaccharides also activate complement 
factors B and D, which form a C3 convertase. This activation of complement via the 
alternative pathway enhances phagocytosis by directing the migration of phagocytes 
(chemotaxis, via C3a), and by opsonisation (via C3b). 
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Phagocytosis is more important for homeostasis than is adaptive immunity. Severe or 
prolonged neutropenia (lack of circulating PMN) or defects in PMN function is life 
threatening because of the risk of bacterial infection. PMN numbers are reduced readily by 
the anti-neoplastic agents used in cancer therapies, and neutropenia can develop within as 
short a period as one week after chemotherapy commences. The significance of phagocytes 
in non-specific defence against infection is also seen in individuals who suffer from defects 
in phagocyte function, such as leukocyte-adhesion deficiency (LAD). Such individuals 
suffer repeated and severe bacterial infections. 
 
There are several stages in the process of phagocytosis: 
1. Attachment – The attachment of phagocytes to microorganisms can occur via non-specific 
cell surface receptors. Attachment is enhanced by complement (C3b) and antibody, both 
of which act as opsonins. 
2. Ingestion - The process of engulfment and the formation of a phagosome (phagocytic 
vacuole) requires energy, which is derived from glycolysis.  
3. Killing – Once phagosomes fuse with lysosomes, killing of engulfed organisms within 
phagosomes can occur using a range of processes. In PMN, oxygen-dependent killing 
mechanisms employ hydrogen peroxide, the superoxide and hydroxyl radicals, 
halogonium compounds and hypochlorous acid; while oxygen-independent mechanisms 
include cationic proteins, lactoferrin, lysozyme, nuclear histones and elastase. There is 
an altered killing process in monocytes, since these cells lack cationic proteins and 
lactoferrin, and also lose myeloperoxidase when the cells mature into macrophages. In 
this situation, the enzyme catalase can substitute for myeloperoxidase.  
 
Bacteria can evade phagocytic destruction by resisting attachment (e.g. using capsules or 
by shedding decoy antigens) or by producing leukotoxins which inactivate the phagocytes. 
If phagocytosed, some bacterial species can evade killing by reactive oxygen species by 
producing catalase or superoxide dismutase. Alternatively, some bacteria (such as 
Mycobacterium tuberculosis) are able to evade intracellular killing by preventing the fusion 
of phagosomes with lysosomes. When these bacteria are ingested by long-lived phagocytes 
(macrophages), intracellular infections occur as the pathogens are able to resist intracellular 
killing. This can be overcome by the adaptive immune system, in which sensitised T 
lymphocytes secrete the cytokine interferon-gamma (IFN-gamma) which “arms” the 
macrophage for oxygen-independent killing and triggers the fusion of phagosomes and 
lysosomes. 
 
Because microorganisms have developed a variety of strategies to enhance their survival 
and disease-causing potential (virulence), the defences of the natural immune system can be 
evaded by many pathogens. While the defensive capabilities of the natural immune system 
are not improved by repeated assaults from a given pathogen, the adaptive immune system 
has the ability to remember a previous contact with a pathogen, to react specifically to it 
and not to react against the self. (These are the three hallmarks of the adaptive immune 
response – memory, specificity, and tolerance). One of the major functions of the adaptive 
immune system is to amplify, direct or enhance phagocytosis. .    It is because of the 
adaptive immune system that it is rare to suffer twice from an infectious disease. The 
obvious exception is when the pathogen is able to mutate at such a rate as not to be 
recognised upon the second exposure to it. This situation is exemplified by the influenza 
virus and the hepatitis C virus, however it is extremely rare for bacteria to be able to 
change at sufficient rate to escape recognition. The generation of effective immunity (either 
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naturally or with vaccines) against pathogens which mutate at high frequency is a major 
challenge which is yet to be overcome. 
 
4.2 The role of cytokines and antibodies 
 
Cytokines are important in promoting the activities of phagocytes in both natural and 
adaptive immune responses. Pro-inflammatory cytokines such as Interleukin-1 (IL-1) and 
Tumour Necrosis Factor-alpha (TNF) are able to  
· activate phagocytes,  
· enhance their microbiocidal properties and  
· assist in their localisation to tissue compartments.  
 
Cytokines also promote the migration of phagocytes to sites of infection by  
· inducing the expression of adhesion molecules on endothelial cells 
· promoting adhesion of circulating phagocytes to endothelial cells  
· promoting transmigration of phagocytes across microvascular networks 
· attracting phagocytes (chemotaxis). 
 
Various cell wall components of bacteria are recognised as antigens by the adaptive 
immune system, and elicit the production of antibody. Such components include capsular 
proteins, fimbriae, and the lipoteichoic acid and lipopolysaccharides which form the cell 
walls of Gram-positive and Gram-negative organisms, respectively.  
 
Antibody plays an essential role in immune response to infection. Although the emphasis up 
to this point has been on opsonisation (enhancement of phagocytosis by increasing 
attachment via Fc and C3b surface receptors on phagocytes) and direct lysis of pathogens 
via activation of complement, it should be remembered that antibody also can: 
· through complement activation lead to the release of pro-inflammatory mediators (C3a, 
C5a) 
· neutralise bacterial toxins, enzymes, and repellents 
· coat the surface of bacteria, which inhibits adherence. 
 
These are important immune defence strategies in bacterial infections. Some bacteria do not 
invade the tissues, but rather cause disease by toxins, and this antibody is important for 
neutralising these toxins and also for blocking adhesion of the pathogen in the first instance. 
For Gram-positive invasive organisms, opsonisation by antibody (followed by  
complement) can lead to killing by phagocytosis. These bacteria are not particularly 
susceptible to direct lytic actions of complement.  
 
For Gram-negative organisms, opsonisation occurs as well as direct destruction of the 
pathogen by antibody-fixed complement-mediated lysis (the classical complement 
pathway). As mentioned earlier, the lipopolysaccharide moieties of Gram-negative bacteria 
can activate the alternative complement pathway, so that destruction by lysis can occur 
independent of the presence of antibody. Gram negative bacteria can evade destruction by 
the antibody-complement pathway by secreting proteases and other enzymes which 
degrade either antibody or fixed complement components.  
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With the first exposure to a bacterial pathogen, a primary immune response occurs. IgM is 
the major antibody produced, with peak production occurring at 14-21 days. While IgM 
can fix complement via the classical pathway (which can cause lysis of bacteria), it does not 
bind to phagocytes. In contrast, the response to a second or subsequent exposure (the 
secondary immune response) is characterised by the rapid production of large amounts of 
specific IgG antibodies, with peak production occurring at 2-3 days. IgG1  and IgG3 can fix 
complement via the classical pathway, and can also bind to phagocytes via their Fc 
receptors. Through these two actions, IgG antibodies are able to enhance phagocytosis. In 
addition, if complement activation proceeds to the formation of the lytic complex, lysis of 
the pathogen can occur. Through a very vigorous secondary immune response, the immune 




An effective immune response to infection relies upon cooperation between the natural and 
adaptive immune systems. Both humoral (antibody) and cellular defences within the 
adaptive immune system are under the direction of lymphocytes, which provide the 
immunological memory necessary for dealing successfully with repeated exposure to 
infectious agents. Vaccines are based upon this feature of immunological memory. The 
principle of vaccination is to employ a relatively innocuous form of the antigen to induce a 
primed population of lymphocytes and thus gain immunological memory. When the antigen 
is encountered in its native form (on a pathogen), the cellular and/or humoral arms of the 
immune system are activated. This activation results in the pathogenic threat being 
neutralised. The mode of delivery of a vaccine is designed such that the appropriate 
immune response is generated - either systemic immunity (with circulating antibody and 
lymphocytes), or mucosal immunity (with secretory IgA).  
 
Immunity can be acquired passively, via a surrogate, such that there is no exposure to the 
pathogen or its products. Passive immunity is conferred to infants who receive maternal 
IgA antibodies in breast milk. This IgA is stabilised against breakdown in the acidic 
environment of the gastrointestinal tract, so is able to provide some degree of protection 
for the neonate. Passive immunity can also be obtained by injection of gamma globulin. For 
example, hepatitis B immune globulin (of human origin) can be injected into non-immune 
individuals who have been exposed parenterally to hepatitis B, and is able to neutralise the 
virus during its transit in the circulation. Passive immunity is of limited value because 
antibody molecules break down over time, and the level of protection declines. This is 
unlike the situation with actively acquired immunity, where immunological memory (in the 
form of sensitised lymphocytes) is present, which allows a secondary immune response to 
be launched rapidly upon future exposure to the pathogen in question.  
 
Because of the debilitating or lethal nature of many infections, it is desirable to obtain 
immunity against infection without the risks posed by exposure to the pathogen itself. 
Vaccination against serious infectious diseases must employ antigens of the pathogen which 
generate protective immune responses, and which are stable or conserved (i.e. not prone to 
mutation). The antigens chosen for use as a vaccine must not induce cross-reactive immune 
responses in the host, and must also retain their antigenicity after modification and 
incorporation into the vaccine. 
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Examples of vaccines to bacterial pathogens include 
· Whooping cough (Bordetella pertussis) – killed bacterium 
· Cholera (Vibrio cholerae) - killed bacterium 
· Tuberculosis (Mycobacterium tuberculosis) - attenuated bacterium (BCG/ M. bovis).  
· Tetanus (Clostridium tetani) – toxoid. 
 
The issue of biological costs and benefits with vaccines should not be overlooked. 
Pathogens may share antigens with the host, such that the host response may be either 
ineffectual (in terms of protection from infection), or damaging to the host. In addition, 
vaccines which are based on attenuated pathogens may not cause illness in a healthy 
individual but may overwhelm an individual whose immune system is compromised. 
 
Vaccination recommendations are outlined below. For further information refer to local 
guidelines such as the Australian Immunization Handbook.  
 
Hepatitis B: 
Demonstrated immunity is essential for dental staff with clinical contact. While the initial 
course of 3 injections gives lifetime immunity in most individuals, boosters may be required 
after a sharps injury if antibody levels have declined below threshold levels. 
 
Hepatitis A: 
The vaccine is recommended for staff who contact risk groups, particularly children, 
refugees, indigenous patients, and patients with disabilities. A combination Hepatitis A and 
Hepatitis B vaccine is available.  
 
Influenza: 
Annual administration of vaccine is needed because of frequent changes to the strains of 
influenza virus. 
 
Combined Diptheria Tetanus (and Pertussis – whooping cough): 
20 year booster injections are recommended as a follow-up to childhood immunization. A 
single booster injection of the adult vaccine diptheria-tetanus-pertussis (DTPa) is available, 
and many adults would have been immunized using a similar “triple antigen” in childhood. 
 
Measles Mumps Rubella (MMR): 
This vaccine uses attenuated viral strains, and requires 2 injections spaced 4 weeks apart. 
MMR should be offered to all staff borne since December 1985 who are either without 
immunization records or who are sero-negative upon screening.  
 
Varicella: 
This vaccine uses an attenuated strain of the virus and requires 2 injections spaced 6 weeks 
apart. It should be offered to all new staff if there is no definite history of chicken pox or 
shingles, or if serological tests for antibodies to the virus are negative.   
 
Poliomyelitis: 
This orally administered vaccine requires boosting following initial immunization in 
childhood. The vaccine is contra-indicated in pregnant females. 
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Tuberculosis: 
Immunization against tuberculosis is no longer a routine requirement, but should be 
considered in staff who work with at-risk populations (e.g. patients infected with HIV). 
BCG vaccine should only be given after Mantoux testing. Repeat Mantoux testing is 





Dental caries is a saliva- and carbohydrate-modified bacterial disease. The caries process 
represents the interaction of many factors over time: 
· salivary factors: flow, pH, F and bicarbonate (HCO3) levels. Reduced salivary flow 
rates result in reduced salivary pH and buffer capacity 
· tooth factors: location, fluoride levels, hypoplasias, etc. 
· plaque factors: amount, composition of plaque – particularly the levels of mutans 
streptococci and other aciduric microorganisms 
· dietary factors: form, frequency, exogenous acid- particularly a high intake of acidic 
foods & drinks which shifts the flora to aciduric organisms 
· oral hygiene: frequency and efficacy, use of F dentifrice – which affects the degree of 
loading of the intra-oral F reservoir 
 
5.1 Lifestyle risk factors for dental caries 
 
For a comprehensive assessment of oral health, primary factors such as dietary intake of 
acidic foodstuffs and fermentable carbohydrates, OTC, prescription and non-prescription 
(traditional or alternative) medicines, must be evaluated. 
 
There is a positive correlation between the frequency of refined carbohydrate intake and 
dental caries as confirmed by the Vipeholm, Hopewood House and other classic studies 
in cariology in the 1940’s and 1950’s. Stephan in 1944 first showed that dental plaque 
exposed to sucrose would rapidly produce acids, with a subsequent rapid drop in pH, 
followed by a gradual recovery toward the baseline plaque pH. It is well accepted that there 
is a direct causal association between the pattern of strong acids produced in response to 
sucrose and caries activity. 
 
With a number of different acidogenic bacteria involved, the final shape of the Stephan 
curve represents the balance between the different metabolic outcomes of this bacterial 
activity.  Thus, a high frequency of intake of fermentable carbohydrates (especially sucrose, 
which is much more cariogenic than glucose and other sugars) will increase the caries rate. 
 
Carbohydrate products that are sticky, retained for long periods in the mouth, or consumed 
with high frequency have a higher cariogenicity than foods that are eliminated quickly from 
the oral cavity. Human pH telemetry studies have consistently shown that subjects who 
consume only three meals a day have short periods of demineralization which are 
counteracted by long periods of remineralization. In contrast, with frequent meal or snack 
periods (grazing behaviour), demineralization cycles will predominate, leading to tooth 
mineral loss. 
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To improve the usefulness of dietary assessment, patient questioning should address 
patterns of snacking or ‘grazing’ behaviour. Regrettably, lifestyle changes in many 
countries have resulted in dramatic increases in the consumption of sugar-containing 
carbonated (“fizzy”) drinks (such as cola drinks and energy drinks), which have a very low 
pH (2.0-3.5) and a high sucrose content (11-14% by weight). These and other dietary 
sources of acid such as fruit juices have a pH lower than the critical pH of apatite (pH 5.5), 
which may contribute not only to an increased caries rate but also to dental erosion. 
 
The importance of the repeated dietary intake of these low pH (acidic) foods is that the 
plaque ecology will change over time, with the ecological pressure favouring aciduric (acid-
tolerant) bacteria, thus increasing the cariogenicity of the plaque, with corresponding drops 
in the growth and metabolism of bacterial species not associated with caries. 
 
For similar reasons, endogenous acid exposure due to eating disorders, chronic gastric 
reflux diseases, or reflux caused by pregnancy or medications, will lower the intra-oral pH, 
and promote higher levels of S. mutans in the plaque biofilm, thus increasing caries risk (as 
well as causing dental erosion). 
 
Some of the key factors are the frequency of sugar exposures and acid exposures between 
meals, where more than >4 hits in either category is very favorable for the initiation and 
progression of dental caries. Patients should keep a 5 day record of everything they put into 
their mouth, so that a risk profile can established. An excellent risk charting system, using a 
‘traffic-light’ analogy to allow easy patient education and recording has been established 
(Ngo & Gaffney, 2005). Patient diet history questions should also include: flavoured milk, 
icecream, yoghurt, chocolate, bakery items (cakes, biscuits), sweet confectionary (lollies, 
jellies), traditional medicines (e.g. Royal Jelly), cough lozenges, fruit bars, dried fruits, 
black cola and other soft drinks, energy drinks, and fruit juices. 
 
Further risks associated with high sucrose consumption include the development of Type 2 
diabetes mellitus and resistance to insulin. Diabetes mellitus is a leading cause of kidney 
failure and blindness, and a major risk factor for death from cardiovascular disease or 
stroke.  
 
Use of milk-based foods, such as cheese (as snacks), since these can prevent or reduce acid 
production. Dairy products, including cheese and milk, can reduce the cariogenicity of 
fermentable substrates, and this has been demonstrated in a variety of animal and in vitro 
systems. Clinical studies have shown that processed cheese is hypo-acidogenic, anti-
acidogenic, and prevents demineralization as well as enhancing remineralization. 
 
Dietary advice to patients should include the following: 
· Dietary restriction of sucrose and other fermentable sugars between meals 
· Dietary replacement of sucrose with poorly fermented / non-fermentable substitutes 
such as maltose, xylitol, sorbitol, sucralose, trehalose and isomalt. Note that 
extrinsic sugars derived from fruit are just as cariogenic as sucrose.  
· Dietary restriction of high starch foods between meals. High starch snack foods 
such as potato chips, donuts, salted crackers remain longer on teeth due to slower 
clearance (compared to low starch, high sucrose foods). Direct breakdown of 
starches by salivary amylase gives total levels of fermentable sugars similar to high 
sucrose confectionary foods. 
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· Dietary restriction of highly acidic foods and drinks, especially soft drinks, energy 
drinks and fruit juices. 
· Use of milk based foods such as low-fat cheese or cheese snacks, which can buffer 
acids and elevate calcium levels. Milk and cheese have been shown to reduce the 
cariogenicity of fermentable substrates through the action of casein 
phosphopeptides (CPP). 
 
Habits –Smoking, Caffeine, Alcohol 
 
Smoking results in reduction in saliva flow via a restriction in blood flow to the salivary 
glands. There is also a local effect of decreasing the oxygen tension in the dental plaque, so 
encouraging the growth of anaerobic pathogenic organisms. Other tobacco habits such as 
tobacco chewing, use of nicotine patches or gums will have the same dose-dependent 
vasoconstrictive effects. 
 
Caffeine intake through various dietary sources (coffee, tea, black cola drinks, energy 
drinks and herbal medicines) may exert a diuretic effect, leading to negative fluid balance 
with significant reductions in resting saliva flow rate and pH. Alcohol has similar diuretic 
and fluid balance effects. 
 
5.2 The biofilm model and ecological catastrophe concept 
 
Dental caries is caused by bacterial species which are both acidogenic (produce acid) and  
aciduric (tolerate acid environments). These species selectively overgrow in low pH 
environments (e.g. high consumption of cola drinks, salivary dysfunction). The organisms 
in cariogenic plaque form a classical BIOFILM, in which the extra-cellular components 
(CHO polymers in this instance) are essential for the long term survival and growth of the 
bacteria under adverse conditions. 
 
The dental plaque biofilm which forms continuously on tooth surfaces, is a critical factor in 
the disease process, because it can mature to become a complex three dimensional structure 
which allows the persistence of the acidogenic and aciduric bacterial species which initiate 
the caries process. 
 
This microbial biofilm is a normal structure, which forms on all surfaces exposed to the oral 
fluids. The first stage of its formation is the deposition of a layer of salivary glycoproteins 
(pellicle), onto which bacteria adhere in a well defined sequence. As the film matures, the 
blend of bacteria and inter-bacterial polysaccharide gel matrix provides a protective 
environment for the bacteria within the plaque. Plaque is a complex mosaic of interrelating 
bacterial micro-environments, and can be described as a sophisticated community (within 
an established infrastructure). 
 
The age and thickness of the plaque biofilm influences the cariogenicity of the plaque. 
Mature plaque has a lower oxygen potential in its deepest aspects, which facilitates the 
growth of facultative anaerobes such as mutans streptococci. These microorganisms can 
produce both intra- and extra-cellular polymers which are a storage vehicle for 
carbohydrates, allowing extended periods of fermentation between meals. By suppressing 
the growth of non-pathogenic bacteria and enhancing the growth of aciduric bacteria, 
frequent intake of dietary fermentable carbohydrates and acidic drinks place ecological 
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pressure on the plaque biofilm. Naturally, peroxide rinses (which raise oxygen levels) and 
sodium bicarbonate rinses (which elevate pH) will have a positive and beneficial effect on 
the supragingival plaque ecology. 
 
A key fact is that repeated conditions of low pH (rather than sugar availability per se), 
select for major bacteria associated with dental caries. The dominance of aciduric 
(acidtolerant) and acidogenic (acid-producing) bacteria results in shifts in the 
demineralization-remineralization balance. This well recognized event has been termed the 
‘Ecological Plaque Hypothesis’ (by Phillip Marsh). 
 
Implicit in this hypothesis is the concept that dental caries can be prevented, not only by 
directly inhibiting the growth of these pathogens, but also by interfering with the 
environmental factors driving the selection and enrichment of these bacteria. Thus, a more 
holistic approach can be taken in disease control and management strategies. 
 
Examples of applying this “ecological manipulation” approach in clinical practice include: 
• Regularly disrupting plaque (through mechanical oral hygiene) to reduce its thickness 
• Avoiding dietary patterns such as frequent snacking or drinking fizzy drinks which place 
ecological pressure on the “healthy” (non-pathogenic) plaque bacteria 
• Discouraging the growth of aciduric bacteria (and encouraging remineralization) by 
increasing the pH of the oral fluids using sodium bicarbonate 
• Avoiding habits which lower oxygen tension (such as smoking) 
• Elevating oxygen levels by using hydrogen peroxide mouthrinses. 
 
It follows from the Ecological Plaque hypothesis, that such manipulation of the oral 
environment will favour the development and persistent of “good” (non-cariogenic) dental 
plaque. This plaque will have limited fermentation capabilities, and any glycolysis will be 
incomplete, resulting in the production of weak organic acids (such as acetic, propionic, 
and butyric acids). These weak organic acids play a vital role in buffering pH changes in the 
plaque biofilm and in so doing, they help protect the tooth from demineralization by strong 
organic acids. 
 
In contrast, “Bad” plaque which is formed in a highly cariogenic environment will ferment 
carbohydrates readily, with glycolysis producing strong organic acids, (such as lactic, 
formic, and pyruvic acids), which will readily demineralize enamel. 
 
Tolerance of low oxygen environments 
 
Mutans streptococci are facultative microorganisms, which can tolerate oxygen levels in 
normal mouth air and in the general atmosphere, but prefer oxygen-poor growth 
conditions. This feature is essential not only to their survival deep within the plaque biofilm 
but is also critical in terms of their favoured growth sites (such as fissures and interproximal 
spaces). 
 
The ability to thrive in an anaerobic environment is also linked to the ability of mutans 
streptococci and lactobacilli to develop dentine carious lesions which do not have obvious 
entry points on the enamel surface. For these so-called lesions of "occult" or hidden caries, 
it is likely that cariogenic mutans streptococci gain access to the dentine-enamel junction 
via lamellae or cracks in the enamel. These lamellae are distributed throughout enamel in 
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both deciduous and permanent teeth. By entering these tooth surface defects, the 
cariogenic bacteria are at a strategic advantage over the host since they are protected from 
saliva and its components as well as oral hygiene and other interventions.  
 
The facultative nature of mutans streptococci explains in part the interaction between 
smoking and caries risk. Smoking creates an anaerobiosis within the oral cavity, and the 
low oxygen environment favours the growth of mutans streptococci. There are two 
additional components involved in the impact of smoking on dental caries. The first is 
salivary dysfunction, which is the result of the pharmacological effects of nicotine on 
salivary gland flow. Reduced flow is linked with reduced pH, which is also a favourable 
parameter for growth. The second factor is the direct effect of nicotine in the salivary 
milieu on mutans streptococci. There is now some evidence that nicotine itself can directly 
affect the growth of Streptococcus mutans, with concentrations of nicotine in the order of 
0.1-1.0 mmol/L able to stimulate growth, although higher concentrations are inhibitory. A 
value of 1.0 mmol/L approximates the salivary levels achieved with some tobacco products, 
including smokeless tobacco. 
  
The tendency for mutans streptococci to occupy an anaerobic ecological niche has an 
interesting consequence in terms of periodontal therapy. It is well known that both 
attachment loss per se and root surface exposure from surgical and non-surgical 
periodontal treatment are associated positively with root surface caries. The susceptibility 
for root surfaces for caries after periodontal therapy has been attributed to a loss of the 
fluoride-rich outer layers of cementum and dentine, however there are two microbial effects 
of periodontal therapy which should also be considered.  
 
First, through soft tissue changes such as recession, the available supragingival area for 
colonization is increased. Even without changes in oral hygiene and diet, this increases the 
ecological niche for mutans streptococci.  
 
Second, the dramatic effects of periodontal therapy on anaerobic bacteria provide an 
additional opportunity which may result in an intra-oral microbial shift during the initial 
phase of the periodontal therapy from a periodontopathogenic toward a more cariogenic 
flora. There is clear evidence that following periodontal therapy, the severity of root 
surface caries is associated strongly with high salivary counts of mutans streptococci. This 
effect is compounded in very elderly patients, in whom polypharmacy causes reductions in 
the resting salivary flow rate and salivary pH, and corresponding increases in both sugar 
clearance time and levels of mutans streptococci.  
 
5.3 Passing into history- the single bacteria concept of dental caries 
 
The work of Walter Loesche, Douglas Brathall and others in the 1970’s led to the specific 
plaque hypothesis which implicated mutans streptococci (MS) as the initiators of dental 
caries. At the time, the lines of evidence taken to support the specific plaque hypothesis 
(SPH) were: 
· MS counts in saliva and plaque were associated with caries incidence and prevalence 
· MS could be isolated from carious sites 
· MS levels correlated with caries progression 
· MS produced extracellular and intracellular CHO polymers 
· It was rare to find caries when MS levels in the saliva and plaque were low. 
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· MS counts in saliva correlated positively although not strongly with past caries (caries 
experience) and future caries (caries increment). 
· MS were acidogenic and aciduric, and this can be demonstrated by acid production by 
plaque both in vivo and in vitro following exposure to fermentable substrates.  
· MS evoked a host immune response involving both IgA and IgG antibodies. 
Immunisation against MS in animal models reduced caries, as did modification of 
MS to delete key pathogenic features. 
 
As we shall see, the SPH concept over-simplified the story and led to a fixation of 
preventive approaches on one organism, whilst failing to recognise that the disease was 
caused by a multi-species biofilm rather than by one or two species of MS working in 
isolation. 
 
Streptococcus mutans is a normal plaque inhabitant. It can produce extra-cellular glucans 
involved in enhancing plaque mass, changing the diffusion properties of the plaque matrix 
and further promoting colonization. Streptococcus sobrinus is very similar in this regard, 
whereas Lactobacilli (discussed below) are recognized as secondary colonizers of cavitated 
lesions and are mainly responsible for caries progression within dentine.  
 
Why dental caries is NOT a specific infection caused by mutans 
streptococci 
 
Since the mid-1970’s when the “specific plaque hypothesis” was first proposed, the key 
pathogens in dental caries have traditionally been considered to be the mutans streptococci 
(MS) family, with S. mutans and S. sobrinus thought to be the major initiators of the 
disease. 
 
Problems with the specific plaque hypothesis for dental caries are many, and in summary 
form include the following: 
• MS levels correlate with caries incidence at the population level, but not necessarily 
at the individual level. MS counts in saliva and plaque are not linearly associated 
with caries incidence in an individual patient, despite evidence for a linear caries 
progression over time. 
• MS negative individuals with coronal or root surface caries can be found, albeit at 
low rates (typically 2 percent). 
• When used as a survey tool for large population cohorts, culture-based tests for MS 
tend to give greater negative than positive predictive values, i.e., they are more 
effective in identifying healthy individuals (low bacterial counts) than patients with 
disease who require treatment. 
• MS counts alone may vary according to the site sampled as well as the caries risk 
status. A study in Dundee which compared the frequency of isolation of S. mutans 
and S. sobrinus from the saliva of 12 month old infants with and without dental 
caries collected saliva samples using the tongue-loop method, for subsequent 
microbiological culture.Of the cohort of 1393 infants, some 39 were diagnosed with 
caries. S. mutans was found at low frequency even in infants with caries, but was 
isolated more often from those infants with caries compared to those who were 
caries-free (29.7 vs 9.8%), however differences in the isolation frequencies of S. 
sobrinus (2.7 vs 1.3%) were not significant. 
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• MS are not unique in the oral flora in being able to secrete glucosyl transferase 
enzymes or in producing extracellular polysaccharides. 
• Many organisms (both bacteria and fungi) in the normal oral microflora are both 
acidogenic and aciduric, and produce organic acids in vitro following exposure to 
fermentable substrates. 
• MS evokes a host immune response involving both IgA and IgG antibodies, but this 
is not always protective. Immunization against MS in some animal models reduces 
the incidence of new carious lesions but does not necessarily eliminate the disease. 
• While cariogenic plaque may contain more than 200 million bacteria per mg wet 
weight, MS counts as a proportion of total plaque bacteria are typically very low 
(1%). 
• Patients who have high levels of both major species of MS (i.e. S. mutans and S. 
sobrinus) tend to have a higher caries rate than those with only one species, but it is 
common to find adult and elderly patients with S. mutans only and not S. sobrinus. 
• There are 300-plus species of bacteria in the non-cultivable normal oral flora in 
humans (i.e. those which at present cannot be grown in the laboratory, but can be 
identified by molecular genetic methods), and many of these are found in significant 
numbers in cariogenic biofilms. 
• There is no obligate requirement for MS in terms of generating a pH drop in 
response to sucrose and other fermentable substrates. Moreover, many bacterial 
species other than MS can grow and survive at pH values low enough to 
demineralize enamel, e.g. Veillonella dispar and Enterococcus faecalis, as well as 
Lactobacillus spp.. 
• There is substantial variation in the microflora at different sub-sites within 
approximal dental plaque. As plaque develops in the interproximal region, MS 
preferentially colonize a specific sub-site below the contact point, at which S. 
mutans is more common than S. sobrinus. S. sobrinus is rarely found in isolation, 
and is more often found in association with S. mutans (if present at all). However, 
S. sobrinus is the more potent of the two species in terms of acid production and 
synthesis of both intra- and extra-cellular polymers. 
• Non-MS aciduric bacteria such as Actinomyces naeslundii are involved in the 
pathogenesis of root surface caries. In root surface caries, neither MS nor 
Actinomyces species secrete collagenases, however proteolytic enzymes originate 
from other biofilm species such as Porphyromonas gingivalis. 
• Strains of MS differ in their virulence traits such as the potential to synthesize 
water-insoluble glucan polymers from sucrose. This is one reason why colonization 
with MS does not always lead to dental caries activity. Strains which synthesize 
small amounts of insoluble glucans show reduced adherence within the biofilm and 
slower accumulation of plaque, with less expression of disease. 
 
5.4 Measuring ecological shifts in dental plaque 
 
The fermentation process (glycolysis) which produces organic acids is a direct result of the 
ecological conditions in the mature plaque biofilm (low pH and low oxygen tension). The 
type and frequency of fermentable carbohydrate in the diet are critical factors, since these 
drive the processes of bacterial fermentation. The organic acids produced from this normal 
metabolic activity of bacteria deep within the plaque biofilm (and thus close to the enamel 
surface), can cause the plaque pH to drop below 5.0 within 1-3 minutes following a sucrose 
exposure.  
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The Plaque-Check test from GC Corporation (invented by this author) allows this process 
to be evaluated chairside in real time using the patient’s plaque and also demonstrated to 
patients as a motivational strategy. Previously this normal metabolic activity of the biofilm 
could not be seen or assessed by the clinician. As facultatively anaerobic microorganisms 
increase numerically, they create a more complex biofilm physical structure by synthesizing 
extra-cellular polymers which give the plaque a sticky, gel-like nature. The thicker the 
biofilm, the more difficult it is for the saliva to buffer the acids produced deep within the 
biofilm.  
 
As already discussed, this mature cariogenic biofilm encourages growth of aciduric and 
acidogenic bacteria. These bacteria ferment carbohydrate substrates, resulting in the 
production of a large number of organic acids. For this reason, clinical assessment should 
not focus on detecting any one particular species of bacteria or a specific acid, but rather 
the entire plaque biomass and the net result of fermentation after sucrose challenge. 
 
The Plaque-Check test kit allows two types of assessment to be carried out. The first is a 2-
tone disclosing reagent that for staining plaque in the mouth. Different retention patterns 
for the two dyes allow the user to determine whether the plaque is “mature” (and thus 
capable of fermentation) or thin (i.e. newly formed).  
 
The second test measures the pH of the total biomass of plaque both before and after 
challenge with a sucrose solution. A low pH result from this fermentation test gives an 
indication of a high level of acidogenic bacteria in the plaque. In this, it is important to 
collect the sample on the disposable collection instruments provided, which allow the 
clinician to ‘scoop’ up the plaque from the tooth surface with the applicator tip, which 
preserves the integrity of the plaque biomass. 
 
Both tests give visible results which are used to educate the patient about the importance of 
daily effective tooth brushing and the dietary patterns which influence the cariogenicity of 
that plaque. Studies of plaque fermentation after sucrose challenge have been undertaken 
over 40 years, however the technology used (intra-oral micro-electrodes) is not suitable for 
everyday clinical use. The Plaque-Check test makes the pH results easily interpreted using a 
traffic-light series of colour changes in a dye. There is a strong correlation between the 
levels of cariogenic bacteria in dental plaque and its acid production as assessed using this 
test. 
 
Repeated falls in the plaque pH below the critical pH of enamel result in demineralization of 
the tooth surface. The cumulative results of the demineralization – remineralization cycle 
dictate whether or not cavitations occur.  
 
Cavitations develop in enamel once the net loss of mineral has exceeded the point where 
the process of re-precipitation of ions from the subsurface reaches the point of exhaustion, 
and catastrophic collapse of the surface occurs. At this point, the white spot becomes a 
cavity. This represents a fundamental turning point in the disease process, since bacteria are 
now able to gain access to the internal aspects of the tooth structure and are protected from 
mechanical oral hygiene by the walls of the newly formed cavity. 
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Saliva can buffer this acid attack and can provide replacement minerals as part of the 
natural repair process. This replacement of minerals through the biofilm into the tooth is 
remineralization. The process of remineralization can be enhanced dramatically through the 
use of bio-mineralizing materials such as casein phosphopeptides-amorphous calcium 
phosphate (CPP-ACP). The development of these materials has heralded a new era in 
prevention, since their use clinically can result in predictable reversal of enamel white spot 
lesions. This has moved the “goalposts” for the treatment of white spot lesions from caries 
arrest to caries reversal. Early ‘white spot’ active lesions which are located beneath thick 
plaque deposits are indicative of the level of current caries activity, while white spot lesions 
which are supra-gingival, not covered by plaque, and associated with healthy gingival 
tissues and gingival recession are likely to be arrested and thus “historical” in nature. 
 
5.5 Transmission of the oral flora 
 
Transmission of oral bacteria including organisms associated with dental caries, from 
mother to child by salivary transfer, has been demonstrated in various studies, through 
behaviours such as kissing, sampling of food, and sharing spoons and other utensils. This 
process has recently been shown to occur in pre-dentate infants, in whom by 6 months of 
age up to 60% of infants have been infected with S. mutans. By the age of 24 months, 84% 
of the infants harbour this organism as part of their normal oral flora (Wan et al, 2001). 
 
Risk factors for early colonization with cariogenic bacteria 
_______________________________________________________   
 




Sweetened fluids taken at bedtime 
Drinking only from bottles 
On-demand formula feeding 
Delayed start for solid foods 
Sucrose exposure more than 3X per day 
Sharing food and utensils with adults 
Regularly kissed on the lips 




High plaque levels 
Sucrose exposure more than 3X per day 
High salivary levels of S. mutans 
________________________________________________________   
Based on Wan et al J Dent Res 2001.  
 
Detailed studies of these transmission events in the early years of life, have shown that early 
colonization and high levels of S. mutans in infants and young children is strongly 
associated with enhanced risk for early childhood caries.  
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Behavioural and lifestyle factors which also contribute to this heightened caries risk 
include: 
•‘Grazing’ eating patterns, with a high frequency of intake of sucrose and other fermentable 
carbohydrates 
• Use of sweetened agents (such as syrups) on pacifiers 
• Intake of acidic fruit juices, cordials and soft drinks (Wan et al, 2003).In addition to 
serving as a source of substrate, these also have an aciduric influence on the flora and can 
exert direct erosive effects on the teeth because of their low pH. 
· A grazing pattern of dietary intake 
· Poor pre-natal nutrition and peri-natal illnesses, which can cause enamel hypoplasia and 
thus predispose the child to early childhood caries. 
 
Because the preferred site for colonization and growth of mutans streptococci are non-
shedding, hard surfaces, it follows that the early introduction of a hard surface into the 
mouth of the pre-dentate infant will provide an alternative site to the teeth for colonization 
of mutans streptococci. This may occur when newborn children with a palatal cleft are 
fitted shortly after birth with a maxillary acrylic appliance to obturate the cleft. Such 
appliances are typically worn until 18 months of age, after which time surgery is undertaken 
to repair the cleft. There is direct clinical evidence that in the pre-dentate environment, such 
an appliance facilitates early colonization of mutans streptococci. A recent study of children 
with oral clefts reported that children wearing an acrylic appliance from shortly after birth 
were colonized earlier with mutans streptococci and lactobacilli than children with clefts 
who did not wear such appliances. Importantly, once significant tooth eruption had 
occurred, the ecological effect of the appliance declined, such that by the age of 18 months 
the prevalence of mutans streptococci was comparable in both groups of children with 
clefts and in the healthy control children. 
 
5.6 Caries risk tests 
 
A. Using MS as surrogate indicators 
 
By acknowledging that MS are no longer regarded as sole or necessarily dominant 
pathogens in dental caries, it follows that assessment of the dental plaque biofilm should be 
based on parameters such as acid production by fermentation under conditions of substrate 
challenge, and perhaps by bacterial growth and survival under conditions of low pH. These 
global assessments will, by definition, be inclusive of all bacteria involved in the caries 
process, and not only MS. Taking a broad approach to the biofilm ecology recognizes the 
so-called “insurance hypothesis”, i.e. that the biodiversity of the biofilm insures it against 
declines in function over time, and makes it more resistant to external stressors.  
 
Because of the properties of the cariogenic plaque biofilm, the presence of MS is still useful 
as a surrogate measure for: 
• Adverse changes in the biofilm ecology driven by low salivary pH,  
• Behavioural factors such as snacking with sucrose, which lower biofilm pH,  
• Lifestyle factors which may transfer significant loads of pathogens to infants by 
salivary microdroplets (such as kissing and on-demand feeding with sweetened 
bovine milk), and 
• Development of a plaque biofilm with tolerance of low oxygen environments. 
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MS are facultative microorganisms, which can tolerate oxygen levels in normal mouth air 
and in the general atmosphere, but prefer oxygen-poor growth conditions. This feature is 
essential not only to their survival deep within the plaque biofilm but is also critical in terms 
of favoured growth sites such as fissures and interproximal spaces. 
 
The ability to thrive in an anaerobic environment is also linked to the ability of bacteria 
involved in dentine caries to survive in the dentine in lesions that do not have obvious entry 
points on the enamel surface. For these so-called "occult" or hidden lesions, it is likely that 
the cariogens gain access to the dentine-enamel junction via lamellae or cracks in the 
enamel. These lamellae are distributed throughout enamel in both deciduous and permanent 
teeth. By entering these tooth surface defects, the cariogenic bacteria are at a strategic 
advantage over the host since they are protected from saliva and its components as well as 
oral hygiene and other interventions.  
 
The facultative nature of MS explains in part the interaction between smoking and caries 
risk. Smoking creates anaerobiosis within the oral cavity, and the low oxygen environment 
favours the growth of mutans streptococci. There are two additional components involved 
in the impact of smoking on dental caries. The first is salivary dysfunction, which is the 
result of the pharmacological effects of nicotine on salivary gland flow. Reduced flow is 
linked with reduced pH, which is also a favourable parameter for growth. The second 
factor is the direct effect of nicotine in the salivary milieu on mutans streptococci. There is 
now some evidence that nicotine itself can directly affect the growth of Streptococcus 
mutans, with concentrations of nicotine in the order of 0.1-1.0 mmol/L able to stimulate 
growth, although higher concentrations are inhibitory. A value of 1.0 mmol/L approximates 
the salivary levels achieved with some tobacco products, including smokeless tobacco. 
 
The tendency for MS to occupy an anaerobic ecological niche has an interesting 
consequence in terms of periodontal therapy. It is well known that both attachment loss per 
se and root surface exposure from surgical and non-surgical periodontal treatment are 
associated positively with root surface caries. The susceptibility for root surfaces for caries 
after periodontal therapy has been attributed to a loss of the fluoride-rich outer layers of 
cementum and dentine, however the microbial effects of periodontal therapy should also be 
considered. Through soft tissue changes such as recession, the available supragingival area 
for dental plaque biofilm is increased. There is clear evidence that following periodontal 
therapy, the severity of root surface caries is associated strongly with high salivary counts 
of MS. This effect is compounded in very elderly patients, in whom polypharmacy causes 
reductions in the resting salivary flow rate and salivary pH, and corresponding increases in 
both sugar clearance time and levels of MS.  
 
A longitudinal study which examined the oral flora in patients with severe periodontitis 
after thorough scaling and root planing in combination with optimal plaque control raises 
some interesting observations. At baseline and after 4 and 8 months, samples were taken 
from the saliva, the tongue dorsum and the supragingival interdental spaces. These samples 
were cultured both aerobically and anaerobically, in order to determine the total number of 
colony forming units (CFU) per sample as well as the numbers of Streptococcus mutans 
and lactobacilli. Although the total number of aerobic and anaerobic CFU in samples from 
the tongue and the saliva remained nearly constant over the 8 month period, there were 
marked increases in the number of S. mutans detected in samples from the teeth, despite a 
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decrease in the total number of anaerobic CFU in samples from the teeth, meaning that the 
relative proportion of the Streptococcus mutans had increased dramatically. Thus, although 
the periodontal conditions improved for all patients, the development of a cariogenic 
plaque biofilm continued. 
 
B. Measuring MS levels at the chairside 
 
Numerous studies over the past two decades have established a strong link between the 
presence of pathogenic bacteria at a young age and greater caries experience. Both cross-
sectional and longitudinal studies of dental caries have established the value of salivary MS 
as a surrogate marker in caries risk assessment. Thus, while not a sole pathogen, 
undertaking periodic (e.g. annual) assessments of MS levels may be useful for identifying 
patients with long-term caries risk in both the primary, mixed and permanent dentitions. 
Today, the range of methods for measuring MS levels includes culture-based tests, 
metabolic tests, antigenic tests such as direct immunoassays, and molecular genetic 
methods. 
 
C. Culture-based tests 
 
Culture-based methods for MS and also for lactobacilli have been available commercially 
for many years, with a wide number of sample collection strategies and culture media being 
suggested as optimal. For culture of oral streptococci, the most common base medium is 
Mitis-Salivarius agar, or Mitis Salivarius agar with bacitracin (MSB). This is inoculated 
with stimulated saliva or dental plaque. In most contemporary culture-based tests, this same 
MSB medium is inoculated with stimulated saliva, which is elicited by chewing small blocks 
of paraffin to dislodge plaque so that it is dispersed into the saliva.  
 
All culture-based tests used in caries risk assessment have several limitations: 
• Live, viable bacteria are necessary. 
• An incubator is required to provide the optimum temperature for growth (37 
degrees Celsius). 
• It takes a substantial time (typically 48 hours) to obtain a result. 
• The shelf life of the kit is limited because of temperature-related decline in some 
components of the growth medium (particularly the antibiotic bacitracin). 
• MSB has been shown to under estimate the actual levels of S. mutans in samples. 
• The growth media are semi-selective and there is little or no discrimination between 
S. mutans and S. sobrinus.  
 
A recent comprehensive assessment of the most suitable culture media for the enumeration 
of S. mutans from clinical samples, undertaken at UQ, determined the specificity and 
sensitivity of five so-called selective media (Wan et al. 2003). Tryptone-yeast-cysteine-
sucrose-bacitracin (TYCSB) was found to be the medium of choice for the isolation of S. 
mutans from saliva samples, giving the best delineation between S. mutans and both S. 
sobrinus and non-mutans streptococci, however this medium is not available currently for 
chairside use.  
 
Culture-based methods of testing for MS 
__________________________________________________ 
Collection methods  Culture media 
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__________________________________________________  
 
Tongue spatula    MSB  
Metal spoon    MSA or MSA-mannitol  
Tongue swab    MSA  
Stamp method    SB20  
Plaque swab    MSB Glass  
Cariescreen    MSB Saccharose  
Modified Cariescreen   MS Sucrose  
Glass adherence   MSS-MUT  
Dip-slide + MSB   MUTV  
Toothpick method   TYC  
Floss method    MST  
Microbrush method   MST Sucrose  
Dentocult Strip mutans   LAPT  
    MKSB  
    TSY20B  
    TYCSB  
_________________________________________________ 
This table lists published variations in culture methods and in culture media for MS. Note that there is no 
relationship between the left and right columns, i.e. different media have often been used with the one 
sample collection strategy. 
 
Confirmation of identity typically requires follow-up biochemical tests conducted in a panel 
using a set of fermentation and enzymatic tests, such as production of acid from N-
acetylglucosamine, arbutin and melibiose, and the presence of alpha-galactosidase and 
alpha-glucosidase activities. 
 
Atmospheric conditions for culture stipulate a low oxygen tension. For clinical samples, 
this often entails using expired air from the mouth, sodium bicarbonate pellets, or depleting 
oxygen using combustion or a catalyst. In contrast, in the laboratory setting, incubation of 
culture plates for mutans streptococci can be undertaken in an anaerobic environment (e.g. 
95% nitrogen and either 5% carbon monoxide or 5% carbon dioxide).  
 
The Snyder test is based upon the fermentation of glucose. The resulting acid production 
lowers the pH of the medium and changes the colour of a pH indicator. This test 
demonstrates total acid production by cariogenic microorganisms but does not delineate 
between mutans streptococci and lactobacilli. A recent modification of this same principle, 
in which the pH-lowering potential of pooled plaque samples was measured in an adapted 
glucose broth showed only a weak association with caries prevalence. In fact, the test 
results showed a greater association with levels of lactobacilli rather than mutans 
streptococci. 
 
Following the work of Krasse in Gothenborg, a selective medium for the cultivation of 
mutans streptococci was developed, Mitis Salivarius Bacitracin (MSB) agar. The inoculum 
is stimulated saliva, which is elicited by chewing small blocks of paraffin to dislodge plaque 
so that it is dispersed into the saliva. Salivary samples are then obtained by inserting a 
specially coated "paddle pop" stick into the subject's mouth, turning it a fixed number of 
times (four) and then withdrawing it so that excess saliva is wiped against the lips. The 
stick is then used to inoculate the MSB medium plate which is incubated anaerobically for 
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24 hours. Colony growth is assessed semiquantitatively based on the density of colonies 
using a visual guide, with a five point scale from 0 to ++++. 
 
A simplified version of this test was produced by using a plastic strip which was covered 
with a film of saliva and then placed into MSB broth containing 30% sucrose to promote 
the adhesion of mutans streptococci to the strip. After culture, the strip can be dried and 
the number of colonies in a specified area counted. The results for this simplified "strip 
mutans" test correlate well with those from the "paddle pop" technique.  
 
For culture of oral streptococci, the most common base medium is Mitis-Salivarius agar, or 
Mitis Salivarius agar with bacitracin (MSB). This is inoculated with stimulated saliva or 
dental plaque. For mutans streptococci, the CRT tests can be used. These employ a mitis-
salivarius-bacitracin medium. Mutans streptococci grow in the medium and adhere to the 
test strip, appearing as coloured colonies. The companion test kit for lactobacilli, the 
“Dentocult LB” relies upon the growth of colonies on agar strip. Recently both MS and 
lactobacilli tests have been placed on either sides of one double-sided strip (the CRT). 
 
Sampling methods for culture-based tests 
 
An important variable in culture-based methods is the requirement for viable organisms, 
which replicate to form colonies. For precise measurement of colony forming units (CFU), 
standardized conditions of culture are required. This makes both clinical and field studies 
problematic in that storage and transport of growth media may influence viability and thus 
colony counts. 
 
As summarized in the Table above, there are several possible methods of sampling which 
can be used when estimating levels of MS in the oral cavity: 
 
• Direct sampling of plaque (e.g. overlying carious lesions) using an absorbent cotton 
tip or sponge 
• Sampling of stimulated whole saliva using a plastic stick or wooden spatula which is 
then withdrawn through the lips, as in the "strip mutans" method 
• Collection of stimulated whole saliva in a cup, the contents of which are then 
poured over a solid agar growth medium or used to inoculate a liquid culture  
• Sampling of unstimulated saliva using an absorbent cotton tip or sponge (e.g. in 
neonates) 
• Sampling of both unstimulated saliva and plaque using an absorbent tip which is 
gently rubbed over the dorsum of the tongue, alveolar ridges, and labial and lingual 
surfaces of all erupted teeth (e.g. in young children) 
• Sampling from the dorsum of the tongue using a loop which is drawn across the 
surface, based on work which shows that levels of MS in whole unstimulated saliva 
correlate significantly with levels in debris collected with a loop from the dorsum of 
the tongue.84   
• Sampling from the dorsum of the tongue using a wooden tongue depressor, which 
is then impressed directly onto culture plates.  
• An oral rinse using a fixed volume of transport medium, which is then used as the 
inoculum. 
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Sampling of the stimulated saliva is preferred because of its simplicity, however it must be 
stated once more that salivary levels are a surrogate measure for plaque levels of cariogenic 
bacterial species. While organisms from plaque will be dispersed into the saliva by chewing, 
deeper portions of the plaque biomass, particularly the less aerobic environments in fissures 
and interproximal spaces, will contribute relatively less to salivary levels by simple 
mechanical dispersion during chewing. It is for this reason that salivary counts and levels in 
plaque do not correlate absolutely.  
 
There is also the effect of surface area, in that an increase in the available hard surfaces will 
tend to result in elevated counts simply because hard surfaces are the preferred ecological 
niche for mutans streptococci. This is amply demonstrated by reports of dramatic increases 
in salivary levels of mutans streptococci following the placement of orthodontic brackets, 
from work at UQ.  
 
C. Antigen-specific assays 
 
These tests utilize highly specific monoclonal antibodies, giving absolute specificity for the 
bacteria of choice, e.g. S. mutans or S. sobrinus. These antibodies can be used in number of 
diagnostic methods, including immunofluorescence, flow cytometry, latex agglutination, 
immunoblots and solid phase immunoassays. The former methods are laboratory-based, 
while immunoassays have been brought to clinical application in dental practice.  
 
The GC Saliva-Check SM ™ uses a combination of three highly specific anti-S. mutans 
monoclonal antibodies (SWLA-1, 2, and 3),87,88 to increase binding and reduce the 
detection limit to 100,000 bacteria per mL of saliva, which is the recognized level for 
increased caries risk. The tests are undertaken at chairside within a short time frame, and 
no special apparatus or techniques are required. Unlike culture-based tests, viable bacteria 
are not needed. Samples of saliva are collected and reacted with buffers to establish a 
constant pH (and thus charge for proteins), and detergents, for proper dispersal of the 
sample. The sample is then placed on a strip of nitrocellulose or other suitable material 
which is impregnated with monoclonal antibodies, which trap S. mutans bacteria, triggering 
a detection reaction. Because this is complete within 5 minutes, the results can be discussed 
with the patient at the same appointment. Control reactants ensure that the detection 
chemistry is working properly, allowing the clinician to interpret a negative result with 
confidence. 
 
Such tests are particularly useful for tracking transfer of MS from mothers to infants, as 
part of assessing strategies designed to reduce the risk of early childhood caries. Using such 
tests provides data which agree with conventional cultural tests, but within the same 
appointment rather than after several days. Typical results with immunoassays reveal that 
one third of an adult population would have levels above 100,000 per mL, and that a small 
proportion of the population would have more than one million per mL. In a large study 
conducted by Wenyuan Shi et al. at UCLA in which nearly 2,000 human saliva samples 
were examined using the three species-specific monoclonal antibodies to detect and 
quantify S. mutans levels in human saliva, values ranged from less than 10,000 to a high of 
36 million cells/mL. Over 15% of the saliva samples examined had counts over 500,000 
cells/mL. 
 
D. Molecular methods 
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Contemporary laboratory studies for analyzing cariogenic plaque typically employ 
molecular methods with specific primers for 16S rRNA genes and amplification in the 
polymerase chain reaction (PCR), for example, competitive PCR, nested PCR, and real 
time PCR, with the latter giving the most rapid results. While giving accurate bacterial 
counts down to low detection limits of 100 organisms or less, because these methods 
require DNA extraction and complex thermo-cycling equipment, they cannot be used in the 
dental office setting. 
 
5.8 The incipient lesion 
 
Because the development of surface cavitation is a late stage in the caries process, there are 
opportunities to intervene in the process to arrest and reverse the lesion, before committing 
to restorative procedures. The number of pre-cavitation white spot carious lesions typically 
exceeds the number of clinically detectable cavitated lesions by a considerable margin, so 
one needs to have a high index of suspicion when discovering a frank cavitation, as it often 
represents the “tip of the iceberg” in terms of sites with disease present. 
 
The “International Caries Detection and Assessment System” (ICDAS), which is now in its 
second version aligns everyday clinical practice and clinical epidemiology. The ‘D’ in 
ICDAS stands for detection of dental caries by (i) stage of the carious process; (ii) 
topography (pit-and-fissure or smooth surfaces); (iii) anatomy (crowns versus roots); and 
(iv) restoration or sealant status, whilst the ‘A’ in ICDAS stands for assessment of the 
caries process by stage (non-cavitated or cavitated) and activity (active or arrested). 
 
The ICDAS approach categorizes six stages in the carious process: ranging from the early 
clinically visible changes in enamel caused by demineralization, through to extensive 
cavitation, as follows:  
 
• Code 0 = Sound 
• Code 1 =  First Visual Change in Enamel (seen only after prolonged air drying or 
restricted to within the confines of a pit or fissure) 
• Code 2 = Distinct Visual Change in Enamel 
• Code 3 = Localized Enamel Breakdown (without clinical visual signs of dentinal 
involvement) 
• Code 4 = Underlying Dark Shadow from Dentine 
• Code 5 = Distinct Cavity with Visible Dentine 
• Code 6 = Extensive Distinct Cavity with Visible Dentine 
 
ICDAS has separate aspects covering coronal caries (pits and fissures, smooth surfaces), 
root surface caries, and caries-associated-with-restorations-and-sealants (CARS), although 
for simplicity the discussion here will omit the latter. A full description of ICDAS can be 
accessed on the web at http://www.dundee.ac.uk/dhsru/news/icdas.htm . 
 
A primer on ICDAS methodology 
 
Using the ICDAS approach for coronal caries, the first step is to classify each tooth surface 
as to being sound, sealed, restored, crowned, or missing. It is important to differentiate 
between fully and partially sealed tooth surfaces, since partially sealed tooth surfaces may 
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be at a higher risk of developing caries compared with sound or fully sealed surfaces. 
Sound surfaces (code 0) include those with developmental defects such as enamel 
hypoplasias; fluorosis; tooth wear (attrition, abrasion and erosion), and extrinsic or intrinsic 
stains. 
 
At the earliest stage of caries, a tooth surfaces may have a ‘first visual change in enamel’ 
(ICDAS code 1), which is defined a little differently for pits and fissures compared with the 
same condition on smooth tooth surfaces. A code 1 lesion fissure is not present when the 
tooth surface is wet, but is evident after air drying for 5 seconds. At this stage of dental 
caries on occlusal surfaces, 55% of the lesions are either sound or confined to enamel, and 
45% are in the outer one-third of dentine On smooth tooth surfaces, these lesions are only 
seen clinically when the tooth surface is dry, and they cannot be seen clinically when the 
surface is wet with saliva.  
 
The next stage (ICDAS code 2) is called ‘distinct visual change’. At this stage, the lesion is 
non-cavitated, and can be seen when the tooth surface is wet with saliva. On pits and 
fissures, these lesions are wider than the confines of the pit or fissure area. Histologically, 
the majority of these lesions either extend to the deeper half of enamel or into the outer 
third of dentine. For proximal lesions, when viewed from the occlusal direction, the opacity 
or discoloration may be seen as a shadow confined to enamel, seen through the marginal 
ridge. 
 
When a tooth surface shows signs of localized enamel breakdown because of caries, but 
with no visible dentine or underlying shadow, the caries process has advanced to stage 3 
(ICDAS code 3). To confirm the visual assessment of a code 3 lesion in a fissure, a 
periodontal probe can be slid gently across the tooth surface, noting if the probe tip drops 
into the surface of the enamel cavity/discontinuity (note that sharp probes are not used).  
 
The next stage (ICDAS code 4) represents those lesions where there are underlying 
shadows indicating that the carious demineralization has progressed into dentine, the 
dentine is discolored, and the enamel surface is un-supported by the dentine. The shadowed 
appearance is often seen more easily when the tooth is wet. The darkened area has an 
intrinsic shadow which may appear as grey, blue or brown in colour.  If the cavitation 
exposes dentine, then the carious process has progressed into a stage referred to as ‘distinct 
cavitation’ (ICDAS code 5). There will often be visual evidence of demineralization at the 
cavity margins, (opaque/ white). A cavity that destroys at least one half of a tooth surfaces 
is referred to as ‘extensive’ (ICDAS code 6). 
 
For root surface lesions, Code 1 is a clearly demarcated area on the root surface or at the 
cemento-enamel junction (CEJ) that is discoloured (light/dark brown, black) but there is no 
cavitation, where as Code 2 has the same appearance but there is cavitation (loss of 
anatomical contour = 0.5 mm). The characteristics of the base of the discolored area on the 
root surface can be used to determine whether or not the root caries lesion is active or not. 
These characteristics include texture (smooth, rough), appearance (shiny or glossy, matte 
or non-glossy) and perception on gentle probing (soft, leathery, or hard). Active root caries 
lesions are usually located within 2 mm of the crest of the gingival margin. 
 
When early (pre-cavitation) lesions are found, a decision should be made as to their likely 
activity. For active lesions, the surface of the enamel is whitish/yellowish opaque with loss 
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of lustre, and feels rough when the tip of a blunt probe is slid gently across the surface. 
Active lesions will be in a plaque stagnation areas, e.g. near the gingival and proximal 
surfaces below the contact point. If cavitated, in active lesions the cavity will feel soft or 
leathery on gently probing the dentine. For inactive lesions, the surface of the enamel can 
be whitish, brownish or black. The enamel may be shiny and feel hard and smooth when the 
tip of the probe is slid gently across the surface. For smooth surfaces, inactive caries lesions 
are typically located at some distance from the gingival margin. 
 
In detecting lesions at the pre-white spot or white spot stage, where preventive approaches 
can be brought to bear, the complexities of clinical decision making need to be borne in 
mind. The table below outlines some of the challenges for detection of lesions at various 
stages. Where white spots are present, gently drying the area will increase the contrast with 
the adjacent normal enamel and make these easier to display to the patient.  
 
Detection of the coronal carious lesion 
Stage of lesion 
development 







Not visible with the unaided eye. Insight gained from saliva tests (e.g. resting 
pH) – for the oral environment - and plaque 
fermentation tests – for the site of the lesion. 
Ancillary information can be obtained from 
assessments of salivary microflora (as a 
surrogate measure). 
Early subsurface 
loss (code 1) 
Pre-white spot. 
Not visible with the unaided eye 
on a moist tooth surface, but 
appear when tooth surface is 
dried. 
Blue-green light induced fluorescence using 
curing light and orange filter shows these as 
dark areas. Inspektor QLF system can image 
and record these for follow-up over time.  
White spot lesion 
(code 2) 
Visible on clinical visual 
examination of moist tooth. 
Presence of overlying mature 
plaque deposits also informative.  
Digital bitewing radiographic images with 
software assistance, and DI-FOTI (enhanced 
fiber optical transillumination) useful for 
detecting and recording proximal lesions. 
Enamel cavitation 
(code 3) 
Smooth surface lesions visible 
with mirror/probe. Proximal 
lesions show limited correlation 
with radiographic appearance. 
Diagnodent pen useful for confirming 
cavitation of proximal surfaces, using 
fluorescence from bacteria. 
Lesion in dentine 
(code 4) 
Occult lesions beneath occlusal 
surfaces difficult to detect. 
Diagnodent is a useful adjunct to careful 
inspection of occlusal surfaces. 
 
Light induced fluorescence is a powerful and simple tool for aiding clinical diagnosis of 
white spot lesions. Green and blue visible light elicit yellow fluorescence from healthy 
dental enamel, which can be seen if a composite curing light (LED, plasma arc or quartz 
tungsten halogen) is used to irradiate the tooth, and it is viewed through an orange 
protective perspex shield (or orange protective glasses). Because the fluorescence signal 
arises predominantly from apatite minerals, loss of fluorescence occurs when mineral is lost 
from enamel. The same principle is used in the Inspektor ™ system (Inspektor Dental Care, 
Amsterdam), which records the lesions. Software such as Inspektor™ Pro (Omni™ 
Pharmaceuticals) can then be used to calculate the mineral loss – for comparison after using 
remineralizing treatments. Another commercial QLF system is the QLF pro (Omnii 
Pharmaceuticals, USA), however most clinicians will find that using blue light with a filter 
provides the desired utility at low cost compared with the purpose built QLF systems. If 
images of this fluorescence are taken with a digital camera (fitted with an orange filter), the 
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images can quantified using software. This can help when discriminating carious white spot 
lesions from fluorosis, and possibly from other enamel opacities. 
 
Clinical approaches for maximum interception 
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White spot carious lesions are typically found beneath mature deposits of dental plaque, 
which produce organic acids through fermentation. A fermentation test (such as the GC 
Plaque Check + pH) is useful for assessing plaque cariogenicity at a particular site, and 
using this to educate and inform the patient regarding diet, lifestyle factors and oral 
hygiene. White spots and pre-white spots (seen with fluorescence but not visible under 
normal lighting conditions) can be screened for, paying particular attention to known risk 
sites, such as adjacent to brackets in patients with fixed orthodontic appliances. These areas 
can then be treated with topical CPP-ACP (GC Tooth Mousse ™) or CPP-ACFP (GC 
Tooth Mousse Plus ™) to reverse the subsurface mineral loss, and achieve a normal enamel 
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translucency. Preventive care of this type is indicated for all non-cavitated enamel lesions 
on smooth surfaces – including proximal surfaces.  
 
A recent large scale clinical trial conducted in Melbourne by Mike Morgan et al. (pubished 
in Caries Research, 2008) has demonstrated the value of CPP-ACP for lesion arrest and 
reversal, even in patients who live in fluoridated areas and who are using traditional 
preventive approaches, including a fluoride dentifrice, and access to professional dental 
care. In this trial, the radiographic progression and regression of dental caries was tracked 
in 2720 adolescents who used a chewing gum containing 54.4 mg CPP-ACP (Recaldent ™ 
gum) over a two-year period. The control group received an identical gum without CPP-
ACP. Subjects were instructed to chew their assigned gum for 10 minutes three time each 
day. Standardised digital radiographs taken at the baseline and at the completion of the trial 
using the Dexis digital X-ray system were scored by a single examiner, and assessed for 
proximal caries at both the enamel and dentine level. The CPP-ACP gum slowed the 
progression of carious lesions compared with the control gum, while fewer surfaces 
experienced caries progression, relative to the normal sugar-free gum used as the control. 
 
There are several unique challenges with proximal smooth surfaces – the plaque biofilms 
environment ecologically is more amenable to the development caries than other smooth 
surfaces, because of low pH, low oxygen tension, and poor access to saliva. It is difficult to 
access proximal surfaces for mechanical oral hygiene, and for visual examination or tactile 
exploration. Augmentation of clinical mirror/blunt probe examinations with bitewing 
radiographs is routine, however one must remember that the correlation between 
radiographic appearance and the histological extent of caries on proximal surfaces is 
imperfect. Devices such as fiber optic illumination and the Diagnodent pen (with its 
periscope tip) can play a valuable role here, when making decisions about how to manage 
radiolucencies which extend to or just beyond the DEJ. 
 
Occlusal surfaces are accessible for examination, but are often obscured by plaque and 
extrinsic stains. The enamel is damaged by forceful probing with sharp sickle probes, so 
probes used to examine occlusal surfaces should be blunt and the probing forces light. It 
may be necessary to use a powder abrasive cleaner to remove stains in order to see the 
surface details. The presence of opacity at the entrance to a fissure or pit (i.e. extending 
into the lateral fissure walls) is the anatomical equivalent to a white spot lesion on a smooth 
surface, but this feature cannot be seen unless the occlusal surface is clean and dry. The 
relatively poor access of deeper parts of occlusal fissures to saliva makes these areas 
unlikely to remineralize spontaneously. For fissures that have been cleaned of plaque and 
stains, the use of quantitative laser fluorescence for the presence of bacteria (Diagnodent) 
allows an estimate of the extent of caries to be gained – since lesions which have reached 
the dentine give strong fluorescence signals (above 30-35).  
 
Once cavitation of enamel has occurred, restorative procedures are necessary, however this 
should be accompanied by preventive home care advice. Rapid chairside tests which can 
give results during a clinical consultation can provide useful data to assist the clinician in 
providing this preventive advice, and for educating the patient. 
 
 
5.8 Cavitated lesions 
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Two distinct zones in carious dentine 
____________________________________________ 
· Affected dentine:  
· Intact collagen matrix,  
· Intact micro-structure,  
· No bacteria,  
· Vital and responsive to stimulation,  
· Remineralisable 
  
· Infected dentine:  
· Disordered dentine structure (no tubules),  
· Bacteria present,  
· Not remineralisable,  
· Non-vital and non-responsive. 
______________________________________________ 
 
With bacterial penetration of the enamel and cavitation, the bacterial ecology within the 
cavity changes resulting in demineralization of the dentinal tubules collagen framework and 
proteolysis (by proteolytic bacteria). The resultant structureless denatured layer is known 
as the infected layer and cannot be remineralized. The softened demineralized affected layer 
lies ahead of this proteolysed infected layer and is distinguished by an intact collagen 
framework which can be remineralized from the pulpal fluids or from external sources 
(such as biomimetic materials). Studies over the past 50 years have shown that the affected 
dentine layer can be stabilized if it is isolated from the oral environment. Massler and 
Brannstrom both found that isolation of the caries from the oral environment and 
elimination of bacteria will bring about stasis in the carious lesion. Mertz-Fairhurst also 
demonstrated that a lesion can be arrested for many years following isolation with an 
adhesive material, while Handlemann showed that sealed lesions which are radiographically 
evident did not progress over a 10 year period. 
 
The affected dentine can be regarded as “pre-carious” rather than actively carious. This 
layer should be retained and remineralized under most circumstances, reducing unnecessary 
removal of tooth structure. The optimal clinical approach can then be best summarized, as 
removal of the infected dentine only, dressing the dentinal wound by sealing the cavity for 
pulp protection and restoration of the functional anatomy with compatible materials. In othr 
words, every effort should be expended to bring about healing of the affected layer (of 
dentine) rather than its removal. 
 
The concept of dentine healing is supported by in-vivo studies showing calcium, phosphate, 
fluoride and strontium ions from the glassionomer material being incorporated into the 
remineralized dentine matrix of affected dentine. Access is gained to the lesion through 
removal of enamel around the margins of the cavitation and debridement is carried out of 
the surface of the internal lesion to remove the infected dentine and clean the walls around 
the complete circumference of the lesion sufficiently to expose sound healthy dentine. Glass 
ionomer materials such as FUJI VII™ can be placed over the affected layer and covered 
with a thick layer of FUJI IX™. This will allow ion exchange adhesion and the 
development of a chemical seal between the restoration and the tooth. 
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The term “Minimally Invasive” (MI) Dentistry can be defined as the management of dental 
caries with a biological/medical approach, as compared to traditional operative dentistry 
which is based on surgical and mechanical principles, focuses on the end results of the 
disease (cavitations), but does not address the disease process itself which precede this. 
 
The MI approach has been developed because of the many failures associated with 
traditional operative dentistry. Traditional diagnosis involves detecting carious lesions at a 
late stage (frank cavitation) and then restoring these cavities, usually with a G.V. Black 
cavity preparation and the use of amalgam or composite. Unfortunately, removing the 
evidence of the disease does not stop the disease process from continuing at other sites. In 
other words, placing dental restorations does not ‘cure’ caries. No restoration can be 
considered permanent. In fact, unless the ongoing causes of the disease are addressed, 
restoration failure from recurrent caries is highly likely, and this premature failure results in 
on-going restoration replacement, with resulting larger and larger cavities, and weakening 
of tooth structure. To overcome this, the caries disease process needs to be managed in 
partnership with the patient and over the lifetime of the patient. 
 
Dental caries is a complex diet and saliva- modified multi-factorial bacterial disease which 
results from alterations in the plaque biofilm and the ionic interactions between saliva, 
plaque fluid, and dental enamel. Recognizing that the formation of cavities in the teeth is an 
end result of the dental caries disease process, the goal of Minimally Invasive Dentistry is 
to arrest (or reverse) this disease process, to maximize the healing potential of the dental 
hard tissues and then to restore lost structure and function with biomimetic materials. 
 
For the infected dentine, several direct anti-microbial strategies exist: 
· Carisolv (NaOCl + NaOH + amino acids) 
· Laser ablation using Er:YAG and Er.Cr:YSGG lasers (heat sterilization) 
· Dye photosensitization techniques and direct ozone therapy (dyes that produces 
reactive oxygen species when activated by light) 
· Antibacterial properties of zinc oxide eugenol, glass ionomers and calcium hydroxide. 
 
Carisolv involves the application of a chemical solution to the caries, selectively softening 
the carious dentine, facilitating its removal with mechanical hand instruments and without 
affecting sound non-carious dentine Carisolv can be used alone, or in combination with 
other methods that may be required to gain access to the lesion. This method is particularly 
suitable for root surface caries and large cavitated coronal cavities. It has the advantage of 
not usually requiring the use of local anaesthesia. 
 
With middle infra-red lasers, the mechanism of hard tissue removal is basically an 
explosive subsurface expansion of the interstially trapped water, with the rapid ejection of 
tooth particles in the opposite direction from the incoming laser beam. As carious tooth 
structure has a higher water content than sound tooth, it is rapidly and effectively removed 
by the laser energy. Lasers have the advantages of reduced need for anaesthesia (a laser 
analgesia effect), have a low annoyance factor (less noise and vibration than rotary 
instrumentation) and leave the cavity surface suitable for adhesive restorations.  
 
Destroying the bacteria present within a carious lesion or changing the ecological niche to 
encourage remineralization, are current topics of research. These treatment approaches are 
especially applicable to open lesions such as root caries which cannot be sealed and where 
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the caries process will continue unchecked. Examples of methodologies that could be 
considered under this grouping are Ozone and Photo-activated disinfection (PAD). 
 
Ozone (O3) is a powerful oxidizing agent which bio-oxidizes molecules. It disrupts the cell 
walls of microorganisms (bacteria and viruses) within seconds, leading to immediate 
functional cessation. O3 also attacks many biomolecules such as the cysteine, methionine 
and histidine residues of proteins, and changes the surface ecology of root surface carious 
lesions. It oxidizes lactate and pyruvate to acetate, thus raising the pH of the affected 
dentine and increasing its micro-hardness over time. Using these features, ozone has been 
used for arresting incipient root surface caries lesions.  
 
Photo-activated disinfection (PAD) is a method of disinfecting or sterilizing a site 
(tissues, wounds and lesions of the oral cavity) by topically applying a photosensitizing 
agent (a dye) and irradiating the site with laser light at a wavelength absorbed by the 
photosensitizing agent. Destruction of the microbes occurs without damage to other tissues 
at the site. The low power laser energy in itself is not particularly lethal to bacteria, but is 
useful for photochemical activation of the dye.The photosensitive dyes release reactive 
oxygen species which cause membrane and DNA damage to the microorganisms. The 
oxygen free radicals from this process are broken down readily by catalase (present in all 
tissues and peripheral blood) and lactoperoxidase (in saliva). PAD does not give rise to 
deleterious thermal effects on teeth or soft tissues. PAD has been shown to be effective for 
killing bacteria in complex biofilms, which are typically resistant to the action of 
antimicrobial agents. It can be used effectively in carious lesions, since visible red light 
transmits well across dentine. Major clinical applications of PAD include disinfection of 
root canals, periodontal pockets, and sites of peri-implantitis, as well as deep carious 
lesions. Typical PAD systems use diode lasers with a wavelength of 635 nm and tolonium 
chloride as the photosensitizing dye. Trials of such systems (e.g. Denfotex SaveDent) show 
the capability of rapidly and effectively sterilize the floor of deep carious lesions (and into 
dentine to 1.0 mm), allowing more conservative approaches to the removal of 
demineralized and infected tooth structure. Of note, PAD is still able to exert significant 
effects even when the cariogenic organisms are protected in a matrix of demineralized 
dentine. 
 
5.9 Prevention of dental caries 
 
Put simply, effective caries prevention (and indeed the reversal of incipient carious lesions) 
occurs when the balance between protective and pathological factors favours repair. These 
protective factors include salivary calcium, phosphate and the related phosphoproteins, 
salivary flow, fluoride in saliva, and antibacterial components.  
 
Key physiological factors that modulate the plaque microflora include the local pH, redox 
potential (eH), and nutrient availability. This is amply demonstrated in the increases in 
mutans streptococci and lactobacilli occur at sites with caries. As previously discussed, 
growth of these organisms is enhanced selectively at low pH. It follows that a key 
preventive strategy is to reducing the frequency of low pH in plaque. This could be 
achieved by:  
 
 
· Restriction of fermentable substrates 
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· Inhibiting acid production, e.g. using high concentrations of fluoride 
· Using non-fermentable sugar substitutes, e.g. xylitol 
· Using alkalinizing mouthrinses and reducing acidic drinks in the diet 
· Promoting alkali generation, e.g. from arginine or urea supplements. 
 
The challenge here is that mature dental plaque is a highly ordered structure with numerous 
metabolic interactions between bacteria. The microbial community may have achieved a 





Saliva affords both static protective effects, which act continuously, and dynamic effects, 
which act during the time-course of a challenge. Salivary buffering and sugar clearance are 
important dynamic effects of saliva which prevent demineralization. Comparing these two 
effects, buffering of acids is the most important as it is linked directly with enhanced 
remineralization. The site distribution of lesions of dental caries and dental erosion 
demonstrates the level of protection offered by the salivary film. Sites of predilection for 
dental caries and dental erosion are those where exposure to saliva is limited, such as 
fissures and proximal sites followed by cervical surfaces for dental caries.  
 
Because saliva contains a number of antibacterial systems, reductions in resting salivary 
output allow plaque biofilms to grow without restraint. Immunoglobulin A (IgA) is a major 
component of saliva proteins, and is able to aggregate bacteria and prevent adhesion. IgG 
and other immunoglobulins derived from the gingival crevice is also present in saliva, 
however little complement fixation is possible in saliva as levels of key complement 
components are too low. The contribution of gingival crevicular fluid to resting salivary 
flow is very small, in the order of 10-100 µL/hr. 
 
The enzyme amylase can inhibit the growth of some species of bacteria. Lysozyme breaks 
down the peptidoglycan in the cell wall of some Gram positive bacteria, including 
Streptococcus mutans. Lactoperoxidase catalyzes the oxidation of salivary thiocyanate by 
hydrogen peroxide to the toxic molecule hypothiocyanite, which inactivates bacterial 
enzymes. 
 
Histatins are histidine-rich proteins which inhibit the growth of Candida albicans and 
Streptococcus mutans. Lactoferrin binds ferric ions and thereby inhibits bacteria from 
gaining the essential nutrient of iron. It can be degraded by some bacterial proteases. The 
related molecule apolactoferrin also exerts antimicrobial effects on a range of 
microorganisms, including Streptococcus mutans. 
 
In terms of dental caries, a particularly important role is played by the salivary buffer 
systems. In the healthy state, the pH of resting saliva is maintained in a narrow range 
between 6.7 and 7.4. The bicarbonate (HCO3-) buffer system is the major buffer system 
present in saliva. As in the peripheral blood, the combination of sodium bicarbonate, 
carbonic acid, and gaseous carbon dioxide is an effective means of removing protons 
(hydrogen ions) from the system. When considering the dynamics of this buffer system, it 
should be remembered that saliva has a higher level of dissolved carbon dioxide than 
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normal room air (5% vs. less than 1 %), and is present in saliva both as bicarbonate (H2O + 
CO2 ?  H2CO3 ?  HCO3- + H+ ) as well as dissolved CO2 gas.  
 
The concentration of bicarbonate ion in resting saliva is approximately 1 mmol/L, and this 
increases to over 50 mmol/L upon stimulation. As the concentration of bicarbonate ion 
increases, so does the pH and the buffer capacity of the saliva. This is a key point in 
interpreting salivary diagnostic tests. Because of diurnal variations in resting flow rate, 
there are corresponding variations in levels of bicarbonate and thus in the pH and buffer 
capacity. The resting pH will be lowest during sleep and immediately upon waking, and 
then increases during the waking hours.  
 
As bicarbonate levels in the saliva increase, this will not only increase salivary pH and 
buffer capacity, and facilitate remineralization, but will also exert ecological effects on the 
oral flora. Specifically, higher salivary pH will suppress tendency for aciduric (acid tolerate) 
microorganisms to grow, particularly cariogenic mutans streptococci and Candida 
albicans.  
 
Mastication of foods and chewing gum is a powerful stimulus of the secretion of sodium 
bicarbonate into the parotid saliva. Strong acids are powerful gustatory stimuli of salivary 
secretion, as can be seen clinically when residues of phosphoric acid or acidulated fluoride 
products contact the tongue. Salt, sweet and bitter are less effective stimulants of salivary 
secretion than acids. While a reflex of increased salivary flow in response to acids has an 
obvious protective function in normal individuals, the stimulatory effect of acids has little, if 
any, therapeutic value in patient care. In fact, frequent use of citric acid-based drops or 
sweets to stimulate salivary flow is contra-indicated in patients with salivary gland 
dysfunction because of the limited buffer capacity of their saliva.  
 
Phosphate also contributes to the buffering capabilities of saliva, particularly in the resting 
saliva situation. A range of proteins in the saliva play a minor role in buffering. In addition 
to these proteins, peptides such as sialin assist by promoting the production of amines 
(which exert an alkalinizing effect) from enzymatic breakdown of salivary proteins and by 
oral bacteria. Similarly, urea in the saliva can be broken down to ammonia. 
 
Chewing gum stimulates salivary flow, and thereby augments its protective properties (e.g. 
clearance, buffering, pH, and supersaturation with minerals). Chewing sugar-free gum 
elevates plaque pH and thus favours mineralisation. This natural repair can be enhanced by 
including phosphopeptides in the gum, as has been shown by Eric Reynolds and colleagues 
who assessed demineralised slices of enamel mounted in intra-oral appliances with 
Recaldent ™ gum containing CPP-ACP. 
 
Protective properties of saliva that increase on stimulation on salivary flow include salivary 
clearance, buffering power, and degree of saturation with respect to tooth mineral. These 
benefits are maximized when saliva is stimulated after the consumption of fermentable 
carbohydrates, by reducing the fall in plaque pH leading to demineralization and by 
increasing the potential for remineralization. When gum is chewed to stimulate saliva after 
a carbohydrate intake, plaque acid production is neutralized, and incipient lesions in enamel 
are remineralized. 
 
pH modification by alkalinizing agents 
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As noted earlier, increases in caries risk can occur when the intra-oral pH is reduced 
because of salivary dysfunction or through the consumption of acidic drink. Using pH 
elevating measures, such as chewing sugar-free gum and sodium bicarbonate rinses can 
raise intra-oral pH and prevent such changes occurring, or reverse them completely to 
suppress the growth of acid tolerant bacteria within the plaque biofilm. Use of fluoride-
containing toothpastes with sodium bicarbonate, which result in significantly less plaque 
acid formation after a sucrose challenge than a conventional (adult-strength) fluoride 
toothpaste. Rinsing with sodium bicarbonate solution, to both buffer plaque acids and 
reduce the aciduric environment. Buffering effects from saliva or mouthrinses may add to 
the buffer systems already present in plaque, such as soluble proteins, peptides, organic 
acids, and phosphate. For these reasons, in patients with ongoing salivary dysfunction, 
routine use of sodium bicarbonate rinses to buffer plaque acids and reduce the aciduric 




It is well established that fluoride works primarily via a series of topical mechanisms. At 
lower concentrations, fluoride inhibits demineralization and enhances remineralization, and 
this is the major mode of action of fluoride in drinking water and in fluoride-containing 
dentifrices. Sub-ppm levels of fluoride in saliva are effective in shifting the balance from 
demineralization to remineralization, through fluoride-enhanced precipitation of calcium 
phosphates, and the formation of fluorhydroxyapatite in the dental tissues. Low fluoride 
levels are found in saliva after toothbrushing with fluoride containing dentifrices. 
 
Low concentrations of fluoride ions are present in saliva and accumulate in dental plaque 
when it is thin. These low levels (0.1 ppm and less) are consistent with healing and 
remineralization of early caries lesions. The reason for this is that the natural repair process 
of remineralization occurs when calcium and phosphate from saliva together with fluoride 
enter the subsurface region of a white spot lesion and form a new veneer on the existing 
crystal remnants in the lesion. Because the dynamic balance between demineralization and 
remineralization determines the end result, dental caries is reversible, if detected early 
enough. 
 
Higher levels of fluoride can influence bacterial metabolism. Fluoride levels of up to 40 
ppm can inhibit glycolytic fermentation of sugars by plaque bacteria, while high fluoride 
products (such as high fluoride toothpastes and gels) can impair energy utilization and thus 
acid production via the fermentation process, with its effects on the two enzymes enolase 
and H+/ATPase. At levels of 0.5 mmol fluoride/L within plaque fluid, the cell cytoplasm of 
mutans streptococci is acidified, and glycolysis glycolysis is inhibited once the intracellular 
pH reaches pH 5.2. It has been estimated that the effects on bacterial metabolism account 
for 75% of the caries-inhibiting effect of high concentrations of fluoride, with the remaining 
25% due to the combined effect of fluoride on enamel solubility. High levels of fluoride 
(0.16-0.3 mol/L) will kill bacteria, and these may be achieved through topically applied 
professional products such as gels and varnishes. This effect supervenes the inhibition of 
bacterial enzymes and reduced utilization of fermentable substrates, and provides a broad 
anti-plaque effect.  
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There is accumulating evidence that using glass ionomer cement as a cavity liner or bulk 
restorative material can suppress cariogenic microorganisms by achieving high levels of 
fluoride release. Recent clinical studies have examined bacterial counts in carious dentine 
under resin-modified glass ionomer cement (RM-GIC) and amalgam restorations over a six 
month or two year period. Patients with clinically and radiographically diagnosed occlusal 
dentine caries in molar teeth underwent a minimal procedure in which the overlying enamel 
was removed to allow the underlying carious dentine to be sampled in the region just 
beneath the dentinoenamel junction. The teeth were then restored without further removal 
of carious dentine, and re-evaluated after 6 months or 2 years, after which time all caries 
was removed and a permanent restoration placed. While both materials showed a 
substantial decrease in numbers of mutans streptococci and lactobacilli over the course of 
the study, the greatest effect occurred with the RM-GIC.  
  
In contrast, the same degree of antimicrobial effect from fluoride released from glass 
ionomer cement restorations does not occur on the exposed surface of the material. Studies 
of fluoride concentrations in dental plaque on 12 month old Class III RM-GIC restorations 
have shown relatively low fluoride levels, with no corelation between the levels of mutans 
streptococci and lactobacilli in the plaque and  fluoride concentrations in the plaque. 
 
High levels of mutans streptococci (as assessed from sampling stimulated saliva) are a 
major contributor to caries risk. For both amalgam and composite resin restorations, 
recurrent caries remains the major reason for failure. Direct analysis of lesions of secondary 
caries in extracted teeth using antibodies to Streptococcus mutans and immunofluorescence 
labelling has shown that this organism is present widely in lesions of secondary caries 
around amalgam restorations. Several studies have shown that tooth factors (choice of 
material, tooth type and cavity design) have only a minor effect on restoration failure, and 
that it is patient factors, particularly caries risk, that must be monitored and managed to 
ensure the longevity of restorations. Recent studies of posterior composite resin 
restorations placed in general practice noted that caries risk was the major determinant of 
restoration failure over a five year period. 
 
Fissure sealing and Tooth surface Protection 
 
More plaque accumulates on the occlusal surfaces of erupting molars compared to fully 
erupted molars with occlusal function. Most plaque forms on the distal and central fossa of 
erupting molars. This is due to the difficulty of gaining effective oral hygiene, with the 
pericoronal tissue sheltering the surface, the adjacent erupted tooth making access difficult, 
and the low occlusal height of the erupting molar. As a consequence, most carious lesions 
are initiated in the distal and central fossa during eruption. The amount of plaque on 
occlusal surfaces of erupting molars, compared with erupted molars with full functional 
wear, explains why almost all occlusal caries in molars is initiated during the extremely long 
eruption period (12 to 18 months) and why occlusal caries is less common in premolars, 
which have an eruption period of only 1 to 3 months. 
 
Sealants applied to the grooves of the posterior teeth can prevent the growth of biofilm into 
the fissures. For maximum value, they should be applied immediately after the eruption of 
the posterior teeth – a challenge because of the presence of an operculum andcrevicular 
fluid. Erupting and newly erupted teeth also present a problem because the carbonated 
apatite structure (Ca10-x (Mx)(PO4)6-y(CO3)yOH2), is a more soluble form of apatite 
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than hydroxyapatite. To address these issues, a new concept, that of “tooth surface 
protection” for erupting teeth was developed by Drs. Hein Ngo and Geoff Knight (from 
Australia) in conjunction with GC Corporation Japan, in which a high fluoride release glass 
ionomer material (GC FUJI VII ™ ) is applied to the complete surface 
of the erupting tooth. In thin layers of half a millimetre or less, this glass ionomer cement 
acts as a semi-permeable membrane, enabling the transfer of calcium, phosphate, fluoride 
and strontium ions into the enamel, whilst also protecting the underlying tooth and also 
making it more resistant to further acid dissolution.  
 
In contrast, when a newly erupted tooth is sealed with a composite resin, the carbonated 
enamel is isolated from the oral environment and the process of maturation from a 
carbonated apatite to fluoroapatite is prevented. These outer layers are then susceptible to 
acid attack if the fissure sealant breaks-down and starts to leak. 
 
The effectiveness of resin-based fissure sealants has commonly been related to the longevity 
of sealant coverage i.e., clinical retention in the fissures. While sealant retention studies 
show conflicting results between resin sealants and glassionomer sealants, the key issue is 
caries prevention and not clinical retention of the sealant per se. Recent studies show that 
the use of high viscosity glassionomer materials (e.g.: GC FUJI IX ™ and 3M-Espe 
KETAC Molar™) give a caries preventive effect of 3 to 4.5 times higher after 3-5 years, 
compared with resin sealants. Importantly, even if GIC fissure sealant is lost, these high 
strength glassionomer materials give a 4 times higher caries preventing action in re-exposed 
pits and fissures of occlusal surfaces in first molars, compared to light cured composite 
resin fissure sealants over a 1-to -3 year period. This suggests a continuing anti-cariogenic 
effect from microscopic residues of glass ionomer cement, even after macroscopic loss, 




Xylitol is a naturally occurring polyol which is taken up by mutans streptococci but is not 
fermentable. Numerous studies have documented the non-cariogenicity of xylitol, however 
more recently attention has been directed to the effects of prolonged consumption of xylitol 
on mutans streptococci. A recent clinical trial demonstrated that chewing a xylitol gum 
three times daily for a minimum of five minutes each time for three months resulted in a 10 
fold reduction in salivary levels of mutans streptococci, and by doing so extended the 
suppressive effect of chlorhexidine therapy in these same patients. One important advantage 
of this approach is that it is suitable for maintaining long-term suppression of pathogens 
without concerns of safety with prolonged use. 
 
Habitual consumption of xylitol in the diet appears to select for mutans streptococci with 
impaired adhesion properties, i.e., they bind poorly to teeth and shed easily from plaque to 
saliva. Capitalizing on this feature, a recent clinical study investigated whether regular 
consumption of xylitol by the mother could interfere with mother-child transmission of 
mutans streptococci. In the study group, all 169 mothers showed high salivary levels of 
mutans streptococci during pregnancy. The mothers in the xylitol group (n = 106) were 
requested to chew xylitol-sweetened gum (65% xylitol w/w) at least 2 or 3 times a day, 
starting three months after delivery. In the two control groups, the mothers were treated 
with either a chlorhexidine varnish (n = 30) or a fluoride varnish (n = 33) at 6, 12, and 18 
months after delivery. The children did not chew gum or receive varnish treatments. 
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Salivary levels of mutans streptococci in the mothers remained high and not significantly 
different among the three study groups throughout the study. At two years of age, 9.7% of 
the children in the xylitol, 28.6% in the chlorhexidine, and 48.5% in the fluoride varnish 
group had detectable levels of mutans streptococci. Thus, habitual xylitol consumption by 





Casein phosphopeptides (CPP) are naturally occurring molecules which are able to bind 
calcium and phosphate ions and stabilize amorphous calcium phosphate (ACP). This 
nanotechnology combines specific phosphoproteins from bovine milk with forming 
nanoparticles of amorphous calcium phosphate (ACP). The precise ratio is 144 calcium 
ions plus 96 phosphate ions and 6 peptides of CPP. The nano-complexes form over a pH 
range from 5.0 to 9.0. Under neutral and alkaline conditions, the casein phosphopeptides 
stabilize calcium and phosphate ions, forming metastable solutions that are supersaturated 
with respect to the basic calcium phosphate phases. The amount of calcium and phosphate 
bound by CPP increases as pH rises, reaching the point where the CPP have bound their 
equivalent weights of calcium and phosphate. 
 
Within milk, the casein phosphopeptides stabilize calcium and phosphate ions through the 
formation of complexes. The calcium phosphate in these complexes is biologically available 
for intestinal absorption, and the same concept has now been applied to create materials 
with bio-available calcium and phosphate in the appropriate form and molecular ratio for 
remineralization of subsurface lesions in enamel. Clusters of phosphorylated seryl residues 
are responsible for the interaction which occurs in bovine milk between the caseins and 
calcium phosphate, and this in turn results in the formation of casein micelles.  
 
Under acidic conditions, CPP are able to release calcium and phosphate ions and thereby 
maintain a state of supersaturation with respect to tooth enamel, reducing demineralization 
and enhancing remineralization. The delivery of CPP or complexes of CPP and ACP to the 
plaque fluid can be achieved by a range of vehicles, including chewing gums, dentifrices 
and topical gels. CPP binds well to dental plaque, and is able to slow or prevent the 
diffusion of calcium ions from enamel during episodes of acid challenge, and serve as a 
source of calcium for subsequent remineralization. CPP also impair binding of mutans 
streptococci to dental plaque and to tooth surfaces, and exert ecological efefcts by 
elevating plaque calcium levels. 
 
Typical CPP-ACP products are Recaldent gum and GC Tooth Mousse, while the fluoride-
containing form (CPP-ACFP) is GC Tooth Mousse Plus. This is now an extensively 
researched technology, with more than 45 published studies in the dental literature, 
including 18 on the widely known topical tooth crème GC Tooth Mousse™/ MI Paste ™, 





Chlorhexidine is regarded as the "gold standard" as a mouthrinse or topical treatment for 
suppressing mutans streptococci. It can be delivered to the oral cavity using a range of 
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products, including mouthrinses, gels, dentifrices, chewing gums, and varnishes.  Cervitec 
is a varnish which contains 1% chlorhexidine (CHX) and 1% thymol. It has been 
extensively investigated for use in suppressing mutans streptococci in children with high 
salivary counts of these organisms and high caries risk.  The degree of success achieved in 
terms of caries prevention (i.e. reduced caries increment) is dependent on the degree of 
microbial suppression achieved.  
 
A recent clinical study of four dental varnishes on the colonization of cariogenic bacteria on 
exposed sound root surfaces compared the effect of Cervitec varnish with a thymol varnish 
(control), and the two fluoride varnishes Fluor Protector and Duraphat. One varnish was 
applied to three buccal root surfaces in each patient at baseline and after 1 week, and 
plaque from the root surfaces was assessed at baseline, after 1 week, 1 month and 6 
months.  Cervitec varnish caused a significant reduction in the levels of mutans streptococci 
in dental plaque on the root surfaces at 1 week and 1 month relative to baseline. The effect 
was relatively selective in that numbers of total streptococci and lactobacilli were not 
affected significantly by treatment with Cervitec. The fluoride varnishes and the thymol 
control varnish did not influence microbial counts.  
 
Unlike fluoride, chlorhexidine does not affect directly the ionic reactions of 
remineralization, but rather exerts its effects solely on the cariogenic microflora. This effect 
explains why the action of a chlorhexidine varnish on plaque may result in a halo effect 
which is some distance from the site of the varnish itself. In a recent clinical trial of varnish 
systems, volunteers wore discs of bovine dentine fixed onto partial dentures for 12 weeks. 
In subjects with a high mineral loss rate, both Cervitec and a 1:1 mixture of Cervitec and 
Fluor-Protector (which contains 0.1% fluoride) inhibited demineralization both at the site 
of varnish application itself and at the periphery, while Fluor Protector gave a larger, albeit 
localised inhibitory effect on mineral loss. 
 
Chlorhexidine (CHX) is particularly useful as part of caries control because it is highly 
effective against aciduric oral bacteria (both MS and lactobacilli). CHX has been used in 
rinse formulations for caries control since the 1970’s, following the seminal work of Walter 
Loesche, Bo Krasse and others. When using CHX, MS are suppressed rapidly (1000 fold 
reduction with one treatment) but then levels re-establish over time and thus intermittent 
use is required. 
 
In addition to its uses in caries control, CHX has established applications as an oral hygiene 
aid in periodontal care, as a pre-procedural and post-surgical rinse, for home care in 
assisting plaque control, in the management of oropharyngeal fungal infections, as an 
adjunct in management of respiratory tract viral infections (to prevent secondary infection), 
and in the treatment of halitosis.  
 
 
LJ Walsh : Microbiology 75 
Advantages of CHX in caries control 
__________________________________________________________________ 
· High effectiveness (control of plaque and gingivitis as well as caries) 
· Acceptable toxicological profile 
· Very poorly absorbed from GIT if ingested accidentally 
· No significant development of resistance 
· Allergy uncommon when used topically 
· Limited effect on GIT flora 
· No problems have been noted during long term use in institutional settings. 
______________________________________________________________ 
 
Problems with CHX mouthrinses 
_________________________________________________________ 
· Compliance problems 
· Taste dysfunction 
· Staining – Teeth, Tongue, Restoration margins 
· Increased calculus formation 
______________________________________________________  
 
Since transmission of oral bacteria to children is inevitable, improving parental dental health 
with a community based education and maintenance approach is important to help reduce 
the dental caries rate in children. Regular (daily) use of chlorhexidine gel has been shown to 
interfere with acquisition of mutans streptococci in infants and young children (Wan et al, 
2003). Chlorhexidine has been used for the past 35 years in the treatment of caries with 
varying degrees of success. While the literature is somewhat mixed on the success of 
chlorhexidine when used in isolation to prevent dental caries, its performance as an 
antimicrobial against Streptococcus mutans is very consistent and powerful. For adult 
patients, current recommendations for chlorhexidine usage in high risk patients are for 
weekly use of a 0.2% gel (0.5 mL) or mouthrinse (20 mL) once per week, to suppress 
levels of mutans streptococci within the dental plaque biofilm (Walsh, 2000; Anderson, 
2003). 
 
Essential oil mouthrinses 
 
Essential oils have a greater antimicrobial effect on mutans streptococci than on other 
streptococci, however their effects on mutans streptococci are modest compared with 
chlorhexidine. Clinical studies in which subjects rinsed twice daily for 30 seconds with 20 
mL of Listerine have shown limited effects on levels of recoverable Streptococcus mutans 
in supragingival interproximal plaque and in saliva. After 12 days, there was a reduction of 
75.4% in recoverable S. mutans in plaque, and 39.2% in saliva. It is unclear whether these 
reductions will translate into reductions in caries incidence over the long term if Listerine is 




Unlike chlorhexidine which has dramatic effects on mutans streptococci and lesser effects 
on non-cariogenic bacteria, triclosan suppresses Gram-negative anaerobes (particularly 
periodontopathic organisms) to a greater extent than Gram-positive bacteria. 
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Replacement therapy 
 
The concept of replacement therapy is to allow a non-pathogenic strain to occupy the 
ecological niche of the pathogen. This could be undertaken by temporarily suppressing 
mutans streptococci with chemical agents or antibiotics, and then substituting genetically 
modified Streptococcus mutans or Streptococcus sobrinus. Potential targets for 
modification include: 
 
· Deletion of the glucosyltransferase enzymes (B/C/D), which synthesize water-insoluble 
glucan through the hydrolysis of sucrose.  
· Deletion of the phosphoenolpyruvate-dependent phosphotransferase system (PTS). 
This is the major source of carbohydrate transport (Honeyman & Curtiss, 2000). 
The transported carbohydrates are fermented to produce large amounts of lactic 
acid which initiates dental caries.  
· Creation of recombinant strains which have urease enzymes. These enzymes hydrolyze 
urea to ammonia, which can neutralize plaque acids. This has been undertaken using 
the urease operon derived from Streptococcus salivarius. Rats infected with the 
recombinant strain and fed a cariogenic diet with drinking water containing 25 mM 
urea had relatively high levels of oral urease activity, as well as dramatic decreases 
in the prevalence of smooth-surface caries. The alkalinizing effect of urease activity 
influenced the plaque biochemistry and metabolism in a manner that reduced 
cariogenicity in this animal model. 
· Deletion of lactate dehydrogenase, which prevents lactic acid generation from the 
metabolism of carbohydrates. This approach has been used successfully at the 
University of Florida to generate a Streptococcus mutans supercolonizing strain. In 
this instance, the lactate dehydrogenase enzyme was replaced with alcohol 
dehydrogenase. The strain has been shown to be of low cariogenicity in rodent 
models, and is able to displace the existing Streptococcus mutans strains. This strain 
holds promise for the replacement therapy of dental caries in humans. 
 
Vaccines to MS 
 
These can be designed to stimulate specific types of immune responses: an ingested vaccine 
will elicit mucosal immunity (salivary sIgA) via the gut (via gut associated lymphoid 
tissues- GALT), while an injected vaccine will activate a systemic immune response (IgG 
etc in gingival crevicular fluid). sIgA may prevent colonisation, while IgG and IgM can 
opsonise mutans streptococci (i.e. enhance phagocytosis). 
 
The earliest candidates for caries vaccines include glucosyltransferases (GTF) which 
sythesise water-insoluble extracellular glucans, the glucan-binding domain of GTF, and 
surface adhesion receptors such as fimbriae and adhesins (which allow the bacteria to 
attach to pellicle or hydroxyapatite). Studies in rodents and primates have shown modest 
efficacy with both mucosal and systemic approaches which elicit salivary IgA and serum 
IgG antibodies, respectively. 
 
Caries vaccines for humans pose several significant concerns: 
· Because of differing mechanisms of immunity between humans and rodents, animal 
results may not be extrapolated directly to humans. 
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· The vaccine must elicit sufficient levels of antibody which are protective, thus the 
epitopes selected must be both immunogenic and linked to virulence factors. 
· The appropriate time for administration will be early in life. 
· Boosters will likely be required. 
· There must be no potential for cross-reactivity with human tissues (particularly cardiac 
tissue). 
· Community acceptance of vaccination programs may not be high. 
· The overall cost-benefit assessment may not be favourable when compared with other 
caries control measures. Since the prevalence of caries is reducing in many parts of the 
industrialized world, other techniques may be better suited to such populations, 
whereas vaccines may be better suited to those developing countries where the 
prevalence of caries has increased dramatically in recent years.  
 
To avoid problems of immunogenicity with whole bacteria and intact extracellular enzymes, 
recent candidate vaccines for dental caries have used small peptides which replicate the 
active sites of enzymes. The most successful vaccine candidates at present appear to be 
peptide constructs from the catalytic (CAT) and glucan-binding (GLU) regions of the 
mutans streptococcal glucosyltransferase (GTF) enzymes. Recent animal studies using the 
rat model have shown that co-immunization (CAT-GLU) resulted in high levels of serum 
IgG and salivary IgA antibody levels in rats. Serum IgG antibodies are able to inhibit S. 
sobrinus GTF-mediated insoluble glucan synthesis and give greater reductions in dental 
caries than after immunization with either CAT or GLU peptides alone. These small 
peptides appear to be a simple alternative to intact GTF for enhancing protective immunity 
against mutans streptococci.  
 
A vaccine against dental caries developed at Guy's Hospital in London has been  
undergoing phase II clinical trials. This vaccine is delivered topically and provides 
protection through mucosal immunity for up to 12 months. The vaccine is produced in 
green plants using the tobacco mosaic virus to generate "plantibodies".  
 
 
6. GRAM POSITIVE BACTERIA 
 
6.1 Disease associations 
 
Diseases associated with Gram positive cocci include: 
 
· viridans family of oral streptococci - subacute bacterial endocarditis (SBE) 
· Strep. pyogenes - skin infections, rheumatic fever, pharyngitis 
· Strep. agalactiae - neonatal meningitis 
· Enterococcus faecalis – endodontic infections, SBE  
· Staph. aureus - abscesses, toxic shock 
· Staph. epidermidis - nosocomial (hospital-based) infections 
· Staph. saprophyticus – urinary tract infections (UTI) in young women 
 
Infections associated with Gram positive rods include:  
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A. Spore forming organisms 
· Bacillus anthrax - anthrax 
· Clostridium tetani – tetanus  
· C. botulinum – botulism  
· C. perfringens - gas gangrene 
· C. difficile - colitis 
 
B. Non-spore forming organisms 
Listeria monocytogenes - meningitis 
Actinomyces israelii - actinomycosis 
Corynebacterium diptheriae - diptheria 
 
6.2 Classification of streptococci 
 
Classification of Gram positive cocci on the basis of catalase activity allows easy distinction 
between the major families of streptococci and staphylococci. The major group of catalase 
negative cocci are the Streptococci, which are responsible for a range of diseases 
(pharyngitis, tonsillitis, lymphadenitis, mastoiditis, rheumatic fever, dental caries). Gram 
positive cocci which are catalase positive, and also Hugh & Liefson fermentative, are 
Staphylococci. Amongst the staphylococci, S. aureus is coagulase positive, while other 
staphylococci are coagulase negative. 
 
Oral streptococci produce a range of extracellular enzymes and products. A major 
classification is based on the ability of organisms to haemolyse red blood cells (RBC) when 
grown on blood agar plates – hence the terminology of alpha and beta haemolytic 
streptococci. Serological (antigenic) classification of streptococci is termed the Lancefield 
classification. Most pyogenic streptococcal infections (90%) are caused by Lancefield 
group A beta haemolytic streptococci. 
 
Pneumococcus (Alpha Haemolytic) 
S. pneumoniae - lobar pneumonia 
 
Group A (Beta Haemolytic) 
S. pyogenes – tonsillitis, scarlet fever 
 
Group B (Beta Haemolytic 
S. agalactiae 
 
Group D (Variable haemolysis) 
Enterococcus faecalis - endodontic infections, urinary tract infections 
 
Viridans group (Alpha Haemolytic or negative) 
S. mitis  
S. salivarius 
mutans streptococci family: (S. mutans, S. sobrinus, S. rattus, S. cricetus, S. ferus, S. 
downei, S. macacae 
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Normal Gram positive oral flora 
 
Gram positive cocci   (A= anaerobic, F= facultative, O = aerobic) 
 
· Streptococci (F) 
· Staphylococci (F) 
· Micrococcus (F) 
· Peptostreptococci (A) 
 
Gram positive rods 
 
· Actinomyces (A) 
· Lactobacilli (F) 
· Propionbacteria (A) 
· Bacterionema (F). 
 
6.3 Viridans streptococci and bacterial endocarditis 
 
Viridans is the term given to the so-called “indifferent” group of streptococci in the 
oropharynx. The organisms have mixed characteristics - most are alpha haemolytic but 
some are beta and some are negative. The group comprises four species groups:  
· mutans (MS family),  
· salivarius,  




Aetiology of subacute bacterial endocarditis (SBE): Bacteria responsible are: 
35% cases -  viridans streptococci (VS) 
25% cases -  skin staphylococci (S. aureus and S. epidermidis)  
13% cases -  S. faecalis. 
 
Bacteria released during dental procedures settle on damaged heart valves in patients with 
some pre-existing endocardial pathology. Turbulence leads to deposits of fibrin and 
platelets. VS settle in these areas (vegetations). 
 
Risk factors for SBE are: 
· Aortic valvular disease 
· Mitral valve insufficiency 
· Ventricular septal defects 
· Patent ductus arteriosus 
· Valve prostheses (synthetic or porcine) 
· Coarctation of aorta 
· Previous infective endocarditis. 
 
SBE treatment: High dose bactericidal antibiotics to eradicate bacteria, delivered IV over 
several weeks (the dense biofilm of the vegetation protects bacteria from the action of the 
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antibacterial agents so extended treatment is necessary). Because of scarring, the site is 
prone to recurrence. 
 
SBE prevention: In addition to prophylactic antibiotics for indicated procedures, 
· Mouthrinsing with chlorhexidine before treatment 
· Good dental hygiene to reduce treatment needs and also self-induced bacteraemias. 
 
Various bodies have issued guidelines for appropriate use of antimicrobial agents for at risk 
patients. There are significant differences between recommendations issued in the United 
States and in Australia, and the advice given changes from time to time. Current guidelines 
(March 2008) do not segregate patients into categories but rather use 2 grams of 
amoxycillin one hour before the appointment as the standard protocol. These guidelines 
differ from those overseas where antibiotic prohhylaxis for such patients has ceased. 
 
In complex cases, it is always prudent to discuss the requirements with the patient’s 
physician (cardiologist, haematologist, etc.). This individual will have information on the 
patient’s recent use of antibiotics and other medications, as well as specific conditions 
which will alter the approach used.  
 
It should be remembered that antibiotic prophylaxis poses risks which need to be discussed 
with the patient, in relation to the risks/benefits of SBE: 
· Allergy to the antibiotic 
· Development of resistance 
· Gastro-intestinal upsets 
· Drug interactions 
· e.g. with oral contraceptives 
· with other antibiotics – penicillins must not be used with other agents which inhibit 
protein synthesis eg. tetracyclines, erythromycin, clindamycin. 
 




· Skin rash 
· Type I hypersensitivity - which can lead to fatal anaphylaxis 
· Gastro-intestinal problems 
· Nausea and vomiting 
· Diarrhoea 
· Colitis – which can be fatal 
· Intestinal candidiasis 
· Rarer conditions 
· Erythema multiforme 
· Liver pathology (drug-induced hepatitis; jaundice) 
· Anaemia, thrombocytopaenia, agranulocytosis 
· Toxic epidermal necrolysis. 
 
LJ Walsh : Microbiology 81 
6.4 Lactobacilli 
 
Lactobacilli are Gram positive rods which grow in chains. Lactobacilli occur naturally on 
vegetation and fruits, in milk, and in the normal flora of the body. They constitute by mass 
approximately 1% of the oral flora, and they are an important component of the normal 
flora of the female genito-urinary tract, where they help to maintain slightly acid pH 
conditions in the vagina to inhibit the growth of pathogens. Lactobacilli are used 
extensively in food production (e.g. yoghurt, pickles) and also play a role in food spoilage 
(souring of wines). 
 
Important properties of lactobacilli can be summarised as follows: 
· Can utilise carbohydrates (CHO) and produce lactic acid in large amounts 
· Are not proteolytic, but are highly saccarolytic 
· Are acidogenic (produce acid) and aciduric (tolerate low pH environments) 
· Can grow aerobically but grow even better anaerobically 
· Ferment glucose to primarily (95%) lactic acid, and traces of acetic acid 
· L. casei and L. plantarum grow better at low temperatures 
· L. acidophilus grows better at higher temperatures 
· L. fermentum produces ethanol and carbon dioxide as well as lactic and acetic acids. 
 
It is thus normal to find some lactobacilli in saliva. Oral lactobacilli are divided into 
homofermentative species, including Lactobacillus paracasei and Lactobacillus 
rhamnosus, and heterofermentative species such as Lactobacillus fermentum. All three 
species are frequent isolates from carious lesions in dentine. Current culture based tests for 
salivary levels of lactobacilli use modifications of the dip-slide method developed in the 
1970's, which does not differentiate between these various species. 
 
Lactobacilli play a secondary role in the pathogenesis of dental caries. They are highly 
saccharolytic, and can utilise carbohydrates (CHO) as an energy source. Their growth 
characteristics are similar to MS in that they can grow aerobically but prefer anaerobic 
(oxygen-poor or oxygen-free) conditions. Lactobacilli are not only acidogenic, but like MS 
are also aciduric, i.e. they tolerate low pH environments which are unfavourable to other 
microorganisms. Lactobacilli also contribute to the plaque biofilm through the synthesis of 
high molecular weight D-glucose polymers, named glucans, from sucrose. These polymers 
provide both a protective matrix for plaque bacteria, and serve as a source of fermentable 
substrates. The glucansucrase enzymes responsible for polymer synthesis by lactobacilli can 




Actinomyces are Gram positive rods which are microaerophilic to anaerobic. Their rod 
forms serve as colonisation foci in dental plaque – which results in the classical corn cob 
appearance.  
· A. israelii. Commensal. Potential pathogen- wound infections, actinomycosis 
· A. viscosus. Commensal. Plaque formation. 
· A. naeslundii. Commensal. Rarely pathogenic. 
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6.6 Staphylococcus aureus and the skin flora 
 
The microbial flora of the skin comprises 3 groups of organisms: 
· Resident flora 
· Transients which are acquired from skin contact with other persons or animals, or 
contaminated surfaces or objects 
· Pathogenic species associated with suppurative skin infections. 
 
Transients are removed easily by normal handwashing, whilst resident organisms are 
suppressed but not removed by handwashing, even when antiseptic solutions are used. 
Pathogens (such as MRSA, Pseudomonas aeruginosa, Herpes simplex) persist until skin 
lesions heal. The resident flora account for the majority of post-surgical infections of skin 
wounds. The risk of wound infection is influenced by the:  
· Dose of pathogen (inoculum) 
· Virulence of the pathogen 
· Host resistance 
· Duration of the surgical procedure 
· Techniques used for wound closure and wound drainage. 
 
S. aureus is part of the normal flora of the skin and nostrils (anterior nares), and the 
organism can be isolated from the nares, hands, axillae, and perineum.  
 
S. aureus is an important cause of epidemic infections in hospital environments, and can 
cause post-surgery wound infections with acute abscesses in both superficial sites (skin) as 
well as deep tissues (lung, brain). Other infections caused by S. aureus include furuncles 
(boils) and osteomyelitis.   
 
The organism has developed resistance against methicillin and other antibiotics (MRSA). 
Identification of strains of MRSA is by bacteriophage typing – the phages cause bacterial 
lysis. S. aureus has a carriage rate of 50% in most adult populations (sampled via nostril 
swabs), and is transmitted in hospital setting through 
· Direct hand contact  
· Poor hygiene practices (lack of handwashing) 
· Environmental contamination of surfaces 
· Inhalation (from patients with MRSA pneumonia). 
 
Using triclosan for handwashing reduces transmission in hospital settings. Triclosan has 
good activity against staphylococci but is not active against Pseudomonas aeruginosa and 
is not sporicidal. 
 
Risk factors for MRSA include: 
· Admission to intensive care 
· Prolonged hospitalisation 
· Previous antibiotic therapy 
· Immune compromised state. 
 
Mechanisms of antibiotic resistance in MRSA are: 
· synthesis of beta-lactamase (inactivates penicillins and other beta-lactam antibiotics) 
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· modification of the site of antibiotic binding.    
 
The problem of beta-lactamase has led to the development of agents such as clavulanic 
acid, which is an irreversible inhibitor of many beta-lactamase enzymes.   
 
7. GRAM NEGATIVE BACTERIA 
 
7.1 Disease associations: Infections mediated by Gram negative bacteria 
 
Aerobes 
· Bordetella pertussis - whooping cough 
· Brucella abortis – brucellosis in cattle 
· Legionella pneumophila - Legionnaire’s disease, Pontiac fever 
· Neisseria gonorrhoeae - gonorrhoea 
· Neisseria meningitidis - meningitis 
· Branhamella catarrhalis – pneumonia 
· Pseudomonas aeruginosa – infections of surgical wounds and burns, urinary tract 
infections, respiratory infections 
 
Facultative anaerobes 
· Eschericia coli - diarrhoea, urinary tract infections, septicaemia 
· Salmonella typhimurium – salmonellosis (food poisoning) 
· Shigella dysenteriae - dysentery 
· Enterobacter aerogenes – urinary tract infections 
· Haemophilus influenzae - meningitis 
· Vibrio cholerae - cholera 
· Yersinia pestis - bubonic plague 
 
Microaerophilic Gram negative organisms 
· Campylobacter fetus - septicaemia 
· Campylobacter jejuni- enteritis 
· Campylobacter rectus – periodontitis (associated with not causal) 
· Helicobacter pylori - gastric ulceration 
· Bacteroides fragilis - abscesses 




· Porphyromonas species (gingivalis, endodontalis) – endodontic and periodontal 
pathology. Implicated in aggressive and refractory disease. 
· Bacteroides species – abscesses 
· Bacteroides forsythus – periodontitis 
· Wolinella recta – periodontal and endodontic pathology  
· Eikenella corrodens – periodontitis 
· Prevotella intermedia - periodontitis 
· Prevotella denticola and loeschii - periodontitis 
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· Actinobacillus actinomycetemcomitans (“Aa”) -  periodontitis, especially early onset 
forms 
 
Intracellular Gram negative parasites 
· Chlamydia trachomatis - trachoma 
· Rickettsia prowazekii - epidemic typhus 
 
Common non-pathogenic gram negative species (e.g. dental plaque, gingivitis) 
· Veillonella spp. (anaerobic, cocci) 
· Neisseria spp.(aerobic, cocci) 
· Haemophilus spp. (aerobic, rods) 
· Leptotrichia buccalis (anaerobic, rods) 
 
7.2 Properties of anaerobes 
 
Anerobes need chemically reduced conditions (negative redox potential), with minimal 
exposure to oxidising agents or oxygen itself in the air. Proper sampling requires pre-
reduced liquid transport and culture media, and their fastidious growth needs make culture 
in the laboratory difficult. Anaerobic hoods and chambers are used, which are flushed with 
nitrogen and carbon dioxide to remove all air. For culture, “Gaspak” kits are used, which 
produce carbon dioxide and hydrogen gases in the presence of a palladium catalyst when 
water is added. 
 
Pathogenic features of Gram negative bacteria include: 
· Enzymes: Collagenases and proteases facilitate tissue breakdown and invasion, e.g. P. 
gingivalis 
· Toxins: Leukotoxins can kill phagocytes such as neutrophils and macrophages, e.g. Aa 
· Outer membrane components: polyclonal B cell activators; IL-1-inducing or IL-1-like 
substances 




The lipid A component of LPS is embedded in outer layer of the bi-layer membrane (this is 
the site of binding of the polymyxin antibiotics). Polysaccharide chains stick out from the 
core, and the configuration of sugars in these side chains can vary widely between strains. 
LPS is shed freely and is released when bacteria die and disrupt. It is very heat-stable. 
 
LPS is able to activate the alternative complement pathway via C3a and C5a. The 
endotoxic activity of LPS (i.e. the biological response to it) varies dramatically between 
species and between strains within the one species, when considered on a weight basis. In 
high concentrations, LPS can be cytotoxic for many cells. LPS is very immunogenic (i.e. it 
elicits a strong immune response), but LPS-induced immune responses are not protective 
(i.e. they cannot prevent infection). 
 
Cells of the monocyte/macrophage lineage are very sensitive to small amounts of LPS 
(picograms to nanograms). LPS is a potent inducer of IL-1 and TNF-alpha secretion by 
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many cells (particularly monocyte/macrophages and endothelial cells) – these cytokines 
appear in the circulation and affect cellular responses both locally and at distant sites: 
· cascade effects such as production of IL-6 and IL-8 which activate neutrophils 
· chemotaxis of neutrophils 
· increased adhesion of neutrophils to blood vascular endothelial cells (mediated via 
selectin and integrin/Ig-superfamily adhesion molecules) 
· endothelial cell pro-coagulant activity.  
· secretion of prostaglandin E2 and other inflammatory mediators 
· bone resorption 
· secretion of collagenases 
 
Systemic effects of the LPS- IL-1 – TNF trilogy include 
· fever (high levels cause malaise and wasting) 
· altered glucose metabolism 
· altered in utero development (low birth weight) 
· premature birth (via prostaglandins) 
· enhanced endothelial pro-coagulant activity may increase risk of atherosclerosis. 
 
7.4 Volatile sulphur compounds: markers of Gram negative anaerobe 
proteolytic activity 
 
Volatile sulfur compounds (such as hydrogen sulfide, methyl mercaptan, dimethyl sulphide) 
and certain acids and amines (propionic and acetic acids, cadaverine and putrescine) are 
occasional ingredients in the gas mixture which is exhaled air. These substances arise 
primarily from putrefaction of the sulphur-containing amino acids within large proteins 
through the action of host and bacterial proteases, with Gram-negative anaerobes featuring 
in the latter. Many practitioners will recall the unique sulphurous odour of tissue fragments 
removed from necrotic teeth on a barbed broach or endodontic file, since the same bacterial 
putrefaction processes occurs within the root canal space of non-vital teeth.  
 
Although nocturnal salivary hypofunction, thick deposits of supra and sub-gingival dental 
plaque and long-standing untreated periodontitis are common contributors to halitosis, 
recently the emphasis has shifted to accumulations of bacterial plaque and debris on the 
posterior aspects of the tongue. Most studies link one or more of these oral causes to 
nearly 90% of cases of halitosis, with the remainder being systemic in nature (e.g. postnasal 
drip and ENT disease, liver cirrhosis, and untreated diabetes mellitus).  
 
Salivary dysfunction can be screened for readily using the Saliva Check Buffer kit (GC 
Corporation), while the maturity of plaque deposits in the mouth can be rapidly assessed 
using the 2-tone plaque disclosing system in the GC Plaque Check + pH kit. This stains 
mature plaque blue and thin immature plaque red. A more high technology approach is the 
Morita Penscope (Penviewer) and the Durr VistaOroof, which use a miniature intraoral 
camera with ultraviolet LEDs and a filter on the corresponding CMOS sensor which shows 
mature plaque deposits in red because of their fluorescence properties. 
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Measuring oral malodour 
 
Sulphide monitors have been used widely for halitosis assessment. Interscan’s Halimeter®, 
which was the first unit specifically designed to measure VSC in clinical dental practice, 
shows an aggregate of all VSCs (in parts per billion, ppb) rather than a breakdown of the 
main components. It has a low sensitivity for methyl mercaptan (which has been linked to 
periodontitis) but high sensitivity for hydrogen sulphide. The Halimeter does however 
allow a rather useful recording of the total VSC level to be obtained, in the form of a chart 
recording which is named appropriately a Haligram ®.  
 
Feeling somewhat behind the scene, the author admits to having in his possession a 
stationary industrial gas measurement system (Draeger) which measures upwards of 200 
ppb for hydrogen sulphide, but without the digital readouts or data recording of the 
OralChroma or Halimeter. It employs a chemical reaction which gives a visible reaction 
product rather than an electronic sensor. 
 
The latest technology for assessing oral malodour is the portable gas chromatograph. 
Seasoned airline travelers will be familiar with the use of these devices at airline security 
checkpoints for detecting explosives and illicit drugs. The same technology has now 
recently become available for dental practice in the form of the OralChroma™, a portable 
gas chromatograph which measures in a sample of mouth air the levels of three key VSCs, 
namely hydrogen sulfide, methyl mercaptan, and dimethyl sulfide. The role of these VSCs 
in oral malodour has been shown in many studies, but previous gas chromatography 
equipment was so bulky that its use was confined to research, where it has appropriately 
served for many years as the “gold standard”.  
 
OralChroma data can be downloaded to a personal computer via a serial or USB cable, and 
OralChroma Data Manager software will graphically display the sensor responses on a 
computer screen, and save the data. An interesting feature is that Data Manager software 
allows individual values for the “halitosis perception threshold” to be set in the range of 0 
to 1,000 for each gas component (most individuals will notice objectional mouth odour at 
VSC levels above 75 ppb). The manufacturers suggest that in cases where the causes are 
not apparent, the differential assessment of the three components can be worthwhile, for 
example, unusually high levels of methyl mercaptan have been linked to untreated 
periodontitis. This of course cannot substitute for a thorough history and careful clinical 
examination (including periodontal probing!). Nevertheless, measuring each major 
component also allows cases of pseudo-halitosis (imaginary halitosis) to be identified and 
formally excluded, so that the patient can be referred for appropriate psychological or 
psychiatric care if indicated. 
 
Treating oral malodour 
 
1. Tongue cleaners 
The range of treatments and remedies currently available for halitosis continues to expand, 
with tongue cleaners now included on a number of “mainstream” toothbrushes 
These are used to clean the dorsal surface of the tongue thoroughly, specifically to remove 
the protease-producing anaerobic bacteria that produce VSCs, along with other bacteria, 
epithelial squames and foreign matter. This is not as simple a task as it first appears, since 
the dorsum of the tongue is irregular and its fissures are ideal low-oxygen ecological niches 
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for anaerobic bacteria, which are protected there from the antimicrobial systems present in 
saliva. 
 
2. Replacement therapy with Streptococcus salivarius (BLIS K12) 
The term BLIS is an abbreviation for bacteriocin-like inhibitory substances, molecules 
which are produced by many bacteria as a means for establishing and maintaining microbial 
microenvironments. S. salivarius is the only probiotic that can live in high numbers on the 
dorsal surface of the tongue. Moreover, laboratory testing has shown that a naturally 
occurring strain of S. salivarius (K12) suppresses the growth of Gram negative anaerobic 
(black-pigmented) bacteria which have been implicated in halitosis.  Healthy individuals 
with low levels of VSCs have a high proportion of S. salivarius on the dorsum of the 
tongue (up to 40% of the cultivable flora), whereas sufferers of chronic halitosis have very 
low levels.  
 
The concept of using BLIS K12 as a probiotic agent was developed by Professor John 
Tagg, a microbiologist at the University of Otago. Based on his work, there are now a 
range of BLIS K12 products, which are also known as KForce™. Treatment for halitosis 
involves using a chlorhexidine pre-rinse to alter the oral microbial ecology before 
introducing the S. salivarius (via lozenges). A recent placebo-controlled clinical study has 
shown that using BLIS K12 used in chronic halitosis sufferers resulted in the majority of 
subjects (85%) achieving a significant reduction in VSCs and in bacterial proteolytic 
(BANA) activity.  
 
Of interest, the same probiotic approach may also have value in altering the ecology of 
dental plaque to prevent dental caries, given that a number of oral bacteria are known to 
produce BLIS activity against Streptococcus mutans. Clinical approaches that are under 
investigation in this regard by the group in Otago include the regular oral administration of 
the purified BLIS molecules, and the genetic modification of existing plaque bacteria such 
that they produce significant quantities of the anti-mutans BLIS in situ. 
 
3. Biocides 
Antimicrobial agents which have been used successfully include chlorhexidine, Triclosan 
products such as Colgate Total ™, essential oils (Listerine ™), and cetylpyridinium 
chloride (BreathRx™). 
 
4. Zinc ions 
Topical therapies can deliver bio-available zinc ions which bind to protein receptors on the 
surface of oral bacteria, preventing the proteins binding and being metabolized. Such 
products are generally formulated with stabilized chlorine dioxide (e.g. TriOral ™ rinse, 
Oxygene ™).  
 
5. Oxidizing mouthrinses and sprays.  
These agents convert VSCs chemically into non-odourous harmless compounds, and exert 
actions against the strictly anaerobic bacteria which lack catalase and thus find oxygen 
based molecules toxic to their normal metabolism. Examples of oxidizing products include 
sodium chlorite and “stabilized” chlorine dioxide (Therabreath ™, CloSYSII ®, ProFresh 
™, DioxiCare ®), other oxychlorine compounds, hydrogen peroxide mouthrinses (Colgate 
Peroxyl ™, Listerine Whitening ™), and freshly ozonated water. Of these, recent interest 
has focused on the latter, since water can ozonated on demand at the chairside for use in 
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mouthrinsing. Ozonated water has been shown by the Belfast research group of Professor 
Ed Lynch (inventor of the Healozone) to oxidize the sulphur-containing amino acids 
cysteine and methionine, which serve as chemical precursors for VSCs, into their 
corresponding primary oxidation products cystine and methionine sulphoxide. 
 
7.5 Periodontal pathology 
 
Established periodontopathogens  
(accepted by the World Workshop on Periodontics):  
· Aggregatobacter actinomycetemcomitans 
· Porphyromonas gingivalis 
· Prevotella intermedia 
 
Microbial virulence factors in periodontal pathology include: 
· Adhesion and colonisation 
· bacterial biofilm (resists antimicrobial agents) 
· corn-cob formation 
· capsules 
· Tissue destruction 
· collagenases  
· proteases 
· hyaluronidases 
· Evasion of host immune response 
· leukotoxins 
· cytotoxic agents 
· shed and soluble antigens (distract the immune response) 
· proteases (destroy host antibody) 
 
Many gram negative anaerobes in subgingival plaque produce proteases, and P. gingivalis 
has a particularly wide spectrum of proteases. Some refer to the ever increasing number of 
these which have been identified by the term YAP (“yet another protease”). Proteases 
stimulate host cells (such as epithelial keratinocytes) to secret collagenase and 
stromeolysins which lead to the destruction of Type I collagen, and impair the turnover of 




· pathogenesis is based on the non-specific plaque hypothesis 
· plaque mass accumulates over time and there is a shift toward more Gram negative and 
more anaerobic organisms with time 
· older plaque has an increased production of LPS, proteases, toxic metabolites, etc. 
· immune response is a Type IV delayed hypersensitivity response with a superimposed 
neutrophil infiltration 
· the immune response is well regulated and is dominated by T cells with a Th1 
phenotype (these lymphocytes produce TNF and interferon gamma) 
· oligo-clonal immune response 
· lesions expand via migration of cells to the lesion via activated endothelium 
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Periodontitis 
· Disease represents the host immune response to plaque products which diffuse through 
the crevicular epithelium 
· Bacterial invasion is not a feature of the disease unless there are defects in neutrophil 
number or function (e.g. periodontal abscess in diabetic patient)  
· Pg, Pi, Aa are accepted pathogens; other Gram negative species likely contribute as 
associated organisms or secondary pathogens 
· Individuals may have pathogens but not disease, due to favourable immune response 
(e.g. cytokine profile, antibody isotype) 
· Immune responses to LPS are not protective against tissue destruction 
· Immune response determines patient susceptibility. Well regulated T cell dominated 
response is associated with a stable situation (Th1 T cell response), while a destructive 
response is associated with a Th2 T cell response (IL-4, IL-5) which enhances B cell 
growth and antibody production 
· Lesions expand by cell proliferation within the lesion 
· The expanding lesion is walled off by a fibrous outer capsule 
· Bone resorption is mediated by IL-1, prostaglandins and other mediators produced 
within the lesion. 
  
Severe and early onset periodontal diseases  
· Includes localised juvenile periodontitis, and rapidly progressive periodontitis 
· Altered host defence (especially in terms of subtle neutrophil defects) 
· Tissue invasion by bacteria may occur 
· Major role for specific organisms such as Aa, and Capnocytophaga spp. 
 
Systemic conditions with defects in neutrophil number and/or function which are associated 
with aggressive periodontal destruction include: 
· Chediak-Higashi disease (reduced chemotaxis and phagocytosis) 
· Papillon-Lefevre syndrome (reduced phagocytosis) 
· Cyclic neutropenia (reduced numbers) 
· Infantile Genetic Agranulocytosis (reduced numbers) 
· Chronic neutropenia (reduced numbers) 
· Down’s syndrome (Trisomy 21) (reduced chemotaxis) 
· Uncontrolled diabetes mellitus (reduced chemotaxis) 
· Leukocyte adhesion deficiency/ lazy leukocyte syndrome (reduced adhesion). 
 
Susceptibility to periodontitis – the role of the host response 
 
An efficient immune response to bacterial infection relies upon cooperation between 
humoral and cellular elements of the immune system. In periodontitis, the immune response 
of the host to periodontopathic bacteria is the major determinant of disease susceptibility. 
The majority of individuals can be exposed to recognised pathogens (such as 
Porphyromonas gingivalis) and yet not develop the disease. Relatively high levels of IgG1, 
IgG2 and IgM serum antibodies to outer membrane proteins of P. gingivalis are uniformly 
present in the general population, independently of the presence of current P.gingivalis 
infection or susceptibility to periodontitis.  This indicates that the presence per se of these 
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antibodies does not protect against disease. Nevertheless, some P. gingivalis-positive 
patients are clearly susceptible to periodontitis, whilst others are not. 
 
As discussed above, neutrophils (PMN) are the host's first line of defence against most 
pathogenic bacteria. In humans, an early PMN response is a characteristic feature of 
responses to plaque. Studies of naturally occurring gingivitis in children and experimental 
gingivitis in adults indicate that this response is protective and does not lead to clinical 
destruction. Although defective neutrophil function contributes to severe and rapidly 
progressive forms of periodontitis, there is no evidence of detectable PMN dysfunction in 
chronic adult periodontitis. Rather, the issue may be the antibody isotypes produced – 
which in turn are related to the genetic background of the patient and the T lymphocyte 
subset distribution within the lesion. Some antibody isotypes may not fix complement and 
may have poor opsonic properties.  
 
In the presence of serum (such as in the gingival crevice), a surface glycoprotein termed 
CD14 is the major receptor on PMN for LPS. A discrete LPS-binding protein (LBP), 
which is normally present in serum, forms complexes with LPS and permits strong binding 
of LPS to CD14. When this binding occurs, the expression of another molecule, CD18, is 
increased transiently. This CD18 can serve as an additional LPS receptor. In a serum-free 
environment, such as exists in tissues, both binding of LBP to CD14 and binding to CD18 
occur, but the latter is much more important. A further pathway for binding of bacteria to 
neutrophils in the absence of serum is via the selectin adhesion molecule CD62-L, which 
can bind the charged phospholipid residues of LPS. In both the gingival crevice and the 
tissues, LPS shed by Gram negative bacteria activates PMN,  however the response of 
neutrophils to live bacteria is ten times greater yet.  
 
Factors in the host immune background which can vary between individuals include: 
· genetic polymorphism for levels of Interleukin-1, TNF, and other pro-inflammatory 
cytokines secreted in response to bacterial products such as LPS 
· genetic polymorphism in the type of receptors for antibody present on PMN 
· altered regulation of T lymphocyte control, and variations in the T lymphocyte antigen 
receptor repertoire 
· the effect of stress on the host response (via psycho-neural-immunological pathways).  
 
All of these factors may impact upon susceptibility to destructive periodontitis. 
 
There are also bacterial factors which influence susceptibility and progression, such as: 
· Presence of pathogen(s) – Specific Plaque Hypothesis 
· Numbers of pathogens (threshold level) 
· Strain of pathogen 
· Presence of inhibitory interactions 
· Destruction of bacteria by the host immune response 
· Factors which alter the oral microbiota – such as smoking which encourages 
anaerobiosis 
· Presence of invasion 
· Impact of antimicrobials used for diseases other than periodontitis. 
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The treatment of periodontitis is clearly based on a non-specific approach (i.e. remove all 
plaque), however because bacterial invasion of the tissues is NOT a feature of common 
types of periodontitis (such as adult chronic periodontitis), the use of systemically-
administered antibiotics is not justified in the management of  adult periodontitis, but rather 
is restricted to the aggressive periodontal diseases. Several clinical studies have shown that 
there is no clinically significant improvement when agents such as tetracyclines and 
metronidazole are used as an adjunct to mechanical treatment (scaling and root planing) in 
adult periodontitis. 
 
7.6 ANUG (Acute necrotising ulcerative gingivitis) 
 
The characteristic features of this condition are: 
· Pain 
· Sudden and acute onset 
· Gingivae are red and swollen 
· The interdental papillae are “punched out” by cratering and the affected areas are 
covered by grey necrotic slough 
· Halitosis (“fetor ex oris”) 
· Variable systemic symptoms include fever, malaise, and anorexia. 
 
Major pathogens are Borrelia vincentii and Treponema spp. (spirochaetes) and 
Fusobacteria (F. nucleatum and F. fusiforme). Spirochaetes are the primary pathogens and 
comprise up to 30% of the total flora. Other bacteria are Prevotella intermedia and 
Veillonella spp. ANUG is likely related to necrotising oral ulceration (e.g. of the buccal 
mucosa) and noma. 
 
There is a strong linkage between ANUG and the immune compromised state. ANUG is a 
common oral lesion in patients with AIDS. In addition to immune suppression, other 
predisposing factors include severe malnutrition, poor oral hygiene, and emotional stress.  
 
The mainstay of anti-microbial therapy in ANUG is metronidazole. This antibiotic interferes 
with nucleic acid synthesis in anaerobic bacteria. The nitro group is reduced under 
anaerobic conditions to product reactive species intermediates or radicals, which then cause 
DNA strand cleavage (primarily at thymine residues). It should be stressed that use of 
metronidazole should be accompanied by debridement at the same visit or within a few 
days once there has been some resolution. If metronidazole is used alone – without 
accompanying debridement – recurrence is extremely likely. 
 
7.7 Endodontic bacteria and medicaments 
 
Current approaches to treatment are based on instrumentation, irrigation and medication of 
the root canal system, with the primary goal of eliminating bacteria prior to placing a root 
canal filling. Molecular methods have demonstrated that bacteria can be detected in the 
root canal system in virtually all cases of root-filled teeth which have persisting periapical 
radiolucencies. These bacteria are found not only within the root canal itself, but also in 
dentinal tubules, accessory canals, canal ramifications, apical deltas, fins and transverse 
anastomoses - areas which are difficult to access using mechanical instrumentation and 
irrigation when re-treatment is contemplated. 
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Disinfection of the root canal system is not an easy objective to achieve. Where bacterial 
biofilms are well established in the root canal, the joint issues of contact time with 
antimicrobial agents, and penetration into biofilms, come to the fore. Even when using 
potent antimicrobial agents and techniques, achieving reliable and complete disinfection 
remains a challenge. The published literature indicates that current treatment protocols with 
rotary NiTi instrumentation and copious antibacterial irrigation will render some 50%-70% 
of infected canals free of microorganisms by culture-based methods. This does not, 
however, mean an absence of viable microorganisms. 
 
The biofilm challenge in the root canal 
 
As we have already discussed, biofilms provide a powerful barrier to the diffusion of 
medicaments, and it is essential that materials and techniques used for endodontics are 
tested not in in plate or broth cultures but rather using biofilm models – since in the latter 
the microorganisms will be in a metabolically less active state, making them less prone to 
inactivation by antimicrobial agents.  
 
Resistance of bacterial biofilms to antibiotics can occur due to several factors. Firstly, the 
polysaccharide matrix of the biofilm retards diffusion of the antibiotic. Secondly, the 
chemical milieu in the biofilm (low oxygen tension, low pH, waste products, enzymes) can 
antagonize the effects on the antibiotic. Thirdly, in response to depletion of substrate 
and/or the accumulation of waste products, bacteria in the biofilm enter a quiescent non-
growing state, rendering them safe from agents which target the metabolic activity of 
bacterial replication. Finally, subpopulations of bacteria in a biofilm may enter a phenotypic 
state with altered gene expression which is akin to spore formation. Because of these 
changes, bacteria in biofilms may display a 1000-1500 times greater resistance to antibiotics 




With incomplete disinfection of the root canal, the spectre of selection and dominance of 
resistant species emerges. In dentistry, it is easy to overlook the fact that Enterococcus 
faecalis possesses several characteristics akin to the “superbugs” associated with hospital-
based nosocomial infections. Of all the organisms which have been found in root canals, E. 
faecalis has the most well developed (and well deserved) reputation as a difficult target for 
antibiotic and microbial therapy.  
 
In relation to antibiotics, the family of enteroccoci have both intrinsic resistance (where the 
gene for intrinsic resistance resides on the chromosome) and acquired resistance (from 
mutations in existing DNA or the acquisition of new DNA). They are inherently more 
resistant to antimicrobial drugs than any other clinically important Gram-positive bacteria 
encountered in dentistry or medicine.  
 
Enterococci are intrinsically resistant to many common antimicrobial agents, including 
cephalosporins, clindamycin, penicillinase-resistant penicillins, and vancomycin, and they 
have acquired resistance to many other classes of antimicrobials, including tetracyclines, 
erythromycin, chloramphenicol, ciprofloxacin and vancomycin. Because of this heredity, E. 
faecalis has intrinsic resistance to clindamycin, cephalosporins and aminoglycosides. There 
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is strong evidence that most clinical strains of E. faecalis isolated from the oral cavity are 
resistant to both clindamycin and to tetracyclines – providing a good reason not to use 
these in root canal medicaments.  
 
These resistance patterns explain why clinical microbiological studies using current 
products show persisting bacterial growth after the use of current inter-visit medicaments. 
In a recent (2006) study conducted in Hong Kong (Chu et al, J Endod. 2006; 32(1):17), 
samples were taken before and after two-visit endodontic treatment from 88 canals with 
apical periodontitis. All of the canals but one had cultivable growth before treatment. After 
dressing with Ledermix, Septomixine, or Calasept (calcium hydroxide), the percentages of 
canals with positive growth on culture were 48% (13 of 27), 31% (8 of 26), and 31% (11 
of 35), respectively. In the Ledermix group, 38 strains of bacteria were recovered, with 25 
from the Septomixine group, and 25 from the Calasept group. A key finding in this study 
was that Gram-positive facultative anaerobic cocci – such as Enterococci - were the 
survivors, whereas the Gram-negative obligate anaerobic rods were easily inactivated. 
 
The great unknown? 
 
Adding to this is the issue of non-cultivable flora present in root canals and other sites 
within the oral cavity – of the more than 700 different species which can be detected by 
molecular methods, 50% are non-cultivable, and thus our understanding of endodontic 
infections is not absolute. In all likelihood, there are other species, yet to be cultivated, 
which may share characteristics of E. faecalis. 
 
 
Survival factors for E. faecalis and related non-cultivable Gram positive facultative anaerobes 
___________________________________________________________________________ 
· Natural resistance to many antibiotics 
· Low susceptibility to many biocides 
· Can live and persist in the poor nutrient environment of endodontically-treated teeth 
· Can survive in a quiescent non-cultivable phase with low metabolic activity for extended 
periods of time 
· Can tolerate a broad range of pH values (from 4-11) 
· Forms dense biofilms 
· Can invade dentinal tubules up to 300 microns 
· Can tolerate calcium hydroxide 
_____________________________________________________________________ 
 
Studies using bacterial cultivation methods have shown that infected necrotic pulps, and 
pulpless, infected teeth (i.e. teeth without any previous endodontic treatment have a 
polymicrobial flora with 4-7 species present, mostly strict anaerobes, with approximately 
equal proportions of gram-negative and gram-positive organisms. In contrast, previously 
root-filled teeth with apical periodontitis have 1-2 cultivable species, and these are 
dominated by facultative anaerobic Gram-positive bacteria such as E. faecalis. Using 
molecular methods, which recover the non-cultivable species, gives a rather different 
picture, with 1-5 species present in well treated cases with sound coronal restorations, and 
2-11 species in teeth with defective coronal restorations. Based on the published literature, 
a reasonable estimate would place the number of bacterial species in infected root canals 
between 10 and 30 – a much greater challenge to disinfection that thought previously. In 
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fact, the argument could be made that endodontic procedures, if done poorly, select for the 
more robust and resilient organisms (such as E. faecalis), because the more susceptible 
Gram-negative anaerobes are relatively easily eliminated. Data from culture and molecular 
studies indicate that E. faecalis may be present in from 29% to 70% of root-filled teeth 
with periradicular lesions. 
 
Taking this on board, and looking at the range of agents currently used as inter-
appointment medicaments, a range of problems can be identified (see Table below). Despite 
recent trends to use other antibiotics in these medicaments, from first principles, in a 
polymicrobial infection the decision to use a single antibiotic can be questioned. It is more 
likely a combination of agents would be needed to address the diverse flora encountered. If 
a combination of antibiotics were used, this would decrease the likelihood of resistant 
strains developing. The typical antibiotic-related long term problems of resistance and 
sensitization would remain, however. 
 
Issues with contemporary endodontic medicaments 
Calcium hydroxide 
pastes 
Effects are limited by buffering of alkaline pH by dentine proteins, particularly 
in the apical third of the canal. Final pH and hydroxyl ion release vary according 
to the vehicle used in the paste. Limited if any penetration into dentine tubules. 
Only limited inactivation of E. faecalis. 
Ledermix (Lederle), 
Endopaste (ADM)  
Based on 3.2% Demeclocycline hydrochloride. This tetracycline has a 
bacteriostatic rather than bactericidal action. Effects are short-lived because of 
diffusion. Demineralizes and complexes with dentine, resulting in staining, a 
process accelerated by light. Limited inactivation of E. faecalis because of 
natural resistance to tetracyclines. 
Odontopaste (ADM) Based on 5% Clindamycin. Does not have the dentine staining issue of 
tetracyclines. Limited inactivation of E. faecalis because of natural (intrinsic) 




Contains neomycin, polymyxin B sulphate, and tyrothricin. Issues with limited 
spectra of activity, since neomycin is bactericidal against Gram-negative bacilli 
but is ineffective against Bacteriodes spp, while polymyxin B is ineffective 
against Gram-positive bacteria. Little or no inactivation of E. faecalis. 
Chlorhexidine 
pastes 
Inactivated by residues of sodium hypochlorite, forming para-chloro-aniline as a 
by-product. Binds to the surface and has substantivity, but does not penetrate 
into tubules. Inactivated by high organic loads. Partly inactivated by serum, 
dentine proteins and hydroxyapatite. Moderately effective against E. faecalis but 
only as an irrigant.  
 
Clues from the past 
 
Given these problems, it may be timely to revisit other strategies for dealing with persistent 
bacteria which do not rely only upon inactivating a specific biochemical pathway (as do 
antibiotics), but instead taking a wide approach by using biocides. Because biocides have a 
broader spectrum of activity, working on multiple target sites within microorganisms, 
bacterial resistance to biocides does not develop, although it should be recognized that 
some bacteria are naturally resistant to certain biocides because of their cell wall structure.  
 
Biocide activity is affected by several factors - notably their concentration, period of 
contact, pH, and temperature. The presence of organic matter is a major issue, since this 
can interfere with the antimicrobial effects exerted by some biocides – with chlorhexidine 
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being a good example. Conversely, the activity of biocides can be enhanced by the use of 
chemical agents such as EDTA which increase the permeability of bacterial cell membranes.  
 
Whilst there are many biocides which could be used, chlorhexidine (CHX) would rate well 
amongst other candidates in the field, despite some of its issues. Slow release forms of 
CHX and mixtures of CHX with other agents (such as calcium hydroxide) appear 
promising in terms of penetration into dentinal tubules and antibacterial effects against E. 
faecalis.  
 
7.8 Dento-alveolar infections 
 
Microorganisms can gain access to dento-alveolar tissues via 
· The root canal system 
· Deep dentinal caries with pulp exposure 
· Pulp exposure via traumatic injury or pathological tooth wear 
· Vertical or horizontal root fractures 
· Endodontic perforations 
· Coronal leakage of a previously root-filled tooth 




Mechanical drainage is usually achieved easily with smaller lesions which arise from the 
periodontium. For periodontal abscesses, this is by 
· Debridement via the periodontal pocket 
· Extraction of the involved tooth 
· Access flap surgery 
 
While for pericoronitis, this draining can be facilitated by 
· Irrigation under the operculum 
· Gentle debridement with an ultrasonic scaler 
· Operculectomy (scalpel, electrosurgery, laser, trichloracetic acid)) 
· Elimination of traumatic occlusion from the opposing tooth 
· Removal of the involved tooth or the opposing tooth.   
 
For lesions which arise via the root canal system, progression to a dento-alveolar 
(endodontic or periapical) abscess can occur, with a localised, circumscribed, purulent area 
of inflammation arising in the periodontal ligament space. The dento-alveolar abscess is a 
classical example of a pyogenic (suppurating or pus-producing) dento-alveolar infection. 
The infection can remain localised to the causative non-vital tooth, and enter a chronic 
phase when draining is established through a draining sinus. Chronic endodontic abscesses 
occur with long standing low grade infection and can frequently be asymptomatic, making 
detection difficult. However, exacerbation of a chronic abscess is accompanied by signs and 
symptoms which attract the patient's attention, and these initiate clinical intervention. Acute 
exacerbations of chronic infections are associated frequently with specific anaerobes 
(particularly Porphyromonas gingivalis and P. endodontalis). 
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In other cases, the endodontic infection results in a diffuse cellulitis, which then spreads 
along fascial planes. In neutropenic patients, a lack of adequate phagocytic defence by 
neutrophils can allow osteomyelitis to spread to frank systemic sepsis. 
 
The 3 means by which infection can spread are: 
 
· Direct spread – spread of pus along naturally occurring anatomical planes and the 
various  interconnecting potential spaces. This may ultimately compromise the airway 
or involve the mediastinal cavities. 
·  Lymphogenous spread (via the lymphatic drainage) to regional lymph nodes in the 
head and neck region (submandibular, deep cervical, submental, parotid, occipital). The 
involved nodes become swollen and painful. A node can suppurate and require 
drainage.  
 
· Haematogenous spread (via the bloodstream – discussed below) to other organs (brain, 
etc). 
 
Common pathways for direct spread 
 
Site Maxillary teeth Mandibular teeth 
Palate Palatal roots of premolars 
and molars; also lateral 
incisors with a palatally 
curved root 
 
Buccal space Canines, premolars and 
molars 




Canines; rarely other teeth  
Maxillary sinus Canines, premolars and 
molars 
 
Upper lip Central and lateral incisors  
Masseteric space, 
Pterygomandibular space, 
Lateral pharyngeal space 
 Lower third molars 
Lower lip  Incisors and canines 
Site Maxillary teeth Mandibular teeth 
Submandibular space  Root apices below insertion 
of mylohyoid – usually 
molars but can also be 
premolars 
Submental space  Incisors and canines 
Sublingual  Root apices above 
mylohyoid /geniohyoid- 
usually incisors, canines 
and premolars; rarely 
molars 
 
In dento-alveolar infections, systemic symptoms such as fever and malaise can result from 
systemic elevation in the levels of inflammatory cytokines such as IL-1 and TNF induced by 
bacterial products such as LPS. The causative bacteria are endogenous commensals, which 
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are derived from root canals or periodontal pockets. The infections are polymicrobial – 
typically a mixture of 3-4 species of strict anaerobes, including Bacteroides species, and 
Prevotella, together with aerobes. When Porphyromonas species, Bacteroides species or 
Fusobacteria are present, more severe clinical infections occur. Other microorganisms 
present include Peptostreptococcus and facultative anaerobes such as Streptococcus milleri 
and S. sanguis, as well as Actinomyces spp. With the latter, infection with A. israelii can 
lead to cervico-facial actinomycosis. 
 
In terms of proper treatment, once the correct diagnosis has been reached via the use of 
radiographs, pulp sensibility tests, etc., surgical drainage is established by incision of any 
soft tissue swelling, accompanied by either extraction of the tooth or extirpation of the pulp 
and endodontic therapy as indicated clinically. The adjunctive use of antimicrobials (e.g., 
amoxycillin plus clavulanic acid, or metronidazole, or clindamycin) is indicated when 
pyrexia and other systemic signs are present. If amoxycillin is selected, the therapy should 
account for the fact that many anaerobes of importance in periapical abscesses produce 
beta-lactamase. Antimicrobial therapy without surgical drainage is not an effective therapy 
over the long term. 
 
Endodontic treatment aims to eliminate microorganisms from the root canal system of the 
affected tooth. The anaerobic bacteria responsible for the abscess are present within the 
apical area of the root canal system, but are usually not found in the area of the apical 
foramen or on the surface of the root apex. Thus, correct biological preparation of the root 
canal system itself is able to bring about resolution of the infection in approximately 90 per 
cent of cases. In the remaining cases, the presence of bacteria within the lesion or the 
persistence of pro-inflammatory bacterial products (such as LPS) within the apical root 
structure are implicated as causal factors. As noted above, Actinomyces and Arachnia 
species may survive for long periods of time in periapical sites and may prevent healing. 
 
If the infectious process spreads to involve the bone of the mandible or maxilla, and the 
associated tissue spaces of the head and neck, it may pose significant risks of morbidity and 
mortality, including 
· Ludwig's angina, an aggressive infection of the submandibular, sublingual, and 
submental fascial spaces. Airway compromise and the need for parenteral antibiotics 
make this condition difficult to manage.  
· Cutaneous sinus tracts may develop on the chin and cheek frequently, which can be 
disfiguring.  
· Bacteraemia and systemic spread of bacterial by-products and immune complexes from 
the dental abscess can occur, and in the immune compromised host, this can result in 
the dissemination of infection to distant sites. In such cases, microorganisms from the 
oral flora may be cultivated from distant lesions, such as brain abscesses. Examples of 
these types of “focal infection” are listed below. It must be stressed that the patient’s 
impaired immune response is the predisposing factor which allows the haematogenous 
spread of infection from a dental focus to a distant site. 
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Management in such cases includes: 
 
· Identifying and eliminating the source of the infection 
· Draining the exudate 
· Pus must be drained as soon as possible 
· If the area does not drain spontaneously, then active measures must be used, e.g.  
· Extirpation of the pulp or extraction of the tooth 
· Surgical access - deep dissection of the fascial spaces (under GA) to achieve 
drainage of pus. GA is often needed because the lowered tissue pH in areas of 
pus may make LA difficult to achieve.  
 
· Obtaining a sample for MCS, so that an appropriate antimicrobial can be used. 
· Sampling may require aspiration of the involved area.  
· Blood culture should also be undertaken (bearing in mind the difficulties associated 
with culture of anaerobes from blood) 
· The antibiotic which is selected MUST 
· be active against the pathogenic microorganisms in the lesion 
· reach the focus of infection in sufficient concentration to be effective 
· not be affected by the local environment (e.g. pus) 
· be used in sufficient DOSE for sufficient TIME 
 
· Systemic symptoms may warrant IV antibiotics 
· Radiographic assessment (OPG, CT, and plain views of  the face and neck) 
· Protection of the airway from compromise. Where possible, referral to an oral surgery 
facility is recommended strongly, at the earliest juncture, since severe infections can 
become life threatening in a short period (less than one day). 
· Supportive therapy (pain control, rehydration, etc.) 
 
In healthy patients, haematogenous spread of infection is fortunately a rare event. Other 
than the special case of bacterial endocarditis (which was discussed earlier), examples of 
infections which can arise from a dental focus: 
 
· Infection of prosthetic joints. 
· Cavernous sinus thrombosis 
· Persistent pyrexia of unknown origin 
· Septicaemia 







Multiple dental infections are relatively common in very immune compromised hospital in-
patients, such as those with acute leukaemia in blast crisis. As many as one third of 
neutropenic patients with a pyrexia (fever) of unknown origin may have a dental focus, and 
this typically is an endodontic lesion. While examination of such patients frequently reveals 
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heavily carious teeth or fistulae, conventional endodontic therapy or extractions cannot be 
undertaken on such patients for medical reasons. It is therefore necessary to manage the 
infections on an emergency basis with antimicrobials. A good response to metronidazole 
can be expected within 24 hours. The selection of metronidazole as an empiric 
antimicrobial is based upon its effectiveness against the gram-negative anaerobes implicated 
in periapical pathology. If an adequate clinical response is not seen in 24 hours, then the 
antimicrobial therapy is altered appropriately. Unfortunately, because of the fastidious 
nature of many of the gram-negative anaerobes implicated in these infections, it is not 
always possible to successfully culture them from peripheral blood to allow conventional 
sensitivity tests to be undertaken. 
 
Several risk situations can be identified in which inappropriate management of endodontic 
infections is more likely to result in major complications. Because of the protective role of 
the immune response in limiting the spread of infection patients affected by a variety of 
disorders of the immune system are more likely to develop complications from untreated or 
improperly treated endodontic abscesses. 
 
Disorders of the immune response in which dissemination of infection is more likely 
include: 
· Low neutrophil count or altered neutrophil function 
· Cancer treatment with chemotherapy or radiotherapy 
· Cyclic neutropenia 
· Cytotoxic therapy 
· Benign chronic neutropenia 
· Depressed neutrophil function 
· Down's syndrome 
· Poorly controlled diabetes mellitus 
· Crohn's disease 
· Chediak-Higashi or Papillon-Lefevre syndromes 
 
· Generalised depression of cell mediated immunity 
· Leukaemias 
· Advanced HIV disease 
· Advanced malignancy 
· Bone marrow transplant recipients 
· Organ transplant recipients 
· Individuals receiving treatment with immunosuppressive agents such as cyclosporin 
or methotrexate. 
 
· Poor tissue healing 
· Localised radiotherapy (e.g., for head and neck cancer) 
· Osteoradionecrosis 
· Malnutrition 
· Poorly controlled diabetes. 
 
Antibiotics which may be considered in the management of such infections include: 
 
LJ Walsh : Microbiology 100 
Metronidazole 
· Limited spectrum – active against Gram negative obligate anaerobes only; has no 
activity against aerobes or facultative anaerobes 
· Good uptake when taken orally 
· Can cause GIT upsets (nausea, altered bowel motions – diarrhoea or constipation, 
abdominal cramping) and pancreatitis 
· Metallic taste is a common side effect 
· Severe interaction with alcohol (ant-abuse effect) 
 
· Other side effects of metronidazole include  
· Headache 
· Anorexia 
· Candidal overgrowth 
· Vertigo 
· CNS effects 
· Ataxia, Convulsive seizures, Hallucinations 
· Depression, Peripheral neuropathy. 
 
Amoxycillin 
· Good uptake when taken orally  
· Has a reasonably broad spectrum which will cover many likely pathogens 
· Inexpensive 
· Well tolerated 
· Allergy is a common problem 
· Can be broken down by beta lactamase producing species such as Bacteroides – hence 
use of clavulanic acid with amoxycillin (e.g. Augmentin) 
 
Cepahalosporins (e.g. Cephalexin / Keflex) 
· Are an alternative to amoxycillin 
· Patients who are allergic to amoxycillin can have a cross-sensitivity to cephalosporins.  
· Similar spectrum to Amoxycillin 
 
Erythromycin 
· Resistance is common 
· Frequently causes GIT upsets 
 
Tetracyclines (e.g. Doxycycline) 
· Bacteriostatic 
· Reasonably broad spectrum in activity 
· Inhibit protein synthesis 
· Blocks the action of penicillins 
· Can cause GIT upsets – must be taken with meals 
· Are concentrated in gingival crevicular fluid (GCF) by 2-4 times 
· Resistance develops frequently, and super-infection with resistant organisms is common 
· Can affect developing teeth and cause discolouration, therefore must not be used in 
children or in pregnant women 
· Common side effects are nausea, vomiting and diarrhoea 
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· Can cause photosensitivity. 
 
7.9 Pseudomonas aeruginosa 
 
This motile aerobic Gram negative organism is a major wound pathogen in the hospital 
setting and can cause fatal septicaemia. Immune compromised patients are particularly at 
risk of infection. The organism can survive and grow in “hospital strength” disinfectants, 
chlorhexidine handwash solutions, liquid soap solutions, and mouthrinses. It is found in 
some biofilms in both dental units as well as the reticulated water supply. Using regular tap 
water during surgical procedures (such as third molar removal) can expose the patient to 
the risk of Pseudomonas infection of the surgical site. Cases of transmission during dental 
care of cancer patients have been documented in the literature. 
 
7.10 Neisseria  
 
These Gram negative non-motile, aerobic cocci include non-pathogenic commensals in the 
mouth such as N. flava, N. sicca, and N. pharyngis. Pathogenic Neisseria include 
· N. gonorrhoeae - gonorrhoea 
· N. meningitidis – meningococcal disease 
· Branhamella catarrhalis (formerly designated as N. catarrhalis) which while a normal 





Bartonella henselae (formerly designated Rochalimaea henselae) is a Gram negative 
bacillus carried long term by cats which can cause cat-scratch disease in humans. This 
condition is characterised by cervical lymphadenitis approximately 6 weeks after contact 
with the animal, sometimes associated with a flu-like illness. The disease is most common 
in children, and is self-limiting. Cat-scratch disease can mimic dental infections and it is 
important to exclude it when faced with lymphadenitis in the submandibular area.  
 
7.12 Microbial succession  
 
Microbial succession is an important event which contributes to oropharyngeal mucositis in 
patients receiving chemo- or radiotherapy. These cytotoxic therapies are used widely in the 
treatment of malignancies of the orofacial region and malignancies arising from the 
haematopoietic system.  Oropharyngeal mucositis represents a major source of morbidity in 
these patient groups.  Mucositis may be defined as a reactive inflammatory process which 
affects the oropharyngeal mucous membranes.  Principal components of mucositis include 
oral ulceration, xerostomia, and infections.  These oral complications cause severe 
discomfort and pain, sleeping problems, speech difficulties, poor nutrition, prolonged 
hospitalisation, and in some cases, life-threatening septicaemia. As such, the generalised 
complaints which result from mucositis present a major challenge to medical and dental 
practitioners responsible for management of oncology patients. 
 
Both the quality and quantity of salivary secretions are altered in patients undergoing 
chemo- or radiotherapy.  Salivary output is greatly reduced, whilst viscosity is increased.  
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The buffering capacity of saliva and its pH decrease, whilst the inhibitory effects of saliva 
on the oral flora are severely reduced. As a result, there is a marked tendency for an 
increase in the total oral microbiota, as well as a change in the composition of the oral 
flora. This is contributed towards by reduced production of IgA, which allows colonisation 
of potentially pathogenic microorganisms, and by reduced mucosal cell turnover. 
 
The emergence and domination of certain Gram negative organisms in the oral flora of 
patients undergoing anti-neoplastic therapy is now recognised to be of prime importance in 
the development of oral ulcerations and infections. The work of Spijkervet and others has 
demonstrated that endotoxins from Gram negative organisms is central to the development 
of mucositis, particularly the ulcerative component. In contrast, yeast colonisation is not a 
significant causal factor in mucositis. In certain groups of oncology patients (patients with 
head and neck cancer, acute leukaemia, or undergoing bone marrow transplantation), there 
is direct laboratory evidence for shifts in flora and high carriage of certain Gram negative 
bacilli (Enterobacteriaceae, Pseudomonadaceae and Acinetobacter spp.) These organisms 
are uncommon in the oropharynx of healthy individuals. Use of chlorhexidine in mouthrinse 
formulations does not appear capable of preventing these microbiologic changes, despite 
apparent beneficial effects on yeast stomatitis gained via inhibition of adherence of Candida 
species.  
 
In view of the importance of Gram negative bacilli in oropharyngeal mucositis, several 
strategies for their selective have been devised. Custom-made lozenges containing 
polymyxin E, tobramycin, and amphotericin B (2 mg, 1,8 mg, and 10 mg, respectively) 
have been reported to eliminate successfully Gram negative bacilli within 2 weeks when 
used at a frequency of 4 applications per day. This regimen completely prevented the 
formation of pseudomembranes in patients undergoing radiotherapy for malignancies of the 
head and neck region. Low grade mucositis (erythema) persisted, however yeast stomatitis 
was prevented and no patients required nasogastric feeding. These beneficial effects were 
attributed to prevention of flora shifts (both antibiotics), neutralisation of endotoxin 
(polymyxin E), and concurrent inhibition of fungal growth within the oral cavity 
(amphotericin B). There were no untoward or toxic effects relating to the decontamination 
regimen. 
 
Prophylactic decontamination of the oral cavity has also been employed for patients 
undergoing bone marrow transplantation. The regimens used have comprised 3 % 
neomycin, 1 % polymyxin B, and 3 % amphotericin B in Orabase used thrice daily, or a 
cocktail of the same or similar agents used as a mouthrinse. Again, no untoward effects 
were reported, despite the occurrence of ulceration (of traumatic origin), which would have 
permitted some degree of absorption of the active ingredients. 
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8. ORAL FUNGAL INFECTIONS 
 
Fungi are relatively large microorganisms, with a size in the order of 100 mm, whereas 
bacteria and viruses are orders of magnitude smaller at 10 and 0.1 mm respectively. They 
are present in significant numbers in the environment, and are common opportunistic 
pathogens.  
 
Fungal infections (mycoses) can be either superficial or deep. Superficial mycoses of a 
minor nature are relatively common, and affect the skin, hair, and mucosal tissues. The 
organisms responsible have an affinity for epithelial keratins, being able to adhere to, and 
degrade, the epithelial cells of the skin and mucosae. 
 
Despite the abundance of fungi in the environment, life-threatening deep mycoses (such as 
mucormycosis, histoplasmosis, and pulmonary infections from Cryptococcus neoformans) 
are generally restricted to individuals with a compromised immune system are rare. Deep 
mycoses may arise by fungal organisms seeded into the circulation from superficial lesions 
(e.g. in the gastrointestinal tract), or by inhalation of fungal spores.  
 
 
8.1 Candidoses (Infections by Candida species) 
 
Many common fungal infections are opportunistic in that the organisms involved are 
members of the indigenous flora. Candida albicans is an opportunistic pathogen which is 
responsible for a variety of cutaneous, mucosal, and systemic fungal diseases. It is a 
resident commensal of the oral cavity in 50% of the population, and is a normal commensal 
of the gastrointestinal tract. In addition to albicans, other candidal species encountered 
orally may include: 
· C. glabrata 
· C. krusei 
· C. tropicalis. 
 
While more than 90% of opportunistic fungal infections of skin or mucosal surfaces are 
caused by Candida albicans, the organism rarely causes disease in the ABSENCE of 
predisposing factors. 
 
Predisposing factors for Candida albicans infection 
______________________________________________________________ 
· Salivary dysfunction 
· High carbohydrate diet 
· Nutritional deficiencies and malabsorption 
· Disturbed oral flora from antibiotics or steroids 
· Smoking 
· Endocrine disorders (e.g. diabetes mellitus) 
· Poor denture hygiene 
· Chronic irritation 
· Immune dysfunction: malignancies, immune suppression, blood dyscrasias 
· Extremes of age (very young or very old). 
_______________________________________________________________  
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Oral candidal infections (candidoses) 
___________________________________________________________________ 
· Pseudomembranous candidosis (Thrush) 
· Atrophic candidosis (Denture sore mouth, Median rhomboid glossitis) 
· Erythematous candidosis 
· Angular cheilitis (which is a co-infection with staphylococci) 
· Hyperplastic candidosis (pre-malignant condition with progression to malignancy in up to 40% 
of cases) 
· Mucocutaneous infections (such as the external skin of the chin). 
_______________________________________________________________  
 
Candida species can be isolated for diagnostic purposes using Sabouraud’s agar, which is 
semi-selective for pathogenic fungi because of its high glucose level and low pH (5.2). 





Histoplasmosis is an infection which can occur in the immune compromised patient – such 
as a patient with AIDS or a bone marrow transplant recipient. Histoplasma is found in the 
environment, particularly soil, and is found in the faeces of birds and bats. Oral lesions can 
occur on virtually any mucosal surface and can have a range of appearances (granular, 
nodular, or atrophic). They are usually a superficial mycosis, with only rare invasion of the 
hard tissues or dissemination to other sites in the body. 
 
8.3 Antifungal agents 
 
Anti-fungal agents include polyenes and azoles. Polyenes cause cell membrane leakage, 
while azole antifungals prevent cell membrane synthesis. Typical polyene antifungals are: 
· Nystatin – for topical use only as it is too toxic for systemic use. 
· Amphotericin – which can be used topically and IV (micellar) - for systemic candidoses 
and deep seated infections (mycoses). 
 
These agents are used systemically for serious fungal infections but must be used with 
caution as they can damage the liver in high doses.  
 
Azole antifungals include: 
· Miconazole – used topically in a cream; It is also active against staphylococci so this 
agent is useful for the treatment of angular cheilitis 
· Fluconazole – which can be used orally or IV 
· Ketoconazole, etc. 
 
For patients who suffer recurrent oral candidosis, topical antifungal agents are of value.  
Nystatin and amphotericin are commonly used agents, and are available as suspensions or 
lozenges (Nilstat, Fungilin). In general, preparations containing nystatin are formulated 
with a sucrose base. Thus, long term use of such products is likely to exacerbate dental 
caries, particularly in patients with salivary dysfunction or impaired oral hygiene. Use of 
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amphotericin products, which are formulated in a sugar-free base, is preferred. For denture-
related candidiasis, miconazole gel (Daktarin) can be applied to the tissue surface of the 
denture, and the denture then worn in the normal fashion. Patients with denture-related 
candidal infections should also mechanically clean the dentures (particularly the fitting 
surface) and brush the denture-bearing mucosa. Brief immersion (2 minutes) of the denture 
in dilute sodium hypochlorite (a tenfold dilution of household bleach) on a regular basis will 
add in suppressing fungal growth on the denture surface. 
 
Recurrent oral candidal infection is a particularly common problem in immune suppressed 
and immuno-deficient patients. Topical antifungals (nystatin and amphotericin B 
suspensions) tend to have limited effectiveness as prophylactic agents in such patients, and 
nausea is a major side effect. Oral fluconazole is much more effective, but poses risks of 
organ toxicity. Because of greater efficacy in preventing oral candidosis and better patient 
tolerance, oral fluconazole is preferred to antifungal suspensions for prophylactic use in 
immune deficient patients. 
 
Strategies for managing peristent fungal infection 
_________________________________________ 
Check for impaired host response 
Check for undiagnosed diabetes mellitus I or II 
Improve diet 
· Reduce fermentable dietary carbohydrate 
· Reduce dietary acid 
· Correct fluid balance deficits 
Improve salivary function ar rest 
Elevate intra-oral pH 
· Use NaHCO3 mouthrinse 
Improve mechanical oral hygiene of teeth and dentures 
Use biocides 
· Chlorhexidine 




8.4 Immune response to fungal infections 
 
While a variety of immune defence strategies are employed in the response to fungal 
infections, T lymphocyte-mediated activation of macrophages is of particular importance 
for destruction of fungi. T lymphocytes provide immunologic memory, which can be 
demonstrated by cutaneous testing for delayed hypersensitivity (Type IV) responses to 
fungal antigens. For many fungal pathogens, this immunological memory provides for a 
degree of resistance to repeated infection.  
 
Antibody participates in anti-fungal immunity. Fungal toxins can be neutralised by IgG and 
IgM antibodies. Neutrophils appear capable of destruction of fungi, particularly through 
oxygen-independent mechanisms involving cationic proteins.  
 
Fungal spores can bind to IgE on mast cells and thereby elicit mast cell degranulation, 
which in turn increases production of mucus in a mucosal site and transudation of plasma 
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from the circulation. Both these phenomena serve to wash out the fungal spores, but may 





Endospores are the metabolically dormant form produced by bacteria under conditions of 
nutritional deprivation (particularly lack of appropriate carbohydrate nutrients). They can 
be produced by Gram positive aerobes (Bacillus and Geobacillus spp.) and anaerobes 
(Clostridium spp).  Because of their thick walls (and low water content), spores are 
resistant to a range of physical and chemical agents which would kill vegetative bacteria.   
 
Spores germinate in response to nutritional triggers. This process of sporulation can be 
inhibited by disinfecting agents, as follows: 
· trigger mechanism – glutaraldehyde, alcohols 
· germination – phenolics, alcohols 
· spore outgrowth – chlorhexidine, glutaraldehyde, quaternary ammonium compounds. 
 
Disinfecting agents are able to affect spores, as follows: 
· Cortex: oxidised by sodium hypochlorite, cross-linked by glutaraldehyde 
· Core: oxidised by hydrogen peroxide. 
 
Layers of a spore, from outside – in 
________________________________________ 
1. Exosporium 
2. Outer protein coat 
3. Inner protein coat 
4. Cortex (peptidoglycan) 
5. Germ cell wall 
6. Plasma membrane 




9.1 Spore-based biological indicators 
 
Because they are difficult to inactivate by sterilisation processes, spores are used 
extensively in biological indicators for quality assurance of sterilisation. The routine weekly 
use of biological indicators to verify the adequacy of sterilisation cycles is an important and 
well accepted part of modern infection control. Several systems have been developed for 
biological monitoring, including spores of the heat-resistant bacteria Geobacillus 
stearothermophilus for autoclaves and Bacillus subtilis for dry heat sterilisers. The 
principle involved is that if spores are inactivated, less resistant microbial forms have been 
killed. 
 
Spore tests for autoclaves typically are sealed glass or plastic tubes that contain spores of 
Geobacillus stearothermophilus, with typically 100,000 spores per test tube or strip.  
Spores of this extremely heat tolerant organism will survive autoclaving for one minute at 
134 Celsius, but will be killed by three minutes at the same temperature.  It should be noted 
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that the spore test tubes have a defined shelf life (typically two years) and they must not be 
stored near X-ray equipment, or sterilant chemicals. 
 
When assessing the viability of spores and subsequent bacterial growth, incubation of 
biological indicator vials for extended periods (24-48 hours) is necessary before a result can 
be obtained.  Because of this delay between test and result, there has been interest in rapid 
readout systems based on enzymes associated with spores. The activity of these enzymes 
can be detected using substrates which undergo changes in colour, which can be detected 
using a spectrophotometer or by gross visual examination. 
 
Two current systems which are available for enzyme-based validation of steam sterilization 
are the 3M Attest and Attest ™ Rapid Readout. Readout for both is visual (pH indicator 
changes from purple to yellow due to production of acid metabolites by bacteria), but when 
read spectrophotometrically the Rapid Readout variant can give quicker definitive results.  
 
AttestTM  (regular) spore test system 
____________________________________________________________________________ 
· Major component is a tube which contains 
· spores 
· growth medium 
· pH indicator dye (bromocresol purple) 
· Tubes must be incubated in heating block  
· Time to result is 24-48 hours 
· Readout is visual (pH indicator changes from purple to yellow due to production of acid 
metabolites by bacteria) 
· Disposal: autoclave any positive tubes before disposal in sharps container. 
_______________________________________________________________________ 
 
AttestTM  Rapid spore test system 
______________________________________________________________________________ 
· Major component is a tube which contains 
· Spores, with enzymes coupled externally 
· growth medium 
· pH indicator dye 
· fluorescent substrate 
· Tubes must be incubated in heating block 
· Time to result is 2 or 3 hours for fluorescence; 24 hours for visual change  
· Readout at 2-3 hours requires ultraviolet spectrophotometer (Attest Autoreader).  
· Readout at 24 hours is visual (pH indicator changes from purple to yellow) 
· Disposal: autoclave any positive tubes before disposal in sharps container 
________________________________________________________________________ 
 
In addition to regular calibration and validation of sterilization, spore tests are useful for 
assessing the effectiveness of sterilization in the following situations: 
· when commissioning a new autoclave;  
· after a suspected malfunction; 
· after servicing or repairs; and  
· as part of the training of new staff in autoclave operation. 
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The proper use of spore tests can be summarised as follows: 
 
· Spore tests are run at calibration and validation (standardization), and written results 
kept of the results. 
· Spore tests are used from a cold start. 
· Spore tests are placed in the innermost part of a typical load. 
· Unused spore tests are kept in a cool dry place away from heat or radiation. 
· Spore tests are used within their expiry date. 
 
9.2 Analysis of spore test failures 
 
When there is a positive result (which indicates a failure of the sterilization cycle), the 
causes of this (equipment malfunction or human error) must be identified and rectified. 
 
Typical human errors:  
· Inadequate cleaning prior to autoclaving 
· Incorrect packaging material (material impermeable to steam) 
· Excessive packaging material 
· Packs trays too large or dense for cycle parameters 
· Poor loading technique: overloading or insufficient separation (entrapment of air and 
prevention of steam penetration) 
· Incorrect choice of cycle 
· Manual alteration of cycle parameters (temperature or time) 
· Incorrect operation - interruption of cycle, failure to process entire load, failure to 
allow heat-up time for large loads 
· Incorrect sterilant – tap water used instead of de-ionised water results in build-up of 
mineral deposits in the autoclave.  
· Water not replaced regularly (contaminated by lubricants) 
· Items not dried after autoclaving 
· Improper storage after autoclaving. 
 
Common equipment malfunctions: 
· Clogged filters or vents 
· Sensors and indicators out of calibration 
· Faulty timer 
· Low water level 
· Controller malfunction 
· Sensor probes out of calibration 
· Incomplete air removal  
· Drain screen blocked by debris 
· Leaking door gaskets 
· Faulty vacuum pump 
· Poor quality steam 
· Wet steam (faulty steam line trap – particularly from a cold start) 
· Superheated steam 
· Inadequate steam pressure – insufficient water. 
· Poor quality sterilant - contaminated by lubricants 
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· Failure to replace autoclave water at weekly intervals 
 
 
9.3 PRION DISEASES 
 
Several slowly progressing, usually fatal neurological diseases are caused by unique 
proteinase-resistant proteins termed PRIONS. The term PRION was coined by Prusiner in 
1982 to describe the concept of a proteinaceous infectious unit. These are a modified form 
of a normal host protein. Prions are resistant to most procedures that modify nucleic acids, 
and can be transferred when tissues containing the prions are ingested by or transplanted to 




The general term used for prion diseases is transmissible spongioform encephalopathies 
(TSE). TSE can be transmitted from one individual to another through transfer of 
contaminated tissues, or genetically (i.e. to one's offspring). Many TSE have long 
incubation periods (2-40 years), which has hampered research into the aetiology and 
transmission of these diseases. An additional factor has been the high resistance of the 
agents which cause TSE to physical and chemical agents such as high temperatures and 
aldehydes.  
 
TSE are rare diseases which effect neural tissue.  The name is derived from the physical 
appearance of the tissues, literally “holes in the brain”.  These diseases occur spontaneously 
in a number of animals, as well as humans, and can be transmitted from one individual to 
another as well as across species. TSEs are also unique in that not only are they 
transmissible diseases, but they are also genetic diseases, since they result from particular 
gene mutations. 
 
While TSEs in both humans and animals have been known about for a number of years, in 
recent years much media attention has been directed to Bovine Spongioform 
Encephalopathy (BSE), which is also known as Mad Cow disease. 
 
Classical Creuzfeld Jakob disease (cCJD) occurs spontaneously in the population with a 
rate of approximately one case per million of population each year.  cCJD has been 
transmitted between patients through contaminated instruments used in neurosurgery, and 
by contaminated materials derived from cadavers, such as dura mater and pituitary extracts. 
Of note, cCJD cannot be transmitted by blood transfusion, or by eating meat or beef 
products.   
 
A condition related to cCJD which is termed Kuru occurs when infected brain tissue is 
eaten. This condition occurred in the highlands of Papua New Guinea and resulted from 
cannibalistic practices.   
 
vCJD is a derivative of BSE which was first described in 1996.  This zoonosis is 
transmitted from affected cattle to humans through the consumption of infected beef 
products, particularly those which are derived from the brains or other neural tissues.  
Following the identification of vCJD, there has been a revision of the infection control 
requirements for patients who are at risk for TSEs in the dental surgery. This topic is 
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addressed in detail in the NH&MRC / CDNANZ Infection Control Guidelines. Note that 
prion disease guidelines were changed in 2008 and that dental procedures in prion 
patients are not regarded as posing a risk of infection, since prions are not present in 
the dental pulp, gingival, periodontal or oral mucosal tissues. Only neurosurgical 
procedures involving the trigeminal ganglion (where prions can be found) require 
strict additional precautions. 
 
A particular difficulty with TSEs is that they do not result in the production of antibodies, 
and thus screening of patients using serology is not possible.  Also, the prions responsible 
for TSEs are extremely resistant to conventional sterilizing processes.  They require 
extended treatments of time and heat, and in some cases, also chemicals, to change the 
shape or confirmation of the prions. 
 
The most reliable diagnostic test for both classical and variant CJD in humans is 
histopathological examination of brain tissue.  Unfortunately, this can only be done at 
autopsy.  Neurological testing, such as electroencephalography, may show abnormalities, 
and inflammatory proteins in the cerebral spinal fluid become deranged.  However, as yet 
no one single specific test has been developed. A specific test has been developed to screen 
cattle for BSE, and it is hoped that an adaptation of this test may be suitable for use with 




The prion protein (termed PrP) is relatively small (27-30,000 molecular weight), and is 
encoded by a normal host gene. PrP is expressed in both normal and diseased neural tissue, 
however there are subtle differences in the structure of PrP in normal and diseased tissue. 
The normal PrP which is found in cells is converted by a conformational change into the 
PrP form which is associated with disease. Thus, the prions which cause TSEs elicit disease 
by acting as a template.  The disease related form of the prion is a specific protein molecule 
which causes adjacent protein molecules to change to an abnormal shape. Transmission of 
prions to a susceptible host results in the modification of the host’s normal PrP, with the 
disease-related PrP serving as a scaffold or template on which this refolding occurs. This 
modification results in the slow accumulation of infectious PrP in the brain over time, 
which results in the clinical disease and the underlying spongioform encephalopathy and 
neural degeneration. The disease develops over a period of years, as the level of altered 
protein in the brain increases. Affected individual develop neurological symptoms.  These 
may include abnormal sensory perceptions, or as in the case of vCJD, neuropsychiatric and 
behavioural disorders. 
 
The PrP gene is termed PRNP, and the disease-related mutation occurs at codon 129 of 
this gene in the most common form, sporadic CJD, which accounts for approximately 90% 
of cases.  
 
As noted above, transmissible spongioform encephalopathies caused by prions include: 
 
· Creutzfeldt-Jakob diseases (CJD) in humans, which includes variant CJD (a zoonotic 
disease in humans which is a derivative of BSE from cattle). The first cases of sporadic 
and familial (also termed classical) CJD were documented in the early 1920's, while the 
first cases of variant CJD were identified (in the U.K.) in 1996. Iatrogenic (medically 
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transmitted) CJD was identified in the 1950's. In terms of total cases in Australia, the 
approximate breakdown is 90% sporadic CJD, 6-9 % familial CJD and 3 % iatrogenic 
CJD. No cases of variant CJD have been recorded outside of Europe, and it is unlikely 
that variant CJD will develop in countries where animal herds are free (and can be 
maintained fee) of BSE and related diseases. 
 
· Kuru (humans). This disease occurred as an epidemic after ingestion of human brains in 
the eastern highlands of New Guinea, and was documented in the 1950's. 
 
· Familial fatal insomnia (FFI) (humans) 
 
· Gerstmann-Straussler-Scheinker (GSS) disease (humans) 
 
· Scrapie (sheep; can also be transmitted to other animals) 
 
· Bovine spongioform encephalopathy (BSE) (“mad cow disease”) 
· In the United Kingdom, BSE was transmitted epidemically in cattle herds through 
cattle feed which was prepared from slaughtered animals. This led to a ban on the 
consumption of British beef, and the destruction of affected herds. 
· Feline spongioform encephalopathy (in domestic cats). 
 
Variant CJD was first reported in 1996 in the United Kingdom, and more than 100 cases 
have now been documented. Variant CJD is attributed to eating foods which contain BSE 
infected meat. Infection of cattle with BSE in turn has been traced to the practice of using 
animal components (particularly meat and bone meal from sheep and cattle) in high protein 
cattle feed. The transmission of BSE from cattle to other species such as primates, sheep, 
goats and mice has also been demonstrated. This raises the spectre of transmission of TSE 
from sheep to humans, although at the time of writing there is no evidence of this 
disturbing possibility. 
 
Key features of variant CJD are: 
 
· Rapid onset (symptoms at 2 years), progressing to death within 12-18 months (median 
14 months) after the appearance of symptoms. 
· A younger mean age of affected patients (30 years) 
· Psychiatric disturbances (depression, delusions, paranoia, insomnia) 
· Pain and abnormal sensory perceptions 
· Uncoordinated and abnormal jerky movements, which progress to a state of akinetic 
(motionless)  mutism. 
 
The possibility exists that variant CJD may be transmitted by blood, as has been shown 
experimentally in sheep. This is the reasoning behind the Australian Red Cross Blood Bank 
instituting a policy whereby blood donations will not be accepted from individuals who 
lived in the United Kingdom during the height of the BSE epidemic. 
 
In contrast, the clinical presentation of classical (sporadic or iatrogenic) CJD in humans is 
characterised by progressive dementia with widespread impairment of neurological 
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function. It usually develops in older patients (mean age 65 years) and has a long 
incubation period. Symptoms comprise: 
· tremors and uncoordinated movements (ataxia) and  
· mental deterioration and dementia. 
· Death usually occurs 5 months after symptoms appear. 
 
Special tests (such as EEG, and cranial CT and MRI scans) are used to exclude other 
causes of dementia and ataxia (such as multiple cerebral infarcts). The EEG in CJD shows 
tri-phasic sharp waves. Definitive diagnosis is made by histopathological examination of 
brain tissue for vacuoles in the grey matter, loss of neuronal cells and proliferation of 
astrocytes and microglial cells. There is no blood test and there does not appear to be an 
immune response to the altered PrP protein. There is some suggestion that analysis of 
cerebrospinal fluid for proteins released from damaged brain tissue (such as the 14-3-3 
protein) may aid in the diagnosis but this marker is not specific for CJD. 
 
With classical CJD, there is a long incubation period (from 15 months to 30 years), and no 
demonstrable inflammatory or immune response. The long incubation period, and low 
incidence of CJD (approximately 1 new case per million population per year) has hampered 
the identification and laboratory study of prion diseases. 
 
Having family members with CJD is clearly a risk factor for familial CJD, while risk factors 
for iatrogenic (medically transmitted) CJD include: 
· dura mater or corneal grafts (from cadavers) 
· extensive neurosurgery 
· injection of human pituitary gland-derived growth hormone or gonadotrophins. 
With iatrogenic transmission involving the cranial cavity, the incubation period can be quite 
short (1-2 years). 
 
Having extensive dental procedures undertaken has been shown NOT to be a risk 
factor for acquiring CJD. The risk of dental staff acquiring CJD from patient contact 
apperars to be zero. Blood and saliva (like bone marrow, hair, skin, urine and sweat) have 
no infectivity for classical CJD, and the risk of exposure to CJD in neural tissue from 
subgingival scaling or pulp extirpation is regarded as negligible. Note that the situation is 
unclear for variant CJD, however blood borne transmission of this condition in humans 
appears possible at least in theory based on existing information from animal studies in the 
laboratory setting. There is no supporting epidemiological evidence for blood transfusion as 
a risk factor for CJD.  
 
Tissues which are regarded as highly infectious for CJD include brain, spinal cord, dura 
mater, cornea, pituitary gland, and cerebrospinal fluid.  
 
TSE agents are remarkably resistant to heat and as a result infectivity can persist 
after conventional autoclave cycles. For this reason, use of single use instruments and 
destruction of all instruments used during surgery (by incineration) are required for 
neurosurgical treatment of high risk patients which involves manipulation of trigeminal 
ganglion and other neurovascular tissues or procedures in which bleeding can occur.  
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Guidelines for CJD and other Prion diseases  
 
There is no epidemiological evidence that dentistry is a risk factor for classical CJD (Collins 
et al 1999, Chan, Collins, Masters and Walker, 2001).  
 
The assignment of different organs and tissues to categories of high and low infectivity is 
chiefly based upon the frequency with which infectivity has been detectable, rather than 
upon quantitative assays of the level of infectivity, for which data are incomplete.  
Experimental data include primates inoculated with tissues from human cases of CJD, but 
have been supplemented in some categories by data obtained from naturally occurring TSE.  
Actual infectivity titres in the various human tissues other than the brain are extremely 
limited, but data from experimentally infected animals is generally consistent with the 
grouping shown in the table below. 
 
Predicted infectivity of human body tissues and fluids  
(adapted from the NH&MRC / CDNANZ Guidelines, 2004) 
 
Infectivity Category Tissues Secretions and Excretions 
High infectivity 





Eye (anterior, cornea) 
 
Low infectivity 
(demonstrated to be infectious, 








Dorsal root ganglia 
 
CSF 
No detectable infectivity 
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10. VIRUSES 
 
Viruses are responsible for a variety of infectious diseases, and are major aetiologic factors 
in immunodeficiency and neoplasia. Viruses are obligate intracellular pathogens in that they 
require the biosynthetic machinery of the cell for replication. The processes involved in 
viral replication differ according to the nucleic acid composition of the virus, whether DNA 
or RNA. RNA viruses require reverse transcription of their nucleic acid to enable virally-
derived DNA to be incorporated into the host cell genome.  
 
The viral genome may be DNA or RNA (this RNA may be single or double stranded).  
 
The genetic material of a virus is contained in the CORE, which is surrounded by a protein 
COAT. This whole structure (the nucleocapsid) may be naked or may be enveloped (using 
proteins, lipids and carbohydrates derived from the cell membrane of the host). The 
presence of an envelope is important in terms of disinfection, since organic solvents can 
inactivate enveloped viruses by destroying the envelope. 
 
· Hydrophilic viruses have small protein coats, for example: 
· Papilloma virus 
· Polio virus 
· Many enteric viruses. 
 
· Lipophilic viruses have a lipid component in their coat or outer envelope (in some 
cases, this is derived by pinching off part of the cell membrane of the host cell). 
Examples of lipophilic viruses include: 
· HIV 
· Human Herpes viruses (HSV-1, CMV, etc.) 
· Respiratory viruses (adenovirus, rhinovirus, respiratory syncitial virus)  
 
Common viruses  
  Enveloped Non-enveloped 
DNA Double stranded Herpes viruses Hepatitis B 
Papilloma virus 
DNA Single stranded   
RNA Double stranded   




Portals of entry for viruses include: 
 
· Skin 
· puncture wounds allow bloodstream contact, e.g. Hep B and C, Ross River virus 
 
· Respiratory tract 
· EBV 
· Rhinovirus (common cold) and influenza 
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· Gastro-intestinal tract 
· Hepatitis A and E 
· Poliovirus 
 
· Genital tract 
· HIV 
· Papilloma virus. 
 
Where there is a local target, the viral infection typically has a rapid onset and there is 
localised disease with direct viral shedding to the exterior, e.g. influenza. 
 
Where the target is distant, there is generally a latent period before infection, and 
viraemia (free virus in blood) e.g. Hepatitis B. Viruses can sequester into various cell 
types in the blood, for example: 
· CMV in lymphocytes 
· EBV in B lymphocytes (which causes proliferation) 
· HIV in T lymphocytes cells (which eventually leads to cytotoxicity). 
 
10.1 Stages of viral infection 
 
The stages of viral infection comprise 
· entry into the host 
· attachment 
· integration of viral nucleic material into the host cell genome 
· replication of new viral components 
· assembly of intact virus particles (virions) 
· release of virus particles (with or without cell lysis). 
 
As a group, viruses show considerable diversity in the pattern of infection and in the 
resultant cytopathic effects and immunopathology. The process of viral infection may be 
fundamentally either cytolytic, integrated, or persistent (latent, chronic, or slow).  
 
With cytolytic virus infection, virus particles are assembled within the cells and are released 
into the extracellular fluid upon lysis of the cell. 
 
In permissive infection, the virus takes over the machinery of the cell and shuts down 
homeostatic functions, virus progeny are shed from the cell, and the cell undergoes 
eventual lysis. In  non-permissive infection, there is persistent infection rather than cell 
death, and the host humoral or cellular immune response is ineffective. The viral genetic 
material which is incorporated into the host genome allows for latent infection as well as 
for the development of malignancy (with oncogenic viruses). 
 
With chronic viral infections, the presence of the virus can be variable. During latency, free 
virus may not be detectable, however sensitive techniques such as the polymerase chain 
reaction (PCR) can detect viral genetic material. While virus shedding and re-activation 
occurs in immune-suppressed states, even in otherwise normal individuals, shedding of 
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virus may occur over many years, e.g. Hepatitis B or C. This has an important relationship 
to subsequent development of malignancy in the infected organ, e.g.  
· Hepatitis  B or C and hepatocellular carcinoma (liver cancer) 
· EBV and Burkitt’s lymphoma. 
 
10.2 Human herpesviruses 
 
The human herpesvirus (HHV) family can be divided into several groups: 
 
· Alpha group 
· Herpes Simplex Type 1 (HSV-1) (HHV1) 
· Herpes Simplex Type 2 (HSV-2) (HHV2) 
· Varicella zoster virus (VZV) (HHV3) 
· Beta group 
· Cytomegalovirus (CMV) (HHV5) 
· Human Herpesvirus 6 (HHV6) 
· Gamma group 
· Epstein-Barr virus (EBV) (HHV4) 
· Human Herpesvirus 8 / Kaposi’s sarcoma virus (HHV8) 
 
Primary infections include: 
· Gingivostomatitis (HSV-1 or 2) 
· Genital herpes (HSV-1 or 2) 
· Whitlow (HSV-1 or 2) 
· Conjunctivitis and keratitis (HSV-1 or 2) 
· Encephalitis (HSV-1 or 2) 
· Chicken pox (VZV) 
· Infectious mononucleosis (EBV) 
 
Recurrent infections include: 
· Shingles (VZV) 
· Herpes labialis (HSV-1 or 2). 
 
A common feature of herpes viruses is latency – the viruses can sequester into cells and 
then be reactivated at some future time, e.g.. 
· HSV-1 and 2 in the trigeminal (V3) ganglion 
· VZV in sensory ganglia 
· EBV in epithelial cells and B lymphocytes 
· CMV in salivary gland cells. 
 




· immune suppression. 
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A classic example of this is Herpes Labialis (“cold sore”) - ulceration on the lip caused by 
re-activation of HSV 1 or 2. Intra-oral HSV lesions are typically small round vesicles with 
a prominent surrounding erythema. These vesicles break down to give small ulcerations, 
which then coalesce to give larger ulcers. With VZV, recurrence typically follows the 
distribution of the affected nerve (e.g. a branch of the trigeminal nerve, or a dermatome). 
Ulcerations follow a distinct unilateral pattern which maps out the distribution of the nerve 
– both on the skin of the face as well as on the oral mucosa. Because of the involvement of 
sensory nerves to the teeth, the symptoms can include deep seated toothache, particularly 
in the early (prodromal) stage. 
 
Another common feature of herpes viruses is that persistent infection can lead to immune 
suppression – with EBV, HHV-6, and CMV the most potent. These viruses have been 
implicated in a range of disorders with recurring infections and fatigue. Infection with 
human herpesviruses has been identified as a modifying factor for accelerated progression 
of HIV infection (and thus a shorter lead time until the development of full-blown AIDS), 





Foetal infection with CMV may cause neurological effects. In adults, asymptomatic CMV 
infection is very common. Blood donations are screened for antibodies to CMV so that 
CMV status can be identified for transfusions (e.g. of platelets) given to CMV-negative 
immune suppressed patients, in whom primary CMV infection of major organs (lungs, liver, 





Infection of B lymphocytes and epithelial cells can lead to cell transformation and frank 
malignancy. EBV-induced conditions include:  
· Burkitt’s lymphoma (Africa) 
· Nasopharyngeal carcinoma (China) 
· oral hairy leukoplakia (OHL) (e.g. in patients with AIDS or severe immunodeficiency). 
· OHL was first described by John and Deborah Greenspan’s group in San Francisco 
in 1984. The presence of EBV has been documented by ultrastructural, 
immunohistochemical and molecular biological techniques. 
· It affects primarily the posterior and mid lateral tongue 
· Other sites which may be affected include the buccal mucosa, soft palate, and floor 
of mouth 
· The lesion has a characteristically corrugated (“washboard”) pattern with vertical 
folds. 
 
HHV 8:  
 
This member of the human herpesvirus family is recognised as the cause of Kaposi’s 
sarcoma (e.g. in HIV and immune suppressed patients). HHV-8 infects the endothelial cells 
which line blood vessels, but is able to infect a range of other cell types (including neural 
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tissue). HHV-8 is related to EBV, and shares with EBV the ability to infect B lymphocytes 
(which can lead to cell transformation and thus to lymphoma). 
 
Treatment for severe herpes virus infections can employ a range of antiviral agents. 
Acyclovir and valacyclovir (Valtrex) can be used for both treatment and prevention of  
HSV-1/2 and EBV infections. Resistant forms can occur, in which case foscarnet is used. 
The antiviral agent gancyclovir is used for both treatment and prevention of CMV 
infections. 
 
10.3 Human papilloma virus (HPV) 
 
HPV has a high prevalence in the oral mucosa of healthy individuals, and approximately 40 
% of the population harbour the virus in their oral epithelium in the absence of any overt 
pathology. The virus can be typed by in situ hybridisation and other molecular biological 
techniques.  
 
HPV is the aetiological agent in a range of epithelial proliferative disorders including 
papillomas (oral warts) and condyloma accuminatum (venereal warts). The lesions are 
typically exophytic and with a broad base. Individual lesions cam coalesce to form large,  
pebbly outgrowths. Oral HPV lesions may occur on a variety of sites, but are most 
common the ventral tongue, gingiva, labial mucosa, and palate. HPV can be transmitted 
readily by sexual activity, and oral lesions can arise from direct contact with the ano-genital 
area or by self inoculation. 
 
HPV is an aetiological agent in frank malignancy, and plays a major role in genital cancer in 
women (cervical intra-epithelial neoplasia / CIN) as well as oral cancer (verrucous 
carcinoma), especially the HPV 16 and 18 subtypes.  
 
Treatment of HPV lesions can employ a variety of approaches, including  
· Surgical excision 
· Laser surgery (ablation or excision) 
· Cryotherapy 
· Podophyllin ointment. 
 
The virus is unusually resistant to damage from electrosurgery, carbon dioxide laser 
ablation and other aggressive therapies, and is able to survive intact and in an infectious 
state in the fumes (such as laser plume) given off during surgical procedures. 
 
10.4 Coxsackie virus 
 
Hand, foot and mouth disease is caused by Coxsackie virus type A16, also types A4,5,9,10, 
while herpangina is caused by Coxsackie virus types A2,4,5,6,8. These mild self-limiting 
conditions are characterised by small papulo-vesicular lesions 1-2 mm in diameter, typically 
on the palate. 
 
LJ Walsh : Microbiology 119 
10.5 Immune response to viral infection 
 
With cytolytic viruses, the natural immune system is a major means of controlling infection. 
Interferon production by infected cells prevents neighbouring cells from supporting viral 
infection. In addition, interferons increase the non-specific cytotoxic capabilities of NK 
cells, so that infected cells are destroyed before viral replication has occurred.  
 
Once the adaptive immune system has been activated, both specific cytotoxic lymphocytes 
and specific antibodies will be produced. These antibodies may be directed against either 
viral antigens or toward host cells which have been infected with virus. Antibodies can 
· prevent binding of virus to host cells 
· cause aggregation of virus particles 
· enhance phagocytosis of virus particles 
· mediate complement-directed lysis of virus 
· mediate antibody-dependant cell-mediated cytotoxicity (ADCC) by binding to K cells. 
 
Protection against repeated infection requires sufficient levels of antibody to be maintained 
within the circulation or upon mucosal surfaces. If the portal of entry and target tissue for a 
virus is the same, (e.g. viruses which infect epithelial tissues), antibody on the mucosal 
surface (sIgA) may block entry or inhibit colonisation. In contrast, where a significant 
viraemic stage exists prior to infection of the target tissue (e.g. hepatitis B), serum 
antibodies (IgG, IgM) can provide protection against repeated infection. 
 
Antigen-specific cytotoxic T lymphocytes participate in anti-viral immunity in an MHC-
restricted fashion. Viral peptides incorporated into cell surface MHC molecules 
(particularly class II MHC molecules) serve as the non-self or "target" antigen. Binding of 
lymphocytes via the T lymphocyte receptor and either CD8 or CD4 allows recognition of 
cells bearing non-self peptides on class I or class II MHC molecules, respectively, with 
subsequent killing of the virally infected cell. This process of killing virally-infected cells is 
augmented by the NK cells of the natural immune system, which are activated by T 
lymphocytes. In addition, T lymphocytes provide help for antibody production by B 
lymphocytes. Because of the central role of T lymphocytes, recurrent and persistent viral 
infections are a major clinical problem in individuals with T lymphocyte 
immunodeficiencies, such as organ graft recipients and individuals infected with HIV..  
 
Viruses which undergo changes in their surface molecules may evade both cellular and 
humoral immune defence mechanisms. Changes in viral antigens occur either by point 
mutations in the viral genome (antigenic drift) or by swapping large quantities of genetic 
material with other viruses (antigenic shift). A new epidemic of viral infection can occur 
once the alterations are sufficiently large that previous immunity is rendered ineffective. 
Viruses which are responsible for the seasonal upper respiratory tract "flu" infections, and 
hepatitis C virus are excellent examples of viruses which evade prior immunity in the host  
by viral mutation.  
 
Where the immune response is unable to eliminate infectious virus completely, the virus 
may persist in the host tissues. Because this process of sequestration may occur without 
clinically recognisable primary infection, the infected individual may be unaware of having 
acquired the infection. Virus particles may or may not be shed from infected cells during 
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"silent" periods of infection, but are released upon activation of the infection, since this 
often results in lysis of the infected cell. Because of the variable presence of extracellular 
virus, neutralising antibodies in the serum are of limited value in preventing ongoing viral 
pathology. Detection of viral antigens on expressed cells and the subsequent targeting of 
these cells is of major importance in recovery from reactivated infections.  
 
 
11. VIRAL HEPATITIS  
 
Viral hepatitis is a condition where infection with a virus causes inflammation of the liver. It 
is important to distinguish viral hepatitis from other causes of liver inflammation, such as 
trauma, alcohol abuse, or drug-induced toxicity. 
 
With viral infection of the liver occurs, there are a variety of possible outcomes: 
 
· Acute hepatitis with full recovery 
· Fulminant hepatitis resulting in death 
· Sub-clinical infection (no signs or symptoms) 
· Chronic carrier state 
· Scarring of the liver (cirrhosis) 
· Liver cancer (hepatocellular carcinoma). 
 
The likelihood of these various events occurring varies according to the causative agent. 
Chronic infection is a problem with B,C and D but not A and E. HCV is the biggest 
contributor to chronic hepatitis in the community, followed by HBV. 
 
The various agents which may cause viral hepatitis may be classified as follows: 
 
· Transmitted predominantly by the faecal-oral route  
· Hepatitis A (HAV) 
· Hepatitis E 
 
· Transmitted predominantly by blood-blood contact (“serum hepatitis”) or percutaneous 
/mucosal exposure to blood-contaminated body fluids 
· Hepatitis B (HBV) 
· Hepatitis C (HCV) 
· Hepatitis D (Delta hepatitis, HDV) 
· Hepatitis G 
 




· Transmitted by contact with faeces 
· Present in high quantities in faeces (1 billion/mL) 
· Poor hygiene is a major contributory factor 
· Poor handwashing after using the toliet 
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· Close personal contact  
· Sexual contact 
· Ingestion of contaminated food and water 
· Occurs in small epidemics in over-crowded institutions, refugee populations, day 
care centres 
· Also present in blood (10,000 /mL) 
· Can be transmitted by transfusion of blood from an infected individual or by 
injecting drug use 
· Low levels in saliva (100 /mL)  
 
There is a high prevalence of HAV infection in:  
· The developing world 
· The Indian subcontinent 
· South East Asia. 
 
Clinical features 
· Incubation period: mean 30 days; range 15-50 days. 
· Jaundice rare in young children (< 10%); but common (80%) in adults  
· No chronic sequelae. 
 
A vaccine to HAV is available: inactivated hepatitis A virus produced in human cell culture: 
There are several products: 
 
· HAVRIX (SmithKline Beecham).  
· VAQTA (Merck) 
 
Two doses are required- the initial dose and a booster at 6-12 months. Immunisation is 
recommended for professionals who work with institutionalised patients. 
 
11.2 Hepatitis B 
 
The hepatitis B virus is composed of a nucleocapsid core (HBcAg) which is surrounded by 
a lipoprotein coat which contains the surface antigen (HBsAg). The surface antigen is 
present in blood, semen, and vaginal fluid in large concentrations, but is also present in 
other body fluids. Surface antigen may be present on both intact whole virions as well as 
components of incomplete virions which are also shed in large numbers into the blood. The 
large number of virus particles in blood is the reason why an extremely small volume of 
blood (less than 10 microliters) can transmit HBV infection.  
 
The virus is endemic in large segments of the world’s population, and it has been estimated 
that approximately 300 million people harbour the virus. Regions with high endemicity (> 
10%) include China, South-East Asia, and Africa. Younger adults (ages 20-30 have a 
particularly high rate of HBV carriage.  
 
Perinatal transmission (mother-child), where the child develops a carrier state and chronic 
infection but without any symptoms, accounts for a large proportion of the HBV problem 
in such populations. For infection at the time of birth, there is a 90% likelihood of 
becoming a chronic carrier. 
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Transmission can be via: 
· Blood-blood contact (parenteral transmission) 
· Sharps injury 
· Tatooing and body piercing 
· Injecting drug use 
· Vertical (perinatal) transmission from mother to infant 
· Sexual transmission 
· Contaminated objects (shared razors, toothbrushes). The virus is stable on such 
surfaces for at least one week. HBV can be transmitted by saliva contact. 
 
The concentration of HBV in various body fluids can be summarised as follows: 
· High 
· Blood 
· Wound exudates  
· Moderate 
· Saliva 
· Semen and vaginal fluid 
· Low or not detectable 
· Urine and faeces 
· Sweat and tears 
· Breast milk. 
 
Clinical features of HBV infection: 
· Incubation period: average 60-90 days; range  45-180 days. 
· Symptomatic infection 
· Birth    0% 
· Age 1-4    10% 
· Age >5   30-50% 
· Recovery rate from acute symptomatic infection    98% 
· Likelihood of becoming a chronic carrier 
· Birth    90% 
· 1-5 years   30-90% 
· Age >5 years    2-10 %  
· Fatality rate 
· From fulminant (acute) infection   0.5-1% 
· From liver disease (chronic infection)    15-25% 
 
The surface antigen of the virus (HBsAg) can be detected in 
· Carriers 
· Individuals with acute HBV infection 
· Recently immunised individuals. 
 
HBsAg is highly immunogenic (i.e. evokes a strong immune response) and this response is 
protective in that it produces antibodies which can prevent HBV infection. Hepatitis B 
immunisation uses HBsAg produced by recombinant DNA technology using baker’s yeast 
(Saccharomyces cerevisiae). The other components of the vaccine are thiomersal (a 
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preservative) and aluminium hydroxide (an immune stimulant/adjuvant).  The full course is 
three deltoid injections, for example, of Engerix® or HB Vax II ®. The injections are given 
at 0, 1 and 6 months. Subsequent screening for seroconversion (anti-HBs) is necessary, 
two months after the third injection.  
 
With HBV vaccines, seroconversion rates are 99% for healthy young people. Older 
individuals have a lower seroconversion rate and usually a less pronounced immune 
response to the vaccine (and thus require more frequent boosters). Double doses and intra-
dernmal injections generate responses in most low- or non-responders to the conventional 
protocol. 
 
Antibodies to HBsAg (Anti-HBs) provide an indication of the level of immunity obtained 
after immunisation (either active immunisation with the vaccine, or passive immunisation 
with HBIG). Individuals should be vaccinated as follows: 
· Prior to commencing studies or employment in a health care field 
· After a sharps injury of serology shows a low level of anti-HBs (<10 IU/L) 
· When regular testing (12 monthly) indicates a declining level of anti-HBs 
· High responders (> 10,000 IU/mL anti-HBs) will have high antibody levels for many 
years. 
 
The vaccine has several side effects which may occur: 
· Tenderness, redness and swelling at the injection site, for 1-2 days. 
· Painful joints (arthralgia) can occur transiently in some older individuals.  
 
The core component of the virus (HBc) is not present in the vaccine and can only be 
encountered with true exposure to the virus. Thus, antibodies to HBc indicate past 
contact with the “real” virus” – and thus will always be seen after infection with 
HBV. 
 
After an acute HBV infection with recovery, the blood will contain antibodies to surface 
antigen (anti-HBs), core antigen (anti-HBc), and e antigen (anti-HBe); but will be 
NEGATIVE for HBs, HBc, and HBe. 
 
If the individual becomes a chronic carrier, the blood will contain HBsAg and HBeAg, as 
well as antibodies to core antigen (anti-HBc). 
 
11.3 Hepatitis C  
 
Hepatitis C virus (HCV) infection is an increasing issue of concern in health care both in 
Australia and overseas, because of 
· high prevalence and incidence of the condition (approximately 0.3 % of blood donors  
are positive for HCV) 
· serious long term health consequences of chronic HCV infection (cirrhosis and 
hepatocellular carcinoma) 
· high frequency of asymptomatic infection 
· high frequency of individuals becoming chronic carriers (50-80%) 
· significant risk of transmission with a sharps injury (2.5 – 10%) 
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· lack of an effective vaccine to protect health care workers and others at risk of 
exposure to the virus. 
 
While HCV is the major cause (>90%) of viral hepatitis not related to the hepatitis A or B 
viruses (the so-called non-A, non-B hepatitis), the identification of HCV cases was 
hampered until 1992-93 by the lack of an effective serological test for antibody to HCV 
(the virus was discovered in 1989). Inability to screen donated blood led to inadvertent 
transmission of HCV by blood transfusions, particularly in the late 1980’s and early 1990’s. 
Up to 90% of haemophiliacs were infected with HCV from blood products in this time 
period. 
 
Since the early 1990’s, it has been common practice in Australia to routinely screen 
donated blood for antibodies to HCV, however instances of accidental administration of 
known HCV-positive blood to patients have occurred, with the predictable unfortunate 
consequences. 
 
World-wide, more than 250 million persons are chronically infected with HCV. In an 
infected individual, the humoral (antibody) response mounted against HCV fails to 
recognise the sequential changes in the virus throughout the course of infection, and 
previously generated antibodies fail to neutralise the mutants. Because of the extreme 
variability of the virus, the possibility of a vaccine to HCV in the near future appears 
remote.  
 
Nevertheless, the combination of alpha interferon and ribavirin has been shown to give 
good clinical results in terms of arresting the progression of HCV infection with some of 
the common genotypes of the virus found in the ANZ region. This holds promise for the 
combined use of the agents as a curative measure. 
 
HCV is an RNA virus. There is marked heterogeneity of the HCV genome as a result of 
mutations that occur during viral replication. This has resulted in variations which are 
designated as either 
· Genotypes – Variation in the genome amongst different HCV isolates can be found 
between different geographical areas. 
· Quasi-species – These are variants which develop from a single HCV isolate in the one 
individual throughout the course of infection.  
 
Features of HCV infection can be summarised as follows: 
· The incubation period varies from 2-26 weeks (average 6-7 weeks). 
· The initial infection of hepatitis C is often asymptomatic, particularly in infants, children 
and young adults. 
· Up to 40 % of adults may have acute symptoms 
· Jaundice occurs in 25-30% of infected individuals 
· Persistent infection is the most common outcome (> 85%) 
· Because of the low frequency of symptomatic infections, many affected individuals are 
unaware of their condition.  
 
Transmission of HCV is similar to hepatitis B: 
· Blood-blood contact 
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· Sharps injury 
· Tatooing and body piercing 
· Injecting drug use (This accounts for 75% of HCV transmission in Australia. The 
likelihood of an IV drug user becoming infected is 40% at 2 years, and 100% at 6 
years) 
· Vertical transmission from mother to infant (in up to 10% of cases where the mother is 
infected) 
· (N.B. Sexual transmission is very uncommon unless there are multiple sex partners) 
· Contaminated objects (shared razors, toothbrushes) 
· Transfusion of infected blood products, transplantation of infected tissue, or 
haemodialysis. 
 
Health consequences of chronic HCV infection are substantial.  
· Spontaneous resolution of hepatitis C infection is rare, even though liver function tests 
may be normal.  
· Persistent chronic infection is the norm, and develops in more than 85% of those 
infected, due to failure of the immune response to neutralise the virus. There are few 
symptoms in first two decades after infection, and the course of infection runs for 40-50 
years.   
· Approximately 70% of individuals with chronic HCV infection will develop chronic 
liver disease, of which cirrhosis of the liver is the most common (30%).  
· The high level of chronic infection following exposure to HCV may reflects both a 
defective humoral (antibody-mediated) immune response, as well as the virulence of the 
particular infective strain of HCV or its mutations over time. 
· In Australia, HCV infection is the leading cause of liver disease and the most common 
indication for liver transplantation.  
 
Health consequences of chronic HCV infection include: 
· Cirrhosis - slowly progressive hepatic fibrosis and scarring. For those individuals who 
develop cirrhosis, there is 19% mortality within 10 years. 
· Altered hepatic function - the liver enzymes alanine aminotransferase (ALT) and 
aspartate aminotransferase (AST) are elevated during active viral replication. Cirrhosis 
is suggested when liver function tests show levels of AST exceed those of ALT.  
· liver failure – this occurs in 5-15% of chronically infected individuals 
· increased risk of developing hepatocellular carcinoma 
· prolonged bleeding after surgical procedures such as tooth extraction 
· extra-hepatic disorders 
· keratoconjunctivitis sicca 
· arthralgia 
· oral lichen planus (particularly in individuals from Italy or Greece) 
· salivary dysfunction (and thus increased caries risk and impaired oral health) due to 
viral infection of salivary gland tissues, and lymphocytic sialadenitis, 
 
Factors which influence the extent of liver disease include: 
· high alcohol intake 
· gender (male) 
· age at infection 
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· extent of immunodeficiency 
· HCV genotype. 
 
Treatment of chronic HCV infection can be summarised as follows: 
· Limitation of alcohol consumption is by far the most effective natural therapy in 
influencing the outcome of chronic HCV infection 
· Alternative therapies such as vitamins and herbal remedies show limited therapeutic 
benefit.  
· Chinese herbal therapies can cause dose dependent hepatotoxicity, so care needs to be 
taken with the dietary intake of any potential therapeutic substance. 
· Interferon-alpha 2b (IFN) therapy is only moderately effective in treating HCV 
(reported success rates range from 15-50 %. 
· The success of IFN therapy is influenced by: 
· Dose and duration of treatment 
· HCV genotype 
· Age at infection and duration of infection 
· Compliance with treatment. IFN has a range of serious side effects, including a flu-
like reaction (with fever, myalgia, headaches,  sweating and fatigue) as well as  
bone marrow suppression and neuropsychiatric disorders (including suicidal 
depression). 
· Combination therapy of IFN with ribavirin. Side effects of ribavirin include dyspnoea, 
pharyngitis, pruritus, rash, nausea, and anorexia. 
 
There is no vaccine for HCV, and there is no effective post-exposure prophylaxis. It is now 
recognised that injection of human immunoglobulin or anti-HCV antibodies does not 
provide any protective benefit. However, if seroconcversion does occur, immediate 
treatment with IFN and ribavirin can be extremely effective at arresting the infection and 
causing a serological "cure". 
 
A range of diagnostic tests are used to screen for HCV infection: 
· Enzyme-linked immunosorbent assay (ELISA) for antibodies to HCV (the current third 
generation ELISA will detect anti-HCV in only 95% of infected people). Testing is 
complicated by the fact that antibodies to HCV usually do not appear until after acute 
infection, with most individuals developing antibodies within 1-3 months, but some 
taking as long as 12 months. 
· Western blotting 
· Polymerase chain reaction (PCR) to detect viral genetic material (RNA) in the blood. 
This assay is hampered by the fact that viraemia is variable during the course of the 
disease, and false negatives may occur as virus will not always be present.  
 
Risk groups for HCV include 
· injecting drug users  
· body piercing and tattooing, and intranasal use of cocaine (snorting with nasal straws) 
· transfusion and blood products pre-1990 
· sharing razors and toothbrushes 
· poor infection control in the health care setting 
· health care workers who sustain sharps injuries from HCV carriers. 
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HCV can be isolated from the saliva in approximately 1 in 5 HCV patients. Viral levels in 
saliva correlate to hepatic function. While there are documented cases of HCV infection 
following a human bite, transmission of HCV by saliva alone is a remote possibility unless 
the saliva is contaminated with blood. The epidemiology of HCV infection argues against 
saliva and other non-parenteral pathways of transmission. No infections have been 
associated with mucous membrane or non-intact skin exposures.  
 
11.4 Hepatitis D 
 
HDV (also known as delta hepatitis) is an RNA virus with a very thin coat of HBsAg. 
Transmission of HDV usually accompanies HBV, e.g. percutaneous exposure such as IV 
drug use, or permucosal exposure such as sexual contact. 
 
HDV infection occurs as either 
· A co-infection with HBV 
· This results in severe acute disease, but rarely results in chronic HDV infection. 
Antibody levels to HDV decline as the infection is cleared. 
· A super-infection in an individual with chronic HBV infection. 
· This usually results in chronic HDV infection, and poses a high risk of chronic liver 
disease.  Levels of anti-HDV antibody remain high. 
 
Because of this dependency on HBV, immunisation against HBV protects against HDV 
infection. 
 
11.5 Hepatitis E 
 
HEV has many similarities to HAV in terms of transmission and outcomes. There are no 
chronic sequelae to HEV infection, and infected individuals usually recover, and show high 
levels of anti-HEV antibodies in the blood.  
 
Most outbreaks are caused by faecally-contaminated drinking water. Other contributing 
factors can be drinks made with ice (where the ice is made from contaminated water), 
contaminated fruits and vegetables, and shellfish. 
 
There is a high rate of HEV infection in China, South-East Asia, the Indian subcontinent, 
Northern Africa, Mexico and the Pan-American region. 
 
The clinical features of HEV can be summarised as follows: 
· Incubation period: average 40 day, range 15-60 days. 
· Clinical illness is more severe with increasing age. 
· Overall fatality rate is 1-3 % 
· Higher fatality rate in pregnant women (15-25 %). 
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Hepatitis G: 
 
Hepatitis G bears some similarities to hepatitis C in terms of the clinical presentation of the 
disease. An effective antibody test for HGV has yet to be developed. While HGV RNA can 
be detected in the serum, there is no effective means for distinguishing acute infection from 
the carrier state.  
 
12. SHARPS INJURIES 
 
With a sharps injury, the obvious concern is transmission to the health care worker. A 
typical sharps injury with a small bore dental needle transmits approximately 1.4 microliters 
of fluid. The transmission risks reflect the number of virus particles in the blood, which is 
extremely high for hepatitis B (10 million per mL), intermediate for hepatitis C, and low for 
HIV (from 10 to 100 per mL).   
 
Transmission rates for hepatitis C vary up to 10%, with average rates between 2 and 6%. 
While this is less than the comparable figure for Hepatitis B (25-35%), it should be 
remembered that HCW’s can be immunized against Hepatitis B but not HCV. With HIV, 
the risk is relatively low (less than 0.5% or 1 in 200 – currently 0.32% in Australia). 
 




· Single or many “strikes” with the contaminated object 
· Wound depth and size 
· Brief or prolonged contact 
· Presence of  barriers (such as gloves) 
· Age and type of fluid involved 
 
The DONOR 
· Stage of HIV disease 
· Viraemia 
· Antigenemia 
· Use of anti-retroviral medication. 
 
Typical sharps injuries in dentistry include: 
· Wound produced by a contaminated instrument 
· Laceration  
· from a bur left in a handpiece (up to 60% of cases) 
· from a scalpel 
· from a matrix band, copper band, or disc 
· Stab injury 
· from a sickle scaler or curette 
· from endodontic file 
· from a sickle probe during instrument cleaning 
· from orthodontic wire 
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· from a suture needle 
   
· Superficial subcutaneous injury with a contaminated needle 
· From improper recapping technique 
· When cleaning up after a procedure 
· Through improper instrument handling (such as passing syringes) 
· From incorrect retraction technique when administering local anaesthesia 
· From improper retraction technique when suturing extraction sockets. 
 
Injuries are most likely to occur: 
· When working blind or under poor visibility/ poor lighting 
· When working under time pressure 
· When using fingers to retract tissues 
· When staff are inexperienced 
· When staff are becoming tired 
· When there is inadequate training or supervision. 
 
The most common sites for sharps injuries are the fingers of the non-dominant hand. 
 
12.1 Prevention of sharps injuries 
 
Dental practice frequently involves the use of sharp instruments in invasive procedures 
under conditions of limited access and poor visibility. Each practice should make a list of 
the types of sharps maintained in the practice. This should  distinguish between disposable 
sharps and re-useable sharps, such as instruments. Have a clear plan (ideally in writing) as 
to how each sharp is dispensed, used and disposed of, and discuss this at a meeting when 
all staff members are present. 
 
A sharp is defined as “any object having acute rigid corners/edges that is capable of cutting 
or penetrating the skin”. Because sharp items are used often in patient care, and frequently 
become contaminated with blood and saliva, the risk of transmission of viral bloodborne 
disease is a significant concern in dental practice. Procedures for the correct handling of 
sharps play an important role in preventing skin penetrating (percutaneous) injuries by 
contaminated sharps. 
 
The following provides a summary of the types of sharps which may be encountered in a 




· Hand Instruments 
· Probes 
· Scalers and curettes 
· Carvers 
· Chisels, hatchets, and knives 
· Scissors 
· Wax knives 
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· Forceps and elevators 
· Endodontic instruments 
· Finger pluggers and spreaders 
· Tungsten carbide and diamond burs 
· Rotary endodontic files 




· Matrix bands 
· Wedges 
· Hand endodontic files and reamers 
· Lentulo-spirals 
· Scalpel blades 
· Suture needles 
· Broken glass LA cartridges and glass vials 
· Stainless steel burs 
· Orthodontic wires, bands and brackets 
· Broken instruments with sharp edges 
 
Biological sharps: 
· Fragments of bone  
· Root tips 
· Extracted teeth and tooth fragments 
 
· Review the circumstances of sharps injuries in the practice, to identify factors which 
may have contributed to the incident, and to develop strategies for prevention 
· Plan procedures involving sharps so that all staff members are aware of their role and 
responsibilities 
· Ensure that the change-over procedure between patients starts with the removal of 
sharps. 
· Remove burs from handpieces immediately after use. Do not reach over the top of 
handpieces with protruding burs. 
· Locate sharps containers close to the point of use. Dispose of sharps containers when 
three quarters full, and do not overfill them. Note that sharps containers must conform 
to the relevant Australian Standard, e.g. AS4031. 
· Consider using accessories such as scalpel blade removal devices. 
· Follow-up any sharps injuries immediately with appropriate first aid, counselling and 
serology (both source/patient and staff member). 
 
Local anaesthesia:  
· Practice syringe handling procedures as part of ongoing staff education and training. 
· Handle syringes and other sharps with care - only one person should hold the syringe at 
any one time.  
· Retract tissues before injection with a mouth mirror or retractor (not fingers). 
· During injection, the assistant can stabilise the patient’s head position to prevent lateral 
or other involuntary head movement. 
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· Keep hands and fingers away from the mouth while injecting. 
· The operator must recap a used syringe (using a single-handed bayonet technique or a 
resheathing device) or dispose of it immediately Recapping is the responsibility of the 
dentist not the dental assistant. Remove needles with care: use artery forceps or other 
holding devices instead of fingers. 
 
Control of the oral environment 
· Poor visibility and poor lighting are major factors in sharps injury. 
· Use a headlight to improve illumination, in addition to operating lights. Battery 
operated or fiber-optic head lights are very useful for surgical, endodontic and 
periodontal procedures and will enhance efficiency as well as safety. 
· Use rubber dam where feasible to reduce contamination of operating field. 
· Use suction judiciously to maintain a clear field. 
 
Oral surgery 
· Be aware of risk situations: blood is present in the mouth from the surgical procedure, 
and there are several potential causes of injury: scalpels, elevators, wires, sutures, as 
well as exposed sharp edges of tooth or bone. Injuries such as puncturing of the fingers 
by wire are more likely to occur in a poorly lit confined space where visibility is further 
reduced by secretions such as blood and saliva.  
· Control bleeding during the procedure using ligation, cautery, or coagulation. 
· Use appropriate vasocontrictors as indicated clinically. 
· All clinical staff must wear protective glasses with side shields to prevent splash injuries 
to the eyes. 
· The use of fingers as cautionary rests when performing dentoalveolar procedures 
should be avoided where possible. Do not position fingers below an elevator tip to 
prevent it slipping into tissues; rather restrict the downward displacement of the tip by 
positioning the fingers above the tip of the instrument and then using a rotational rather 
than vertical movement. 
· Do not suture “blind” or attempt to find a suture needle in a vestibule by feel.  
· In areas of limited visibility, use single sutures rather than continuous suturing. The 
needle can be cut from the suture after tissue penetration has been achieved fully, and 
the knot then tied using instruments and fingers. 
· Ensure adequate retraction. 
· Maintain a clear field and improve visibility by removing secretions such as saliva and 
blood with suction. 
· Minimise the use of wiring in awkward and inaccessible sites to reduce the possibility of 
sharps injury from wiring. 
· Use an experienced trained assistant for all oral surgical procedures. 
· Where appropriate, use a custom-made scalpel blade removal device for detaching 
blades from handles. 
· Some oral surgeons prefer to wear either two pairs of gloves or orthopaedic gloves for 
major oral surgical procedures.  
· Consider using alternative “non-sharp” cutting approaches (e.g. lasers) for soft tissue 
procedures where appropriate. If lasers are used for surgery, wear the correct 
protective glasses, and ensure appropriate suction is available to prevent inhalation of 
laser plume (see Australian Standard AS/NZS 4173:1994 and AS2211). 
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· Each operator should maintain awareness of their own infectious disease status (HBV, 
HCV, HIV) 
 
Personal protective equipment 
· Remember that gloves develop porosities during use, particularly in the areas of the 
thumb and forefinger 




· To prevent residues of dental materials or blood drying onto instruments, place 
instruments in a holding solution (containing detergent) if they are not cleaned 
immediately. 
· Clean conventional hand instruments using ultrasonic cleaners rather than by hand 
scrubbing. 
· Use instrument cassettes or trays where possible during instrument processing to 
minimise the risk of sharps injuries to staff. 
· Develop a clear policy on which sizes and types of burs and endodontic files are 
discarded after use. 
· After cleaning, inspect instruments carefully under good lighting. Dry the instruments 
prior to this inspection, but do not wipe them by hand as this will increase the 
likelihood of a sharps injury occurring. 
 
12.2 Sharps injury management  
 
The size of the problem 
 
Injuries from sharps remain a concern in dental contemporary dental practice because of the 
underlying possibility of transmission of blood-borne viruses. The estimated transmission 
rates for hepatitis B (HBV) to non-vaccinated recipients, hepatitis C (HCV) and human 
immunodeficiency virus (HIV) after a needlestick injury from a dental needle are 6-30%, 
2.7-10% and 0.1-0.3% respectively.  
 
Because of the rise in HCV positive patients in the community in the past decade, this 
group now tends to attract greater attention. Recent (mid-2005) data for Queensland from 
a major pathology laboratory show that the rate of notification for HCV was 40 times 
higher than for HIV and HBV, respectively (2400 new HCV vs. 60 new HIV and 720 
HBV in 12 months). Similar trends can be seen in the nationally compiled data for the 
Communicable Diseases Intelligence (CDI) network over recent years.  
 
The emphasis must therefore be on prevention, which comes down to two key factors: 
Firstly, workplace design and proper work practices – to reduce the likelihood of a sharps 
exposure; and secondly, anticipation, planning and training - to reduce the incidence of 
injuries and to minimize their impact, in terms of both human and fiscal costs. The latter 
can be very substantial following a sharps injury in the dental workplace, with a major 
contribution coming from staff absences which reduce productivity. Estimates of direct 
costs (which include where the source patient is negative for blood borne viruses (and thus 
there is no intervention required) or HIV positive (when post-exposure prophylaxis may or 
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may not be used), including administrative and staff costs, for a 30 minute consultation and 
blood tests, in a report in the Britsih Dental Journal (2001) are as follows (based on an 
exchange rate of AUD $1 = GBP 0.44). 
• Sharps injury, no antiviral drugs required: $ 309  
• Sharps injury, with starter pack but no further drugs: $ 675 
• Sharps injury, full course of anti-retroviral drugs course: $ 4890  
• As above but with absence due to illness or side effects: $ 8740  
 
Australian data clearly show that the three most common causes of contaminated sharps 
injuries are burs left in handpieces by the operator (which then cause a puncture injury in 
the operator or the assistant), incorrect (two-handed) needle recapping methods, and 
manual cleaning of probes in the sterilizing room. Changes to techniques as well as to 
equipment would prevent such incidents.  
 
In terms of equipment, this could mean a shift from the traditional needle/syringe unit to 
systems with engineered built-in safety mechanisms. The design of the traditional dental 
metallic cartridge syringe dates back to the 1920’s, and other than the inclusion of an 
aspirating plunger, there have been few changes since that time. The design poses an 
inherent problem in that unless the needle is re-sheathed, there is a risk of sharps injury 
when dismantling the unit. The literature consistently shows that it is during the process of 
re-sheathing and disposing of the needles that most needle-caused sharps injuries occur. 
This also means that the needle has been contaminated, as it has already been used in the 
patient's mouth. The one handed 'scoop' technique for recapping has been promoted widely 
and there is objective evidence from studies in Australia and elsewhere that it is highly 
effective, even for novice users. Interestingly, local data also suggest that plastic shield-type 
devices for recapping, such as the Needleguard (Biosafe) may not necessarily lower the 
rates of sharps injury. Recapping if undertaken should be followed by placing the syringe 
out of reach of the patient. 
 
Several safety systems have been developed for use in medicine, and some specifically for 
dental practice. Needle-protective devices are based on the conventional syringe concept 
but incorporate a safety mechanism that, when activated, covers the needle tip and thus 
assists in the prevention of sharps injuries. Design features, usability by the practitioner, and 
safety to the patient are important issues to consider when choosing a system. Personal 
preference and appropriate training have a large influence on the workability of most 
systems.  
 
The author uses the SafetyPlus ™ (Septodont) system in his own clinical practice. This 
system, which does not require the re-sheathing or removal of a needle from its syringe, 
was evaluated extensively at the Royal London School of Medicine and Dentistry in a 
controlled study. Avoidable needle stick injuries reduced from an average of 11.8 to 0 
injuries per 1,000,000 hours worked per year, compared to a control unit who reduced 
their frequency from 26 to 20 injuries per 1,000,000 hours worked. The cost of safety 
syringes was comparable to non-disposable syringes however the reduction in the cost of 
managing sharps injuries was substantial. This system is now used in some departments of 
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There must be a visible sharps container in every surgery, and this should be located close 
to the normal working position of the dentist or oral health therapist, since it is the 
responsibility of the clinical operator to dispose of their own sharps, such as local 
anaesthetic needles. 
 
In particular, clinical operators must be aware of the correct method for recapping LA 
needles. A one-handed method must be used, such as the bayonet (scoop) technique. Any 
two-handed methods, such as grasping the needle cap with artery forceps, pose a risk of 
sharps injury. There are a range of devices which offer improved safety for sharps handling, 
such as self-sheathing needles (e.g. the Safety-Smart system). 
 
It is essential that dental staff know how to handle sharps properly. Needles should never 
be bent, broken, or removed by hand before disposal. In endodontic procedures requiring 
irrigation, a disposable needle and disposable syringe unit should be used. Once empty, this 
can be disposed of directly into the sharps container as one unit. If further irrigation is 
required, a new needle and syringe is then used (pre-filled with the appropriate irrigant). 
Dental LA cartridges are classed as a single use device, and must never be refilled with 
sodium hypochlorite, EDTA, or other endodontic irrigants as this poses the risk that these 
materials may accidentally be injected into a patient’s soft tissues. 
 
When cleaning up, the operator must ensure all the disposable sharps have been placed in a 
sharps container (or in a kidney dish or tray) before removing their gloves. Dental assistants 
must check visually for sharps before approaching the bracket table or other working 
surfaces to remove waste or materials. 
 
There should be set procedures for loading, passing, and disposing of sharps in the surgery. 
The established procedures should be rehearsed from time to time.   
 
Educating new staff members about the correct management of sharps is essential prior to 
their commencing employment. It is also important to remember that in larger dental 
facilities, support staff such as cleaners also require appropriate education and training in 
relation to sharps handling. 
 
The final “point” of attention relates to burs. Operators who habitually reach across 
handpiece cradles to pick up instruments from their bracket table are at high risk of 
puncture injuries from burs. At the end of the appointment, burs should be removed from 
handpieces and placed into a suitable container for reprocessing (if not being discarded into 
the sharps container). The dental assistant must check that the operator’s working area is 
“safe” in terms of sharps before commencing cleaning. This means looking specifically for 
local anaesthetic syringes and burs, as well as for endodontic files and other sharps which 
could penetrate the gloved hands during the cleaning up process. 
 
Safe Disposal of Sharps 
 
It is critical that sharps are not disposed of into normal waste bins. Staff members who do 
not dispose of sharps appropriately are in breach of both the workplace safety and health 
legislation as well as environmental protection legislation.  
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All disposable sharps containers must be labelled clearly and must comply with AS4031. 
They must be coloured yellow, and carry the black international biohazard symbol for 
clinical waste. They must be made from puncture-proof material which can be incinerated. 
The opening must be wide enough to allow easy disposal of items using one hand, but at 
the same time small enough to prevent the insertion of a child’s hand.  
 
Smaller sharps containers should be secured to the wall or benchtop using a bracket to 
ensure their stability if knocked accidentally. Ideally they should be located 1 metre or more 
above floor height to prevent access by children. 
 
Sharps containers must not be over-filled, but rather replaced when 3/4 full. Inserting items 
above the maximum fill line may cause a sharps injury from the contents, and also may 
prevent adequate closure. If a chute is used in a benchtop to a hidden sharps container in a 
cupboard beneath, the sharps container must be inspected each daily to ensure that it is not 
over-filled. 
 
Sharps waste is one of the designated waste streams from a dental practice. Sharps 
containers should only be collected by a medical waste contractor, and should adhere to the 
Australian Dangerous Goods (ADG) Code. 
 
There should be documented procedures for cleaning sharp instruments such as probes and 
curettes. The use of instrument cassettes and mechanical cleaning of instruments (in an 
ultrasonic cleaner or thermal disinfector) is known to reduce the risk of sharps injuries to 
dental staff during instrument reprocessing. 
 
Each dental practice should have its own clinical and related waste management plan 
established with regard to minimizing, disposing of, segregating, treating and recycling of 
the waste that it generates. This plan should also include staff training programs. The plan 
should be regularly reviewed at least once every 5 years and updated if necessary.  
 
Sharps injury management 
 
Protocol for exposure incidents (including sharps injuries) 
 
The definition of an exposure is  
• an injury that involves direct skin contact with blood or saliva visibly contaminated 
with blood AND there is compromised skin integrity such as an open wound 
(including a skin penetrating injury), abrasion or dermatitis, OR 
• direct mucous membrane contact (eye or mouth) with blood or blood contaminated 
saliva .  
For exposure to skin, the larger the area of skin exposed and the longer the time of contact, 
the more important it is to verify that all the relevant skin area is intact. 
 
An exposure incident record must be completed, and this should include the following 
details: 
• name of the injured person 
• their date of birth 
• exposure details (body site affected, extent of the exposure, severity of the injury)  
• nature of the exposure (percutaneous or mucous membrane exposure),  
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• location in the practice, 
• activity or procedure being undertaken at the time, 
• implement causing the injury (e.g. instrument, ligature wire, bur, needle),  
• identifying details of the source patient and their blood borne virus risk  
• infectious agent involved if known,  
• details of treatment and prophylaxis given, 
• procedures for investigating the circumstances of the incident and measures to 
prevent recurrence (this may include changes to work practices, changes to 
equipment, and/or training)  
• outcome of the incident. 
 
The exposure should be documented on a standard incident or accident reporting form 
AND reported to the practice principal. This documentation ensures a record for the 
employer and the insurer, should there be a later claim. It also provides valuable 
information about potentially unsafe practices, environments, or equipment. 
 
Staff should be educated to report occupational exposures immediately after they occur, 
whether or not they involve contamination. Sharps injuries may occur which do not involve 
contamination, e.g. when setting up fresh instruments prior to a patient visit, or when 
handling orthodontic wire which has not been in contact with the oral environment. Such 
“clean” sharps injuries must be documented and followed up with investigation of the 
causes, but it is NOT necessary to undertake serological testing of the injured person.  
 
Testing should be offered following all occupational exposure to blood or body substances, 
particularly all “contaminated” sharps injuries, e.g. those involving exposure to blood or 
blood-contaminated saliva via an instrument, bur, or contaminated wire.  
 
Baseline serum should be collected from the injured staff member AND the patient, and 
expert counselling provided on the implications of the event. 
 
The practice principal should ensure that there is access to appropriately experienced 
counselling services for staff who may become anxious about their health as a result of 
exposure to a potential hazard, whether actual or perceived.  
This counselling and the collection of blood samples would normally be undertaken outside 
the practice, e.g. at a nearby hospital by an infectious diseases physician. 
 
Step 1. Administer First Aid 
 
• Clean the wound/site with soap and water. 
• Further management of wound is dependant on nature of injury (e.g. suturing, 
application of a dressing).  
• Consider whether a booster immunisation for tetanus is indicated (e.g. If the 
exposure involves an injury from an object which may be contaminated with soil or 
dust). 
• There is no advantage to the use of a stronger solution than soap and water for 
cleaning, as some disinfectants may inhibit wound healing. 
• For a splash to the eyes or mouth, flush the mucous membranes/conjunctiva with 
copious volumes of normal saline or water. If contact lenses are worn, remove after 
flushing the eye and clean as usual. 
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Step 2. Assess the severity of the exposure 
 
• The risk assessment will determine if post-exposure prophylaxis (PEP) is warranted. 
The risk assessment is urgent, as initiation of PEP may potentially prevent a life-
threatening disease. On the other hand, PEP is also expensive and may have 
significant side effects, so an accurate risk assessment is also important in ensuring 
PEP is only recommended when warranted. 
• Because this step is crucial to the management process, the exposed person must be 
immediately relieved from duty to be assessed.  
• The practice principal must be aware of how to access a person who is able to 
assess risk. The initial risk assessment may be by telephone. 
 
Factors which influence whether an exposure has the potential to transmit a blood-borne 
virus (BBV) infection include: 
· the type of exposure (mucosal splash vs. a deeply penetrating skin injury) 
· the type of body substance (e.g. how much blood is present in the saliva) 
· the volume of blood or body fluids 
· the length of time in contact with blood or body fluids 
· the time which has elapsed since the exposure 
In addition, after a sharps injury, the following factors should be considered: 
· the presence of visible blood or body substance on the device causing the injury 
· the type of device involved 
· whether a hollow bore needle or solid sharp object was involved 
· the procedure for which the device was used (for example, into a vein or artery) 
· the gauge of the needle or device 
· whether the injury was through a glove or clothing 
· whether a deep injury occurred in the exposed person; and 
· whether the source patient is viraemic, e.g. with advanced / terminal HIV disease or 
a high viral load. 
 
Step 3. Test the injured staff member (baseline tests) 
 
The exposed person (staff member) should be tested at the time of the injury, to establish 
their serological status at the time of the exposure for  
• HIV antibody,  
• HCV antibody and 
• antibody to Hepatitis B surface antigen (Anti-HBs)  
 
This testing should be done as soon as possible after the injury (ideally the same day), and 
certainly within 2 weeks, bearing in mind the window period of the tests. 
 
These baseline test results are essential for the purposes of enabling Work Cover insurance 
in the unlikely event of transmission of infection. 
 
If the staff member has ever had a blood test which demonstrates Hepatitis B immunity 
(anti-HBs antibodies > 10 IU/L) (whether from vaccination or past infection), they are 
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protected, and there is no need for hepatitis B immunoglobulin after a potential or 
confirmed exposure to hepatitis B. 
 
In the event of sero-conversion for Hepatitis C or HIV, all reasonable attempts should be 
made to confirm that the virus strain transmitted is identical in both the patient and the 
source. 
 
If the source patient is found to be positive, additional testing of the injured staff member 
will be required, and other matters will need to be addressed. This point is expanded upon 
below. 
 
Step 4. Test the source patient 
 
• If a situation arises where there is a need to know the infectious status of a patient 
(such as a sharps injury), the 2004 CDNA Infection Control Guidelines state that 
“the patient has a responsibility to provide information or consent for testing that 
enables the practice or responsible health professional to ensure the safe 
management of the injured staff member.” 
 
• A designated person in the practice should explain to the source patient the reasons 
for the tests, and advise them of the types of tests that may be needed and the 
necessary arrangements (e.g. that they will need to see a medical practitioner). 
 
• Informed and voluntary consent must be obtained before taking a blood sample to 
test for any purpose. When the responsible medical practitioner is obtaining this 
consent, the patient should be offered pre-test counselling to provide details on the 
test procedure, and the long- and short-term consequences to the patient of the test 
results. Post-test counselling may also be required, particularly if the result is 
positive. 
 
Pre-test counselling includes: 
· Reason for testing 
· Risk assessment for the injury (likelihood of disease transmission) 
· Confidentiality arrangements 
· Explanation of testing procedures 
· Explanation of the window period for HIV 
· How positive or negative tests are interpreted 
· An assessment of how well the person understands the tests and the implications of the 
results 
· Information on safe practices (which is appropriate to the person’s gender and culture). 
 
The source individual should be tested for: 
• HIV antibody, 
• HBsAg (hepatitis B surface antigen), and 
• HCV antibody (hepatitis C antibody). 
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If the source individual tests positive for either of these hepatitis B or C markers, additional 
tests would usually then be ordered to assess infectivity, e.g. Hepatitis B “e” antigen, and 
Hepatitis C RNA (the latter by polymerase chain reaction assay). 
 
If the source is unknown: 
 
• Reasonable efforts should always be made to identify the source. The source 
individual may sometimes not be identifiable, e.g. when a staff member is injured by 
an instrument in the sterilising room and it is not known on whom it was used.  
• If the source remains unknown, appropriate follow-up should be determined on an 
individual basis depending on: 
– the type of exposure; 
– the likelihood of the source being positive for a blood pathogen; and 
– the prevalence of HIV, HBV and HCV in the community of the likely source on 
whom the instrument or item was used, e.g. The prevalence of HCV antibody 
positivity in random blood donors in Australia is 0.3 %. 
 
If the source refuses testing: 
 
• Patient refusal for testing should be documented.  
• In this case, treat the situation the same as the “positive patient” scenario below, 
and consider whether post-exposure prophylaxis and appropriate long-term follow-
up should be offered.  
 
· Certain precautions (e.g. for sexual relations) may be necessary until the injured person 
is cleared by testing. Laboratory results may be available within 24 hours (in large 
centres). In remote areas, intermediate testing kits (such as the AGEN SIMPLIRED) 
may be used by appropriately trained staff to give a verbal report to the treating 
physician, to help determine the need for anti-retroviral therapy. The samples must 
immediately be sent to a recognised reference laboratory for confirmation. 
 
Interpretation of hepatitis B serological tests 
 
The core component of the virus (HBc) is not present in the vaccine and can only be 
encountered with true exposure to the virus. Thus, antibodies to HBc indicate past 
infection with HBV. After an acute HBV infection with recovery, the blood will contain 
antibodies to surface antigen (anti-HBs), core antigen (anti-HBc), and e antigen (anti-
HBe); but will be NEGATIVE for HBs, HBc, and HBe. If the individual becomes a 
chronic carrier, the blood will contain HBsAg and HBeAg, as well as antibodies to 
core antigen (anti-HBc). 
 
If blood tests show that the source patient is negative: 
 
If the source person is found to be HIV, HBV and HCV negative, no further follow-up of 
the exposed person is generally necessary, unless there is reason to suspect the source 
person  
• is sero-converting to one of these viruses, or  
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• was at high risk of blood-borne viral infection at the time of the exposure (because 
they have recently engaged in behaviours that are associated with a risk for transmission of 
these viruses). 
 
The window period causes a FALSE NEGATIVE test result. The patient may be 
infectious, but this is undetectable by testing. The window period for HIV is usually three 
months but it can, very rarely, be longer. The use of the polymerase chain reaction (PCR) 
testing for HIV/viral RNA can identify 90% of infections within four weeks, significantly 
reducing this window period. The window period is 6 months for Hepatitis B and Hepatitis 
C.  
 
If the source is KNOWN or SHOWN to be positive for Hepatitis B surface antigen 
(HBsAg): 
 
If the staff member is immune to Hepatitis B (anti-HBs antibodies > 10 IU/L), they are 
protected. If levels of immunity are relatively low (i.e. between 10 and 50 IU/L), a booster 
injection would be prudent. 
 
If the staff member is NOT IMMUNE (e.g. has never been immunised, did not seroconvert 
to the vaccine (a non-responder), or has antibody levels to HBsAg less than 10 IU/mL), the 
correct treatment is to  
1.  Give a single dose of hepatitis B immunoglobulin (HBIG) within 48–72 hours, 
AND  
2.  Start a course of HBV immunisation. HBV vaccine should be given within 7 days of 
exposure, and then repeated at 1–2 months and again at 6 months after the first 
dose. Following the final vaccine dose, the level of immunity (antibodies to surface 
antigen) should be checked 2-4 weeks later. 
 
If this HBV prophylaxis is not undertaken, the risk of transmission of HBV is 6.3% if the 
source is “e” antigen negative, but more than 30 % if the source is hepatitis B ‘e’ antigen 
positive. 
 
If the source is KNOWN or SHOWN to be positive for antibodies to Hepatitis C: 
 
• There is no effective post-exposure prophylaxis (PEP) for Hepatitis C, however 
interferon alpha and ribavirin may be employed subsequently to intercept HCV 
infection if seroconversion occurs. Treatment with these two antiviral agents during 
the acute phase of the disease may prevent establishment of the carrier state. 
 
• If the HCV antibody test of the source patient is positive, then HCV RNA 
polymerase chain reaction (PCR) assay should be performed to test for HCV RNA. 
Not all anti-HCV antibody-positive subjects are currently HCV infected. 
 
• The risks of transmission after a sharps injury from a positive source varies 
according to whether active viral replication is occurring. If the source is HCV 
RNA negative by PCR assay, the risk is 1.8-3.1%; however the risk increases to 
10% if the source is PCR positive.  
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The injured staff member should be re-tested for HCV antibodies at 3 and 6 months, in 
addition to their baseline test. 
 
In addition, regular liver function tests such as ALT and AST (e.g. at 2, 3 and 6 months) 
and the monitoring of clinical signs and symptoms should be undertaken by an infectious 
diseases physician or gastroenterologist, and specific therapy (such a ribavirin and alpha 
interferon) considered if appropriate. 
 
If the source is KNOWN or SHOWN to be positive for antibodies to HIV (or is at 
high risk of seroconverting): 
 
The risk of seroconversion is as follows: 
• after a sharps injury with HIV-infected blood: 0.3 % 
• after a mucous membrane exposure to HIV-infected blood: 0.09 % 
 
As only a small proportion of occupational exposures to HIV result in transmission of the 
virus, the toxicity of HIV post-exposure prophylaxis (PEP) must be carefully considered 
against its efficacy.  
 
PEP is only indicated if there has been a significant exposure, and a proper risk assessment 
has been undertaken by a medical practitioner experienced in HIV management. This 
person will gather information on the stage of infection in the source, and current and 
previous anti-retroviral therapy, in order to decide on an appropriate prophylactic regimen. 
 
HIV PEP is an experimental, not a proven, therapy. There is some evidence that taking 
PEP reduces the risk of transmission of HIV after an occupational exposure. Nevertheless, 
there are also documented cases of seroconversion, despite early use of PEP. It is the 
exposed individual’s choice whether or not to take PEP, and they can stop at any time 
 
• PEP is recommended for percutaneous (skin penetrating) exposure to potentially 
infectious blood or body fluids (because of the increased risk of HIV transmission). 
• PEP should be offered (but not actively recommended) for exposure of ocular 
mucous membrane or non-intact skin to potentially infectious blood or body fluids 
(as there is less increased risk of HIV transmission). 
• PEP should not to be offered for an exposure to non-bloodstained saliva (as this is 
not potentially infectious for HIV). 
 
HIV PEP is typically 2 or 3 orally administered anti-retroviral drugs (e.g. Zidovudine 
[AZT/ZVD] or Lamivudine, and a protease inhibitor), and should be administered to the 
recipient within 24–36 hours after exposure (preferably within 2 hours). This therapy 
should be continued for 4 weeks, on the advice of an infectious diseases physician. of a 
“starter pack”, for example 
· Zidovudine 250 mg bd (“AZT”, “RETROVIR”) 
· Lamivudine 150 mg bd (“3TC”) 
· Indinavir 800 mg tds (“CRIXIVAN”). 
 
The need to continue this therapy will be determined after the HIV results are known 
(within 24 hours). If the source patient is known at the time of the injury to be HIV 
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positive and is currently receiving AZT, 3TC or a protease inhibitor, then the prophylactic 
agents will be altered – typically to AZT plus ddC or ddI and a protease inhibitor. 
 
If the source is known to be on anti-HIV medications, the treatment history will influence 
the medications prescribed by the infectious disease physician. An individual would 
normally only be commenced on HIV PEP on the advice of a physician specialising in HIV 
or infectious diseases. 
 
Follow-up blood tests for the injured person should be undertaken at 1, 3 and 6 months, 
and follow-up undertaken to detect any febrile illness occurring within 3 months of 
exposure (possibly representing a HIV seroconversion illness).  
 
All anti-retroviral agents may cause significant side effects, particularly gastrointestinal. 
There can be difficulties taking PEP (especially if working). Up to 40% of individuals do 
not complete the course of PEP due to side effects. It is important that the exposed person 
knows the difference between PEP side effects and HIV seroconversion symptoms.  
Discussions as to the value of HIV PEP in exposed females should include the possibility of 
pregnancy. Anti-retroviral therapy is safe during pregnancy, and is effective at reducing the 
risk of transmission of HIV to the unborn child. 
 
Some people find the experience of an occupational exposure to HIV very distressing, and 
they should be given the opportunity for immediate counselling to address anxieties. The 
exposed person should be advised on ways to prevent transmission of blood-borne viral 
diseases to others. This will include advice about safe sex, safe injecting / safe needle use, 
breastfeeding, blood donation and safe work practices. A staff member who has been 
exposed to HIV (or Hepatitis C) should not donate blood, semen, organs or tissue for six 
months, and they should not share implements that may be contaminated with even a small 
amount of blood (e.g. razors or toothbrushes). 
 
Post-test counselling for individuals with positive results must address issues such as: 
· Immediate medical needs 
· Referral to appropriate medical specialists for further care 
· Support mechanisms 
· Safe sex practices 
· Ongoing counselling 
· Legislative requirements such as contact tracing and notifications 
· Referral to an expert group or advisory panel.  
 
Special issues for exposure incidents in females 
 
Both the employer and pregnant members of staff have an obligation to reduce risks to the 
foetus. In general, adherence to standard and additional precautions, vaccination and high 
standards of general hygiene in the workplace should protect pregnant members of staff. It 
is the responsibility of pregnant staff to advise their medical practitioner and employer of 
their pregnancy. 
  
If the source patient is positive for HBV, HCV or HIV, pregnancy testing should be 
offered to women of child-bearing age who have been exposed and whose pregnancy status 
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is unknown. If the exposed person is pregnant, she should be informed about the available 
limited data on the toxicity of anti-HIV post-exposure prophylaxis in pregnant women. 
 
12.3 Voluntary testing of health care workers 
 
Health care workers 
· must be immunised to hepatitis B 
· must have post-vaccination testing so that non-responders can be alerted to the need 
for additional boosters and also to the need for HBIG if an occupational exposure to 
HBV occurs. 
· should undergo boosters for HBV according to the level of immunity which they show 
· should consider their individual risk of exposure to HBV, HCV and HIV, and seek 
voluntary testing where appropriate 
· must be aware of their status for HBV, HCV and HIV by serological testing every 12 
months if they are 
· presently performing exposure-prone procedures 
· about to commence performing exposure-prone procedures. 
 
Post-test counselling for health care workers with positive results for HIV, HBV or HCV 
must address issues such as: Immediate medical needs; referral to appropriate medical 
specialists for further care; support mechanisms; safe sex practices; ongoing counselling; 
legislative requirements such as contact tracing and notifications; and referral to an expert 
group or advisory panel. 
 
Various limitations on work practices may be imposed by a regulatory authority. If 
seroconversion occurs, limitations may be placed on specific procedures or wider classes of 
clinical activity. Because exposure-prone procedures have been associated with the 
transmission of HIV, HBV and HCV from seropositive health care workers to patients, 
restrictions from undertaking such procedures are clearly in the public good.  
 
Individuals who are (by laboratory tests performed on two separate occasions) 
· Hepatitis B e antigen or HBV DNA positive, or  
· Hepatitis C antibody and PCR positive, or  
· HIV antibody positive 
must NOT perform exposure-prone procedures. 
 
Regular testing of HCW who are not performing exposure-prone procedures is not 
justified. 
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13. HIV INFECTION 
 
The Acquired Immune Deficiency Syndrome (AIDS) was first reported in June 1981. It 
was now recognised in 1984 that the causative agent is the Human Immunodeficiency 
Virus (HIV). HIV is a member of the lentivirus group of retroviruses, and has similarities 
to viruses which cause immunodeficiency in primates (e.g. simian immunodeficiency virus), 
cats, and other animals, as well as to other human viruses such as HTLV-1. The virus has 
undergone many mutations and two major strains are now recognised- HIV-1 and HIV-2.  
 
While AIDS is often thought of a disease which first occurred in the early 1980’s and then 
spread around the world over the following decade, it is clear from look-back studies which 
have examined stored blood samples that individuals in sub-Saharan Africa (e.g. Zaire) may 
have died from AIDS as far back as 1959.  
 
Over the past two decades, HIV infection has become a global pandemic. 
· More than 12 million people have died from AIDS 
· More than 30 million people currently are HIV positive 
· Globally there are 16,000 new HIV infections each day (most of which are in 
developing countries) 
· 10 % of new cases of HIV infection are children, and 50-60% are in young adults (ages 
15-25). 
· Rates of HIV infection in the population vary considerably. 
· USA : approximately 1900 cases per million 
· Australia : approximately 350 cases per million 
· Lowest rates are in Singapore, Hong Kong and Japan. 
 
In Australia 
· More than 19,000 people have been infected with HIV 
· The major means of transmission have been 
· male homosexual contact (more than 80%) 
· heterosexual contact (10%) 
· injecting drug use (5%) 
· other (transfusion, transplantation, mother/child transmission) (3%) 
 
· Approximately 8,000 have developed AIDS 
· Approximately 5,600 have died  
· Approximately 12,000 people are HIV positive 
 
· There has been relatively little change in the incidence of HIV infection, however the 
incidence of AIDS is dropping (as a result of better anti-viral and other treatments). 
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13.1 HIV transmission 
 
For transmission of HIV, contact with blood or body fluids is required. This can occur in 
several ways: 
· perinatal transmission (vertical transmission from mother to foetus or infant) 
· sexual transmission (homosexual or heterosexual; vaginal, anal or oral intercourse; 
receptive partners are more at risk than insertive partners) 
· parenteral exposure 
· exposure to blood and blood products 
· blood transfusions (prior to the mid-1980’s) 
· intravenous drug use 
· sharps injuries in health care workers 
  
The following have been DISPROVED as means of transmission of HIV: 
· Casual contact 
· Insect bites (including mosquito bites) 
· Laser plume generated during laser surgery 
· Exposure to saliva, tears, or urine 
· High speed dental handpiece aerosols. 
 
Blood contains 10-100 viral particles per mL. Other body fluids such as semen also contain 
viral particles. In the absence of blood contamination, saliva is not a particular concern 
because 
· few viral particles are present (less than one per mL of saliva), even when there is 
marked viraemia systemically 
· viral particles are present in only a minority (5-10%) of infected individuals.  
· salivary enzymes such as amylase and proteases may strip off glycoproteins from the 
surface of viral particles, while other enzymes such RNases destroy viral RNA. Saliva 
has been shown to deactivate infectious virus within 30 minutes. 
· saliva may also contain antibodies (sIgA) which prevent the virus adhering to host cells.  
· the epidemiology of HIV infection does not support salivary transmission.  
 
There are several factors which influence the nature of HIV disease and the risk of its 
transmission: 
· Some apparently defective HIV strains have been identified which do not produce 
disease. 
· Partners of some HIV-positive individuals may show serum antibodies to HIV 
(indicating exposure to HIV) but are not infected with the virus, despite frequent 
unprotected sexual intercourse. 
· Some strains of the virus have unusually high virulence (current strains of HIV are 
classified alphabetically from A through I, based on sequence differences in the genes 
which code for envelope components). 
· Rates of infection are increased when the individual has a history of previous infections 
which signify or cause immune suppression. 
· Human herpes viruses such as HSV and CMV can stimulate HIV replication infection 
and may accelerate the progression of HIV disease. For this reason contemporary anti-
viral therapies often include anti-herpetic agents. 
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· Other viruses may be co-transmitted with HIV, such as the Kaposi’s sarcoma virus, 
HHV-8. 
 
The risk groups for HIV vary substantially across the globe: In Australia and the USA, the 
major risk group is male homosexuals, while in the Mediterranean (Italy and Spain),  
recreational injecting drug users are a major risk group. In central Africa, transmission has 
reached almost epidemic proportions and heterosexuals are the major risk group. 
 
13.2 The process of HIV infection 
 
HIV is an RNA virus and thus must generate DNA so that the viral genetic material can be 
inserted into the genome of the host. This is achieved by the enzyme reverse transcriptase 
which transcribes viral RNA into complementary DNA. A second enzyme, integrase, then 
inserts the virally-derived DNA into the host cell DNA. The virus has two molecules of 
single stranded RNA and two molecules of reverse transcriptase.  
 
The stages of infection and replication of HIV can be summarised as follows.  
1. Exposure of host to HIV through blood or body fluids. 
2. Adherence of virus to host cells. This can use interactions with host cell CD4 surface 
molecules and other mechanisms. HIV is able to infect many cell types, including CD4 
positive cells such as T lymphocytes, Langerhans cells, macrophages, monocytes, 
neurons, glial cells, and epithelial (enterochromaffin) cells in the gut, as well as CD4 
negative cells such as endothelial cells and fibroblasts. HIV uses a range of secondary 
receptors, including CCR5 and CXCR4) to gain entry into the cell.   
3. Internalisation of virus into the host cell 
4. Reverse transcription of viral RNA to DNA by reverse transcriptase. This process can 
be inhibited by  anti-viral agents such as azidothymidine (AZT). 
5. Integration of viral DNA into host cell DNA by integrase 
6. Transcription of the proviral DNA to mRNA 
7. Translation of the mRNA to viral proteins 
8. Assembly of progeny (virions) 
9. Release by budding from the host cell (using protease) 
10. Activation of the host immune response. 
· Antibodies that bind to HIV are produced but these are not protective. 
· Cytotoxic T lymphocytes are produced which can kill virus-infected cells. 
· The infection is not cleared by the immune response. 
 
The infection can proceed via a seroconversion illness to a variable length period of 
apparent health. Eventually the individual develops persistent generalised 
lymphadenopathy, CD4 counts fall, and accompanying this is significant immune 
dysfunction. When indicator conditions occur, the condition is termed AIDS. 
 
When HIV virus particles (virions) bud from the host cell, a portion of the cell membrane is 
taken to form the form the envelope of the virus. The various specific glycoproteins of the 
virus are embedded in this outer envelope. These include gp160, which consists of the 
trans-membrane component gp41 and the extra-membranous component gp120.  This 
gp120 can bind to CD4 on other host cells, and allow direct cell-cell transmission.  
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13.3 Testing for HIV 
 
Other than in the case where there has been an occupational (e.g. sharps) injury to a staff 
member, it is uncommon for dentists to request a HIV test for a patient. When patients 
present with unusual oral lesions, referral to a specialist is indicated, as well as to the 
patient’s medical practitioner.  
 
The standard regimen of testing for HIV infection uses: 
· ELISA tests of blood for antibodies to HIV (both HIV-1 and HIV-2), followed by 
· referral of samples with positive results to reference laboratories for confirmation by 
Western blotting. This detects envelope glycoproteins as well as antibodies to core 
proteins, including reverse transcriptase and p24 (an inner structural component which 
is detectable very early in the infection). 
 
In addition to these routine means, additional laboratory assays may be used, including: 
· serology for p24 antigen 
· radio-immune assays (RIA) for Antibodies to p24, gp41, and gp120  
· PCR 
· Cell culture of HIV. 
 
In the ELISA test, antibodies to envelope glycoproteins within 2-4 weeks following 
infection and then remain at high levels for life. This window period of 2-4 weeks reflects 
the kinetics of the primary immune response.  
 
The sensitivity and specificity of current generation ELISA tests are 99.9%. 
 
False positive ELISA test results can be caused by: 
· Antibodies  to MHC Class II 
· Antibodies to T cell, leukocyte, and nuclear antigens 
· Haematological malignancy 
· Renal failure or transplant. 
 
False negative results can caused by: 
· The window period (as described above), where there is acute disease (such as a mild 
flu-like illness) but seroconversion has yet to occur. 
· Failure to mount a primary antibody response because of  
· Malignancy 
· Immune suppression 
· B cell dysfunction 
· Recent bone marrow transplantation. 
 
On the part of the potentially infected individual, the risks and benefits of HIV testing can 
be summarised as follows. 
 
Risks: 
· False positive result 
· False negative result 
· Stress and adverse psychological reactions 
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· Loss of confidentiality 
· Societal discrimination. 
 
Benefits: 
· Anti-retroviral treatment (which can delay disease progression) 
· Prophylaxis for Pneumocystis carinii pneumonia (PCP) 
· Screening for tuberculosis  
· Education 
· Reduced risk behaviours. 
 
13.4 HIV Vaccines 
 
Vaccines for HIV are problematic because: 
· The virus has highly variable surface proteins 
· Once infection is established, further mutation of the virus occurs (much like HCV). 
 
Nevertheless several candidate vaccines for HIV are currently under development and some 
have progressed to the stage of clinical trials. A successful vaccine could: 
· Provide long-term protection against exposure to HIV 
· Prevent chronic infection by allowing the immune response to clear the virus 
completely 
· Reduce the incidence and prevalence of HIV infection in the community. 
 
Strategies for vaccination include: 
· Humoral immunity: antibodies against the gp120 or gp160 membrane components 
which will block binding and entry of HIV into cells. These could be developed from 
the attenuated HIV strains which have been observed on rare occasions. 
· Cellular immunity: activation of cytotoxic T lymphocytes which are specific for highly 
conserved components such as gag (p55 core protein), nef (regulates viral production) 
and pol (protease, reverse transcriptase and integrase precursor). These lymphocytes 
would kill off virally infected cells. 
 
13.5 Oral lesions  
 
AIDS provides an excellent example of the intimate relationship between the immune 
system and the challenges posed to it by overt and opportunistic pathogens. Indeed, it was 
the unusual pattern of appearance of Pneumocystis carinii pneumonia which led to the 
identification of AIDS as a specific disease entity. Patients with HIV infection have a range 
of defects in cell mediated immunity, which predispose them to  
· viral infections (e.g. HSV, CMV, HHV-8) 
· fungal infections (e.g. Candida) 
· infections by bacteria which survive inside phagocytes (e.g. Mycobacterium 
tuberculosis). 
 
In addition to the range of unusual viral, bacterial, fungal and parasitic infections, patients 
with HIV infection suffer from malignant diseases and marked immune dysregulation, 
which leads to a range of auto-immune disorders. 
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This spectrum of disorders occurs because of perturbed cell mediated immunity. In addition 
to loss of the regulating influence of CD4 T cells, HIV infection of dendritic cells and 
Langerhans cells impairs antigen presentation. Patients are unable to mount effective 
immune responses to new antigens, and have impaired T lymphocyte memory to antigens 
encountered previously.  
 
Common oral manifestations of HIV infection include: 
· Candidoses (erythematous and pseudomembranous) 
· Particularly on the palate, tongue, or buccal mucosa.  
· Usually C. albicans, but can also be C. glabrata or C. krusei.  
· Resistance to fluconazole can be a significant problem. 
 
· Oral hairy leukoplakia (OHL) 
· Caused by EBV 
· Can have superimposed candidal infection 
· May occur on areas other than the posterior lateral tongue 
 
· ANUG (HIV-AUG) 
· Signs and symptoms resemble those of ANUG in HIV-negative patients 
· The interdental papillae are “punched out”, and are covered by a necrotic slough 
 
· Linear gingival erythema (LGE) 
· Brightly erythematous band on the marginal attached gingiva 
· May arise from well defined multiple small petechiae  
· Spontaneous gingival bleeding can occur 
· Does not resolve in response to oral hygiene measures and conventional therapy 
 
· HIV-related periodontitis (HIV-P) / necrotising ulcerative periodontitis 
· Rapid loss of interdental papillae, attached gingiva and alveolar bone 
· Frank necrosis of soft and hard tissues can occur rapidly 
· Sites of destruction are typically isolated foci, typically in the incisor region first 
before involving the molar areas   
· The condition is very painful 
· The flora includes periodontopathogens as well as the occasional appearance of 
unusual organisms such as Klebsiella and E. coli. 
 
· Kaposi’s sarcoma (KS) 
· Caused by HHV-8 
· Occurs in approximately 1 in 5 patients with AIDS 
· Often occurs at multiple sites within the oral cavity as well as on the skin 
· Most common site is the hard palate (lateral to the midline) 
· Can occur at other sites, such as the gingiva and buccal mucosa 
· Lesions are often painful 
· Treatment modalities include radiation, systemic chemotherapy, intra-lesional 
injected chemotherapy. 
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Less common oral manifestations include: 
 
· HHV infections (HSV, VZV, CMV) 
· Can be very severe 
· Recurring infections are common 
· HSV strains can be resistant to acyclovir, and other agents (such as foscarnet) must 
be used. 
· VZV infections often involve the trigeminal nerve, with both oral and extra-oral 
lesions occurring along the distribution of the affected nerve (in a unilateral pattern) 
· CMV infection can involve the salivary glands (and lead to parotid gland 
enlargement and xerostomia) or the soft tissues (which leads to oral mucosal and  
peri-oral ulcerations). 
 
· HPV lesions - multiple and recurrent oral papillomas 
 
· Major aphthous ulcerations 
· Large lesions ( more than 6 mm in diameter) which persist for weeks to months 
· Can cause significant morbidity 
· Shape is irregular and cavernous; lesions lack the red halo which is characteristic of 
minor aphthous ulceration – thus biopsy is important to differentiate the lesions 
from necrotising ulceration and bacterial ulcers. 
 
· Other oral mucosal ulcerations with an immune pathogenesis 
· Vasculitis 
· Reiter’s syndrome 
· Medication-induced lesions 
· Fungal lesions (Histoplasma and Cryptococcus spp.) which can appear as ulcerations or 
surface epithelial pebbling. 
 
· Mycobacterial lesions (M. tuberculosis, M. avium) 
 
· Bacterial infections (A. israellii, E. coli) 
· Ulcerative lesions may be caused by T. pallidum, Neisseria, Klebsiella, and 
Enterobacteria. 
 
· Hyper-pigmentation of the oral mucosa (as well as the lips and nails) 
· dark brown-black pigmentation from increased melanin synthesis 
· can also occur as a side effect of AZT therapy 
] 
· Xerostomia 
· From CMV salivary gland infection 
· From autoimmune conditions which resemble Sjogren’s syndrome in that there is 
lymphocytic infiltration of the salivary glands (particularly the parotid gland) 
· From stress 
· As a side effect of medications  
 
· Malignancies (SCC, NHL) 
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· NHL can occur as a result of EBV –induced malignant transformation of B 
lymphocytes 
· Can occur both in the oral cavity and in the cervical lymph nodes 
· Can have a range of appearances – typically is a irregular rapidly growing mass in 
the posterior oral cavity (palate or retro-molar region) 
· Treated by radiation and chemotherapy. 
 
Some of these lesions (particularly candidoses, ANUG, and OHL) can occur in patients 
with immune deficiencies other than HIV. The likelihood of such lesions occurring in 
HIV-negative patients depends on: 
· The duration and depth of immune suppression 
· Previous or current use of antibiotics  
· Oral hygiene 
· Isolation of the patient 
· Breaches in the oral mucosa (ulcerations) 
· General health status of the patient. 
 
The seroconversion illness associated with the initial events of HIV infection occurs within 
3 to 6 weeks after exposure to the virus. A significant proportion of individuals 
(approximately 1 in 4) develop a flu-like acute illness which resolves within several days.  
 
Signs of the seroconversion illness include: 
· fever 
· rash (macular exanthem) on the upper body  
· oral lesions, particularly erythema, erosions, and aphthous ulcerations – these may 
persist for several weeks even though the systemic signs of illness have settled. 
 
13.6 Antimicrobial therapy 
 
In patients with AIDS, candidoses, periodontal pathology, and viral lesions are common, 
whilst mucositis and caries are rare. In contrast, in patients undergoing chemotherapy, 
radiotherapy or bone marrow transplantation, mucositis is common, and is accompanied 
frequently by candidoses, viral lesions, and dental caries (because of salivary dysfunction), 
whilst aggressive periodontitis and OHL are rare.  
 
Antimicrobial prophylaxis is an important part of the management of immune compromised 
patients. The goal is to prevent colonisation or multiplication in these susceptible hosts. 
Antimicrobial prophylaxis may include: 
· For fungal infections: 
· Fluconazole 
· Amphotericin if resistant to fluconazole. 
· For Pneumocystis carinii pneumonia (PCP) 
· Bactrim 
· For Human Herpesvirus infections  
· Valacyclovir 
 
When considering the need for and type of antimicrobial prophylaxis, the following must be 
considered: 
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· cost 
· biological cost – from toxic effects of the antimicrobial agents on organ systems 
· development of resistant strains 
· financial costs 
· benefits 
· reduced morbidity from infection 
· reduced length of hospitalisation 
· reduced need for in-patient and out-patient health care 
· cost effectiveness. 
 
Antibiotics can also be used as an adjunctive measure – such as in the treatment of HIV-P 
(NUP) – where it accompanies periodontal debridement. This condition usually responds to 
the combination of metronidazole and amoxycillin. The combination causes strong 
suppression of the commensal flora, and there is a risk of overgrowth of opportunistic 
pathogens, particularly fungi such as Candida albicans. 
 
 
13.7 Disease progression 
 
Both oral candidoses and OHL are major predictors of disease progression, and their 
appearance indicates progression from mild or early disease and thus the need for altered 
anti-retroviral therapy.  
 
For example,  
· When a HIV positive patient develops OHL, there is a high probability (approximately 
80%) that the patient will develop full-blown AIDS within 2.5 years. 
· Once NHL develops, only 1 in 5 patients will survive more than 2 years. 
 
Other predictors of disease progression comprise: 
· CD4 count 
· CD4:CD8 ratio 
· p24 antigen level 
· extent of HIV-related anaemia 
· erythrocyte sedimentation rate (ESR). 
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The count of CD4 T lymphocytes per cubic millimetre is closely related to the underlying 
immune disorder. 
CD4 count Typical conditions present 
600 Lymphadenopathy 
Thrombocytopaenia 
500 Oral candidoses 
Bacterial skin infections 
HSV and VZV lesions 
400 Kaposi’s sarcoma 
300 Oral hairy leukoplakia 
Tuberculosis 
200 Pneumocystis carinii pneumonia 
Toxoplasmosis and other unusual infections 
100 CMV 
Lymphomas (such as Non-Hodgkins lymphoma) 
 
13.8 Anti-retroviral therapy 
 
In addition to anti-herpetic agents (as discussed earlier), modern anti-HIV therapy 
includes both: 
· Anti-retroviral agents (reverse transcriptase inhibitors) 
· Zidovudine (AZT) 
· Zalcitabine (ddC) 
· Didanosine (ddI) 
· Lamivudine (3TC) 
· Protease inhibitors (which interfere with the assembly of viral progeny) 
· Indinavir (Crixivan) and others. 
 
Typically, a triple therapy approach is used, for example Zidovudine 250 mg bd (“AZT”, 
“RETROVIR”), Lamivudine 150 mg bd (“3TC”), and Indinavir 800 mg tds 
(“CRIXIVAN”). 
 
AZT is usually well tolerated. Side effects are usually transient and resolve within the first 
few weeks of treatment. Side effects of AZT predominate when AZT is used with other 
reverse transcriptase inhibitors, such as 3TC. Common side effects of AZT include nausea 
and gastric upsets, headaches and sleeplessness, loss of appetite and weight loss, muscle 
pain, skin rash, anaemia and lowered white blood cell count. 
 
AZT is excreted by the kidneys, and paracetamol can reduce the levels of AZT in the 
circulation. 
 
Indinavir, which is a protease inhibitor, exerts a range of side effects which are similar to 
those of AZT, and in addition can cause nephrolithiasis (kidney stones). Patients therefore 
are encouraged to drink at least 2 litres of water per day. Drug interactions occur between 
Indinavir and a range of agents, including erythromycin and some benzodiazepines. There 
are major interactions with food (it cannot be taken with food) and grapefruit juice is a 
particular concern as it lowers blood levels because of its effects on the cytochrome P450 
system.  
 




Disinfection eliminates many or all pathogenic microorganisms, but does not kill bacterial 
spores. Disinfectants can be applied to either living or inanimate surfaces to prevent 
microbial growth.  
 
Disinfectants are often categorised as follows: 
 
High-level disinfection: destroys all types of microorganisms (except large numbers of 
spores) – e.g. high temperature thermal disinfection, chemical treatments. 
 
Intermediate-level disinfection: destroys Mycobacterium tuberculosis, vegetative bacteria, 
most viruses and fungi, but few if any spores. 
 
Low-level disinfection: Kills most bacteria, and some fungi and viruses, but not resistant 
forms, Mycobacterium tuberculosis, or spores. – e.g. cleaning of protective glasses and 
other items that contact intact skin (but not mucous membranes), using detergent and 
water. 
 
High-level disinfection is used for semi-critical items – those which come into contact with 
intact mucous membranes (e.g. plastic cheek retractors). 
 
There is no “perfect” disinfectant; all products represent a compromise between a range of 
attributes: 
 
· Spectrum of activity 
· Speed of action 
· Susceptibility to interference from physical factors 
· Cost 
· Corrosion of surfaces 
· Toxicity 
· Safety and occupational health issues 
· Bio-degradability and environmental impact. 
 
For a chemical antibacterial agent used therapeutically in dentistry in oral care products 
(such as mouth rinses), the additional ideal properties include: 
 
· Selective elimination of pathogens but not normal flora 
· Binds on hard or soft surfaces to give sustained release (substantivity) 
· Not damaging to teeth, restorations or soft tissues 
· Does not cause staining 
· Acceptable taste, and does not cause taste alterations 
· Simple to use 
· Reduces both dental plaque and gingivitis. 
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Targets for antimicrobial activity include: 
 
· The cell wall 
· Penicillins 
· Lysozyme and other enzymes 
· Aldehydes 
· Surfactants 
· The outer membrane 
· EDTA 
· Polymyxins 
· The cytoplasmic membrane 
· Moist heat 
· Phenols 
· Quaternary ammonium compounds 
· Chlorhexidine 
· Protein synthesis 
· Tetracyclines 
· Nucleic acids 
· Actinomycins 
· UV and ionising radiation 
· Folate utilisation 
· Sulphonamides 
· Enzymes/proteins 
· Metal ions (such as the stannous ion) 
· Oxidising agents  
· Alkylating agents and halides (including the fluoride ion). 
 
Physical antimicrobial processes include: 
· Dry heat (160 Celsius) 
· slower than moist heat 
· Moist heat 
· >121 Celsius for sterilisation 
· <100 Celsius for disinfection 
· Ionising radiation 
· gamma radiation for medical devices 
· Ultraviolet radiation 
· for disinfection of surfaces, e.g. laminar flow hoods. 
 
Combined antimicrobial processes include: 
· Heat + chemical  
· for sterilization, e.g. of eyedrops 
· chemical vapour with formaldehyde 
· Irradiation + chemical 
· Chemical + ultrasonics 
· Antisera - for therapy 
· Vaccines and toxoids - for prophylaxis 
· Interferons - for chemotherapy. 
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Antimicrobial chemical agents with high selectivity comprise: 
· Synthetic anti-bacterials 
· metronidazole 
· Synthetic antifungals 
· imidazoles such as fluconazole 
· Synthetic anti-virals 
· Acyclovir 
· AZT 
· Antibacterial antibiotics 
· tetracyclines 
· clavulanic acid (beta lactamase inhibitor) 










· e.g. acridines 
· Silver compounds 
· Organic mercury compounds 
· Organic arsenic compounds 
· Aldehydes 
· Metals (e.g. Zn) 
· Phenolics 
· Biguanides (e.g. CHX) 
· Quaternary ammonium compounds 
· Halogens (e.g. Cl, I) 
· Chelators (EDTA) 
 
Physical factors which influence the activity of antimicrobials include: 
· Solvents 
· Surface tension and micellar effects 
· Miscibility 
· pH 
· Temperature (a reduction by 10 degrees Celsius halves the speed of reaction) 
· Electrolytes (salts) 
· Formation of complexes 
· Binding to macromolecules 
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14.1 Chlorines 
 
Available chlorine (AC) is a measure of the oxidising capacity and is expressed as the 
equivalent amount of elemental chlorine. 
· NaOCl contains 70.91g AC per mole 
· Pure NaOCl has 95.8% available chlorine 
· Many common bleach products are 5.25% NaOCl and have 1% available chlorine, e.g. 
“Snow White” contains 4% NaOCl (40 g/L) 
· Miltons hospital strength stabilised NaOCl has 7.88% NaOCl and has 1% available 
chlorine  
· 1% available chlorine corresponds to 10,000 ppm available chlorine 
· Common hypochlorites: Na, Ca, Li 
· Disinfection of impressions uses 0.5 % NaOCl for 3 minutes while immersion 
disinfection of bitewing radiographs uses 5.25% NaOCl for 30 seconds. 
 
There is an extensive literature on the disinfection of dental impressions by sodium 
hypochlorite. The following are the major points of practical importance: 
· Cleaning by rinsing is essential, as this removes the bulk of the bioburden 
· Use of a detergent facilitates removal of bioburden 
· The optimal concentration is 0.5% NaOCl; using higher concentrations (with the 
intention of reducing exposure time) cause a deterioration in the surface quality of the 
casts. 
· 10 minutes is the maximum time before deleterious changes occur; while 3-5 minutes is 
sufficient (either immersion or spray; provided there is contact for the entire period)  
· NaOCl is compatible with all impression materials. Those with a hydrophobic surface 
(such as zinc-oxide-eugenol and polysulphide) require brief treatment with a wetting 
agent (such as dilute liquid soap) to allow proper wetting of the surface  
· Dimensional changes with NaOCl are not significant. 
· Casts which are contaminated can be disinfected in 0.5% NaOCl, but in this case the 
hypochlorite is diluted in slurry (saturated calcium sulphate) rather than water. 
 
The disinfecting ability of sodium hypochlorite is affected by: 
· Concentration: There are shorter killing times with higher concentrations, while very 
low concentrations may not kill at all 
· Temperature: There is increased killing with increasing temperature. 
· Organic material such as proteins: These consume available Cl (by forming 
chloramines) 
· Other halogens: (iodine, bromine): These enhance biocidal activity of chlorine 
· pH: Because of the dissociation of hypochlorous acid HOCl, a  decrease in pH 
increases biocidal activity. 
· Water hardness (level of Mg and Ca): This has no effect. 
 
Properties of sodium hypochlorite can be summarised as follows: 
· Economical 
· Rapid broad spectrum kill 
· Non-poisonous at the concentrations used 
· Colourless 
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· Easy to handle 
· Corrodes metals 
· Loses activity when diluted 
· Loses activity with bio-burden. 
 




The properties of iodine compounds as disinfectants can be summarised as follows: 
· Rapid action 
· Limited residual effect on surfaces 
· Is three times less prone to inactivation by protein than for chlorine compounds 
· Stains 
· Unstable 
· Mild irritant 
· Non-toxic 
· Possible allergen. 
 
Examples of iodine-based products: 
· Lugol’s iodine 
· tincture of iodine 
· povidone iodine 
· iodophors. 
 
Iodophors are a complex of iodine/iodide with a solubilising agent or carrier. The 
formulation increases the solubility, and acts as a reservoir which releases small amounts of 
iodine. Many iodine preparations are used for disinfection of skin prior to surgery. 




In high concentrations the fluoride ion can be toxic to bacteria, while in lower 
concentrations it can impair acid production. These effects occur through interactions with 
enzymes as well as by combination with hydrogen ions to produce hydrofluoric acid.  
 
 
14.3 Hydrogen peroxide  
 
Hydrogen peroxide (H2O2) has many applications in dentistry: 
· 30% solution for bleaching teeth 
· bleaching gels with carbamide peroxide 10% (which release 3.5% hydrogen peroxide) 
· used in combination with sodium bicarbonate ("baking soda") in dentifrices 
· AMOSAN mouthrinse (Oral-B) = H2O2  + sodium perborate 
· periodontal irrigant – particularly in ANUG (suppresses obligate anaerobes) 
· injected into water to reduce biofilms in DUWL (e.g. Dentosept in Sirona equipment). 
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H2O2 is relatively unstable, and decomposes slowly to oxygen and water. This 
decomposition is accelerated by light and heat, a feature which is exploited in various 
“power-bleaching” techniques. As will be discussed below, H2O2 is also broken down by 
enzymes such as catalase.  
 
Hydrogen peroxide is completely soluble in water, and gives an acidic solution, the pH of  
which varies according to the concentration. The pH of a 1% solution is 5.0-6.0 
 
Reactive oxygen species (ROS)  
· ROS includes H2O2 and radicals 
· Radicals are chemical species which contain one or more unpaired electrons), such as 
superoxide (O2.-), hydroxyl (HO.), peroxyl (ROO.) and alkoxyl (RO.)  
· H2O2 is formed by the reaction of superoxide (O2.-) with itself, i.e., a dismutation 
· Within cells such as neutrophils, H2O2 and the superoxide and hydroxyl radicals can be 
formed enzymatically and non-enzymatically. 
 
Hydrogen peroxide and other ROS damage DNA. The formation of DNA strand breaks 
leads to activation of poly-ADP-ribose polymerase which in turn causes depletion of NAD 
and ATP, followed by calcium ion influx and eventually cell lysis. Defences against H2O2 
and ROS include anti-oxidants (free radical scavengers) such as vitamins C and E, beta-
carotene, coenzyme Q10, selenium and zinc; and catalase. Anaerobes are more sensitive to 
killing by H2O2 as they do not produce catalase. 
 
As a disinfectant, hydrogen peroxide  
· is active against bacteria, fungi, viruses and spores 
· is relatively low cost 
· leaves no residue 
· has an excellent safety profile 
· prevents bacterial growth at a concentration of 25 ppm 
· is better at killing in solution when at acid pH 
· can also kill in a vapour phase 
· can produce gaseous oxygen, which has cleansing effect 
· has major uses in water treatment  
· dental unit water lines 
· health care facilities 
· horticulture 




Alcohols kill by denaturing proteins. This killing is accelerated by presence of water, thus 
70-80% is used most commonly concentration. Alcohols are bactericidal against vegetative 
forms of bacteria but are less active against spores. Alcohols exert antiviral effects, and are 
highly active against HIV. 
 
Ethanol, methanol, and isopropanol are the most active disinfectants. Long-chain alcohols 
are less active than simple alcohols. 
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Alcohols have been popular for skin preparation before cannulation, injection and other 
minor procedures, as well as a pre-surgical handwash. The following table summarises the 





Hand wash solution 
2.1 Plain soap 
2.9 7.5% povidone iodine liquid soap 
3.1 4.0% CHX liquid soap 
3.3 70% v/v isopropyl alcohol 
3.4 70% isopropyl alcohol + 0.5% CHX 
 
Properties of alcohols can be summarised as follows: 
· Cheap 
· Readily available 
· Flammable 
· Limited sporicidal activity 
· Inactivated by organic material 
· Optimal concentration is 70-80% in water. 
 
14.5 Membrane-active agents 
 
Membrane-active agents used in disinfection include: 
 
· Phenols (e.g. Medol ™) 
· These cause generalised membrane damage with leakage, lysis, and protein 
denaturation  
· Quaternary ammonium compounds (e.g. Pine-O-Clean ™) 
· These cause membrane damage and leakage 
· Interact with membrane phospholipids 
· Chlorhexidine 
· low concentrations cause leakage of cell membranes 




These are derived from carbolic acid (phenol) which was first used by Lister for treatment 
of wounds. Modern phenolics are modified phenols, which are halogenated and alklyated to 
increase antibacterial properties. Linking two phenolic molecules to give bisphenols also 
increases effectiveness. Most commercial products have phenolics in combination with 
detergents and solvents such as alcohols. 
 
Phenols are typically used at 400-1300 ppm final concentration either in solutions or in 
spray packs. They are used for low to intermediate level disinfectants.  
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Phenolics 
· are active against Gram positive and Gram negative bacteria, as well as the tubercle 
bacillus, fungi, and lipophilic viruses 
· are not  sporicidal 
· are relatively tolerant of bio-burden (organic load) and hard water 
· have residual activity and are biodegradable 
· have a bitter taste 
· can be irritant – resulting in mucosal burning 
 
Many phenolic compounds occur as essential oils from plants, e.g. tea tree oil (from the tea 






Listerine® (Johnson & Johnson)  
· is a mix of essential oils and phenolics agents (Thymol, eucalyptol, menthol, and methyl 
salicylate).  
· can cause modest reduction in plaque and gingivitis  
· has a good effect on existing plaque because thes molecules are uncharged and thus can 




· a phenolic compound 
· chemical name is 2,4,4’-trichloro-2’-hydroxydiphenyl ether. 
· a non-ionic agent (no net charge)  
· acts on the cytoplasmic membranes of bacterial cells 
· At low concentrations, prevents uptake of essential amino acids –  bacteriostatic 
· At high concentrations, disrupts bacterial cell membrane causing leakage of the 
cytoplasmic contents and cell death – bactericidal. 
· Has poor substantivity 
· Has anti-nflammatory properties 
 
· Skin care 
· Used in skin care products and surgical hand washes 
· Effective at preventing transmission of MRSA 
 
Colgate triclosan products 
· Triclosan combined with Gantrez®  
· Gantrez is a co-polymer of polyvinyl methyl ether and maleic acid 
· The combination with Gantrez greatly increases effectiveness since it gives substantivity 
· Toothpastes: 0.3% Triclosan + 2.0% Gantrez (Colgate Total). 
 
 
14.8 Quaternary ammonium compounds 
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“Quats” disrupt bacterial cell membranes, and precipitate cell contents. They are slightly 
more active at alkaline pH. Newer 3rd generation dual quats have better biocidal and 
detergent properties than earlier quats. Modern quats are also compatible with non-ionic 
detergent soaps, unlike earlier products. 
 
Typical quats are 
· Benzalkonium chloride: 0.01% in Ora-Sed Gel 
· Cetrimide 
· Cetylpyridinium chloride (CPC): Major active ingredient of supermarket mouthrinses, 
typically at a concentration of 0.05%. 
 
The major properties of quats as disinfectants can be summarised as follows: 
 
· Bacteriostatic for Gram positive bacteria, but are less effective against Gram negative 
bacteria 
· Fungical 
· Virucidal against lipophilic viruses (when at 10-50 ppm) 
· Similar spectrum of activity to chlorhexidine 
· Can cause a modest reduction in gingivitis 
· Not tuberculocidal 
· Not active against hydrophilic viruses 
· Effectiveness is reduced by hard water and bio-burden 
· When used in mouthrinses, quats absorb readily (better than CHX) but have poor 
substantivity 




Chlorhexidine (CHX) was first synthesised in 1950 by ICI England. It is a cationic 
bisguanide molecule, which is usually prepared as salts (acetate, digluconate, nitrate, 
hydrochloride) which dissolve to give positively charged molecules at neutral pH. Solubility 
depends on the chemical formulation. The most soluble form is the di-acetate form. The di-
hydochloride and di-nitrate forms are poorly water soluble. CHX is more soluble in alcohol 
than water.  
 
CHX is positive (two positive charges) and thus binds rapidly to bacterial cell membranes  
which are negative. It also binds to other anionic (negatively charged) substances:  
· Oral mucosal epithelial cells 
· Hydroxyapatite 
· Carboxylate residues 
· Phosphate residues 
· Pellicle 
· Sulphate residues. 
This same property also makes it difficult to combine CHX and fluoride ions (which are 
negatively charged) into the same product in a stable formulation. 
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CHX is compatible with other cations (e.g. Quats), however non-ionic detergents may 
inactivate CHX, and CHX is incompatible with anionic organic molecules such as soaps 
(e.g. sodium lauryl sulphate) (SLS). A delay between SLS and CHX obviates this problem. 
 
In terms of its disinfectant properties, CHX  
· Is adsorbed onto cell membranes, and kills by inducing membrane leakage and 
precipitation of cytoplasm 
· Is most active against vegetative bacteria (both Gram positive and Gram negative) 
· Inhibits but does not kill Mycobacterium tuberculosis 
· Is inactive against spores except at high temperatures (70 degrees Celsius) 
· Is fungicidal for Candida albicans  
· Is rapidly effective against most lipophilic viruses (e.g. HIV, HSV, influenza virus) 
· Has an optimal pH of 5.5 to 7.0 
· Is bacteriostatic at low concentrations 
· Is rapidly bactericidal at higher concentrations 
· Rapidly kills aciduric oral bacteria such as mutans streptococci and lactobacilli 
· Is released slowly, which caused a prolonged bactericidal effect (substantivity). 
 
CHX inhibits a variety of microbial cellular processes, causing membrane damage, leakage 
of bacterial cell contents, loss of structural organization, and congealing and denaturation 
of cytoplasmic contents. These rather non-specific detergent-like effects explain why 
resistance to CHX (and to other biocides) does not develop over time – because multiple 
pathways of attack are employed, unlike antibiotics where typically only one biochemical 
pathway is blocked. Some bacteria are particularly susceptible to CHX (such as mutans 
streptococci), and others completely resistant (such as some Gram negative bacilli, 
particularly Pseudomonas aeruginosa, a common water-borne pathogen which can cause 
pneumonic and other infections). 
 
There are a number of important differences in the targeting between CHX and the 
phenolic agents (including Triclosan and essential oils), since CHX is charged, and binds to 
pellicle and the early Gram positive layers of bacteria. The phenolics are uncharged, do not 
bind electrostatically to bacteria, but rather interact more with the outer layers of plaque 
where they can diffuse into the structure of the biofilm. This difference explains why CHX 
is preferred as a post-surgical rinse, since it can interact with the early stages of plaque 
biofilm formation and prevent the plaque increasing in thickness. The binding properties of 
CHX (substantivity) involve interactions with oral mucosa and saliva, as well as with 
pellicle and plaque. Individuals vary in terms of their binding and release of CHX, however 
in most patients, release of CHX to useful concentrations occurs over a 12 hour period. 
 
Because of its role in interfering with early stages of plaque formation, CHX when used 
thrice daily in a mouthrinse after oral or periodontal surgery (times when a patient is unable 
to brush) can keep plaque levels low. Clinical trials of CHX, which have used standardized 
scoring methods for measuring plaque, gingivitis, and soft tissue responses over 6 months 
of usage have shown reductions of plaque of 60+ %, and reductions in gingivitis by 50-
80%.  Note that while CHX inhibits plaque formation, new plaque will form normally when 
CHX is stopped. 
 
Uses of CHX in dentistry include: 
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· Handwash 
· Surgical scrub 
· Pre-procedural rinse (to reduce aerosols) 
· Chemical plaque control 
· Patients with periodontitis 
· Orthodontic patients 
· Physical disabilities 
· Institutionalised patients 
· Mental disabilities 
· Plaque control adjunct – gives 60% reduction in established plaque, and over 80% 
reduction of new plaque formation 
· Post-surgical rinse 
· Adjunct in the treatment of candidal infections 
· Adjunct to caries control (to suppress cariogenic bacteria and prevent transmission of 
bacteria) 
· Recurrent aphthous stomatitis and upper respiratory tract infections. 
 
Looking in more detail at the uses as a chemical djunct to mechanical oral hygiene, 
indications for use of CHX mouthrinses products include 
 
• Reduction in bacteraemia for at-risk patients for infective endocarditis 
• Pre-procedural rinsing to reduce aerosolized oral microbes 
• Patients having problems with mechanical plaque control 
• Physically disabled patients and patients with impaired physical dexterity (stroke, 
arthritis, Parkinson’s disease) 
• Assist supragingival plaque control in periodontal patients after subgingival 
debridement 
• Patients with intraoral fixation after jaw fractures 
• Patients with fixed orthodontic appliances and over-dentures 
• Suppression of oral fungal infections 
• Reduction of oral malodour / halitosis 
• Medically compromised patients having in-hospital cancer treatment, who develop 
neutropenic and other severe forms of oral ulceration (mucositis). This includes 
patients undergoing cancer therapy with cytotoxic agents (e.g. leukaemia); radiation 
therapy of the head and neck; transplants of solid organs (organs (kidney, liver, etc.) 
or of bone marrow/stem cell/cord blood. 
 
Indications for use of CHX gel products include 
 
• Caries control 
• Bedridden patients who are at risk of developing aspiration pneumonia.  
 
Silent aspiration of bacteria from the oral cavity and upper aero-digestive tract, particularly 
from dental plaque. More elderly and medically compromised patients are potentially at 
risk. Regular use of an antimicrobial agent in a toothpaste or mouthrinse may help prevent 
aspiration pneumonia, as well as improving or maintaining oral health. 
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In the past, CHX was used for subgingival irrigation, delivered either as a gel into the 
pocket after debridement was completed, or used as the liquid irrigant delivered through 
ultrasonic scalers. Clinical studies indicate no clinically significant benefit as an adjunct used 
in this way.  
 
Typical products 
· Paradontal gel (0.5% or 2%) (Curasept) 
· Savacol mouthrinse (0.2% CHX + 12% alcohol) (Colgate) 
· Plaqacide mouthrinse (0.2%) (Oral B) 
· Difflam Dental mouthrinse (3M) (0.12% CHX + benzydamine + 7% alcohol) 
· Cervitec varnish  
 
In the USA, typical plaque control products are formulated at 0.12% not 0.2%. There is no 
significant difference in efficacy between these two concentrations. 
 
CHX has an excellent safety profile. In 40 years of use there have been few adverse 
reports. Staining and taste alterations are the major side effects experienced by patients on 
long term programs. CHX is 
· Not absorbed through skin, mucosae, or the gastrointestinal tract 
· Largely excreted unchanged in faeces 
· Not carcinogenic 
· Not a sensitiser 
· Neurotoxic when in direct contact with the brain, ear, or cerebrospinal fluid. 
 
Side effects include: 
· Taste alterations (reduced sensation) 
· Bitter taste 
· Staining of plaque 
· Staining of restoration margins 
· Increased supragingival calculus deposition 
· Mucosal desquamation and ulceration (mild irritant). 
 
14.10 Side effects of biocides 
 
When considering long term usage, there are a number of potential problems to consider, 
namely microbial resistance, adverse effects of ethanol, and staining. The long term use of 
CHX (and other common biocides) has been shown to be microbiologically safe, with no 
evidence of antimicrobial resistance. Long-term use does not result in the emergence of 
opportunistic or oral pathogens after long-term, daily use. Because CHX, triclosan and 
essential oils have modest anti-fungal actions, long term use prevents overgrowth of 
Candida albicans.   
 
In long term clinical trials, the most common side effect of CHX is extrinsic staining of 
teeth and restoration margins in regions where plaque control is more difficult (e.g. 
interdentally). Staining is greater when the lifestyle includes tannins and red wine, although 
such stains are easily removed by professional cleaning. Increased supragingival calculus 
formation may also occur in some patients, through elevated salivary pH and thus enhanced 
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mineral deposition. CHX rinse may also cause a bitter after taste or a temporary dulling of 
taste perception. In contrast, the main issue with essential oil products is taste, and the 
intens flavouring used to disguise the taste – although it should be recognized that CHX, 
essential oils and Triclosan are all rather bad tasting when in the purse form.  
 
Some home care anti-plaque rinses contain ethanol (up to 22% by volume), however low- 
alcohol and alcohol-free products are becoming more widely available. Any oral care 
products containing ethanol should be stored out of reach of children, because of the 
possible risks of toxicity if ingested. Several large scale studies have demonstrated that 
there is no link between the pure alcohol used in mouthrinses, and the risk of oral cancer. 
 
14.11 Adverse skin reactions to hand care agents 
 
Intact skin (i.e. with no cuts or abrasions) is our first and most important natural barrier 
against infection. Gloves are an imperfect layer above this, yet it is common for staff to 
consider their disposable gloves are the most important barrier – they are not. The natural 
rubber latex in gloves breaks down when exposed to soaps and detergents (such as sodium 
lauryl sulphate), as well as a range of other materials including ethanol and acetone 
(solvents for bonding agents), eugenol, eucalyptol, and other essential oils, 
orthophosphoric acid, and epoxy resins (such as AH26).  
 
Knowing that gloves are an imperfect barrier provides the rationale for dental staff having 
an obsession with hand care, since any breaks in the skin (from trauma or various lesions 
such as weeping dermatitis) will be potential locations for entry for pathogens. Improper 
hand care can damage the protective systems of the normal skin (such as its lipid fatty acid 
layer and commensal bacterial flora), particularly when detergents or solvents are used 
excessively on the hands. Cuts and abrasions should be covered by water-resistant 
occlusive dressings (such as Liquid Band-Aid ™) that can be changed as required. Staff 
who have skin problems such as exudative lesions or weeping dermatitis must seek medical 
advice and must be removed from direct patient care until the condition resolves. 
 
Dental health care workers report a variety of reactions to glove use.  Dry skin and itching 
from irritant dermatitis are the most common complaints. These problems are caused by 
inappropriate hand care, particularly: 
· Using too much handwash solution 
· Failing to wash residual soap from the hands 
· Failing to dry hands properly before gloving. 
 
In addition to correcting these basic errors, a variety of remedies to these glove-related 
problems can be used, including 
· using moisturising hand cream 
· changing the type of glove worn to powder-free or hypo-allergenic gloves 
· changing gloves more frequently 
· changing the type of handwashing solution or the method of handwashing. 
  
While the importance of true allergies to glove materials and powders should be 
recognised, the incidence of such problems in dental staff is low. Most true allergic 
responses are either 
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· Type IV delayed type hypersensitivity 
· Type I immediate hypersensitivity (with the risk of anaphylaxis) 
 
Unnecessary trauma to the hands should be avoided. Zealous use of scrubbing brushes can 
easily abrade the skin, as can forceful use of poor quality paper toweling for drying the 
hands. To minimize chapping of hands, the 2004 Infection Control Guidelines recommend 
that for handwashing warm water be used, and the hands dried by patting them to blot 
away the moisture (leaving the lipid layer intact), rather than by rubbing them, which will 
abrade the skin surface.  
 
Irritant contact dermatitis in response to wearing disposable gloves is a very common 
problem in dental staff, and surveys conducted by this author have identified prevalence 
rates of greater than 70% in dentists and dental assistants. The problem has a clear 
occupational cause, and to elucidate this more clearly a 5 year longitudinal study is being 
conducted with dental student cohorts at the University of Queensland, to track the 
emergence of the problem as the students gain greater exposure to the clinics in successive 
years.  
 
Irritant contact dermatitis is a non-allergic response, caused primarily by detergents (such 
as sodium lauryl sulphate) and disinfectants. It occurs with all types of gloves, and thus is 
not specific to latex gloves or even to health care.  
 
Contact with these types of agents is a particular problem when excessive amounts of 
handwash are used. Residues are left on the skin, and they are then held in contact with the 
outermost layers of the skin because of the occlusive action of the glove material, which 
acts like a dressing in this regard.  
 
It is interesting to note that water in itself can be a mild irritant if the skin is exposed to it 
frequently for prolonged periods of time. Water combined with antiseptics and detergents 
removes the protective lipid layer on stratum corneum of the skin, and as a consequence 
liquids can spread onto and penetrate into the skin itself. The loss of lipid also increases the 
rate of trans-epidermal water loss and makes the skin more susceptible to subsequent 
irritants. This is why the condition becomes self-perpetuating.  
 
Dental staff may notice an improvement during vacations, however the problem re-appears 
when they return to work. The history may reveal that non-occupational factors are 
contributing, for example, for example, exposure to detergents and solvents domestically 
can exacerbate the condition. This is the reason why gloves should also be worn when 
washing dishes by hand after meals.   
 
The appearance of irritant contact dermatitis is typically dry fissured skin, which may then 
become itchy. The outer layers of the skin can break down and begin to peel into layers. If 
this develops, the staff member should check their hand care protocol, and reduce the use 
of irritant handwash whilst improving rinsing and drying of the hands before gloving (to 
remove traces of detergent).  
 
Use of a water-based emollient hand cream (not a barrier cream) three or more time daily is 
also recommended, to provide some additional protection. The product chosen should be 
low in fragrances, emulsifiers and other additives which can in themselves cause irritation.  
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As an aside, oil-based hand preparations should be avoided as traces of these on the skin 
may cause latex gloves to deteriorate, and may leave oily residues on handled items such as 
clean instruments. If these measures do provide resolution, changing the brand/type of 
handwash should be considered. Medical assessment is warranted in more severe cases, 
however irritant contact dermatitis can resemble allergic contact dermatitis (and other skin 
diseases) and in fact both the irritant and allergic forms can co-exist, which can further 
complicate diagnosis.   
  
While it is harmless yet annoying, irritant contact dermatitis should not be ignored since its 
effects on the skin, namely reduced skin integrity, can enhance direct absorption of glove 
materials, which could accelerate the onset of a true immunological reaction to 
polymerizing agents or to latex itself. This can occur because these components are water 
soluble, and thus when in contact with the skin under occlusive conditions will dissolve in 
perspiration and traces of moisture and penetrate into the skin evoking an immune 
response. 
 
Care should taken that liquid handwash used does not become contaminated with water-
borne opportunistic pathogens (such as Pseudomonas aeruginosa). This can occur when 
refillable containers are topped up repeatedly. Instead, when empty they should be washed 
thoroughly and left to dry overnight before filling with new solution. Alternatively, systems 
with a fully disposable reservoir and nozzle can be used. 
 
Hot and cold water taps should be operated in a “no-touch” fashion, for example using 
sensor controls or elbow, knee or foot controls. A neutral pH liquid handwash solution 
applied for 10-15 seconds onto wet hands is sufficient. The important thing to remember is 
to rinse off all traces of detergent under running water. The hands are then dried gently. Do 
not rub, to avoid chapping, however be sure to remove traces of water – particularly 
between the fingers, otherwise powder-free gloves will not slide on. 
 
It is always prudent to spend a second or so to check the quality of the gloves that have 
been donned. Any batch of gloves that has a defect rate (holes, macroporosities and other 
visible defects) of greater than 4 percent (1 glove in 25) is unacceptable, since this is the 




Glutaraldehyde is a powerful biocidal agent which is used widely in medicine for the 
disinfection of instruments (such as endoscopes) which cannot be autoclaved. It is used 
rarely in dentistry, as most non-critical items can be treated by disinfection with sodium 
hypochlorite (e.g. radiographic films in envelopes) or by thermal disinfection (e.g. plastic 
cheek retractors).  
 
In addition to being used for disinfection (e.g. 2% solutions, glutaraldehyde is also found in 
developing solutions used in automatic X-ray processors (e.g. 25%), and in some older  
dentine bonding agents.  
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Glutaraldehyde is both an irritant and a potent sensitiser, so that both short term and long 
term effects of exposure must be considered. There is no evidence that glutaraldehyde is 
mutagenic or carcinogenic. 
 
Exposure of skin, oral and ocular mucous membrane, and respiratory mucosa to 
glutaraldehyde can occur with any of the materials mentioned above. Adverse reactions can 
occur in surgery staff as well as in patients, who may be exposed to instruments processed 
through glutaraldehyde or to materials containing it.  
 
The toxicologic aspects of glutaraldehyde have been the subject of much research, and 
there have been successful legal cases for compensation for illness and injury from work-
related exposure to glutaraldehyde in the health care setting. 
 
The free aldehyde groups of glutaraldehyde react strongly with the free amino groups of 
proteins, and this reaction increases with pH. This reaction is responsible for the three 
major biological effects of relevance to dentistry:  
· biocidal effects on microorganisms 
· sensitisation upon contact with skin or mucosal surfaces 
· formation of cross-links with proteins such as collagen when used as a component of 
dentine bonding systems.  
 
Short-term immersion in glutaraldehyde produces high level disinfection but not 
sterilisation. 
 
The stability of glutaraldehyde is affected by both temperature and pH, which influence the 
tendency for polymerisation. With polymerisation, fewer free aldehyde groups are available, 
and biocidal activity is reduced. At acid pH, increasing temperature produces more free 
aldehyde groups, while at alkaline pH, the converse is true. At neutral and alkaline pH, the 
tendency to polymerise increases with time, and eventually the polymers become so large 
that they precipitate, and biocidal activity declines rapidly.  
 
There is an interaction between biocidal activity and stability. With different products on 
the market, pH varies, and thus expiry dates and conditions for use vary accordingly. Over 
a period of weeks, alkaline solutions will undergo significant polymerisation, and thus the 
stated minimum expiry dates must be adhered to rigidly. 
 
The effect of pH on the biocidal activity of glutaraldehyde can be summarised as follows: 
· Acid pH (pH = 4) 
· Poor activity 
· Good stability (low tendency to polymerise) 
· Activity can be improved by increasing either pH or temperature 
 
· Alkaline pH (pH = 8) 
· Good activity 
· Low stability 
· Strong tendency to polymerise with increasing time or temperature 
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Glutaraldehyde possesses a broad spectrum of activity, and kill times for most agents are 
relatively short. However, glutaraldehyde is only capable of producing sterility if the 
exposure time is long enough. While killing times for vegetative bacteria and fungi are short 
(typically 1-2 minutes with an aqueous 2% alkaline solution at 25oC), killing times for 
viruses (such as HBV and HIV) and the tubercle bacillus are longer (10 minutes), while for 
spores, the killing times are in the order of 3 hours. Some spores (e.g. Bacillus subtilis) 
require extended times (10 hours). Short contact times (e.g. less than 45 minutes) therefore 
only result in a decontamination effect, not a sterilizing effect. Cases have been documented 
where transmission of infection from instruments (particularly endoscopes) occurred when 
a short, "disinfecting" regimen was used. 
 
Use of sub-lethal concentrations (i.e. less than 2%) cannot ensure a sterilising effect is 
achieved, even with prolonged (overnight) exposure). Sub-lethal concentrations can easily 
arise in practice because of: 
· in-use dilution 
· polymerisation of alkaline solutions 
· adsorption onto organic and inorganic materials 
· sub-standard preparation of the "activated solution (incorrect dilution and mixing) 
· failure to replace solutions which have deteriorated on standing. 
 
Glutaraldehyde is most often formulated as a 2% acidic solution, to which an "activator" is 
added to bring the solution to alkaline pH (pH = 8). This activated solution typically has a 
shelf life in the order of 14 days, although some newer formulations have a lower pH (and 
longer shelf life), with potentiating agents such as surfactants added to increase the 
otherwise low level of activity observed. A prudent practice would be that no solution, 




The major routes of absorption are inhalation of vapours and skin contact with solutions. 
Common skin reactions are itching and cracking, as well as staining. Eye irritation, nasal 
and throat discomfort, chest tightness, and headache have also been reported. The fumes 
are particularly pungent, and can be recognised at a concentration of 0.04 ppm in air. Since 
this is less than the level at which eye and respiratory irritation occur (0.3 ppm), detecting 
the characteristic odour should trigger action as to the cause, before harmful levels are 
reached.  
 
Ingestion of glutaraldehyde by a patient can occur if instruments processed in 
glutaraldehyde are not adequately washed before being returned to service. Glutaraldehyde 
binds to rubber and plastic, and the amount absorbed into the material increases according 
to the time of contact with the solution. Most bound glutaraldehyde is removed by rinsing 
for 2 minutes. However, for latex materials, more extensive rinsing is required as a build-up 
occurs with repeated exposure. 
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Limiting exposure 
 
The following measures will reduce exposure and minimise the possibility of both short 
term toxic effects and the risks of developing hypersensitivity: 
 
· Ensure that staff are informed of the risks, and the measures in place to minimise those 
risks. 
· Wear rubber gloves, protective clothing and eyewear when working with materials 
containing glutaraldehyde. 
· Keep solutions in covered containers, and only remove the lid for short periods for 
access. Locate the container in a well ventilated area. Install positive exhaust ventilation 
(i.e. exhaust fan with hood) if these requirements cannot be fulfilled. 
· Do not use glutaraldehyde for processing instruments which can be autoclaved. 
Autoclave them instead. 
· Do not use glutaraldehyde in situations where a vapour will be created. Do not use it as 
a spray-on agent for treating working surfaces, or in ultrasonic cleaners. 
· Remember that the concentration of glutaraldehyde in different materials can vary over 
a wide range. Typically the concentration is 10 times higher in developers for automatic 
processors than in disinfecting solutions. 
· Ensure that materials which have been processed through glutaraldehyde solutions are 
washed extensively before re-use. 
· Corrosive effects can occur, and instruments should be inspected carefully for damage 
after rinsing and drying. 
· If it is intended that sterility is achieved, a prolonged period of contact will be 
necessary. Additional instruments must not be added during this period. Rinsing with 
sterile water will be required, as will sterile drying, and packaging. 
· Seek medical attention for skin, respiratory, or other reactions which occur following 
exposure to glutaraldehyde, and keep a detailed record of such incidents. 
· Comply strictly with the manufacturer's instructions regarding preparation and storage 
of solutions. Ensure that solutions are labelled with the date of preparation and/or date 
of expiry. 
· When purchasing products, make sure that a material safety data sheet (MSDS) is 
requested from, and supplied by, the manufacturer. 
· With heavy use of disinfectant solutions, solution levels will drop considerably. Do not 
add water or other liquids to replace the lost volume, rather discard and replace with a 
freshly prepared solution. 
· Cleaning up following spills of glutaraldehyde solutions is particularly hazardous. 
Ensure that good ventilation is present in the area. It may be necessary to open the 
windows and evacuate the area for a short time.  
· Follow-up any patient complaints regarding unpleasant tastes arising after use of 
instruments processed through glutaraldehyde. 
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15. INSTRUMENT RECIRCULATION 
 
Cleaning is the essential pre-requisite to sterilising – an item cannot be sterilised if it is not 
clean, because the bio-burden protects microorganisms from the sterilising action (e.g. the 
latent heat of condensation). 
 
Instrument recirculation can be divided into several phases: 
· Pre-cleaning disinfection/pre-soaking 




Pre-soaking   
 
Instruments and re-useable items are pre-soaked to prevent drying of organic material onto 
the instruments, and to make cleaning easier. The solutions used are generally detergents or 
mild disinfectants. These should be discarded daily as bacterial overgrowth can occur. 
Glutaraldehyde or sodium hypochlorite (bleach) should not be used as these are toxic and 
will damage instruments respectively.   
 
Pre-sterilization cleaning  
  
This is necessary to remove visible traces of bio-burden (such as dried blood or saliva) and 
debris such as cement. These prevent steam penetration and thus protect microorganisms 
from the sterilising effect of steam. Effective instrument recirculation involves removing all 
visible contamination from instruments prior to their routine sterilization using an 
autoclave. 
 
Minimal handling of instruments during the cleaning phase is achieved by using an 
instrument tray system in combination with ultrasonic cleaners or high temperature thermal 
disinfectors. The most efficient way of cleaning instruments is via these mechanical cleaning 
methodologies.  High temperature thermal disinfectors operate at high temperatures (90oC 
or above) and use highly alkaline detergents as part of the cleaning process.  Ultrasonic 
cleaners dislodge material through the transfer of sonic energy on to the instruments.  
Because of this, instruments which have resilient components (such as rubber or plastic), 
cannot be effectively cleaned in an ultrasonic cleaner.  
 
Instruments that have been pre-soaked are rinsed, placed directly into the ultrasonic cleaner 
basket and ultrasonicated with the lid on for the standard time (typically 2-10 minutes). 
Items should not be placed directly onto the tank of the ultrasonic cleaning unit, but rather 
should be placed in a perforated basket.  Perforations are necessary to allow sonic energy 
to penetrate the load during cleaning.   
 
The solution should be changed at least daily. As noted above, the operation of the 
ultrasonic cleaner should be checked daily using the foil test (perforation of thin aluminium 
foil by a 10 second immersion period). If the ultrasonic cleaner fails to work effectively, 
this can be due to degradation of the piezoelectric transducer or overloading of the 
chamber. The foil test must be run after the unit has been degassed. Degassing is 
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essential to remove dissolved air which otherwise reduces the amount of available sonic 
energy in the first several minutes of operation of the ultrasonic cleaner.   
 
After cleaning, the instruments can then rinsed and inspected.  Any residual material is 
removed by further cleaning. This should be a rare event, as an ultrasonic cleaner when 
used correctly will remove almost all residues (saliva, blood, cements, etc.) from 
instruments. Any instrument which shows visible contamination must be recleaned either by 
hand or mechanically.  It is a key principle that an instrument cannot be sterilized until it is 
clean.   
 
Following rinsing, instruments can be either  
· autoclaved within instrument cassettes, or 
· placed directly in autoclave trays, or  
· dried before being placed in pouches or wraps (paper or a porous polyfilm), which is 
then  heat-sealed or double-folded and taped. 
 
Instruments for surgery or otherwise intended to be sterile at point of use, need to be 
placed into the appropriate package or pouch, and the exterior of this labelled with a batch 
number. Prior to autoclaving, instruments of a hinged nature, such as forceps, should have 
the hinges opened to improve the penetration of steam in these areas.   
 
Personal protective equipment must be worn by staff working in the sterilizing area as there 
is the opportunity for exposure to contaminated materials both from aerosols and from 
splashing. The lid must be placed on the ultrasonic cleaner during use as these cleaners 
generate aerosol during their normal operation.   
 
At the end of the day, the solution must be removed from the ultrasonic cleaner, and the 
chamber allowed to dry. Ultrasonic cleaners have only limited disinfecting capabilities, and 
large numbers of viable microorganisms are present in the solution at the end of the day.  
Regular cleaning of the ultrasonic chamber improves the efficiency of the unit and removes 
the potential for additional contamination being deposited on to the instruments during the 
cleaning process. 
 
The role of detergency 
 
Cleaning is an essential step since the sterilizing process does not physically remove growth 
areas of organic bioload from instruments.  If such are present, they prevent the removal of 
air and the penetration of steam.  For this reason, as noted already, instruments must be 
visibly clean prior to being placed in an autoclave.  If instruments have visible 
contamination, then the effects of heat on this will cause it to harden.  This will make 
further cleaning more difficult.   
 
To assist in instrument cleaning, some type of detergent or surfactant agent is used.  This 
assists in the removal of organic bioload.  Cleaning in the presence of such surfactants helps 
to emulsify the lipids which are present.  Having said this, the effectiveness of a detergent 
or surfactant is greatly enhanced through a mechanical action.  This mechanical action 
underlies not only hand cleaning, but also ultrasonic cleaning and the use of high 
temperature thermal disinfectors.  
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The detergents which are used for household cleaning (such as dishwashing in the domestic 
setting) are unsuitable for use in a dental surgery.  They lack the appropriate properties for 
such use.   
 
The charge properties of surfactants 
 
A surfactant is a surface active agent.  Its role is to concentrate at the interface of two 
phases which cannot be otherwise be mixed together.  It reduces the interfacial tension 
between these two phases.  The two phases could both be liquids, or a liquid and a solid.  
Surfactants are of several types, anionic, cationic, nonionic or neutral, and amphoteric.  The 
latter group are sometimes called zwitterionic.   
 
A common anionic (negatively charged) surfactant encountered in dentistry is sodium 
lauryl sulphate.  This dissociates giving a positively charged sodium ion, and a strongly 
negatively charged lauryl sulphate ion.  Because the negatively charged component would 
be attracted to a positive electrode (the anode), it is called anionic.   
 
In contrast, a cationic detergent has a net positive charge, and thus would be attracted to a 
negative electrode (the cathode).  Cationic detergents are rarely used in cleaning because 
they tend to stick very strongly to glass because of its negatively charged surface.  In some 
cases, they can make a surface more greasy or lipophilic. 
 
The importance of alkaline pH 
 
It is common for detergents designed for instrument cleaning to have an alkaline pH.  
Typically this is done by having a concentrate solution which has a high pH (typically in the 
range of 12 to 13) which is then diluted down several hundred fold to give the working 
solution, which typically would have a pH between 9.5 and 10.5.   
 
There are several reasons for having a higher pH, and these relate to the ability of the 
detergent to dissolve lipids and proteins.  Lipids are not easily washed away from 
instruments.  Alkaline agents can remove films of lipid by solublizing and emulsifying them.  
This occurs because fats and oily materials contain small amounts of free fatty acids.  In 
alkaline conditions, these react to form small amounts of soluble materials which are then 
removed by simple rinsing.  Any oils, lipids or fats which are unchanged are emulsified by 
the surfactant combined with the mechanical action of the cleaning process, whereas fats 
and oils which undergoes saponification under alkaline conditions form water, glycerine 
and soluble soaps.  With regard to proteins, these can also be solublized under alkaline 
conditions.  This occurs because acidic groups on the amino acids which comprise the 
protein will form water soluble salts in alkaline conditions.   
 
In addition to this, the alkaline builders used in such detergents can help soften water which 
has increased levels of calcium or magnesium ions in it, so called “hard water”.  The 
alkaline builders found in instrument surfactants will chelate these calcium and magnesium 
ions, and this softens the water and improves the cleaning process.   
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Desirable properties of detergents 
 
The requirements for detergents to be used in instrument cleaning are specified in both AS 
4815 and 4187.  Some of the key properties include: 
 
1. Having excellent wetting across a broad range of temperatures.  This characteristic is 
sometimes referred to as detergency. 
2. Producing a low level of foam under conditions of dynamic flow.  This characteristic is 
sometimes described as low foaming.  
3. Having an inhibitor of corrosion incorporated into the cleaning agent. 
4. Having the ability to provide effective cleaning even in conditions of increased levels of 
calcium and magnesium salts in the water, a situation commonly referred to as hard 
water. 
5. Having low or no levels of substances which are hazardous or irritating when 
volatilized. 
6. Being able to rapidly remove blood, protein, lipids from the surface of instruments.   
 
Several products have been designed for use both in instrument cleaning and for cleaning 
suction systems.  It is important that low foaming agents be used in a suction system.  Low 
foaming alkaline surfactants can be used in several applications in the dental surgery, 
including instrument cleaning and for cleaning of hard surfaces such as the dental chair 
itself and adjacent bench tops.  If it is anticipated that a cleaning product will be used in 
multiple application, it is important to test compatibility with the upholstery of the dental 
unit. 
 
For environmental reasons, it is preferred that detergents used in a dental practice are 
biodegradable, as this reduces the environmental impact when these components are 
released either into the sanitary sewer system or into the general waste stream.  The 
properties of biodegradation are described in Australian Standard 4351.  Items which are 
classified as biodegradable will have been tested to ensure their compliance with AS4351, 
and will be so marked on the product label to indicate this.   
 
In summary, when selecting an appropriate detergent surfactant for instrument cleaning, it 
is important to bear in mind the above features, and to assess compliance in terms of the 
relevant Australian Standards 4187 and 4815.  The use of an efficient low foaming 
surfactant can simplify the cleaning process which proceeds autoclaving of instruments. 
Finally, it should be remembered that sterilization is not a substitute for thorough 
instrument cleaning. Sterilization cannot occur if instruments are not cleaned adequately. 
 
Design and layout of the Instrument Reprocessing Area (IRA) 
 
The IRA (“sterilizer room”) can be divided into a number of logical areas: 
• a receiving area 
• a cleaning area, which includes the ultrasonic cleaner, thermal disinfector,  
handpiece lubricating system, and the deep sinks used for rinsing. These sinks 
should be used only for cleaning equipment and instruments (NOT handwashing)  
• a sorting area, where items can be assembled and packaged as necessary. 
• a sterilizing area, where the autoclaves are located.  
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• a sterile storage area where items in pouches and packs are kept. This area needs to 
be completely free from contamination and splatter.  
• an area for storing items that require to be kept aseptically, but not in a sterile 
fashion. 
 
Space: Consideration should be given to the movement of staff in and out of the IRA. The 
entrance or passageway into the IRA should be sufficiently wide that 2 people can pass in 
opposite directions without their arms colliding. A suggested minimum (based on current 
construction standards for doorways) is greater than 810 mm wide. Note that the main 
passageways in the practice (i.e. those from which 2 or more passageways arise) will 
normally be wider and are typically at least 1200 mm in width. 
 
Benchtops: The horizontal dimensions of the benchtops in the IRA need to be adequate for 
instrument reception, holding, sorting, cleaning, inspection, and packagaing. At the same 
time, the benches need to be sufficiently deep in parts to locate autoclaves without these 
“hanging over” the front of the bench. Modern benchtop materials made from temperature 
and chemical-resistant polymers provide a smooth easily cleaned surface which will not 
retain moisture or debris.  
 
Sufficient benchtop space in the IRA needs to be allowed for specialized items such as 
handpiece cleaning/lubricating systems (such as the W&H Assistina), as well as for a heat 
sealer if this is used for instrument pouches. The location of sharps containers, scalpel blade 
removers, and clinical waste containers should be planned so that these are conveniently 
positioned in the receiving area. 
 
The autoclave log book which records data from each cycle needs to be readily accessible 
in the IRA, since data will be entered into this before and after each autoclave cycle during 
the day.  There also needs to be space for storing printouts from autoclaves, and for items 
that will be used during the day for quality assurance, such as air-removal tests for pre-
vacuum autoclaves, and chemical indicator strips. 
 
Lighting: Appropriate lighting in the IRA is essential for proper visual inspection of 
instruments for cleanliness before they are sterilized. Conventional ceiling lighting 
combined with the location of eye-height cupboards and the standing position of staff 
members creates shadows which makes proper visual checking of instruments impossible. 
The general requirements for environmental lighting are that for high tolerance work, that 
is requiring the worker to detect dimensions of 25 microns, a minimum light intensity of 
1600 lux is required. In comparison, for computer data entry, the minimum illumination 
intensity is 600 lux. Correct positioning of under bench lights (with pelmets to prevent 
glare from these) will ensure that staff in the IRA have sufficient light to inspect 
instruments prior to packaging/sterilizing.  
 
Ventilation: Ventilation in the IRA must be sufficient to prevent the buildup of aerosols 
(from hand cleaning of specialized items in the sink), water vapours (from instrument 
washers and autoclaves) and vapours of other materials. Air conditioning will often be 
adequate for this purpose, however if problems with vapour buildup are anticipated or 
experienced, the addition of negative pressure ventilation (e.g. through an exhaust fan) may 
be very useful. Because of the large amount of heat generated in the IRA from instrument 
washers and autoclaves, it is important to ensure adequate air flow through this area. A 
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normal airconditioning specification provides air movement at body level at a rate of 6-12 
metres/minute. The temperature in the IRA should be between 20-22 degrees Celsius (the 
limits of comfort are 18 and 25 degrees (unless the outside shade temperature is more than 
32 degrees). Using a “peak tracking” digital thermometer (available from electronic stores 
for ~ $80), the temperature variations in the area of the IRA where staff normally work can 
be assessed. One needs to consider that the “human comfort” factor in the IRA will be 
influenced by the additional personal protective wear that staff may be wearing (e.g. hair 
net, plastic apron), since these reduce the normal cooling effect of the movement of 
dehumidified air from the airconditioning system.  
 
Floors: Welded vinyl materials are the most commonly used materials for floors in the IRA 
as these are leakproof in the event of splashes of water or other fluids. Lapping this 
material 75 mm up the walls is recommended to contain fluid spills and to simplify cleaning. 
If welded vinyl is not used, the alternative flooring material should provide a smooth, 
impermeable and seamless covering of the underlying floor. These physical requirements 
exclude carpeting as well as ceramic floor tiles from being used in the IRA. 
 
Instrument flow: In the IRA, the flow of instruments from the contaminated receiving area 
through to the clean storage areas should be a straightforward linear progression through 
the various parts of the IRA (Holding area, Instrument cleaning, Inspection and drying, 
Instrument packaging, Autoclaving, Storage). Using instrument cassettes can simplify this 
and at the same time reduce risks of sustaining a sharps injury during instrument 
reprocessing. Contemporary instrument cassettes are designed to fit into ultrasonic 
cleaners, thermal disinfectors, and autoclaves, which again improves efficiency. 
 
Autoclaving: Because packaged items can only be processed in a steam sterilizer that has a 
built-in drying cycle, dental practices that previously used benchtop sterilizers without a 
built-in drying cycle are now acquiring pre-vacuum units since these are optimized for 
sterilization of instruments in pouches (e.g. those required for surgical or endodontic 
procedures). These autoclaves tend to be larger in the depth dimension because of the 
vacuum pump and thus require a sufficiently deep bench. 
 
If possible, each autoclave should be on a separate electrical circuit from the main 
distribution box in the dental practice. This will reduce interference from other electrical 
devices in the practice, and prevent circuits being overloaded. Sufficient electrical outlets 
should be provided nearby to supply autoclaves as well as their ancillary devices such as 
printers. If a distiller or deionizer is not used, sufficient storage must be provided for water 
for the autoclave, ideally at waist height to minimize the possible adverse effects of 
mechanical handling of water containers on a regular basis. Several on-demand water 
deionizer units are available and these provide an excellent means of providing high quality 
deionized water for autoclaves, at modest cost and with greatly increased efficiency in 
terms of staff time. Many modern autoclave systems use water once and then dump it to 
prevent build-up of lubricants and other residues. 
 
Storage for sterilized packaged instruments for critical (surgical) procedures : Instruments 
and equipment used in critical sites, i.e. those that come into contact with sterile tissue, 
must be sterile at the point of use. To achieve this, they must be packaged (e.g. in a pouch) 
and the autoclave parameters used in the cycle linked using batch numbers to the eventual 
use of the individual instrument sets in patient care. In other words, requirements for 
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instrument tracking apply to instruments used to intentionally enter or penetrate into a 
sterile tissue environment. 
 
Dry, sterile, packaged instruments and equipment must be stored in a clean, dry 
environment which protects them from environmental contamination (from splashes of 
water, aerosols or splatter), and at the same time protects the packages from being pierced 
from sharp objects within or without.  
 
Aseptic storage for sterilized routine (non-surgical, semi-critical) instruments: Determining 
the appropriate areas for keeping sterilized packs and pouches away from aerosols and 
splashes of water and body fluids is an essential step when planning the flow of these 
instruments from the IRA back to the operatory. Often such storage includes pass-through 
cabinets, cupboards, and drawers. The key factor is the isolation of these instruments from 
the contamination which occurs during clinical procedures. Many tray systems are well 
suited for storage in large clear plastic bins and other systems which can be adopted from 
normal business supply/storage systems. 
 
The unitized IRA: A recent trend has been the development of components which suit the 
needs of the individual practice and can be assembled into a “pre-assembled” IRA. These 
systems provide a logical instrument flow, have sufficient space for all the activities of the 
IRA, and have purpose built lighting, ventilation and storage. The Infection Control Centre 
(ICC) concept from A-DEC is an excellent example os a modern system which can be 
customised to the needs of the individual practice through selecting various modules. These 
systems have a number of design features for containing splashes of water from the 
instrument cleaning operations, and preventing vapour and heat buildup from equipment, 




Sterilisation is the destruction of all types of microorganisms (including spores). Routine 
sterilisation does not inactivate non-viable agents of infection (prions). 
 
Sterilisation can be achieved using: 
 
· High temperature methods 
· Autoclaves 
· Downward displacement type 
· Assisted air removal type (e.g. Sirona Validator with ECARS) 
· Pre-vacuum type (for wrapped items); Single or multi-pulse  
· Dry heat sterilisers 
· Chemical vapour sterilisers 
 
· Low temperature methods 
· Gamma radiation 
· Ethylene oxide (“STERIVAC”) 
· Plasma sterilisation (“STERRAD”) 
· Peracetic acid (“STERIS”). 
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Dry heat is used uncommonly in dentistry. Typical parameters are 170 degrees Celsius for 1 
hour, or 160 degrees Celsius for 2 hours. The main problems with this method of sterilising 
are: 
· Cycle times are long 
· Heat-sensitive items will be damaged 
· Packaging materials may insulate the contents of packs from heat 
· Cycles may be interrupted by the user unless the door is locked during a cycle 
· Temperature sensors may not give an accurate readout of the chamber parameters 
(sensors placed at the top of the chamber record the hottest point) 
· Air should be fan forced to achieve circulation 




Autoclaving is the most commonly used method of achieving instrument sterilization in 
dentistry. While virtually all dental practices have autoclaves and use them on a daily basis, 
often only scant attention is paid to the operating principles of these devices, until 
malfunctions occur or problems develop with processing of loads.. 
 
Advantages of autoclaving include: 
· short cycle time 
· can process loose or bagged instruments 
· can process a variety of materials 
· easy to monitor. 
 
Disadvantages include: 
· corrosion of some carbon steel instruments such as burs 
· cutting edges may dull 
· heat-sensitive materials can be damaged 
· wrapped items remain wet without a drying cycle 
· wrapped/bagged items require a longer cycle time. 
 
Many factors work in harmony to ensure contact of steam with items in the load occurs for 
sufficient time to transfer the latent heat of condensation of water, which is responsible for 
denaturing proteins and thereby rendering microorganisms non-viable. Both human factors 
(such as instrument cleaning, and chamber loading methods) and equipment factors operate 
in achieving the desired outcome (Fig. 1). Saturated steam is an efficient means for killing 
microorganisms since it is able to quickly transfer heat energy onto the items which are 
being sterilized.  As saturated steam condenses, this heat is transmitted onto the surface and 
the microorganisms are inactivated by direct thermal effects.  Thus, for sterilization to 
occur, the steam must be saturated to the correct level. 
 
Displacement autoclaves (also called “flash” or gravity) utilise superheated steam to 
displace air downwards and out of the sterilizing chamber. These are used for sterilization 
of unwrapped instruments (so-called "flash sterilization"), and typically are small bench-top 
units. Under current standards (AS/NZS 4815:2006), all new autoclaves for use with 
bagged loads must have a drying cycle. 
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During a cycle, the following events occur. The temperature rises in an almost linear 
fashion during the first portion of the cycle, to reach the boiling point of water During this 
first phase, air is being displaced passively from the chamber by steam.  
 
Once the air removal valve closes to seal the chamber, the pressure inside the chamber 
begins to rise above atmospheric levels. At the same time, there is an inflection in the 
temperature curve because now the chamber is pressurized and the temperature of water 
can rise above its boiling point. Both temperature and pressure then increase linearly, to 
reach the achieving the intended sterilizing conditions. This is followed by the “holding 
time” at sterilizing temperature and pressure conditions.  
 
The chamber contents are then vented, and the chamber pressure reaches atmospheric 
levels, allowing the door to be opened. At this stage, the temperature inside the chamber 
has fallen back to the boiling point of water (100 degrees Celsius). It will continue to fall 
after this, since no additional heating is being provided through the heating elements.  
 
Assisted air removal autoclaves use pulsing of steam from a steam generator to facilitate 
air removal from the load.(e.g. Sirona Validator) 
 
Pre-Vacuum autoclaves (sometimes called pre-vacuum autoclaves) pump air from the 
chamber prior to entry of superheated steam. These are preferred for sterilization of porous 
loads (e.g., surgical packs). They are larger and more costly units. (e.g. W&H Lisa) 
 
More recent prevacuum autoclaves use multi-pulsed vacuum rather than continuous 
vacuum to assist in air removal, particularly from items with internal cannulae. Active 
drying is achieved in vacuum autoclaves by applying negative pressure to facilitate vapour 
removal, with the door remaining sealed. This ensures that the load is dry and thus not 
prone to environmental contamination (unlike the situation for a load which is wet on exit). 
Heat from the chamber and the load itself helps to remove moisture. Vacuum and multi-
pulse vacuum autoclaves require daily testing to ensure proper air removal - this includes 
the air leak test and air removal (Helix or Bowie-Dick) test. 
 
In a conventional downwards displacement autoclave, air is removed by the action of steam 
falling vertically by gravity in the chamber. In an assisted air removal autoclave, pulses of 
steam facilitate this process. 
 
In contrast, in a pre-vacuum autoclave, the air is removed as the first stage of the sterilizing 
process.  This can be done in one continuous phase or in several separate phases.  In the 
latter, this sterilizer is referred to as a multi-pulsed pre-vacuum sterilizer.  Air removal is 
undertaken using a vacuum pump. The removal of air is designed to facilitate the entry and 
penetration of steam into the load.   
 
Following the evacuation of the chamber, steam is injected into the chamber, until the 
entire chamber is full, as determined by a temperature controller which monitors the 
temperature in the chamber’s drain line. At the completion of the cycle, air is re-admitted to 
the chamber via a HEPA filter.   
 
In order to monitor the chamber vacuum, a vacuum test gauge is normally fitted to a pre-
vacuum sterilizer.  This is one of the requirements of Australian Standard 1410.  Simple 
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visual examination of an autoclave can indicate whether it is of the pre-vacuum type. If so, 
the pressure gauge will show both a negative and a positive range.  The section which is the 
negative (typically from –100 to 0 kPa) is the vacuum portion of the scale, and should be 
marked to indicate such, whereas in a conventional downward displacement autoclave the 
pressure gauge will read in the positive range, typically from 0 – 300 kPa. 
 
An additional equipment change with a pre-vacuum sterilizer is the presence of an air 
detector test valve.  This is a small needle valve that can admit air into the chamber at a 
point which is distant from the drain line.  This valve is necessary in order to undertake an 
air detector test.   
 
An additional difference is that a pre-vacuum autoclave will be marked using a sticker with 
the words “Not to be used for the sterilization of fluids”.  The intention of this is to indicate 
that in a vacuum sterilizer, that any fluids placed within this will evaporate or boil under 
vacuum conditions and be lost during the sterilization process.  This is of little direct 
concern to dentistry since fluids are not sterilized in clinical practice.   
 
The tests that are required for a pre-vacuum autoclave include the conventional validation 
tests undertaken for all autoclaves and additional tests.  Of these, the most important is the 
air removal test with a process challenge device, either a Helix test or a Bowie-Dick test.  
The intention of the Bowie-Dick test is to determine whether there has been even and rapid 
penetration of steam into a porous load, while the helix tests a solid load.  Clearly, if air and 
other gases are not removed from the load in the chamber, their trapping would prevent 
penetration of steam and subsequently there would not be sterilization.   
 
16.2 The correct steam parameters 
 
Variables influencing the process of sterilization 
____________________________________________  
· extent of pre-cleaning (bio-burden) 
· choice of packaging materials 
· packaging technique 
· steriliser loading technique 
· sterilant quality (levels of ions and lubricants)  
· cycle parameters (time, temperature, saturated steam) 
_____________________________________________ 
 
Being able to appreciate the air/steam interphase relationships and applying the gas laws 
allows some useful information to be gained in terms of the autoclaving process. For 
example, with regard to steam saturation, whether water exists as a liquid or as a gas is 
entirely dependent upon the temperature and the pressure. When the pressure is increased, 
the boiling point of water is elevated. In an autoclave, it is essential that the steam be very 
close to the phase change temperature or boiling point. If the temperature is higher than 
this, the steam is superheated and this impairs its ability for killing. There are several 
reasons for this. Firstly, when saturated steam comes into contact with a cooler object, 
such as an instrument, the steam changes immediately to liquid water and this phase change 
is associated with the release of a large amount of energy in the form of heat. This 
transferred heat rapidly increases the temperature of the object involved. Secondly, when 
the steam changes back to water, there is a dramatic reduction in size and this contraction 
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pulls in yet more steam to replace that which has already changed to water. This process 
continues until eventually the entire load in the sterilizer has been raised to the same 
temperature as the steam. The third reason relates to the moistening effect. When steam 
changes to water, this moistens the organisms, which increases the kill rate. When steam is 
superheated, the temperatures fluctuate considerably around the chamber and consistent 
killing is not achieved. Transfer of heat is less, shrinkage of steam is less, and for these 
three reasons, superheating of steam is a problem.  
 
The purity of steam is an important parameter in effective autoclaving. Pure steam is pure 
water is a gaseous phase.  Any impurities in steam could be of a liquid form, e.g. droplets 
of water or fog, or they may be of a gaseous nature, e.g. entrapped air. Solid impurities in 
steam, such as particles of rust or instrument coatings, can also occur. When small amount 
of air are present in steam as an impurity, this has little effect provided the air is mixed 
thoroughly with the steam and the amount of air is very low, e.g. less than 1%. If the air is 
present at a level beyond this, the air does not readily mix with the steam, but remains 
rather compressed by the steam into pockets of air which are cool. Cool air pockets, which 
may be caused by an overcrowded chamber, or by incorrect wrapping, or incorrect 
positioning, or incorrect use of packaging materials, are a very common cause of failed 
autoclaving in downwards displacement autoclaves. Air pockets occur less often in pre-
vacuum autoclaves. 
 
When water droplets or fog are present as an impurity in the steam, materials inside the 
sterilizer may become wet. The presence of a very small amount of entrained moisture, e.g. 
less than 2%, is beneficial since this reduces the tendency of the steam to otherwise 
superheat. 
 
16.3 Autoclave operation 
 
Modern autoclaves offer a number of important performance features: 
· Automated cycles – with door locking (to prevent interruptions by the user) 
· Automated water filling 
· One-way water flow (separate storage and discharge tanks) 
· Drainage of the water reservoir to facilitate weekly replacing of water  
· Accurate regulation of chamber parameters, particularly temperature 
· Warning of common instrument failures 
· Print-outs of cycle parameters, or the ability to up-load data. 
 
Commonly used operating parameters for autoclaves in dental practices 
_______________________________________________________________ 
Unwrapped items     Wrapped items 
15 minutes at 121 Celsius and 103 kPa.  20 minutes at 121 Celsius 
3.5 minutes at 134 Celsius and 206 kPa.  8 minutes at 134 Celsius 
______________________________________________________________  
 
These times represent the Holding Times, as distinct from the Cycle Time, which varies 
from 6 to 30 minutes depending on the size of the chamber and thermal mass of the load. 
The parameters used for each type of packaging material must be validated using biological 
indicators, to ensure that the time allowed for air removal is adequate. 
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A busy practice may find it more efficient to run two autoclaves to allow easy instrument 
turn-over for 30 minute appointments.  A drying cycle is essential for wrapped instruments, 
however this requires holding times to be extended to allow steam penetration to the centre 
of the pack. A spore test must be run when wrapping materials are changed to ensure that 
parameters are appropriate. 
 
Improper loading is a common error. A disarray of instruments does not allow free 
circulation of steam to all surfaces and may compromise sterilization.  Pockets of air can 
occur in non-vacuum autoclaves, and these will insulate instruments and packages causing 
small cool spots where sterilisation will not occur.  
 
16.4 Batch identification (Critical instrument tracking) 
 
Since the April 2004 release of the CDNA / NH&MRC Infection Control Guidelines, 
greater attention has been placed within everyday infection control onto risk management 
strategies. Tracking of critical instruments is exactly that – a risk management action which 
can be taken on the part of the practice at very low cost, but which can help prevent the 
potentially catastrophic consequences of the following two scenarios (amongst others): 
 
• A trainee or junior staff member who returns a set of oral surgical instruments to 
circulation from the sterilizing area, thinking that they have already been 
sterilized, when this is not the case (they have only been cleaned and packaged in 
preparation for sterilization). These instruments are then used unwittingly on other 
patients, raising the spectre of cross-contamination between patients.  
 
• A patient who develops a post-surgical infection and then launches litigation 
against the practitioner for damages, alleging that the instruments used for 
surgery were not sterile at the point of use.  
 
Tracking critical instruments used in certain clinical procedures (such as oral surgery) back 
to a particular autoclave cycle is an administrative process which requires several 
actions: 
• Maintaining a comprehensive log of autoclave cycles at the time of loading 
• Identifying which cycles critical instruments will be processed in 
• Instituting a batch numbering system, either manually or with a labeling gun 
• Placing batch codes on instrument packs 
• Checking packs after autoclaving for batch numbering data 
• Completing the sign-off of the cycle release based on physical and chemical 
indicator results, and 
• Entering batch codes into patient records after surgical procedures. 
 
Rationale for tracking (batch identification) 
 
The recommendation for tracking critical instruments is contained in section 3.5 of the 
2004 CDNA guidelines. Tracking is recommended only for critical instruments, i.e. those 
that intentionally enter or penetrate a sterile tissue, cavity or the bloodstream, because of 
the risk of introducing infection into these sites. Single use instruments do not require 
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tracking, however any reusable instruments used for the following procedures should be 
tracked:  
• oral surgery, including routine extractions, soft tissue procedures and surgical 
removal of teeth 
• oral and maxillofacial surgery 
• implant surgery,  
• periodontal surgery, including the use of electrosurgery  
• endodontic surgery. 
 
Moreover, as specified in sections 4.4 and 6.4 of the CDNA guidelines, any instruments 
used in critical sites must be: 
• packaged in a pouch,  
• processed in an autoclave with a dedicated drying cycle using validated cycle 
parameters, 
• sterile at the point of use,  
• able to be tracked back to a specific autoclave cycle.  
 
Instruments used on intact non-sterile mucosa (semi-critical sites) or that only contact 
intact skin (non-critical sites) do not require tracking. These categories comprise the 
majority of the instruments used in the everyday general clinical practice of non-surgical 
aspects of dentistry. Routine instruments nevertheless need to be sterilized between 
patients, but they do not need to be tracked back to a particular autoclave cycle.   
 
Because tracking refers to instrument packs or sets, rather than individual instruments, 
there is logic in simplifying the inventory of instruments used for surgical procedures, 
specifically how these are packaged into sets. It is more efficient to combine several critical 
instruments into a set, rather than to keep isolated instruments in separate pouches. 
Moreover, in a practice where few critical (surgical) procedures are undertaken, there may 
be efficiency gains by autoclaving surgical instrument sets together in one load, since this 
must employ a drying cycle. 
 
Batch numbers can be a simple sequence of numbers, such as that produced from a 
labelling gun, or can be combinations of a number sequence with codes for the date and the 
autoclave number (if the practice has several autoclaves). 
 
Batch information is recorded on packs prior to autoclaving using non-soluble permanent 
marker ink, or by using adhesive labels applied with a labeling gun, provided that the inks 
and adhesives used can tolerate autoclaving. Several segmented (piggyback) adhesive label 
systems are available, where one part of the label is peeled off the pack when setting up for 
the procedure, and placed directly under the day’s entry on the patient’s chart. 
 
At the time of the critical procedure, as instruments are removed from their packages, the 
now empty packages should not immediately be placed into the waste, bit rather put to one 
side in a clean zone of the operatory so that the batch number information can later be 
recorded into the treatment records of the patient by the clinician responsible, as part of 
their writing up the notes for the procedure.  
 
The log of autoclave cycle data is an essential part of the tracking process, as it provides 
the necessary written documentation of sterilization, and includes parameter information on 
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the batches processed. An entry into this log should be made for all autoclave cycles, 
regardless of whether or not they include any packs of critical instruments.  
 
The log comprises a book with ruled columns, and the following headings: 
• Date 
• Time at the commencement of the autoclave cycle 
• Cycle number in that day 
• Cycle temperature and time parameters (which will differ according whether the 
load contains wrapped items or unwrapped items) 
• Nature of the load (numbers of packs, instrument cassettes, etc) 
• Batch numbers of packs included in that load (if any) 
• Result of the autoclave physical readouts or printout for that cycle. 
• Result of the particular chemical indicators (Class 1, 4, 5 or 6) used in the cycle. 
This checking should include all external and internal chemical indicators. 
• Identification (signature or initials) of the person who has checked the autoclave 
readouts and chemical indicator result, and who authorizes release of the load for 
use. 
 
A separate book should be kept for each autoclave, if several autoclaves used in the 
practice. It is also prudent to compile a list of names, initials and abbreviations of operators 
of the autoclave, for reference purposes. 
 
Data for physical autoclave parameters can be obtained easily if the autoclave has a 
printout. When selecting a printer, ink-based printouts are preferred to thermal printouts as 
there is less likelihood of degeneration and fading over time.  Since it is necessary to keep 
printouts for an extended period, it is important that the readouts are still legible after this 
time. 
 
16.5 Monitoring autoclaves 
 
Autoclave Quality Assurance (AS/NZS 4815) 
 
The installation, commissioning, and testing of newly installed autoclave will be carried out 
by the installation technician.  This individual should leave a detailed document which 
specifies the tests undertaken as part of this commissioning procedure.   
 
The user must then validate the conditions which they will use for the various types of 
packaging systems in the practice.  This is necessary in order to insure that the time allowed 
for in the autoclave cycle for air removal and steam penetration is in fact adequate for the 
packaging system being used.  It follows that when there is a major change in the type of 
packaging material, this validation must be repeated.  AS4815 and AS4187 also specify 
that validation must be repeated annually, even when there has been no change in the type 
or method of instrument packaging. 
 
Regular monitoring of autoclaves is necessary to prove that sterilization process parameters 
are adequate.  The use of chemical monitors is dictated by the type of autoclave and the 
relevant standards, such as AS/NZS 4815. Such routine testing ensures that sterilization 
process parameters are being met on a regular basis and when the results are recorded in a 
permanent log.  
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Monitoring is by several methods: 
 
· Physical monitors (gauges, displays, print-outs) – from every load. These provide a 
first line of defence since they identify gross malfunction as soon as it occurs. Data for 
physical autoclave parameters can be easily obtained if the autoclave has a printout. It is 
expected that modern autoclaves will come with printing or data transfer capabilities. 
When selecting a printer, ink-based printouts are preferred to thermal printouts as there 
is less likelihood of degeneration and fading over time.  Since it is necessary to keep 
printouts for a specified period (typically seven years), it is important that the readouts 
are still legible after this time.  
 
· Chemical indicators – which change colour when proper sterilising conditions have 
been achieved (e.g. adhesive inks, tapes, strips) – used on packs and pouches. These 
provide a visual assurance that conditions for sterilisation were met (heat, steam) 
however they do not prove sterility. Some chemical indicator systems change colour 
relatively easily or quickly (e.g. heat only), while others (integrating types, class 4 to 6) 
require combinations of time, steam and temperature. Class I indicators show that an 
item has been processed, whereas Class 6 indicators require correct combinations of the 
sterilizing parameters (e.g. 3.5 minutes at 134 degrees Celsius at correct pressure and 
steam dryness). 
 
· Biological indicators (BI’s, spore tests) – which are used at calibration and validation. 
(refer to Chapter 9 for more detailed information on these). Spore testing should 
be undertaken after installation of a new autoclave, a major redesign or relocation, 
servicing or major repair, after suspected malfunction, whenever the type of load or 
packaging system is changed, and during and after training of new staff in autoclave 
operation. Spore tests are placed in the most inaccessible part of the load, to create the 
greatest challenge to air removal and steam penetration.  The corners of the pack and 
the inner recesses of the pack are the preferred areas for placement.  
 
16.6 Interpreting Chemical indicators 
 
Chemical indicators which change colour when proper sterilizing conditions have been 
achieved must be used on packs and pouches of critical items. The use of chemical 
indicators is described in AS4815:2006. The mechanism of action of chemical indicators is 
generally a simple heat-sensitive reaction. For many years, chemical indicators were based 
on sulphur and lead compounds, which reacted under the conditions of steam sterilisation 
to produce lead sulphide, giving rise to a change in colour from yellow to black. Despite 
the widespread use and low cost of such indicators, there were disadvantages associated 
with them. The coloured products could transfer to and stain articles with which it came 
into contact in the autoclave. Moreover, the stability of the colour over time was not high, 
especially when stored in humid conditions. For these reasons, numerous other colour 
change systems capable of detecting steam sterilisation have been devised, including esters 
derived from organic acids (which break down to liberate protons, causing a pH change). 
Many current systems use a tetrazolium salt (such as neotetrazolium chloride or nitroblue 
tetrazolium chloride) as the indicator molecule, to overcome the problems of the other 
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types. This compound is bound into a polymeric base comprised of ethyl cellulose and 
nitrocellulose, and then deposited on a paper substrate either by coating or printing. 
 
Chemical indicators give information regarding the performance of the sterilizer during the 
holding phase of the sterilizing cycle. This holding phase is the critical time period since this 
the time during which the microorganisms are inactivated. Statistically, a sterilizing cycle is 
designed so that the opportunity for a microorganism to survive is less than 1 in 1 million. 
At a temperature of 134 degrees Celsius, this time interval is 3.5 minutes. 
 
The types of chemical indicators used will depend on the configuration of the autoclave.  
When the autoclave is of the pre-vacuum type, additional tests are necessary to assess air 
leakage and air removal.  In a conventional downwards displacement or assisted air 
removal autoclave, these air leak and air removal tests are not required.   
 
Process indicators (Class 1 chemical indicators) include inks which change colour which 
are incorporated into the paper of an autoclave bag or pouch, and tape with diagonal 
stripes which is used to either seal packs or as a specific indicator. These Class 1 indicators 
are required on the outside of each pouch or pack of sterile items to show that the item has 
been through the sterilizing process.  Examples of Class 1 indicators include tape with 
diagonal stripes which is used to seal packs, and inks which change colour which are 
incorporated into the paper of a autoclave bag or pouch. 
 
Class 4, 5, or 6 chemical indicators should be used inside each pouch which contains 
critical items.  
 
A Class 4 indicator provides a graded response with a gradual colour change.  It has an 
accuracy of 2 degrees in temperature and 25% in time.  
 
A Class 5 indicator has a tolerance of 1 degree on temperature and 15% on time, while a 
Class 6 chemical indicator has a narrow transition period, with a 5% tolerance on time and 
a 1 degree tolerance on temperature. Thus, a Class 5 or Class 6 indicator will not show a 
“pass” colour change if the temperature is one degree too low. Class 5 and 6 indicators are 
labelled to indicate their specifications, for example, 134 degrees Celsius for 3.5 minutes. 
 
The gradual nature of colour change in Class 4 and Class 5 chemical indicators is important 
to recognise. The 3M Comply SteriGage™ Steam Chemical Integrator is a Class 5 
indicator with a simple visual readout in the form of a progress bar. The indicator consists 
of a paper wick and a steam and temperature sensitive chemical pellet contained in a 
paper/film and foil laminate envelope. Steam enters the permeable topside of the device. 
The chemical pellet melts, and the liquid migrates as a colour along the paper wick. Thus, 
the distance or extent of migration depends on exposure to steam, time, and temperature. 
The migration is visible through a window which has marked “Accept” or “Reject” points. 
 
A typical Class 6 indicator will give a colour change at 1340 for 3.5 minutes at the correct 
level of steam dryness.  The colour change expected for these indicators is both marked on 
the strip itself, and is also provided on a reference chart from the manufacturer.  The results 
of such tests must be recorded in a log book.  
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Major brands of Class 6 indicators are Albert Browne, Titems, and Interster. The Titems 
TST units are preferred by this author because of their ability to provide additional 
information on steam quality which is not provided by other indicators, in particular, the 
presence of superheated steam. The problem of superheated steam can also be detected by 
placing several thermocouples throughout the autoclave chamber, but this is not a practical 
method in everyday practice. Routine use of Class 5 or 6 indicators is essential for loaned 
autoclaves and when awaiting calibration or validation of a new or repaired autoclave. In 
this author’s view, it is prudent to include a Class 6 indicator in every pack of critical 
instruments, e.g. those used for oral surgery. 
 
Thus, while the standard specifies that this can be a Class 4, 5 or 6 indicator, Class 6 
indicators are preferred because of their much tighter tolerance on the conditions of steam, 
temperature and time. The colour change expected for these indicators is marked as a 
colour reference bar on the strip itself. Special attention should be given to proper 
placement of these chemical indicators within larger packs. They should be placed in those 
areas which are most likely to entrap air. When a paper-plastic pouch is used, the indicator 
should be placed in such a way that it can be easily seen when the pouch is inspected. 
 
Australian/New Zealand Standard 4815:2006 permits chemical indicators between Classes 
4 and 6 to be used when there is no printer or data capture device fitted to the autoclave.  
 
16.7 Special requirements for pre-vacuum autoclaves 
 
Air leak rate test (for Pre-Vacuum autoclaves only) 
 
This test is done weekly rather than daily.  The rationale for this test is that if air leaks into 
the chamber, the presence of this air will impairs penetration of the load by steam.  In 
addition, if air leaks into the chamber, it would not have passed through the HEPA filter 
and there is therefore a risk that the load could be re-contaminated by this unfiltered 
external air.   
 
A leak rate test involves establishing a vacuum in the chamber of the autoclave.  All valves 
leading to the chamber are then closed, and the chamber pressure then observed for a set 
period.  The time to be observed is normally specified in the instruction manual for the 
autoclave.  If the reading on the pressure valve rises, in other words, if the pressure goes 
from being negative towards zero, this indicates that the chamber is leaking.  Most pre-
vacuum autoclaves have an automatic program setting for the leak rate test.  This normally 
involves a period of approximately five minutes after the vacuum pump has stopped for full 
closure of valves and stabilization of conditions.  The vacuum gauge reading should then be 
observed over a period of ten minutes, and the difference in readings recorded.  A leak rate 
greater than 133 pascals per minute over a period of ten minutes is regarded as 
unacceptable.  Note that 133 pascals per minute is 0.133 kilopascals per minute.  Leak 
rates in excess of this tend to create inconsistencies in sterilizer performance.   
 
Air detector test (for Pre-vacuum autoclaves only) 
 
Air detector tests can be either of two types.  An air detector function test is undertaken 
when the performance of the air detector is suspect, whereas the air detector performance 
test is undertaken during commissioning.  The latter test requires the use of thermocouples, 
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and would be done by a NATA-accredited technician, rather than by the user.  In both 
variants of air detector tests, air is introduced into the chamber at a controlled rate through 
a port made specifically for this purpose.   
 
Class 2 chemical indicators (Air removal tests, for Pre-vacuum autoclaves only) 
 
With a pre-vacuum autoclave, an air removal test must be run each day to test the ability of 
the vacuum pump system to remove air adequately.  Also known as a Class 2 chemical 
indicator, these tests assess air removal and steam penetration in a pre-vacuum autoclave. 
 
Process challenge devices for pre-vacuum units comprise the Bowie-Dick test (for porous 
loads) and the helix test (for hollow loads). Both tests assess air removal and steam 
penetration, and thus confirm the correct operation of the vacuum system in the autoclave. 
These tests prove that steam penetration has been rapid and even, and that air and non-
condensable gases were not present at the time of steam entry. Most Bowie-Dick tests 
employ a “pack of cards” design, with a centrally placed thermally sensitive card which 
undergoes a uniform colour change when exposed to steam at the correct temperature and 
moisture, for sufficient time.  
 
Several designs for helix tests are available. These tests employ a reservoir in which is 
placed a chemical indicator strip. A “pass” result occurs when all air has been removed and 
steam enters the reservoir fully, causing a colour change. A “fail” result occurs when there 
is incomplete colour change. Depending on their design, helix tests have a limited life, with 
the chamber and/or helix requiring replacement after a specified number of uses (after 
several hundred cycles) to prevent leakage which would give false positive “pass” results.  
 
In contrast, Bowie-Dick test packs can only be used once and are then disposed. 
Depending on the nature of the load, either helix or Bowie-Dick tests must be undertaken 
each day that a pre-vacuum autoclave is used, according to the types of loads intended for 
that day. More detailed information can be found in Table C1 of Australian Standard 
AS1410.   
 
The test pack which is used in a Bowie-Dick test is designed to represent the maximum 
possible density of a porous load.  The more air there is present to be removed, the more 
difficult the challenge posed by the test.  It is for this reason that the test package is used by 
itself in an otherwise empty chamber.  In other words, the Bowie-Dick test is not placed in 
the chamber at the same time as an instrument load.   
 
The indicator is simply not simply heat dependent, in that exposure to dry heat only rather 
than steam will not result in a colour change. Gases trapped in the middle of the test pack 
form a bubble or a pocket, which impairs the entry of steam, causing a persistence of the 
original colour. Air will show as a centrally placed persistence of colour, whilst non-
condensable gases will give radial patterns of colour persistence, as will superheated steam. 
Several brands of Bowie-Dick test are now available, and all are based on the seminal 1963 
Lancet paper which first described the test. Of note, some brands of thermo-chromic 
Bowie-Dick tests (such as Albert Browne) allow complex diagnosis of gas entrapment 
problems by analysis of patterns of failed indicator cards. 
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Because it relies on a simple colour change in a type I indicator material, the Bowie-Dick 
test itself does not prove sterility, rather it is simply showing the correct operation of the 
vacuum system in the autoclave.  The test, however, does prove that steam penetration of 
the test pack has been rapid and even, and that air and other gases were not present at the 
time of steam entry.   
 
The Bowie-Dick test comprises an adhesive tape printed with a chemical substance which 
will change colour depending on exposure to temperature and moisture.  This tape is fixed 
in the shape of a cross to a suitable piece of material, and this is then placed at the center of 
a stack of towels or similar material.  The depth of the colour change is dependent on the 
time of exposure and the temperature and moisture.  The indicator is simply not simply heat 
dependent, in that exposure to the pack to dry heat only rather than steam will not result in 
a colour change.  To obtain an optimum colour change for interpretation, the test must not 
be run for longer than 3.5 minutes at 134 degrees Celsius.  If this period is exceeded, 
colour changes in the tape will make it difficult for the operator to detect colour variations 
which might have been caused by failed air removal.  If air remains trapped behind, that 
bubble of air will cause a reduction in the colour change, and this can be seen when the tape 
cross is examined at the end of the cycle.   
 
The test pack which is used in a Bowie-Dick test is designed to represent the maximum 
possible density of a porous load.  The more air there is present to be removed, the more 
difficult the challenge posed by the test.  It is for this reason that the test package is used by 
itself in an otherwise empty chamber.  In other words, the Bowie-Dick test is not placed in 
the chamber at the same time as an instrument load.   
 
The Bowie-Dick test is equally valid in single phase vacuum and in multi-pulse vacuum 
autoclaves.  There is no significant danger of obtaining a false result unless the air removal 
stage is unusually long, for example, if the air removal stage exceeds 15 minutes.   
 
Bowie-Dick tests can be purchased pre-made for single use, or can be made by the user 
following the instructions in Appendix C of Australian Standard 1410. If the latter, the 
external part of the test (the pack of towels) is reused, whereas, the inner paper with the 
tape cross is a single use item.  The test results will be invalid if the correct materials (as 
specified in this Standard) have not been used. 
 
During use, the test pack must be placed in the center of the chamber, a distance of 100 
mm from the door, and approximately 100mm above the base of the chamber. It is then 
subjected to a standard cycle, bearing in mind that, as mentioned above, the holding time 
must not be more than 3.5 minutes at a temperature of 134 degrees Celsius.  It is important 
that some level of warming up is performed before the Bowie-Dick test run is commenced, 
since the effectiveness of air removal might be influenced by all parts of the sterilizer being 
at the normal working temperature.  If the temperature is below the normal working 
temperature, a satisfactory sterilizer may in fact give a false fail result. 
 
The step-by-step procedure for running a Bowie-Dick test can be described simply as 
follows: 
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1. The Bowie-Dick test is used for the very first cycle of the morning, once the autoclave 
has been warmed to its normal operating temperature.  No other items are loaded into 
the chamber for this test.   
2. The Bowie-Dick test pack can either be made or can be purchased already configured. 
3. The test pack is placed horizontally on to a perforated tray above the chamber drain, at 
least 100 mm from the door.   
4. At the completion of a vacuum cycle, the pack is removed, and the test sheet removed 
from the center of the test pack.  This is unfolded and the colour change on the 
indicator tape on the inside of the pack is compared with than provided by the 
manufacturer.  Where there is an uneven colour change, this indicates problems in air 
removal and steam penetration which must then be further investigated.  The Bowie-
Dick test should show a consistent colour change across all areas of the test pack.  The 





Whenever instruments are packaged, it is essential to determine what autoclave cycle 
parameters are required for successful air removal and steam penetration. This validation of 
the conditions is necessary when there is a change in the type of packaging material used. 
AS4187:2006 also specifies that validation must be repeated annually, even when there has 
been no change in the type or method of instrument packaging.  
 
Validation of cycle parameters involves using multiple biological (spore) tests. For long 
thin pouches, it is necessary to use three biological indicators in each test pack, one placed 
at either end and one in the middle of the pouch.  With larger packs, one indicator should 
be placed in each corner and one in the centre of the pack. The test pack with multiple 
indicators must be prepared in triplicate such that one can be processed on each of three 
consecutive cycles. A tenth indicator is not sterilised, but rather is used as a positive 
control. After the three cycles have been completed, the ten biological indicators 
comprising the nine which have been processed, and the tenth (as a control) are then 
developed and the results recorded.  
 
The test pack with multiple indicators must be prepared in triplicate such that one can be 
processed on each of three consecutive cycles.  A tenth indicator is not sterilised, but rather 
is used as a positive control.  A typical biological indicator used for validation is the Attest 
1261P from 3M Corporation or the 3M Rapid Attest. After the three cycles have been 
completed, the ten biological indicators comprising the nine which have been processed, 
and the tenth (as a control) are then developed and the results recorded.   
 
Where the parameters are appropriate for the removal of air and the penetration of steam, 
then all nine autoclaved indicators should show no colour change, in other words, they 
should indicate complete killing of the spores or deactivation of the spore enzymes as 
appropriate.  If there is a colour change, which signifies a failed test result, the holding time 
for the autoclave should be increased in increments of one or two minutes, and the entire 
validation procedure repeated, in order to establish the minimum time required.  The results 
of the validation process must be recorded.   
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The information should include: 
1. The date of the test 
2. The brand and type of packaging system tested 
3. The type of biological indicator used and the batch number.  It is important to ensure 
prior to the validation process that the biological indicators to be used have not expired. 
4. The location and number of the autoclave (if there are multiple autoclaves in the 
practice) 
5. The name of the operator running the validation tests 
6. The exact parameters which have been validated.   
 
With instruments for routine dentistry which are handled in trays and do not require 
packaging, problems of air removal are minimal. For such loads, validation is not necessary.  
Rather, validation is directed to items required to be sterile at point of use.   
 
Note that for autoclaves, the indicator systems use spores of Geobacillus 
stearothermophilus, while for dry heat, the indicator system uses spores of Bacillus subtilis 
var. globogii. The latter requires rather more specialised equipment for proper incubation 
and development. For more details, see Chapter 9 Endospores. 
 
16.9 Storage of sterile items 
 
Following autoclaving, the sterility of an item is critically dependent upon the conditions of 
its storage.  The shelf life of a packaged item is event related.  Events which can lead to a 
breach in the packaging and therefore contamination of the contents of a pack include the 
following: 
 
1.Over-handling of the pack. e.g. through excessive transferring from one place to another, 
or during rotation of instrument packs.  It is good practice to rotate packaged instruments 
so that those with the latest expiry dates are placed at the rear of the storage drawer or 
cabinet. 
 
2. Moisture contamination of the pack.  If a dry instrument pack is placed on a wet bench 
top, or is wet by splashing of water, other liquids or by aerosols, the pack must be deemed 
to be contaminated and unsterile. The contents cannot be used for a procedure, but must be 
cleaned and resterilized.   
 
3. Penetration.  If during handling any instruments break through the surface of the pack or 
pouch, this breaches the protection of the pack, and the contents must be regarded as 
unsterile.   
 
For the above reasons, it is important that wrapped instruments are stored in a clean dry 
area, and are subjected to minimal handling before use.  Unwrapped instruments (i.e. 
instruments in trays) must be stored in a clean dry dust-free environment, and must be 
separated from any possible contamination from the chairside.  This can be achieved using 
large plastic bins with close fitting lids, which can be placed on to eliminate environmental 
and aerosol based contamination.   
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When an instrument pouch intended for use in a surgical procedure is about to be used, the 
outer wrapping of the package should be checked to make sure there are no holes or tears 
in it.  When the package is opened, the internally located Class 6 indicator should also be 
checked.  If the pouch has a clear plastic side, this check can be done without opening the 
instrument pack.  If there is any doubt that sterility was obtained during processing, the 
items should be considered contaminated and not used during a procedure. 
 
16.10 Sterile procedures 
 
For surgical procedures, there are several principles which are fundamental.  
  
· Items placed within a sterile field should themselves be sterile. 
· If a sterile barrier has become penetrated then the items protected by that barrier cannot 
be regarded as sterile.  
· Gowns which are used should be considered sterile in front but not on the back side. 
· Sterile persons and items should only touch sterile areas. 
· Unsterile persons and items must only touch unsterile areas.   
· Movement of a person or an item around a sterile field must not contaminate that field.  
· In order to protect the sterility of gloved hands, these should be kept within the sterile 
boundary of the gown. 
· As the area under the arm pits is not considered sterile, the arms should never be 
crossed or the hands positioned in the armpits if gloves are being worn. 
 
In the context of the above, it is important to remember that the definition of sterility is the 
state of being free from viable microorganisms.  For an item which has been terminally 
sterilized, the theoretical possibility of there being a viable microorganism present on or in 
the device must be less than one in a million.  This is called the Sterility Assurance Level 
(SAL).   
 
Evidence that a medical device or instrument is sterile comes from the validation process, 
and from information gathered about the cycle parameters from printouts and chemical 
indicators.  This comprehensive approach provides an assurance that all items which are 
used in surgical procedures have been treated to the sterility assurance level.  
 
16.11 Waste Management 
 
Waste which is generated within the clinical setting must be disposed of according to 
national, state and local regulations.  Local regulations are set by the relevant municipal or 
city council.  National guidelines on waste have been prepared by the National Health and 
Medical Research Council and by a consultative industry group of medical waste 
contractors, the Australian and New Zealand Clinical Waste Management Industry Group 
(ANZCWMIG).  Both these documents are based on the principle that waste should be 
categorized.   
 
A variety of containers are used in dental practices for waste disposal. The containers need 
to be suitable for their intended use and the choice of their colour, thickness and quality 
have to meet the relevant standards. They need to be secured to prevent spillages, and 
labelled clearly to indicate the type of waste they are intended for. 
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In general, waste segregation should begin at the point of generation.  It should take place 
as close as possible to where the waste is generated. Waste must remain segregated during 
storage areas and during transport.  Moreover, movement of waste through patient care 
areas should be avoided.  Waste chutes are considered to be an inappropriate means of 
transporting clinical and related wastes as containers or bags may split or be damaged on 
impact. 
 
The recognized categories of waste include the following: 
 
Stream 1. Waste for Recycling: Disposed of via a recycling bin provided by the Local 
Council, or a Council-sponsored recycling service. Items in this category include steel cans, 
aluminium soft drink cans, empty aerosol cans, milk and juice cartons, cardboard (except 
for waxed or glossy cardboard), office paper, photocopy paper, invoices, letterhead, 
newspapers and magazines, folders, envelopes, junk mail, telephone books, and code 1 – 
code 3 recyclable plastics. 
 
Stream 2. General Domestic waste: This includes office items and selected items from the 
dental office which have no patient contact or have saliva contamination, as well as 
extracted teeth. This waste is to be placed within thick walled plastic bags (sealed at the 
end of the day) and placed into the domestic waste bin for disposal to landfill. Included in 
general waste is a range of items, including food scraps, used paper towelling, dental 
plaster, wax and acrylic waste from the dental laboratory, used dental masks, plastic-
backed paper covers, cling film, plastic sheaths used to cover equipment, mixing pads, 
capsules and carpules of used dental materials, used prophy cups, used autoclave pouches 
and paper wraps, residues of impression materials, disposable mixing tips, residues of 
dental restorative materials other than amalgam, and extracted teeth. Extracted teeth must 
not be put in the sharps waste  since this waste is routinely incinerated. The national 
(NH&MRC) guidelines on waste explicitly prohibit the incineration of extracted teeth 
because many of these will contain dental amalgam.  The resulting atmospheric mercury 
emissions are undesirable from an environmental health standpoint. 
 
Stream 3. Chemical waste: This category includes amalgam waste, lead waste, and 
quantities of liquids (fixer and developer) greater than that allowed for disposal to sewer. 
These wastes will be collected by a registered waste contractor, for subsequent recycling or 
disposal. 
 
Stream 4. Sharps waste - which includes not only burs, needles, but other potentially sharp 
objects or devices capable of cutting or penetrating the skin by having acute rigid corners, 
edges, points or protuberances. This includes items such as matrix bands, anaesthetic 
cartridges, endodontic files, orthodontic ligature wires, suture needles, scalpel blades and 
disposable scalpels, glass vials, and broken instruments.  
 
Clinical operators responsible for the generation of sharps must ensure that sharps are 
disposed of immediately following their use. Commercial sharps containers and blade 
containers (such as the Qlicksmart ® scalpel blade removal device) must be positioned 
close to the point of use. Sharps containers must be disposed of when three quarters full, 
and the containers used in dental practices must conform to either Australian standard 
AS4031 or AS 4261, which specify the requirements of non-reusable and reusable sharps 
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containers, respectively.  Containers must be large enough to cope with the volume and 
bulk of disposable sharps used, and not be penetrable by sharp items during normal use. 
Sharps containers must be sealed prior to disposal by high temperature incineration via a 
registered medical waste contractor. 
 
Stream 5. Clinical waste: The principle adopted by NH&MRC in classifying materials as 
clinical waste is  “materials or solutions that contain free flowing or expressible blood and 
other body fluids that are removed during surgery, or autopsy.” The definition excludes 
extracted teeth and portions of gingival tissue. This category includes blood-soaked cotton 
rolls and gauze from oral surgical procedures. This waste is to be placed in yellow thick 
walled plastic bags which are then sealed, and kept in an appropriately labelled yellow 
clinical wastes bin until disposed of (for incineration) by a registered medical waste 
contractor. Plastic bags intended for use of collection of clinical waste should be made of 
material that has sufficient strength to safely contain the waste it is designated to hold.  The 
plastic bags should not be filled to more than two-thirds of their capacity or 6 kg, 
whichever is the lesser. They must be able to be securely sealed.  The bags should conform 
to the colour coding and marking system specified (a yellow colour with a black biohazard 
symbol). Similarly, all containers and plastic bags for clinical waste must be yellow and 
marked with the international biohazard symbol in black, with the wording “Clinical Waste” 
in black. 
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This chapter provides in summary form a listing of key items in practical infection control 
in the dental surgery, to serve as a framework for students and clinical staff in ensuring 
compliance with current infection control practices.  
 
Dentists should draw on national guidelines (such as the NH&MRC/CDNANZ Infection 
Control Guidelines 2004; as well as relevant Australian Standards such as AS4187 and 
AS4815) and the 2008 ADA Inc Infection Control Guidelines when preparing their own 
protocol. It must be remembered that recommendations change with time as new 
information comes to light. 
 
In this document, emphasis is placed on standard precautions (previously termed universal 
precautions).  The detailed requirements for "additional precautions" (required for 
conditions such as active tuberculosis) have not been included in this checklist. 
 
Part 1. Orientation 
 
· There is an induction program for new staff, which includes the practical 
implementation of infection control measures. 
· This written infection control protocol is available for inspection by patients or 
others. 
· In each clinical area, training sessions for dental assistants are held to discuss new 
information, materials and techniques, and to allow practicing of procedures (e.g. 
changeover and instrument transfer). 
 
Part 2: Hygiene in the health care establishment 
 
· Clinical treatment areas are kept clean and free of clutter. 
· Benchtop areas in the clinic outside the contaminated zone are cleaned daily. 
· Both walls and floors are cleaned immediately after spills occur. 
 
Part 3. Immunization 
 
· Staff are encouraged to maintain current vaccination status for hepatitis B, tetanus, 
measles, mumps, rubella, poliomyelitis, diphtheria, tuberculosis, and influenza.  
Boosters are required for tetanus every 10 years, and for influenza each year. 
Hepatitis A vaccination is optional but is encouraged. (Boosters every 5 years for 
Hepatitis B are now no longer required). 
· All new staff who are scheduled for the initial course of hepatitis B immunizations 
undergo pre- an post-immunization tests, and any failures to seroconvert following 
vaccination are followed up. 
· Staff who refuse vaccinations or follow-up tests are counselled regarding the 
implications of this, and complete a signed statement to indicate this has occurred. 
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It is prudent that all staff with clinical contact are immunised to hepatitis B, and have post-
vaccination testing so that non-responders can be alerted to the need for additional boosters 
and also to the need for HBIG if an occupational exposure to HBV occurs. Staff should 
undergo boosters for HBV according to the level of immunity which they show, so their 
antibody levels are above 10 IU/L. 
 
Individual clinicians should consider their individual risk of exposure to HBV, HCV and 
HIV, and seek voluntary testing where appropriate. It is prudent for clinicians to be aware 
of their status for HBV, HCV and HIV by serological testing if they are performing 
exposure-prone procedures. Individuals who are 
· Hepatitis B e antigen or HBV DNA positive, or  
· Hepatitis C antibody and PCR positive, or  
· HIV antibody positive 




Part 4. Medical history questionnaire and confidentiality 
 
· All new patients must complete the standardized comprehensive written medical 
history.  The patient is informed that the information contained therein is 
confidential, and is offered the opportunity to discuss any issue with a supervising 
dentist in private. 
· Medical histories on current patients are updated at recall visits. 
· All staff, including receptionists, must maintain confidentiality of patient details. 
· Personal medical details (and records) are not disclosed to other health care 
practitioners without the patient's permission. 
 
Part 5. Sharps handling and disposal 
 
· Sharps include scalpel blades, suture needles, glass local anaesthetic cartridges, 
glass vials, needles, matrix bands, wedges, burs, endodontic files, orthodontic and 
ligature wires, and broken instruments. 
· Change-over procedures distinguish clearly which sharps are disposable and which 
are reuseable (and therefore must be processed). 
· During clean up, sharps such as burs and orthodontic wires are removed first. 
· Each clinical working area has a sharps container, of an approved type (Australian 
Standard 4031) which is sturdy, puncture proof, able to withstand handling without 
breakage or rupture, and is labelled with a biohazard symbol.  These are located as 
close as possible to the point of use. Smaller sharps containers should be fixed with 
a holder to prevent their tipping over. 
· Sharps containers are closed securely to prevent tampering or access to their 
contents. 
· Sharps are not placed in the regular waste, and are not left in gowns. 
· Sharps containers are disposed of for incineration when three quarters full, and are 
not overfilled.  When filled containers are removed, they are kept away from 
personal traffic and public areas until disposed of. 
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· Sharps handling procedures are practiced and rehearsed as part of ongoing 
education of staff. 
· Syringes and other sharps are handled by only one person at any one time.  A used 
syringe is either recapped or disposed of immediately. 
· Needles are recapped by operators using a single-handed bayonet technique (or a 
resheathing device), but NEVER using a two person or two-hand technique. 
· Scalpel blades are always removed from scalpel handles using a blade removal 
device such as the QLICKSMART, and never by hand or with artery forceps. 
 
Part 6. Sharps injury Protocol 
 
· All sharps injuries are recorded on a government-approved accident reporting form, 
and are followed up with appropriate education by the supervising staff member. 
· Post-injury counselling is undertaken by designated staff. 
· Injured staff are offered follow-up tests after a significant exposure incident, and 
blood samples are obtained from the source (i.e. the patient) wherever practicable.  
These tests include hepatitis B, hepatitis C, and HIV.  Where the source is positive, 
these tests will be repeated at intervals on the injured person to assess the extent of 
seroconversion. 
· All serology results are maintained in a separate confidential file, and not available 
without the written permission of the individual involved.  
 
Part 7. Standard operating procedures: Gloves 
 
· Bulk supplies of gloves are stored in clean dry cool area, and opened boxes of 
gloves are not kept within the contaminated zone. 
· New gloves are worn by both the operator and assistant for each new patient 
· Gloves are worn for all intra-oral clinical procedures. 
· High quality non-sterile latex gloves are worn for most procedures, and sterile 
gloves are worn for surgical procedures. 
· Individuals with proven hypersensitivity to latex (i.e. true delayed hypersensitivity, 
NOT irritant dermatitis) will wear Nitrile or vinyl gloves. 
· Gloves are checked for visible defects immediately upon gloving, and are changed 
during a procedure when visibly torn or punctured. 
· Gloves used in patient care are never washed or re-used. 
· Fresh new gloves are worn by the assistant during surgery set-up for a new patient. 
· During treatment, contact between gloves and incompatible materials (e.g. solvents, 
some impression materials, open flames) is minimized. 
 
Part 8. Standard operating procedures: Handcare 
 
· Taps are operated by elbow controls or foot controls, or using a no-touch 
technique. 
· Hands are washed before leaving the surgery for meal or toilet breaks, and again 
upon return. 
· Rings, watches, bracelets and other items of hand jewellery are removed before 
handwashing, and are never worn beneath gloves. 
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· Nails are scrubbed only once at the beginning of a session (unless required for 
surgical scrub or for reasons of personal hygiene). 
· Any breaks in the skin (cuts, abrasions, etc) are covered with a waterproof barrier 
(tape or spray-on film) before commencing clinical work. 
· A thorough and consistent handwashing technique is used, which includes forearms, 
fingertips, thumbs, knuckles, and intertriginous areas. 
· Liquid soap used for routine handwashing (not bar soap), and anti-microbial liquids 
(such as chlorhexidine) are used for handwashing prior to surgical procedures. 
· Liquid soap or disinfectant dispensers are thoroughly cleaned and dried when 
empty, and not topped up with additional solution. 
· Hands are dried thoroughly before gloving, using disposable paper towel (not 
cloths). 
· Gloves are donned as the last step before treatment commences, and hands are 
washed immediately after glove removal. 
· Routine use of moisturizing cream at end of each treatment session is 
recommended. 
· Nails are kept short, and manicured on a regular basis. 
 
Part 9. Standard operating Procedures: Masks 
 
· The operator must change their mask after every procedure involving aerosols or 
splatter, and ideally after every patient. 
· Masks are adapted well to the face, and cover the nose and mouth completely. 
· The metal insert is adapted to the bridge of the nose, and the mask strings are tied 
firmly (both upper and lower). 
· Masks are not worn under the chin, touched with gloves during treatment, or worn 
outside the treatment zone. 
· Masks are worn beneath full face shields. 
 
Part 10.  Standard operating procedures: Protective Clothing 
 
· Hair is kept short/tied up, or a hair net is used. 
· Protective clothing (gowns, coats) is worn at all times in the clinical treatment areas 
and sterilising room, to cover the body and street wear. 
· Gowns are not worn to work, or worn home after work. 
· Gowns are only worn when performing clinical duties, and are not worn in meals 
rooms or other common areas. 
· Used gowns are transported to the laundry in a bag, and gloves are worn when 
handling them in the surgery. 
· Gowns are changed when visibly soiled. 
· Gowns not wet during handwashing (short or rolled-up sleeves are preferred). 
· An additional waterproof apron may be worn in the sterilising room if there is likely 
to be significant splashes during instrument cleaning. 
 
LJ Walsh : Microbiology 200 
Part 11.  Standard operating procedures: Protective Eyewear 
 
· Eyewear is worn by the operator, assistant, and patient, during all procedures. 
· Eyewear is worn during changeover and instrument cleaning, and at all times in the 
sterilising room. 
· Glasses and attachments (e.g. loupes), and faceshields are cleaned regularly, and 
when visibly soiled. 
· Wherever possible, side protection is incorporated into eyewear. 
 
Part 12. Clean and contaminated zones 
 
· There is a clear demarcation of clean and contaminated zones in the surgery and the 
sterilising room.  The contaminated zone boundaries which must be set up include 
radiography equipment and other ancillary equipment (e.g. curing light, 
amalgamator, ultrasonic scaler, electrosurgery unit, intraoral camera). 
 
· Contaminated instruments and materials are not set down in a clean zone. 
· Reception, office areas and the general work areas of the dental laboratory are 
regarded as clean areas (unless a specific 'barrier laboratory" has been set up). 
· Patient charts, radiographs, clean instruments, instrument packs and bulk supplies 
are kept within the clean zone at all times, while minimal equipment is kept within 
contaminated zone in the surgery (no plants, supplies, computers etc. in this zone). 
· Gloves are removed and hands washed when leaving the contaminated zone 
midway through a procedure, to deal with telephone calls and other interruptions. 
· The extent of contamination during a procedure is minimized by using rubber dam 
where appropriate, or pre-procedural mouthrinses with an antimicrobial agent (such 
as chlorhexidine rinse) before splatter-prone procedures, where feasible. 
· A standard procedure and sequence are followed during clean-up and changeover 
between patients.  Clinical supplies and instruments are obtained before gloving. 
· No eating or smoking occurs within contaminated zones. 
· Procedures are pre-planned so that a defined amount of common items (cotton 
rolls, gauze squares), essential equipment (e.g. turbine handpieces), and the 
required dental materials are dispensed into the working area as part of the set-up. 
 
Part 13.  Equipment 
 
· Items of equipment or stores which are not used frequently are either kept out of 
the treatment areas or kept in cupboards. 
· Evacuator tips, triple syringe tips, and saliva ejector tips are autoclavable or 
disposable. 
· Where feasible, trays are set up so that minimal items of equipment are used, yet so 
that there will rarely arise a need to obtain additional instruments during the 
procedure. 
· Equipment which has broken down is cleaned and disinfected before maintenance 
staff commence work on it. 
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Part 14.  Waterlines 
 
For medically compromised patients, the exit water from dental waterlines should contain 
less than 200 CFU/mL of bacteria. In addition, sterile irrigants must be used for surgical 
procedures. The extent of DUWL biofilm can be assessed by culturing exit water using 
commercially available test kits such as Millipore ® Heterotrophic Plate Counter dip-sticks. 
These estimate the number of free floating aerobic mesophilic heterotrophic bacteria in the 
water. Once a sample is taken, 2-3 days incubation at room temperature is required before 
the plates can be read. 
 
Biofilm levels in dental equipment are minimised by using a range of measures, including: 
· chemical treatment of water with hydrogen peroxide (by continuous instillation and 
by regular purging), or by dosing (e.g. ozonation or A-DEC ICX). 
· preventing aspiration into DUWL during patient treatment by using anti-retraction 
systems 
· not using triple syringe heaters or Venturi units, which encourage biofilm formation 
· flushing DUWL (e.g. triple syringe and handpieces) after each patient (30 seconds) 
· flushing waterlines for 2-3 minutes at the start of the day to reduce overnight or 
weekend biofilm accumulation. This is particularly important after periods of disuse 
(such as the vacations and non-teaching periods). 
· purging DUWL according to the manufacturer’s recommendations 
· Cleaning suction lines daily with an approved disinfectant/cleaner combination, as 
per the manufacturer's instructions. 
 
Part 15.  Handpieces 
 
· Handpieces and ultrasonic scalers are autoclaved between patients. 
· Handpiece surfaces are cleaned thoroughly, and internal aspects are cleaned and 
lubricated prior to autoclaving, according to the manufacturer's instructions, using 
either an aerosol spray or a mechanical lubricating device (such as a W&H 
Assistina). 
· Handpieces are not left in the autoclave overnight, unless a drying cycle is used. 
· Handpieces are run to remove excess lubricant before use on patients. 
· Handpiece are not placed in the treatment area (i.e. fitted to the dental unit) unless 
intended for use on that patient. 
 
Part 16.  Surface Treatment: Barriers and Disinfection 
 
· Touched surfaces are pre-selected to allow for appropriate use of barriers or 
disinfection. 
· Surfaces are treated after all patients and all procedures, and a standard procedure 
and sequence are followed during clean-up and change-over. 
· There is a defined cleaning stage that precedes disinfection.  
· Glutaraldehyde and sodium hypochlorite are never used on surfaces. 
· Disposable paper towels or impregnated wipes are used for surface cleaning (not 
cloths or reuseable wipes). 
· The following surfaces are treated: light handle, bracket table and its handle, suction 
tube and suction tube cradles, cradles for handpieces and triple syringe, hand-
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operated switches, amalgamator, capsule activator, hand-held cosmetic-type 
mirrors, curing light, fiber-optic lights, intraoral cameras and other intra-oral light 
sources. 
· There are defined surface treatments for ancillary items of equipment used in patient 
treatment: e.g. electric pulp tester, electronic root canal measuring equipment, 
electronic anaesthesia equipment, air powder prophylaxis equipment, laser 
equipment. 
· Bulk stores of materials, and trays containing autoclaved instruments and 
handpieces are stored well away from the zone of contamination. 
 
Part 17. Instrument management 
 
· Treatment/procedure trays are pre-planned and set up beforehand. 
· There is a defined flow of instruments in the treatment area. 
· If it is necessary to obtain any items outside the treatment area, either a scout or 
assistant is used, or the assistant or operator degloves, washes their hands, obtains 
the items then regloves with fresh gloves. 
· Staff are informed as to which items are single use and disposable (e.g. prophy 
cups, matrix bands, wedges, needles, anaesthetic cartridges, polishing discs). 
· Endodontic files, reamers and broaches are discarded after use, or if re-used on the 
same patient are tracked using batch numbering. 
· Instrument packs for oral surgery are batch coded to allow tracking. All such 
instrument packs contain chemical indicators (Class 4 – 6; Class 6 preferred). 
 
Part 18.  The sterilising room 
 
· Thorough cleaning and washing of all instruments is undertaken prior to 
sterilization or disinfection. 
· Dental assistants working in the sterilising area wear full personal protective 
equipment. 
· Utility gloves are worn during instrument processing stages prior to sterilization, 
and these same contaminated gloves are NEVER used to unload the sterilizers at 
the end of a cycle. 
· Utility gloves are checked frequently for leaks and defects 
· Heat-proof gloves or appropriate carrying instruments are used when unloading the 
autoclave or dry heat sterilizer, and these are kept within the clean zone. 
 
Part 19.  Instrument cleaning 
 
· There is a clearly designated flow of instruments through each stage, with one-way 
traffic of instruments around the sterilising area. 
· Instruments are placed in a holding solution (containing detergent) if not cleaned 
immediately.  Items are disassembled where possible prior to cleaning. 
· High temperature washers or ultrasonic cleaners used for the routine cleaning of 
instruments, rather than hand scrubbing. 
· Handpieces, powered scalers and other items which cannot be cleaned safely or 
efficiently by high temperature washers or ultrasonic cleaners are cleaned either by 
hand or using purpose-built equipment. 
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· Cassettes or trays are used where possible to minimize the risk of sharps injuries to 
staff during instrument processing. 
· After cleaning, instruments are inspected carefully under good lighting prior to 
further processing. 
· The ultrasonic cleaner is not operated with the lid off at any time. 
· The efficacy of ultrasonic cleaner is checked each day using the 10 second 
aluminium foil perforation test. 
· The solution in ultrasonic cleaner is changed on a regular basis (at least daily) and 
when visibly cloudy. 
· Utility gloves are worn or a "no touch" technique used when placing instruments in 
or removing instruments from the high temperature washer or ultrasonic cleaner. 
· There are defined areas for lubricating handpieces, and for wrapping and bagging 
instruments. 
 
Part 20.  Autoclaves 
 
· Autoclaves are not overpacked with instruments or cassettes. 
· Water levels are checked daily, and the water replaced weekly, to prevent build-up 
of lubricants and residues. Note that some newer autoclaves have single use water 
systems). 
· Autoclaves are calibrated 6 monthly and a log is kept of servicing and calibration 
for each individual autoclave. 
· Chemical/process (colour change) indicators are run on the outside of all instrument 
packs, and the packs marked with the batch number, date of processing, the type of 
contents, and the autoclave number. Packs for oral surgery should have a Class 4, 5 
or 6 chemical indicator inside the pack. 
· Physical indicators (gauges, displays and printouts) are checked for signs of 
malfunction of the autoclave. 
· Autoclave bags are not re-used. 
· A drying cycle is used for bagged instruments. 
· Upon removal from the autoclave, bagged instruments are not placed onto wet 
surfaces. 
· Residues in the chamber are cleaned away weekly as necessary using the method 
prescribed by the manufacturer, using a non-abrasive nylon scouring pad. 
· Pre-vacuum autoclaves have daily air leak and class 2 chemical indicator tests 
(Helix or Bowie-Dick) run at the start of the day before the first clinical load. 
· A log book is maintained which records each cycle for each autoclave: 
1. Batch number 
2. Date 
3. Autoclave Number 
4. Type of load 
5. Cycle parameters 
6. Satisfactory completion (e.g. from printout and chemical indicators) 
7. Identification of the person who entered this data 
· Biological indicator tests are run annually to validate cycle parameters, and written 
records kept of the results, as per AS4815. 
· Spore tests when used for validation are used from a cold start and are placed on 
the innermost part of a typical load (cold spot). 
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· Spore tests are used within their expiry date. 
· Unused spore tests are kept in a cool dry place away from heat or radiation. 
· Spore tests are run when: packaging materials or technique are changed; after 
servicing or repairs; and as part of the training of new staff in autoclave operation. 
· Any user-programmable cycles (time, temperature) which vary from established 
standards have been verified (validated) using spore tests. 
· Packages of sterile items are stored away from areas where splashing may occur. 
· Packages of sterile instruments are checked for integrity before use. 
 
Part 21.  Dry heat sterilizers 
 
· Items which can be autoclaved are processed in this manner, rather than by dry heat 
sterilization. 
· Cycles are not interrupted during use. 
· The chamber is not overfilled. 
· Calibration of the thermocouple is checked during annual servicing, and a log kept 
of servicing and calibration.  The operating instructions are kept close to the 
equipment. 
· Bagged items are marked with the date. 
· Bagged items include a class 3 chemical indicator strip. 
· Packages are never re-used. 
· The chamber is kept clean. 
 
Part 22.  Waste 
 
· Staff handling waste wear utility gloves and protective clothing. 
· Staff are aware of the management of spills, including those from: 
1. Clinical waste containers 
2. the suction system and its attachments 
3. containers holding pathology specimens 
4. amalgam waste. 
 
The protocol for cleaning up spills of blood and body fluids includes 
1. immediate attention given to the spill situation 
2. absorbent material to soak up liquids 
3. use of detergent to clean the area 
4. Note that application of sodium hypochlorite to the spill area for disinfection 
is NOT required. 
 
· Instruments and materials are not left in clinical gowns. 
· There is segregation of waste into several streams 
1. Non-contaminated, recyclable items, such as paper and cardboard 
2. Non-contaminated general waste, such as handwashing paper towels 
3. Clinical waste - in yellow bags in yellow bins. 
4. Sharps - in sharps containers. 
5. Amalgam waste 
 
· Waste amalgam, developer, and fixer are dealt with via recycling programmes. 
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· Waste receptacles designed to minimize contamination (e.g. chutes, knee-
operated bins). 
· Waste receptacles are emptied on a regular basis and not over-filled. 
· Gloves are worn when handling pathology specimens, and these specimens are 
packaged appropriately to prevent leaks during transport. 
· Appropriate biohazard labelling is placed on pathology containers before 
dispatch. 
 
Part 23.  Radiography 
 
· There are defined areas for touching radiography equipment: these are fitted with a 
disposable barrier or are cleaned and disinfected after use. 
· Gloves and other aspects of personal protective equipment are worn when placing 
intraoral film . 
· To prevent contamination of film processing equipment, either film envelopes or 
cling wrap are used.  Alternatively, plastic-enveloped films are disinfected with 
5.25% sodium hypochlorite for 30 seconds and then washed. 
· Benchtop processors and darkrooms are designated as part of the clean zone. 
 
Part 24. Dental Laboratory 
 
· There is a well documented potential for cross contamination with bacteria and 
viruses to occur from the oral cavity to the dental laboratory via impressions.  While 
the principal potential route of transmission to dental laboratory personnel is via 
saliva and blood on infected impressions, transfer of pathogenic agents via other 
surfaces and materials can also occur. 
 
· Clinical areas will be considered "unclean" from an infection control viewpoint.  All 
materials which have come in contact with patient fluids shall be regarded as 
contaminated. 
 
· It is the responsibility of the clinician involved to ensure that decontamination of all 
patient materials is performed at the chairside prior to their transport to the 
laboratory. To further decrease the possibility of cross infection, it is essential that 
very high standards of cleanliness and tidiness be all personnel working in the 
laboratory. These measures will ensure that a prosthesis or appliance can be 
processed in the laboratory without the need to disinfect or sterilize laboratory 
instruments and materials following each use. 
 
· A further measure of protection against cross infection contamination is gained by 
disinfecting materials exiting from the laboratory.  This overcomes potential 
problems relating to inadvertent contamination during processing of laboratory 
work.  Thus, all items of work are disinfected prior to leaving the laboratory. 
 
· The general areas of the laboratory are defined as clean areas. 
 
· Contamination of equipment and materials in the laboratories will be prevented by 
ensuring that decontamination of ALL patient materials Impressions, appliances, 
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prostheses, etc.) are cleaned and disinfected at the chairside prior to transport to the 
laboratory. 
 
· Impression disinfection involves rinsing in running waterm, applyoing detergent, 
then further rinsing. Note that the additional use of 0.525% sodium hypochlorite 
(e.g.for 2 minutes minimum, 5 minutes typical, 10 minutes maximum) is no loner 
regarded as necessary for effective disinfection.  
 
· Aseptic techniques are used when loading impression trays in the clinic. 
· A high level of personal hygiene is maintained in the laboratory. 
· Eating and smoking are not permitted in the laboratory. 
· After use, stainless steel impression trays will be cleaned and autoclaved between 
patients. 
· Impression materials shall be dispensed by chairside assistants from bulk supplies 
maintained in the sterilising room.  Premeasured unit quantities of impression 
materials (e.g. alginate powder) shall be provided for clinical use.  Measuring 
spoons used to dispense materials are to remain "clean" so as to prevent 
contamination of these bulk supplies. 
 
· Adjustments to dentures and appliances (removal of high spots, etc) will be 
completed in clinical areas either using burs fitted to autoclavable low speed straight 
handpieces, or using appropriate mobile workstations or barrier laboratories. 
 
· Dentures and appliances shall cleaned and then decontaminated before being 
transported to the laboratory for final polishing.  The decontamination protocol 
shall involve thorough rinsing and mechanical cleaning with detergent followed by 
final rinsing in water.  
 
· Wax rims, try-ins and bite records shall be decontaminated by rinsing and detergent 
as detailed above for impressions. 
 
· Care must be taken to prevent contamination of articulators and casts.  If this 
occurs, these are to be thoroughly decontaminated using detergent prior to their 
leaving the clinical area. 
 
· When dispensing materials in the clinic, the unit-dose concept will be applied to 
waxes, pastes, impression materials, compound, petroleum jelly, indelible pencils 
and other items. 
 
· Willis gauges, dividers, pliers, mixing spatulas, articulating paper holders, occlusal 
plane guides, shade guides, mould guides, prosthetic rulers and other items not 
suitable for autoclaving will be decontaminated using the spray/wipe method with 
detergent after each use. 
 
· Wax knives, Le Cron carvers, standard dental instruments (mirrors, probes etc.) and 
straight handpieces will be autoclaved after use. 
 
LJ Walsh : Microbiology 207 
· Mouth preparation procedures which involve intraoral use of handpieces will be 
subject to standard infection control protocols, including autoclaving of handpieces 
after use. 
 
· Indelible marking pencils will be cut into short pieces to permit their being 
discarded after single use. 
 
Protective wear in the dental laboratory 
 
· Wearing of appropriate personal protective equipment is mandatory for personnel in 
both laboratory and clinical areas. 
 
· Gowns worn in clinical areas must not be worn in the laboratory.  Dedicated 
laboratory coats are to be worn for personal protection.   
 
· Protective glasses must be worn in both clinical and laboratory areas to prevent eye 
injuries. 
 
· Disposable "sharps" such as scalpel blades and trimming blades shall be identified 
and placed in an appropriate "sharps" container within the laboratory. 
 
· Because of their frequent contact with clinical materials, hepatitis B immunization 
for dental technicians is essential. 
 
· Bench surfaces should be cleaned and then wiped down before use to remove any 
surface contamination.  Because of the risks of fire, alcohol sprays should not be 
used. 
 
LJ Walsh : Microbiology 208 






· Samaranayake LP. Essential microbiology for dentistry. 2nd edition. Churchill Livingstone. 2002.  
· Seymour GJ, Savage NW, Walsh LJ. Immunology: An introduction for the health sciences. 




· Block SS. Disinfection, sterilization and preservation. 4th edition. Philadelphia, Lea & Febiger. 1991.  
· Brunette DM. Critical thinking: understanding and evaluating dental research. 2nd edition, Chicago, 
Quintessence. 2007. 
· Chin J. Control of communicable diseases manual. Washington, American Public Health Association, 
2000. 
· Koneman EW, Allen SD, Janda WM, Schrekenberger PC, Winn WC. Color atlas and textbook of 
diagnostic microbiology. 5th Edition. Philadelphia, Lippincott, 1997. 
· Lee G, Bishop P. Microbiology and infection control for health professionals. Sydney: Prentice Hall. 
1997. 
· Lim D. Microbiology. 2nd edition. Boston: McGraw Hill. 1998. Mims C, Playfair JH, Roitt I, Wakelin 
D, Williams D. Medical microbiology. 2nd edition. London:Mosby. 1999. 
· Madigan MT, Martinko JM. Biology of microorganisms. 11th edition. Upper Saddle River NY, Pearson 
Orentice Hall, 2006. 
· Miller CH, Palenik CJ. Infection control and management of hazardous materials for the dental team. 
3rd edition. St Louis: Elsevier Mosby, 2005. 
· Oral and dental expert group. Therapeutic Guidelines: oral and dental. Melbourne, Therapeutics 
Guidelines Ltd, 2007. 
· Volk WA, Gebhardt BM, Hammarskjold ML, Kadner RJ. Essentials of medical microbiology. 5th 
edition. Philadelphia, Lippincott-Raven. 1995. 
· Infection control in oral health.  CD-ROM, Queensland Health / Ice-T Multimedia, 1998. 




From other authors 
 
· Brook I. et al. Aerobic and anaerobic microbiology of the periapical abscess.  Oral Microbiology 
and Immunology. 1991;6:123-125. 
· Chen HA, et al. Immunodominant antigens of Porphyromonas gingivalis in subjects with rapidly 
progressive periodontitis. Oral Microbiology and Immunology 1995;10:193-201. 
· Currie WJ, Ho V. An unexpected death associated with an acute dentoalveolar abscess- report of a 
case. British Journal of Oral and Maxillofacial Surgery 1993;31: 296-298. 
· Fejerskov O. 1995. Strategies in the design of preventive programs. Advances in Dental Research. 
1995;9:82-88. 
· Heimdahl A, et al. The oral cavity as a port of entry for early infections in patients treated with 
bone marrow transplantation. Oral Surgery Oral Medicine Oral Pathology 1989;68:711-716. 
· Krasse B. From the art of filling teeth to the science of dental caries prevention: a personal review. 
Journal of Public Health Dentistry 1996;56:271-277. 
· Luoma H. Chlorhexidine solutions, gels and varnishes in caries prevention. Proceedings of the 
Finnish Dental Society. 1992;88:147-153. 
· Marshall MV, et al. Hydrogen peroxide: a review of its use in dentistry. Journal of 
Periodontology. 1995;66:786-796. 
LJ Walsh : Microbiology 209 
· Nair P, et al.  Intraradicular bacteria and fungi in root-filled, asymptomatic human teeth with 
therapy resistant periapical lesions: A long-term light and electron microscopic follow-up study.  
Journal of Endodontics. 1992;16:580-595 
· Pankhurst CL et al.  Microbial contamination of dental unit waterlines: the scientific argument.  
International Dental Journal 1998;48:359-368. 
 
 
Selected publications by LJ Walsh 
 
Immunology and Immunopathology 
 
· Seymour GJ, Savage NW, WALSH LJ. Immunology: An introduction for the health sciences. 
Sydney: McGraw Hill. 1995. ISBN 0-07-452810-6. 
· Savage NW, WALSH LJ. Dermatopathology of the oral mucosa. In Dermatopathology – a 
practical guide to common disorders, Ed. Murphy GF. Philadelphia: W.B. Saunders. 1995. ISBN 
0721624189 pp. 421-444.  
· Savage NW, WALSH LJ. Dermatopathology of the oral mucosa. In Atlas of Dermatopathology.  
Ed. Murphy GF, Herzberg AJ. Philadelphia: W.B. Saunders. 1996. ISBN 072164886X. Chapter 
23. pp. 421-444.  
· WALSH LJ, Seymour GJ, Bird PS, Powell RN. Modulation of HLA-DR antigens in the gingival 
epithelium in vitro by heat-killed Fusobacterium nucleatum and E. coli lipopolysaccharide. 
Journal of Oral Pathology 14,833-843. 1985. 
· WALSH LJ, Lavker RM, Murphy GF. Determinants of immune cell trafficking in the skin. 
Laboratory Investigation 63,592-600. 1990. 
· WALSH LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells 
contain and release tumor necrosis factor-alpha which induces endothelial leukocyte adhesion 
molecule-1. Proceedings of the National Academy of the Sciences USA 88,4220-4224. 1991. 
· Waldorf HA, WALSH LJ, Schechter NM, Murphy GF. Early cellular events during evolving 
cutaneous delayed hypersensitivity in humans. American Journal of Pathology 138,477-486. 1991. 
· WALSH LJ, Murphy GF. The role of adhesion molecules in cutaneous inflammation and 
neoplasia. Journal of Cutaneous Pathology 19,161-171. 1992. 
· WALSH LJ, Davis MF, Xu LJ, Savage NW. Relationship between mast cell degranulation and 
inflammation in the oral cavity. Journal of Oral Pathology and Medicine. 26, 266-272. 1995. 
· WALSH LJ, Anasthanas-Platsis S, Savage NW. Reconstitution of cutaneous neural - 
immunological networks following bone marrow transplantation. Transplantation  61, 413-417. 
1996. 
· Pujic Z, Savage NW, Bartold PM, WALSH LJ. Identification of neural-immune interactions by 
triple labelling immunohistochemistry. Advanced Immunohistochemistry 6(3): 150-153, 1998.  
· Egan COL, Viglione-Schneck MJ, WALSH LJ, Green B, Trohanowski JQ, Whitaker-Menezes D, 
Murphy GF.  Characterization of unmyelinated axons uniting epidermal and dermal immune cells 
in primate and murine skin.  Journal of Cutaneous Pathology 25:20-29, 1998. 
· Pujic Z, Savage NW, Bartold PM, WALSH LJ. The neural-immune network of nerve fibers, mast 
cells and Langerhans cells in human gingiva. Periodontology 23(1):16-21 
· WALSH LJ. Mast cells and oral inflammation. Critical Reviews in Oral Biology & Medicine 
14(3): 188-198. 2003.  
 
LJ Walsh : Microbiology 210 
Caries microbiology and risk assessment 
 
· WALSH LJ. The preventive management of extensive caries induced by self-administered 
medications. Clinical Preventive Dentistry 11,17-20. 1989. 
· WALSH LJ, Gan A. Proximal root surface caries in an Australian periodontal population. 
Periodontology 12,33-36. 1991. 
· Chang HS, WALSH LJ, Freer TJ. Enamel decalcification during orthodontic treatment - aetiology 
and prevention. Australian Dental Journal.  42: 322-327, 1997 
· Chang HS, WALSH LJ, Freer TJ. Effect of orthodontic treatment on salivary flow, pH, buffer 
capacity, and levels of mutans streptococci and lactobacilli. Australian Orthodontic Journal. 
15(4), 229-234, 1999. 
· WALSH LJ. Preventive Dentistry. (Book with CD-ROM). Brisbane: Knowledge Books and 
Software. 2001. ISBN: 1875219978 
· WALSH LJ. Lifestyle impacts on oral health. In: Mount GJ and Hume WR. Preservation and 
restoration of teeth, 2nd edition. Brisbane, Knowledge Books and Software. 2005. pp. 83-109. 
ISBN: 192082474X. 
· WALSH LJ. Preventive dentistry for the general dental practitioner. (Invited review). Australian 
Dental Journal. 45(2): 76-82. 2000. 
· WALSH LJ. Plaque formation and oral diseases. Dental Prosthetists Journal. 6(1): 12-13. 
· WALSH LJ. Anti-cariogenic actions of milk and cheese products, and their clinical application. 
ADA News Bulletin. 278: 17-20. 
· WALSH LJ. Fifteen strategies for caries prevention: Towards target zero. DA News Bulletin. 2000. 
279: 5-8. 
· Wan ALK, Seow WK, WALSH LJ, Bird P, Tudehope DI, Purdie DM. Association of 
Streptococcus mutans infection and oral developmental nodules in pre-dentate infants. Journal of 
Dental Research 80: 194501948, 2001. 
· WALSH LJ. Salivary dysfunction: management approaches for the dry mouth patient. Hygiene 
Today. 11(1): 4-7. 2001. 
· Wan AKL, Seow WK, Purdie DM, Bird PS, WALSH LJ, Tudehope DI. Oral colonization of 
Streptococcus mutans in six-month-old pre-dentate infants. Journal of Dental Research 80(12): 
2060-2065, 2001. 
· Wan AKL, Seow WK, WALSH LJ, Bird PS. Comparisons of five selective media for the growth 
and enumeration of Streptococcus mutans. Australian Dental Journal. 47(1): 21-26. 2002. 
· Wan AK, Seow WK, Purdie DM, Bird PS, WALSH LJ, Tudehope DI. A longitudinal study of 
Streptococcus mutans colonization in infants after tooth eruption. Journal of Dental Research 
82(7):504-508. 2003. 
· Wan AK, Seow WK, Purdie DM, Bird PS, WALSH LJ, Tudehope DI. Immunoglobulins in saliva 
of preterm and full-term infants. Oral Microbiology and Immunology 18(2):72-78. 2003. 
· Wan AK, Seow WK, Purdie DM, Bird PS, WALSH LJ, Tudehope DI.  The effects of 
chlorhexidine gel on Streptococcus mutans infection in 10-month-old infants: a longitudinal, 
placebo-controlled, double-blind trial.  Pediatric Dentistry 2003;25(3):215-22. 
· WALSH LJ. In-Office fluoride products: current concepts for maximal effectiveness. Australasian 
Dental Practice 2006;17(4):76-78. 
· WALSH LJ.  Oral health care issues for patients with special needs.  Dental Auxiliary 
2006;16(4):12-13. 
· Coulter C, WALSH LJ.  Saliva testing good practice, good sense.  New Zealand Dental 
Association News 2006;129:32-35. 
LJ Walsh : Microbiology 211 
· Brostek AM, Bochenek AJ, WALSH LJ.  Minimally invasive dentistry: A review and update. 
Shanghai Journal of Stomatology 2006; 15(3):225-249. 
· WALSH LJ.  Pit and fissure sealants: current evidence and concepts. Australasian Dental Practice 
2006;17(6):122-124. 
· WALSH LJ.  Home care self-applied fluoride products: current concepts for maximal 
effectiveness. Hygiene Today 2007(May):14-16. 
· WALSH LJ.  Clinical aspects of salivary biology for the dental clinician.  International Dentistry 
(Australasian Edition). 2007;2(3):16-30. 
· WALSH LJ. Clinical applications of Recaldent products: which ones to use where. Australasian 
Dental Practice 2007;18(3):144-146. 
· WALSH LJ. Clinical applications of saliva testing in dental practice. Dental Outlook 
2007;110(1):33-40. 
· Vlacic J, Meyers IA, Kim J, WALSH LJ.  Laser-activated fluoride treatment of enamel against an 
artificial caries challenge: comparison of five wavelengths. Australian Dental Journal 
2007;52(2):101-105. 
· Vlacic J, Meyers IA,  WALSH LJ.  Laser-activated fluoride treatment of enamel as prevention 
against erosion. Australian Dental Journal 2007;52(3):175-180. 
· WALSH LJ. Maximum interception: things to try before you drill. Australasian Dental Practice 
2007;18(5):90-98. 
· WALSH LJ, Mubarak S, McQuillan A. Autopilot laser-based systems for guiding caries and 
calculus removal: from concept to clinical reality. Australasian Dental Practice 2007;18(5):122-
128. 
· WALSH LJ.  Dry mouth: a clinical problem for children and young adults.  International 
Dentistry Australasian Edition 2007;2(4):12-20. 
· Vlacic J, Meyers IA, WALSH LJ. Combined CPP-ACP and photoactivated disinfection (PAD) 
therapy in arresting root surface caries: a case report. British Dental Journal. 2007;203:457-459. 
· WALSH LJ, Shakibaie F. Ultraviolet-induced fluorescence: shedding new light on dental biofilms 
and dental caries. Australasian Dental Practice 2007; 19(6). 
· WALSH LJ. Application of the System for Total environmental Management (STEM) to 
dysmineralization, dental erosion and toothwear. Australasian Dental Practice 2008; 19(1): 52-
58. 
· Vlacic J, Meyers IA, WALSH LJ. Photonic Conversion of Hydroxyapapite to fluorapatite: A 
Possible Mechanism for Laser-Activated Fluoride Therapy. Journal of Oral Laser Applications 
2008, in press. 
· WALSH LJ. A System for Total Environmental Management (STEM) of the oral cavity, and its 
application to dental caries control. International Dentistry 2008, in press. 
· WALSH LJ, Tsang AKL. Chairside testing for cariogenic bacteria: current concepts and clinical 




· Clarke DF, WALSH LJ. The effect of smoking on the periodontium. Periodontology 10,30-33. 
1989. 
· WALSH LJ, Stritzel F, Yamazaki K, Bird PS, Gemmell E, Seymour GJ. Interleukin-1 and 
Interleukin-1 inhibitor production by human adherent cells stimulated with periodontopathic 
bacteria. Archives of Oral Biology 34,679-683. 1989. 
· Seymour GJ, Gemmell E, WALSH LJ, Powell RN. Immunohistological analysis of experimental 
gingivitis in humans. Clinical and Experimental Immunology 71,132-137. 1988.  
LJ Walsh : Microbiology 212 
· Wynne SE, WALSH LJ, Seymour GJ. Specialized post-capillary venules in human gingival tissue. 
Journal of Periodontology 59,328-331. 1988.  
· Gemmell E, WALSH LJ, Savage NW, Seymour GJ. Adhesion molecule expression in chronic 
inflammatory periodontal disease tissue. Journal of Periodontal Research 29,46-53. 1993. 
· Verdickt GM, WALSH LJ. Expression of immunoglobulin gene superfamily adhesion molecules 
in experimental gingivitis. Periodontology 14,45-51. 1993. 
· Pietrzak ER, Savage NW, Xu LJ, WALSH LJ. Differential reactivity of anti-E-selectin monoclonal 
antibodies in human gingival tissue. Journal of Periodontal Research. 30, 375-381. 1995. 
· Pietrzak ER, Savage NW, WALSH LJ. Human gingival keratinocytes express E-selectin (CD62E). 
Oral Diseases 2, 11-17. 1996. 
· Pietrzak ER, Savage NW, Aldred MJ, WALSH LJ. Expression of the E-selectin gene in human 
gingival epithelium. Journal of Oral Pathology and Medicine. 25:320-324, 1996. 
· Gemmell E, Bird PS, Bowman J, Xu LJ, Polak B, WALSH LJ, Seymour GJ. Immunohistological 
study of lesions induced by Porphyromonas gingivalis in a murine model. Oral Microbiology and 
Immunology. 12: 288-297, 1997. 
· Pietrzak ER, Polak B, WALSH LJ, Savage NW, Seymour GJ. Characterization of serum 
antibodies to Porphyromonas gingivalis in individuals with and without periodontitis. Oral 
Microbiology and Immunology. 13,65-75. 1998. 
· PM Bartold, LJ WALSH, AS Narayan Molecular and cell biology of the gingiva. Periodontology 
2000. 24: 28-55. 2000. 
· Patni R, WALSH LJ, Marshall RI, Cullininan MP, Bartold PM. Changes in the periodontal status 
of patients undergoing bone marrow transplantation. Journal of Periodontology. 71(3): 394-402. 
2000. 
· Pattni R, WALSH LJ, Marshall RI, Seymour GJ, Bartold PM.  Periodontal manifestations of 
immunodeficient states: Manifestations and management.  Journal of the International Academy 
of Periodontology. 2: 79-93. 2000. 
· Wan AKL, Seow WK, Tudehope DI, Purdie D, WALSH LJ. Associations between maternal 
periodontal health and prematurity of newborns – a cross-sectional study of an Australian group. 
Periodontology 23(2): 40-49. 
· WALSH LJ.  New concepts of dental plaque.  Australian Dental Practice 2005;16(6):60-61. 
· WALSH LJ. On the nose – new diagnostic and treatment approaches for oral malodour. 
Australasian Dental Practice 2006;17(4):60-62. 
· WALSH LJ.  Periodontal-systemic health interactions: challenging the boundaries of dental 
medicine.  Australasian Dental Practice 2006;17(6):50-51. 
· WALSH LJ.  Periodontal diagnosis: more than meets the eye. Australasian Dental Practice 
2007;18(1):56-57. 
· WALSH LJ.  Implant hygiene: clues, caveats and cautions. Australasian Dental Practice 
2007;18(2):54-55. 
· WALSH LJ.  Taking the hard line on soft tissue management.  International Dentistry 
2007;9(5):4. 
· WALSH LJ. The problems of furcations: what lies beneath. Auxiliary 2008; 19(2): 28-30.  
· WALSH LJ. Exploiting sound and the piezoelectric effect for real time calculus detection: 
PerioScan and the transducer concept. Australasian Dental Practice 2008; 19(3): in press. 
 
LJ Walsh : Microbiology 213 
Endodontic microbiology 
 
· Davis MF, Savage NW, WALSH LJ. Lymphocyte homing in periapical lesions. Australian 
Endodontic Newsletter 22, 29-30. 1996. 
· Gentner MR, Savage NW, WALSH LJ. Modulation of dental pulp adhesion molecule expression 
in vitro. Australian Endodontic Newsletter 22,32-34. 1996. 
· WALSH LJ. Serious complications of endodontic infections: some cautionary tales. Australian 
Dental Journal.  42: 302-306, 1997. 
· Thomas GJ, WALSH LJ. Role of substance P in inflammation in dental pulp. Australian 
Endodontic  Newsletter 23(3): 38-40, 1997. 
· WALSH LJ.  Photoactivated disinfection (PAD) and endodontics.  Australasian Dental Practice 
2003;14(5):88. 
· WALSH LJ.  Germ warfare in the dental surgery.  Australasian Dental Practice 2003;14(5):22. 
· Lee MT, Bird PS, WALSH LJ.  Photo-activated disinfection of the root canal: a new role for lasers 
in endodontics.  Australian Endodontic Journal 2004;30(3):93-98. 
· Athanassiadis B, Abbott PV, WALSH LJ.  The use of calcium hydroixide, antibiotics and biocides 
as antimicrobial medicaments in endodontics. Australian Dental Journal 2007;52(1 Suppl):S64-
S82. 
· WALSH LJ, Athanassiadis B. Endodontic aesthetic iatrodontics. Australasian Dental Practice 
2007;18(3):62-64. 
· WALSH LJ, Athanassiadis B. The challenge of endodontic “superbugs” in clinical practice. 
Australasian Dental Practice, 2008; 19(3): in press. 
 
Biocides and disinfectants 
 
· WALSH LJ. Anti-plaque enzyme systems: their use in preventive periodontics. Periodontology 
5,14-20. 1984. 
· Grant PB, WALSH LJ. Problems and adverse effects associated with the use of chlorhexidine in 
dental practice. Periodontology 6,33-38. 1985. 
· WALSH LJ, Longstaff J. The antimicrobial effects of an essential oil on selected oral pathogens. 
Periodontology 8,11-15. 1987. 
· WALSH LJ.  The role of natural and synthetic phenolic compounds in home oral health care. 
Australasian Dental Practice 2004;6:22-25. 
· WALSH LJ.  The role of natural and synthetic phenolic compounds. Periodontology 
2006;24(1):7-16. 
· WALSH LJ.  Chlorhexidine and its role in chemical plaque control. Australasian Dental Practice 
2006;17(6):60-62. 





· WALSH LJ, Tuffley M, Young WG. An unusual dental presentation of catscratch disease. 
Australian Dental Journal 30,29-32. 1985. 
· WALSH LJ, Hill G, Seymour GJ, Roberts A. A scoring system for the quantitative evaluation of 
oral changes during bone marrow transplantation. Special Care in Dentistry 10,190-195. 1990. 
· WALSH LJ, Cleveland DB, Cumming CG. Quantitative evaluation of Langerhans cells in median 
rhomboid glossitis. Journal of Oral Pathology and Medicine 21,28-32. 1992. 
LJ Walsh : Microbiology 214 
· WALSH LJ. Preventive dentistry for the medically compromised patient. Dentistry Today 8,1-7. 
1992. 
· Quirk PC, Osborne PJ, WALSH LJ. Efficacy of antifungal prophylaxis in bone marrow 
transplantation. Australian Dental Journal 40, 267-270. 1995. 
· Sawyer HE, Smith ASA, WALSH LJ. Acute gingival pathology following bone marrow 
transplantation.  Periodontology  18: 39-45, 1997. 
· Coates EA, WALSH LJ, Logan R. The increasing problem of hepatitis C virus infection. 
Australian Dental Journal. 46(1): 13-17. 2001. 
 
Personal protective equipment 
 
· Lange P, WALSH LJ, Savage NW. An assessment of the permeability of dental protective gloves. 
Australian Dental Journal 38,309-315. 1993. 
· WALSH LJ, Lange P, Savage NW. Problems encountered with the wearing of protective gloves in 
general dental practice. Quintessence International 26, 203-209. 1995. 
· Lange P, Savage NW, WALSH LJ. Utilisation of personal protective equipment in general dental 
practice. Australian Dental Journal. 41, 164-168. 1996. 
· McDonald RI, Savage NW, WALSH LJ. Analysis of workplace injuries in dentistry.   Australian 
Dental Journal. 42(2): 109-113, 1997. 
· WALSH LJ. Prevention and management of natural latex allergy in dental practice. Chapter A2, 
in: The Practical Guides, 7th edition. Australian Dental Association Inc, Sydney, 2006. 
· Coates L, WALSH LJ. Risk-reduction in the dental surgery. ADA News Bulletin. 273: 7-9, 1999. 
· WALSH LJ. Risk reduction for dental unit biofilms. ADA News Bulletin. 283: 30-32. 2000. 
· WALSH LJ.  Sharps injuries in dental practice: getting the point.  Australasian Dental Practice 
2006;17(1);70&72. 
· WALSH LJ.  Itchy and scratchy: the problem of irritant dermatitis. Australasian Dental Practice 
2006;17(2):70&72. 
· WALSH LJ.  Disinfection of dental unit water with ozone. Australasian Dental Practice 
2006;17(3):68&70. 
· WALSH LJ. Waste management issues for dental amalgam.  ADA News Bulletin 2006;345:12-19. 
· WALSH LJ.  Legionellosis – an unseen hazard from dental unit waterline biofilms. Australasian 
Dental Practice 2007;18(1):6062. 
 
Instrument recirculation, autoclaves and sterilization 
 
· Savage NW, WALSH LJ. The use of autoclaves in the dental surgery. Australian Dental Journal. 
1995; 40: 197-200. 
· WALSH LJ. Enzyme-based validation of steam sterilisation. ADA News Bulletin. 271:18-19, 1999. 
· WALSH LJ.  Designing the dental practice environment for optimal infection control. 
Australasian Dental Practice 2007;18(1):132-134. 
· WALSH LJ. Operation and testing of pre-vacuum autoclaves. ADA News Bulletin. 2002; 306:32-
35. 
· WALSH LJ. Infection control: Autoclave water. ADA News Bulletin 2004;323:19. 
· WALSH LJ. Infection control: Instrument tracking. ADA News Bulletin 2004; 322:12-14. 
· WALSH LJ. Infection control: handpiece lubrication.  ADA News Bulletin 2007;359:50-51. 
 
LJ Walsh : Microbiology 215 
19. LEARNING OBJECTIVES IN MICROBIOLOGY 
 




· The varying nature of infectious agents 
· The range of techniques used for diagnostic microbiology 
· The varying growth requirements of bacterial species in the oral cavity 
· The principles of disease transmission in the oral cavity and the dental environment 
· The ecological determinants of the oral flora  
· The protective immune response to infective agents, including the role of both humoral 
and cellular aspects of the immune system 
· The principles and application of vaccination 




· The role of bacteria in the aetiology of diseases of the oral cavity 
· The management of dental infections using microbiological principles 
· The use of salivary diagnostics and caries activity tests in clinical patient care 
· The differing mechanisms of disease causation with bacteria, fungi, viruses and prions 
· Principles of instrument recirculation 
· The mechanisms of operation and limitations of commonly used sterilisation methods 




· The formation of biofilms, including dental plaque 
· The role of oral bacteria in systemic diseases such as infective endocarditis 
· Protocols for antibiotic cover 
· The role and selection of disinfectants in clinical dentistry 
· The mechanism of action of common classes of antimicrobial agents 
· The clinical manifestations of infections of the oral cavity 
· Oral lesions associated with immune suppressed states such as AIDS 
· Pathways of the spread of infection involving inanimate surfaces in the dental surgery 
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20. MICROBIOLOGY REVIEW QUESTIONS 
 
 
1. What are the prospects for a vaccine for: 
· Hepatitis C? 
· HIV? 
 
2. Microbiologically, what is the difference between adult periodontitis and a 
periodontal abscess? 
 
3. How does antibiotic resistance develop? 
 
4. How do you treat erythematous candidosis? 
 
5. Why are some patients susceptible to aggressive periodontitis? 
 
6. What organisms would you suspect in a long term (3+ months) refractory 
endodontic lesion, with a draining sinus? 
 
7. What are the limitations of Chlorhexidine as a disinfectant? 
 
8. How do you control biofilm in your own dental practice? 
 
9. Why shouldn’t glutaraldehyde be used for surface disinfection? 
 
10. What are the problems with decntaminating impressions? 
 
11. How can dental unit biofilm be controlled? 
 
12. What might happen if Chlorhexidine handwash containers are topped up after use? 
 
13. How do you select an antibiotic for treating: 
 - an endodontic abscess 
 - a periodontal abscess 
 
14. How do you approach the situation of a failed spore test from an autoclave ? 
 
15. Should HCW (health care workers) be tested regularly for bloodborne infections? 
 
16. Is the test for HIV always correct? 
 
17. What diagnostic bacterial tests for caries are available? 
 
18. How do you determine is a patient needs antibiotic cover? 
 
19. How do you recognize and treat ANUG? 
 
20. What oral flora changes occur with a high acid diet? 
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21. What microbial factors lead to failure of endodontic treatment? 
 
22. Are spore forming bacteria normally found in the mouth? 
 
23. How do we acquire the oral flora? 
 
24. What are the phases of bacterial growth? 
 
25. How do you take a specimen for microscopy/culture/sensitivity (MCS) tests? 
 
26. What are possible side effects of: 
 -  amoxycillin 
 -  metronidazole 
 -  tetracyclines 
 
27. What factors make dentoalveolar infections more likely to spread to distant sites? 
 
28. What precautions do you take for a patient with: 
 -  active TB 
 -  proven CJD 
 
29. How is hepatitis C transmitted? 
 
30. Why is there no vaccine for Hepatitis D? 
 
31. What are some side effects of anti-retroviral treatment or prophylaxis for HIV? 
 
32. How does an ELISA test work? 
 
33. How are bacteria identified in the laboratory? 
 
34. How might the laboratory identify Candida albicans?  Is it normal to find this 
fungus in the mouth? 
 
35. How would you test a lesion for the presence of viruses? 
 
36. Why do antibiotics sometimes not work? 
 
37. Why do some patients seem more susceptible to common infections? 
 
38. How does immunization work?  
 
39. What are some members of the mutans streptococci family? 
 
40. What are the preferred growth conditions for: 
 -  mutans streptococci 
 -  lactobacilli 
 
41. Why is HIV not transmitted by saliva? 
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42. How do antibiotics protect against: 
 -  viral infection 
 -  bacterial infection 
 
43. How do bacteraemias occur?  How often ? 
 
44. What are some ways that infection might be transmitted in a dental surgery? 
 
45. What are the differences between affected and infected carious dentine? 
 
46. Why is Chlorhexidine useful in caries management? 
 
47. How can infective endocarditis be prevented (other than by antibiotic cover)? 
 
47. What infections may occur if you irrigate an extraction site with water from the 
triple syringe? 
 
49. Does hand washing with a pre-surgical scrub make your hands sterile? 
 
50. How is MRSA transmitted? 
 
51. What are the systemic effects of LPS? 
 
52. What is IL-1 gene polymorphism and why is this important? 
 
53. What conditions have an associated neutrophil defect? 
 
54. Where do the bacteria in endodontic infections come from? 
 
55. What is pericoronitis, and how is it managed? 
 
56. What are prion diseases? 
 
57. Is it feasible to cure a patient of HSV?  What about Hepatitis C? 
 
58. In a patient with infra orbital swelling with malaise and pyrexia, which teeth do you 
suspect? 
 
59. What is Ludwig’s angina and how is it managed? 
 
60. What is microbial succession, and what is the relevance of this to the cancer 
patient? 
 
61. What are the predisposing factors for oral fungal infection? 
 
62. What is an endospore? 
 
63. Why is the incidence of tuberculosis increasing? 
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64. Why is the tubercle bacillus difficult to kill with disinfectants? 
 
65. What viral infections can be transmitted by saliva? 
 
66. How might a virus cause cancer? Give an example. 
 
67. How common is it to find papilloma virus in the oral tissues? 
 
68. What is the likelihood of: 
 -  fatal HBV infection? 
 -  transmission of HIV from a needlestick injury? 
 -  developing chronic carrier state from HCV? 
 
69. What are the side effects of a Hepatitis B booster? 
 
70. How does HIV evade the immune response? 
 
71. What is the HIV seroconversion illness? 
 
72. What oral lesions might suggest HIV infection? 
 
73. How should matrix bands and burs be disposed of after use? 
 
74. Are viruses present in dental unit waterline biofilms? 
 
75. How is Legionnaire’s disease transmitted? 
 What are the risk groups for this disease? 
 
76. Why can’t disposable latex gloves be washed and re-used? 
 
77. What is the difference between domestic and hospital grade disinfectants? 
 
78. What active ingredients are in: 
 -  Listerine 
 -  Cepacol 
 -  Miltons 
 
79. What are reactive oxygen species and why are they important? 
 
80. What inactivates Chlorhexidine? 
 
81. What are the disadvantages of autoclaving instruments? 
 
82. What is the foil test for an ultrasonic cleaner? 
 
83. How long does a bagged item remain sterile? 
 
84. Why should recycled autoclave water be changed regularly? 
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85. Why are autoclaves subjected to regular calibration? 
 
86. Why won’t regular autoclaving inactivate prions? 
 
87. How is dental lab work disinfected? 
 
88. Should all dental practice waste be incinerated? 
 
89. What infection control measures do you use for intra-oral Xrays? 
 
90. For how long does a dental mask work? 
 
91. What are the properties of the ideal disinfectant? 
 
92. How is tuberculosis transmitted? 
 
93. Why should handpieces be autoclaved? 
 
94. How can smoking affect the oral flora? 
 
95. Why are there increased levels of Streptococci mutans in orthodontic patients? 
 
96. Where do we acquire Streptococci mutans from? 
 
97. What are some physical sterilizing methods other than autoclaving? 
 
98. When should staff have HBV boosters? 
 
99. Why shouldn’t infected HCW perform exposure prone procedures? 
 
100. Can either HCV or HBV be transmitted by saliva alone (with no blood)? 
 
 
 
 
 
